評 估 與 依 據

指南與文獻庫

本站的每一條事實都標明出處。這裡是全站 1860 條出處的總目錄,按國家標準與規範、指南與專家共識、研究論文、圖書、網頁與公開記錄分組,年份從新到舊;每條註明被哪些頁面引用,可點到原文。

國家標準與規範71

  1. 孤獨症兒童康復機構服務質量及評價規範(GB/T 47041—2026)[S]. 國家市場監督管理總局, 國家標準化管理委員會, 2026. (訪問於 2026-09-30).引用於:應用行為分析(ABA)、自然發展行為干預(NDBI)
  2. 國家疾病預防控制局, 國家衛生健康委員會. 關於印發國家免疫規劃疫苗兒童免疫程序及說明(2026 年版)的通知(國疾控衛免發〔2026〕16 號)[S]. 國家疾病預防控制局, 2026. (訪問於 2026-10-07). 2026 年 6 月 17 日印發,正文為通知所附文件。引用於:22q11.2 缺失綜合徵
  3. 國家衛生健康委員會. 86 個罕見病病種診療指南(2025 年版)[S]. 國家衛生健康委員會, 2025. (訪問於 2026-09-10). 對應第二批罕見病目錄的 86 種病,Rett 綜合徵為第 72 章。引用於:Rett 綜合徵、West 綜合徵、脆性 X 綜合徵、神經纖維瘤病、CDKL5 缺乏症、異染性腦白質營養不良、軟骨發育不全、原發性生長激素缺乏症、兒童罕見病、罕見病政策與保障、發育倒退、語言發育遲緩、癲癇發作、頭圍增長異常、手部刻板動作、腦性癱瘓的鑑別與病因評估:何時需要進一步檢查、孤獨症譜系障礙的鑑別與病因評估、全面發育遲緩:病因評估與後續管理、神經發育障礙與癲癇性腦病、術語表
  4. 國家醫療保障局、人力資源社會保障部. 國家基本醫療保險、生育保險和工傷保險藥品目錄(2025 年)[S]. 國家醫療保障局, 2025. (訪問於 2026-09-12). 2026 年 1 月 1 日起執行。引用於:脊髓性肌萎縮症、尼曼匹克病、肝豆狀核變性、多巴反應性肌張力障礙、Lennox-Gastaut 綜合徵、罕見病政策與保障
  5. 國家醫療保障局, 人力資源社會保障部. 關於印發《國家基本醫療保險、生育保險和工傷保險藥品目錄》以及《商業健康保險創新藥品目錄》(2025 年)的通知(醫保發〔2025〕33 號)[S]. 國家醫療保障局, 2025. (訪問於 2026-09-11). 新版目錄自 2026 年 1 月 1 日起執行;《商業健康保險創新藥品目錄》第 2 項為鹽酸沙丙蝶呤片,有效期 2026 年 1 月 1 日至 2027 年 12 月 31 日。引用於:四氫生物蝶呤缺乏症
  6. 中國殘聯, 民政部, 國家衛生健康委. 關於印發《殘疾人基本康復服務目錄(2025 年版)》的通知[S]. 中國殘疾人聯合會, 2025. (訪問於 2026-10-02).引用於:姿勢管理與體位擺放、認知能力訓練、日常生活活動能力訓練、康復與干預方法
  7. National Institute for Health and Care Excellence. Epilepsies in children, young people and adults(NICE guideline NG217)[S]. NICE, 2025. (訪問於 2026-10-07).引用於:結節性硬化症、West 綜合徵、嬰兒嚴重肌陣攣性癲癇
  8. National Institute for Health and Care Excellence. Ganaxolone for treating seizures caused by CDKL5 deficiency disorder in people 2 years and over(TA1033)[S]. NICE, 2025. (訪問於 2026-09-10).引用於:CDKL5 缺乏症
  9. 宜昌人福藥業有限責任公司. 2024 年國家醫保藥品目錄調整申報材料(公示版):氯巴佔片[S]. 國家醫療保障局, 2024. (訪問於 2026-09-12). 載明說明書適應證、中國大陸首次上市時間與批准文號。引用於:Lennox-Gastaut 綜合徵
  10. 北京市殘疾人聯合會, 北京市民政局, 北京市市場監督管理局. 北京市殘疾兒童康復服務定點機構協議管理辦法(試行)[S]. 首都之窗 政策文件, 2024. (訪問於 2026-10-08).
  11. 北京市殘疾人聯合會. 北京市殘疾兒童康復服務定點機構准入標準[S]. 北京市殘疾人聯合會網站 政策法規—康復, 2024. (訪問於 2026-10-08).
  12. 北京市醫療保障局. 北京市醫療保障局關於調整物理、康復治療醫保報銷政策的通知[S]. 北京市醫療保障局網站 政策文件, 2024. (訪問於 2026-10-08).
  13. 中國殘聯, 教育部, 民政部, 等. 孤獨症兒童關愛促進行動實施方案(2024—2028 年)[S]. 中國殘疾人聯合會, 2024. (訪問於 2026-09-30).引用於:應用行為分析(ABA)、家長介導干預
  14. 國家醫療保障局. 康復類醫療服務價格項目立項指南(試行)[S]. 國家醫療保障局, 2024. (訪問於 2026-10-02).引用於:姿勢管理與體位擺放、認知能力訓練、日常生活活動能力訓練、物理因子治療、康復與干預方法
  15. 國家衛生健康委辦公廳. 嬰幼兒早期發展服務指南(試行)(國衛辦婦幼函〔2024〕467 號)[S]. 中國政府網, 2024. (訪問於 2026-10-02).引用於:養育照護
  16. 人力資源社會保障部辦公廳, 中國殘疾人聯合會辦公廳. 關於頒佈聽覺口語師國家職業標準的通知[S]. 中國殘疾人聯合會, 2024. (訪問於 2026-09-30).引用於:構音與語音訓練、康復與干預方法
  17. 國家衛生健康委辦公廳. 康復治療專業人員培訓大綱(2023 年版)(國衛辦醫政函〔2023〕386 號)[S]. 中國政府網, 2023. (訪問於 2026-10-02).引用於:姿勢管理與體位擺放、認知能力訓練、日常生活活動能力訓練、物理因子治療、康復與干預方法
  18. 國家衛生健康委員會, 科學技術部, 工業和信息化部, 國家藥品監督管理局, 國家中醫藥管理局, 中央軍委後勤保障部衛生局. 關於公佈第二批罕見病目錄的通知(國衛醫政發〔2023〕26 號)[S]. 中華人民共和國工業和信息化部, 2023. (訪問於 2026-09-10). 收錄 86 種罕見病。引用於:Rett 綜合徵、West 綜合徵、脆性 X 綜合徵、神經纖維瘤病、CDKL5 缺乏症、異染性腦白質營養不良、軟骨發育不全、原發性生長激素缺乏症、DYRK1A 綜合徵、Kabuki 綜合徵、Cornelia de Lange 綜合徵、Sotos 綜合徵、21 三體綜合徵、22q11.2 缺失綜合徵、Phelan-McDermid 綜合徵、Smith-Magenis 綜合徵、貓叫綜合徵、CHARGE 綜合徵、SYNGAP1 相關智力障礙、ADNP 綜合徵、CHD8 相關神經發育障礙、PTEN 錯構瘤腫瘤綜合徵、MECP2 重複綜合徵、15q11.2-q13.1 重複綜合徵、Potocki-Lupski 綜合徵、Pitt-Hopkins 綜合徵、Mowat-Wilson 綜合徵、KBG 綜合徵、Coffin-Siris 綜合徵、Koolen-de Vries 綜合徵、7q11.23 重複綜合徵、Kleefstra 綜合徵、Rubinstein-Taybi 綜合徵、Smith-Lemli-Opitz 綜合徵、腦肌酸缺乏綜合徵、GLUT1 缺乏綜合徵、神經元蠟樣脂褐質沉積症、四氫生物蝶呤缺乏症、X-連鎖腎上腺腦白質營養不良、線粒體腦肌病、尼曼匹克病、神經節苷脂貯積症、戊二酸血症Ⅰ型、楓糖尿症、生物素酶缺乏症、同型半胱氨酸血症、肝豆狀核變性、多巴反應性肌張力障礙、Lennox-Gastaut 綜合徵、非綜合徵型耳聾、1p36 缺失綜合徵、Wolf-Hirschhorn 綜合徵、Joubert 綜合徵、無腦回畸形、FOXG1 綜合徵、STXBP1 相關發育性癲癇性腦病、CTNNB1 相關神經發育障礙、SATB2 相關障礙、鳥氨酸氨甲酰基轉移酶缺乏症、瓜氨酸血症、精氨酸酶缺乏症、丙酸血症、異戊酸血症、半乳糖血症、原發性肉鹼缺乏症、戈謝病、全身型重症肌無力、低鹼性磷酸酶血症、馬凡綜合徵、面肩肱型肌營養不良症、先天性肌營養不良(膠原Ⅵ相關肌病)、慢性炎性脫髓鞘性多發性神經根神經病、Pelizaeus-Merzbacher 病、亞歷山大病、Canavan 病、Zellweger 譜系障礙、Menkes 病、Aicardi-Goutières 綜合徵、L1 綜合徵、共濟失調毛細血管擴張症、KCNQ2 相關障礙、進行性骨化性纖維發育不良、Dandy-Walker 畸形、Sturge-Weber 綜合徵、多小腦回、Bardet-Biedl 綜合徵、Leber 先天性黑矇、早產兒視網膜病變、芳香族 L-氨基酸脫羧酶缺乏症、胱氨酸貯積症、發作性睡病、Christianson 綜合徵、Alagille 綜合徵、早老症、Krabbe 病、PMM2-CDG、吡哆醇依賴性癲癇、Lesch-Nyhan 綜合徵、非酮性高甘氨酸血症、3-甲基巴豆酰輔酶 A 羧化酶缺乏症、先天性肌病、先天性多發性關節攣縮、嬰兒神經軸索營養不良、泛酸激酶相關神經變性、兒童交替性偏癱、白質消融性白質腦病、SCN2A 相關疾病、Landau-Kleffner 綜合徵、Wiedemann-Steiner 綜合徵、Costello 綜合徵、心-面-皮膚綜合徵、煙霧病、Beckwith-Wiedemann 綜合徵、PIK3CA 相關過度生長綜合徵、新生兒持續肺動脈高壓、綜合徵性顱縫早閉、Ehlers-Danlos 綜合徵、Pierre Robin 序列徵、萊倫氏綜合徵、假性甲狀旁腺功能減退症、視隔發育不良、Usher 綜合徵、Waardenburg 綜合徵、兒童罕見病、罕見病政策與保障、術語表
  19. 廣東省教育廳, 中共廣東省委機構編制委員會辦公室, 廣東省發展和改革委員會, 等. 關於加強殘疾兒童少年義務教育階段隨班就讀工作的實施細則(粵教〔2023〕17 號)[S]. 廣東省人民政府門戶網站, 2023. (訪問於 2026-10-02).引用於:日常生活活動能力訓練
  20. Fresenius Kabi Austria GmbH. Lactulose 10 g / 15 ml oral solution sachets - Summary of Product Characteristics (SmPC)[S]. electronic medicines compendium (emc), 2023. (訪問於 2026-10-07). 乳果糖口服溶液在英國的產品說明書,emc 上最近一次更新在 2023 年 10 月 26 日。引用於:遺傳性果糖不耐受症
  21. United Nations Children’s Fund. The Early Childhood Development Index 2030: A new measure of early childhood development[S]. UNICEF, 2023. (訪問於 2026-09-10). 24–59 月齡人群指標,20 條照護者報告題,服務於可持續發展目標指標 4.2.1引用於:寶秀蘭兒童神經發育綜合評估系統
  22. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).引用於:孤獨症譜系障礙(自閉症)、兒童發育與行為評估、行為矯正訓練、語言發育遲緩、手部刻板動作、孤獨症譜系障礙的鑑別與病因評估、應用行為分析(ABA)、自然發展行為干預(NDBI)、回合式教學(DTT)、關鍵反應訓練(PRT)、早期介入丹佛模式(ESDM)、語言行為與 VB-MAPP、問題行為的功能評估與正向行為支持(PBS)、家長介導干預、地板時光(DIR)、結構化教學(TEACCH)、社交技能小組訓練、社交故事、遊戲治療與沙盤遊戲、家長行為管理培訓(PMT)、孤獨症(自閉症)的干預方法、康復與干預方法、評估量表一覽、術語表
  23. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).引用於:兒童注意力不集中、餵養困難與兒童營養諮詢、家庭育兒指導課程、養育照護、日常生活活動能力訓練、術語表
  24. 國家衛生健康委. 7 歲以下兒童生長標準 WS/T 423—2022[S]. 中華人民共和國衛生行業標準, 2022. (訪問於 2026-09-07).引用於:餵養困難與兒童營養諮詢、餵養困難、頭圍增長異常、身材矮小、全面發育遲緩:病因評估與後續管理、骨骼與結締組織、內分泌與生長、0~1 歲神經運動 20 項檢查、評估量表一覽、術語表
  25. 中國營養學會. 中國嬰幼兒餵養指南(2022)[S]. 中國營養學會, 2022. (訪問於 2026-09-07).引用於:餵養困難與兒童營養諮詢、小兒推拿、餵養困難
  26. 北京市殘疾人聯合會, 北京市財政局, 北京市衛生健康委員會, 北京市醫療保障局. 北京市殘疾兒童康復服務辦法[S]. 北京市人民政府, 2022. (訪問於 2026-09-10). 以持有殘疾人證或指定醫療機構的診斷評估報告為條件,未按病因分列。引用於:罕見病政策與保障
  27. 國家市場監督管理總局, 國家標準化管理委員會. 中醫技術操作規範 兒科 第 4 部分:小兒推拿療法 GB/Z 40893.4—2021[S]. 國家標準化指導性技術文件, 2021. (訪問於 2026-09-07).引用於:高危兒與早產兒早期干預、兒童腦癱康復、全面發育遲緩、餵養困難與兒童營養諮詢、小兒推拿、嬰兒撫觸與被動操、小兒推拿、術語表
  28. 北京市殘疾人聯合會, 北京市民政局. 北京市殘疾兒童康復服務定點機構准入標準[S]. 北京市人民政府門戶網站, 2021. (訪問於 2026-10-02). 《關於做好民辦殘疾兒童康復機構評估認定工作的通知》(京殘發〔2021〕24 號)附件 2。引用於:認知能力訓練、日常生活活動能力訓練
  29. 國家衛生健康委. 健康兒童行動提升計劃(2021—2025 年)(國衛婦幼發〔2021〕33 號)[S]. 中國政府網, 2021. (訪問於 2026-10-08).引用於:家庭育兒指導課程、養育照護、康復與干預方法
  30. 人力資源社會保障部. 國家職業資格目錄(2021 年版)[S]. 人力資源社會保障部, 2021. (訪問於 2026-09-30).引用於:強制性誘導運動療法與雙手強化訓練(CIMT)、減重步行與跑臺訓練、懸吊訓練(SET)、應用行為分析(ABA)、回合式教學(DTT)、早期介入丹佛模式(ESDM)、語言行為與 VB-MAPP、問題行為的功能評估與正向行為支持(PBS)
  31. 國家衛生健康委辦公廳. 關於印發 0~6 歲兒童眼保健及視力檢查服務規範(試行)的通知(國衛辦婦幼發〔2021〕11 號)[S]. 中國政府網, 2021. (訪問於 2026-10-07). 0~6 歲共 13 次眼保健和視力檢查;出生體重低於 2000 g 或出生孕周小於 32 周列為眼病高危因素。引用於:早產兒視網膜病變
  32. 國家醫療保障局, 人力資源社會保障部. 關於印發《國家基本醫療保險、工傷保險和生育保險藥品目錄(2021 年)》的通知(醫保發〔2021〕50 號)[S]. 國家醫療保障局, 2021. (訪問於 2026-09-10). 2021 年 11 月 24 日印發,自 2022 年 1 月 1 日起執行。引用於:脊髓性肌萎縮症、罕見病政策與保障
  33. 教育部. 教育部關於加強殘疾兒童少年義務教育階段隨班就讀工作的指導意見[S]. 中國政府網, 2020. (訪問於 2026-09-30).引用於:社交技能小組訓練、社交故事、康復與干預方法
  34. 國家衛生健康委辦公廳. 精神障礙診療規範(2020 年版)(國衛辦醫函〔2020〕945 號)[S]. 國家衛生健康委, 2020. (訪問於 2026-10-02). 全文見國家心理健康和精神衛生防治中心網站。引用於:認知能力訓練、日常生活活動能力訓練、康復與干預方法
  35. 北京市殘疾人聯合會. 關於印發《北京市殘疾兒童康復服務辦法實施細則》的通知[S]. 北京市殘疾人聯合會網站 政策法規—康復, 2020. (訪問於 2026-10-08).
  36. U.S. Food and Drug Administration. HETLIOZ(tasimelteon)· Drugs@FDA 藥品檔案(申請號 205677)[S]. 美國食品藥品監督管理局, 2020. (訪問於 2026-09-10). 2020 年 12 月 1 日批准補充適應證:Smith-Magenis 綜合徵相關的夜間睡眠紊亂。引用於:Smith-Magenis 綜合徵
  37. 西安楊森製藥有限公司. 麥格司他膠囊(澤維可)說明書[S]. 西安楊森製藥有限公司, 2019. (訪問於 2026-09-12). 核准日期 2016 年 11 月 23 日,修改日期 2019 年 4 月 11 日。引用於:尼曼匹克病
  38. 北京市殘疾人聯合會, 北京市教育委員會, 北京市財政局, 北京市民政局, 北京市衛生健康委員會. 關於印發《北京市殘疾兒童康復服務辦法》的通知[S]. 首都之窗(北京市人民政府門戶網站)政策文件, 2019. (訪問於 2026-10-08).
  39. 中國殘聯, 民政部, 國家衛生健康委, 等. 關於印發《殘疾人基本康復服務目錄(2019 年版)》的通知[S]. 中國殘疾人聯合會, 2019. (訪問於 2026-10-02).引用於:姿勢管理與體位擺放、認知能力訓練
  40. 國家衛生健康委員會辦公廳. 關於印發罕見病診療指南(2019 年版)的通知(國衛辦醫函〔2019〕198 號)[S]. 國家衛生健康委員會, 2019. (訪問於 2026-09-10). 對應第一批目錄的 121 種病,由北京協和醫院牽頭編寫。引用於:脊髓性肌萎縮症、杜氏肌營養不良、腓骨肌萎縮症、肌強直性營養不良、先天性肌無力綜合徵、遺傳性痙攣性截癱、結節性硬化症、嬰兒嚴重肌陣攣性癲癇、Angelman 綜合徵、Prader-Willi 綜合徵、威廉姆斯綜合徵、Noonan 綜合徵、Silver-Russell 綜合徵、苯丙酮尿症、糖原累積病Ⅱ型、黏多糖貯積症、甲基丙二酸血症、成骨不全症、低磷性佝僂病、21-羥化酶缺乏症、四氫生物蝶呤缺乏症、X-連鎖腎上腺腦白質營養不良、線粒體腦肌病、尼曼匹克病、神經節苷脂貯積症、戊二酸血症Ⅰ型、楓糖尿症、生物素酶缺乏症、同型半胱氨酸血症、肝豆狀核變性、多巴反應性肌張力障礙、非綜合徵型耳聾、鳥氨酸氨甲酰基轉移酶缺乏症、瓜氨酸血症、精氨酸酶缺乏症、丙酸血症、異戊酸血症、半乳糖血症、原發性肉鹼缺乏症、戈謝病、全身型重症肌無力、低鹼性磷酸酶血症、馬凡綜合徵、糖原累積病Ⅰ型、遺傳性果糖不耐受症、全羧化酶合成酶缺乏症、多種酰基輔酶 A 脫氫酶缺乏症、長鏈 3-羥酰基輔酶 A 脫氫酶缺乏症、β-酮硫解酶缺乏症、賴氨酸尿蛋白不耐受症、3-甲基巴豆酰輔酶 A 羧化酶缺乏症、肢帶型肌營養不良、DYT-TOR1A 肌張力障礙、McCune-Albright 綜合徵、萊倫氏綜合徵、新生兒糖尿病、Waardenburg 綜合徵、兒童罕見病、罕見病政策與保障、急性代謝危象、視覺行為異常、其他系統與多系統受累
  41. 國務院辦公廳. 關於促進 3 歲以下嬰幼兒照護服務發展的指導意見(國辦發〔2019〕15 號)[S]. 中國政府網, 2019. (訪問於 2026-09-07).引用於:家庭育兒指導課程
  42. 國家衛生健康委員會辦公廳. 關於建立全國罕見病診療協作網的通知(國衛辦醫函〔2019〕157 號)[S]. 中國政府網, 2019. (訪問於 2026-09-10). 首批 324 家醫院:國家級牽頭醫院 1 家(北京協和醫院)、省級牽頭醫院 32 家、成員醫院 291 家;北京市共 15 家,其中成員醫院 13 家。引用於:脊髓性肌萎縮症、杜氏肌營養不良、腓骨肌萎縮症、肌強直性營養不良、先天性肌無力綜合徵、遺傳性痙攣性截癱、Rett 綜合徵、結節性硬化症、West 綜合徵、嬰兒嚴重肌陣攣性癲癇、脆性 X 綜合徵、神經纖維瘤病、CDKL5 缺乏症、Angelman 綜合徵、Prader-Willi 綜合徵、威廉姆斯綜合徵、Noonan 綜合徵、Silver-Russell 綜合徵、苯丙酮尿症、糖原累積病Ⅱ型、黏多糖貯積症、甲基丙二酸血症、異染性腦白質營養不良、成骨不全症、軟骨發育不全、低磷性佝僂病、21-羥化酶缺乏症、原發性生長激素缺乏症、DYRK1A 綜合徵、Kabuki 綜合徵、Cornelia de Lange 綜合徵、Sotos 綜合徵、21 三體綜合徵、22q11.2 缺失綜合徵、Phelan-McDermid 綜合徵、Smith-Magenis 綜合徵、貓叫綜合徵、CHARGE 綜合徵、SYNGAP1 相關智力障礙、ADNP 綜合徵、CHD8 相關神經發育障礙、PTEN 錯構瘤腫瘤綜合徵、MECP2 重複綜合徵、15q11.2-q13.1 重複綜合徵、Potocki-Lupski 綜合徵、Pitt-Hopkins 綜合徵、Mowat-Wilson 綜合徵、KBG 綜合徵、Coffin-Siris 綜合徵、Koolen-de Vries 綜合徵、7q11.23 重複綜合徵、Kleefstra 綜合徵、Rubinstein-Taybi 綜合徵、Smith-Lemli-Opitz 綜合徵、腦肌酸缺乏綜合徵、GLUT1 缺乏綜合徵、神經元蠟樣脂褐質沉積症、四氫生物蝶呤缺乏症、X-連鎖腎上腺腦白質營養不良、線粒體腦肌病、尼曼匹克病、神經節苷脂貯積症、戊二酸血症Ⅰ型、楓糖尿症、生物素酶缺乏症、同型半胱氨酸血症、肝豆狀核變性、多巴反應性肌張力障礙、Lennox-Gastaut 綜合徵、非綜合徵型耳聾、1p36 缺失綜合徵、Wolf-Hirschhorn 綜合徵、Joubert 綜合徵、無腦回畸形、FOXG1 綜合徵、STXBP1 相關發育性癲癇性腦病、CTNNB1 相關神經發育障礙、SATB2 相關障礙、鳥氨酸氨甲酰基轉移酶缺乏症、瓜氨酸血症、精氨酸酶缺乏症、丙酸血症、異戊酸血症、半乳糖血症、原發性肉鹼缺乏症、戈謝病、全身型重症肌無力、低鹼性磷酸酶血症、馬凡綜合徵、面肩肱型肌營養不良症、先天性肌營養不良(膠原Ⅵ相關肌病)、慢性炎性脫髓鞘性多發性神經根神經病、Pelizaeus-Merzbacher 病、亞歷山大病、Canavan 病、Zellweger 譜系障礙、Menkes 病、Aicardi-Goutières 綜合徵、L1 綜合徵、共濟失調毛細血管擴張症、KCNQ2 相關障礙、進行性骨化性纖維發育不良、Dandy-Walker 畸形、Sturge-Weber 綜合徵、多小腦回、Bardet-Biedl 綜合徵、Leber 先天性黑矇、早產兒視網膜病變、中鏈酰基輔酶 A 脫氫酶缺乏症、極長鏈酰基輔酶 A 脫氫酶缺乏症、HHH 綜合徵、原發性酪氨酸血症、芳香族 L-氨基酸脫羧酶缺乏症、法佈雷病、胱氨酸貯積症、眼皮膚白化病、視網膜色素變性、脊髓小腦性共濟失調、發作性睡病、Christianson 綜合徵、自身免疫性腦炎、先天性脊柱側凸、先天性高胰島素性低血糖血症、先天性肌強直、血友病、遺傳性大皰性表皮鬆解症、Alagille 綜合徵、早老症、糖原累積病Ⅰ型、遺傳性果糖不耐受症、全羧化酶合成酶缺乏症、多種酰基輔酶 A 脫氫酶缺乏症、長鏈 3-羥酰基輔酶 A 脫氫酶缺乏症、β-酮硫解酶缺乏症、賴氨酸尿蛋白不耐受症、Krabbe 病、PMM2-CDG、吡哆醇依賴性癲癇、Lesch-Nyhan 綜合徵、非酮性高甘氨酸血症、3-甲基巴豆酰輔酶 A 羧化酶缺乏症、肢帶型肌營養不良、先天性肌病、先天性多發性關節攣縮、嬰兒神經軸索營養不良、泛酸激酶相關神經變性、DYT-TOR1A 肌張力障礙、兒童交替性偏癱、白質消融性白質腦病、SCN2A 相關疾病、Landau-Kleffner 綜合徵、Wiedemann-Steiner 綜合徵、Costello 綜合徵、心-面-皮膚綜合徵、煙霧病、Beckwith-Wiedemann 綜合徵、PIK3CA 相關過度生長綜合徵、新生兒持續肺動脈高壓、綜合徵性顱縫早閉、Ehlers-Danlos 綜合徵、Pierre Robin 序列徵、McCune-Albright 綜合徵、萊倫氏綜合徵、假性甲狀旁腺功能減退症、新生兒糖尿病、視隔發育不良、Usher 綜合徵、Waardenburg 綜合徵、兒童罕見病、罕見病政策與保障
  43. 全國人民代表大會常務委員會. 中華人民共和國精神衛生法(2018 年修正)[S]. 中國政府網, 2018. (訪問於 2026-09-07).引用於:注意缺陷多動障礙(多動症)、術語表
  44. 北京市衛生和計劃生育委員會, 北京市殘疾人聯合會, 北京市財政局. 北京市衛生和計劃生育委員會 北京市殘疾人聯合會 北京市財政局關於開展 0-6歲兒童殘疾篩查工作的通知[S]. 北京市衛生健康委員會網站 政策文件, 2018. (訪問於 2026-10-08).
  45. 北京市衛生和計劃生育委員會. 北京市衛生和計劃生育委員會關於落實《早產兒保健工作規範》的通知[S]. 北京市衛生健康委員會網站, 2018. (訪問於 2026-10-08).
  46. 國務院. 國務院關於建立殘疾兒童康復救助制度的意見(國發〔2018〕20 號)[S]. 中國政府網, 2018. (訪問於 2026-09-30).引用於:減重步行與跑臺訓練
  47. 湖南省殘疾人聯合會, 湖南省衛生和計劃生育委員會. 湖南省殘疾人證管理辦法實施細則[S]. 岳陽市君山區人民政府網站(地方政府轉發文件附件 2), 2018. (訪問於 2026-10-17). 附件裡載有全國統一的《中華人民共和國殘疾評定表》與申請表樣式;只用於說明評定表的欄目與省級細則的寫法,不代表北京的規定。
  48. 國家衛生健康委員會, 科學技術部, 工業和信息化部, 國家藥品監督管理局, 國家中醫藥管理局. 關於公佈第一批罕見病目錄的通知(國衛醫發〔2018〕10 號)[S]. 中國政府網, 2018. (訪問於 2026-09-10). 收錄 121 種罕見病。引用於:脊髓性肌萎縮症、杜氏肌營養不良、腓骨肌萎縮症、肌強直性營養不良、先天性肌無力綜合徵、遺傳性痙攣性截癱、結節性硬化症、嬰兒嚴重肌陣攣性癲癇、Angelman 綜合徵、Prader-Willi 綜合徵、威廉姆斯綜合徵、Noonan 綜合徵、Silver-Russell 綜合徵、苯丙酮尿症、糖原累積病Ⅱ型、黏多糖貯積症、甲基丙二酸血症、成骨不全症、低磷性佝僂病、21-羥化酶缺乏症、DYRK1A 綜合徵、Kabuki 綜合徵、Cornelia de Lange 綜合徵、Sotos 綜合徵、21 三體綜合徵、22q11.2 缺失綜合徵、Phelan-McDermid 綜合徵、Smith-Magenis 綜合徵、貓叫綜合徵、CHARGE 綜合徵、SYNGAP1 相關智力障礙、ADNP 綜合徵、CHD8 相關神經發育障礙、PTEN 錯構瘤腫瘤綜合徵、MECP2 重複綜合徵、15q11.2-q13.1 重複綜合徵、Potocki-Lupski 綜合徵、Pitt-Hopkins 綜合徵、Mowat-Wilson 綜合徵、KBG 綜合徵、Coffin-Siris 綜合徵、Koolen-de Vries 綜合徵、7q11.23 重複綜合徵、Kleefstra 綜合徵、Rubinstein-Taybi 綜合徵、Smith-Lemli-Opitz 綜合徵、腦肌酸缺乏綜合徵、GLUT1 缺乏綜合徵、神經元蠟樣脂褐質沉積症、四氫生物蝶呤缺乏症、X-連鎖腎上腺腦白質營養不良、線粒體腦肌病、尼曼匹克病、神經節苷脂貯積症、戊二酸血症Ⅰ型、楓糖尿症、生物素酶缺乏症、同型半胱氨酸血症、肝豆狀核變性、多巴反應性肌張力障礙、Lennox-Gastaut 綜合徵、非綜合徵型耳聾、1p36 缺失綜合徵、Wolf-Hirschhorn 綜合徵、Joubert 綜合徵、無腦回畸形、FOXG1 綜合徵、STXBP1 相關發育性癲癇性腦病、CTNNB1 相關神經發育障礙、SATB2 相關障礙、鳥氨酸氨甲酰基轉移酶缺乏症、瓜氨酸血症、精氨酸酶缺乏症、丙酸血症、異戊酸血症、半乳糖血症、原發性肉鹼缺乏症、戈謝病、全身型重症肌無力、低鹼性磷酸酶血症、馬凡綜合徵、面肩肱型肌營養不良症、先天性肌營養不良(膠原Ⅵ相關肌病)、慢性炎性脫髓鞘性多發性神經根神經病、Pelizaeus-Merzbacher 病、亞歷山大病、Canavan 病、Zellweger 譜系障礙、Menkes 病、Aicardi-Goutières 綜合徵、L1 綜合徵、共濟失調毛細血管擴張症、KCNQ2 相關障礙、進行性骨化性纖維發育不良、Dandy-Walker 畸形、Sturge-Weber 綜合徵、多小腦回、Bardet-Biedl 綜合徵、Leber 先天性黑矇、早產兒視網膜病變、中鏈酰基輔酶 A 脫氫酶缺乏症、極長鏈酰基輔酶 A 脫氫酶缺乏症、HHH 綜合徵、原發性酪氨酸血症、芳香族 L-氨基酸脫羧酶缺乏症、法佈雷病、眼皮膚白化病、視網膜色素變性、脊髓小腦性共濟失調、Christianson 綜合徵、自身免疫性腦炎、先天性脊柱側凸、先天性高胰島素性低血糖血症、先天性肌強直、血友病、遺傳性大皰性表皮鬆解症、糖原累積病Ⅰ型、遺傳性果糖不耐受症、全羧化酶合成酶缺乏症、多種酰基輔酶 A 脫氫酶缺乏症、長鏈 3-羥酰基輔酶 A 脫氫酶缺乏症、β-酮硫解酶缺乏症、賴氨酸尿蛋白不耐受症、Krabbe 病、PMM2-CDG、吡哆醇依賴性癲癇、Lesch-Nyhan 綜合徵、非酮性高甘氨酸血症、3-甲基巴豆酰輔酶 A 羧化酶缺乏症、肢帶型肌營養不良、先天性肌病、先天性多發性關節攣縮、嬰兒神經軸索營養不良、泛酸激酶相關神經變性、DYT-TOR1A 肌張力障礙、兒童交替性偏癱、白質消融性白質腦病、SCN2A 相關疾病、Landau-Kleffner 綜合徵、Wiedemann-Steiner 綜合徵、Costello 綜合徵、心-面-皮膚綜合徵、煙霧病、Beckwith-Wiedemann 綜合徵、新生兒持續肺動脈高壓、綜合徵性顱縫早閉、Ehlers-Danlos 綜合徵、Pierre Robin 序列徵、McCune-Albright 綜合徵、萊倫氏綜合徵、假性甲狀旁腺功能減退症、新生兒糖尿病、視隔發育不良、Usher 綜合徵、Waardenburg 綜合徵、兒童罕見病、罕見病政策與保障、急性代謝危象、視覺行為異常、其他系統與多系統受累、術語表
  49. 國家衛生計生委. 0 歲~5 歲兒童睡眠衛生指南 WS/T 579—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).引用於:兒童注意力不集中、注意缺陷多動障礙(多動症)、家庭育兒指導課程、術語表
  50. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).引用於:高危兒與早產兒早期干預、兒童腦癱康復、孤獨症譜系障礙(自閉症)、語言發育遲緩與構音障礙、全面發育遲緩、感覺統合與感覺處理困難、兒童注意力不集中、兒童發育與行為評估、家庭育兒指導課程、兒童罕見病、肌張力低下、粗大運動發育落後、語言發育遲緩、全面發育遲緩、癲癇發作、頭圍增長異常、共濟失調、身材矮小、咖啡牛奶斑、色素脫失斑與鮮紅斑痣、全面發育遲緩:病因評估與後續管理、寶秀蘭兒童神經發育綜合評估系統、評估量表一覽、術語表
  51. 上海市人力資源和社會保障局, 上海市醫療保險辦公室, 上海市衛生和計劃生育委員會, 等. 上海市基本醫療保險醫療康復項目醫保支付規範(滬人社醫〔2017〕536 號)[S]. 上海市人民政府, 2017. (訪問於 2026-10-02).引用於:認知能力訓練、日常生活活動能力訓練
  52. 中國殘疾人聯合會, 國家衛生和計劃生育委員會. 中華人民共和國殘疾人證管理辦法[S]. 岳陽市君山區人民政府網站(地方政府轉發文件附件 1), 2017. (訪問於 2026-10-17). 2018 年 1 月 1 日起施行,2008 年的管理辦法同時廢止。官方全文來自地方政府轉發件,轉發件附件 2 是湖南省的實施細則,另見 hunan-canzheng-xize。
  53. 國家衛生計生委辦公廳. 危重新生兒救治中心建設與管理指南(國衛辦婦幼發〔2017〕40 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-10-02). 全文見《發育醫學電子雜誌》2018 年第 6 卷第 1 期轉載。引用於:姿勢管理與體位擺放
  54. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-25).引用於:高危兒與早產兒早期干預、兒童發育與行為評估、早期綜合訓練、高危兒早期干預、袋鼠式護理(KMC)、嬰兒撫觸與被動操、養育照護、姿勢管理與體位擺放、日常生活活動能力訓練、小兒推拿、高危兒與早產兒的早期干預方法、康復與干預方法、0~1 歲神經運動 20 項檢查、術語表
  55. 國家衛生計生委. 國家基本公共衛生服務規範(第三版):0~6 歲兒童健康管理服務規範(國衛基層發〔2017〕13 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-07).引用於:全面發育遲緩、兒童注意力不集中、兒童發育與行為評估、評估量表一覽、術語表
  56. 國務院. 殘疾人教育條例(國務院令第 674 號)[S]. 中國政府網, 2017. (訪問於 2026-10-17). 2017 年 2 月 1 日公佈,5 月 1 日起施行。第二章「義務教育」規定入學年齡、普通學校與特殊教育學校、送教上門與殘疾人教育專家委員會的評估。
  57. 國務院. 殘疾人教育條例(國務院令第 674 號)[S]. 中國政府網, 2017. (訪問於 2026-10-02).引用於:康復與干預方法
  58. 教育部. 培智學校義務教育生活適應課程標準(2016 年版)[S]. 教育部課程教材研究所, 2016. (訪問於 2026-10-02).引用於:日常生活活動能力訓練
  59. 教育部. 培智學校義務教育康復訓練課程標準(2016 年版)[S]. 教育部課程教材研究所, 2016. (訪問於 2026-10-02).引用於:認知能力訓練、康復與干預方法
  60. 人力資源社會保障部, 國家衛生計生委, 民政部, 等. 關於新增部分醫療康復項目納入基本醫療保障支付範圍的通知(人社部發〔2016〕23 號)[S]. 中國政府網, 2016. (訪問於 2026-10-02).引用於:日常生活活動能力訓練、康復與干預方法
  61. 教育部. 特殊教育教師專業標準(試行)(教師〔2015〕7 號)[S]. 教育部, 2015. (訪問於 2026-09-30).引用於:引導式教育(CE)
  62. 中華醫學會眼科學分會眼底病學組. 中國早產兒視網膜病變篩查指南(2014 年)[S]. 中華眼科雜誌, 2014. (訪問於 2026-09-12). DOI: 10.3760/cma.j.issn.0412-4081.2014.12.017. 規定我國早產兒視網膜病變的篩查對象、初次篩查時間、隨訪間隔與終止篩查條件。引用於:早產兒視網膜病變
  63. 國家衛生計生委辦公廳. 兒童心理保健技術規範(含兒童心理行為發育問題預警徵象篩查表)[S]. 國家衛生計生委, 2013. (訪問於 2026-09-07).引用於:高危兒與早產兒早期干預、兒童腦癱康復、孤獨症譜系障礙(自閉症)、語言發育遲緩與構音障礙、全面發育遲緩、兒童發育與行為評估、言語認知訓練、運動訓練、作業訓練、兒童罕見病、肌張力低下、粗大運動發育落後、語言發育遲緩、寶秀蘭兒童神經發育綜合評估系統、評估量表一覽、術語表
  64. 中華人民共和國教育部. 3-6 歲兒童學習與發展指南(教基二〔2012〕4 號)[S]. 中華人民共和國教育部, 2012. (訪問於 2026-09-10). 五個領域 11 個方面 32 個目標,按 3~4 歲、4~5 歲、5~6 歲三段列典型表現引用於:家庭育兒指導課程、寶秀蘭兒童神經發育綜合評估系統
  65. 衛生部辦公廳. 常用康復治療技術操作規範(2012 年版)(衛辦醫政發〔2012〕51 號)[S]. 衛生部, 2012. (訪問於 2026-10-02). 委託中國康復醫學會組織編寫;全文見四川大學華西醫院康復醫學中心網站轉存的 PDF。引用於:姿勢管理與體位擺放、認知能力訓練、日常生活活動能力訓練、物理因子治療、康復與干預方法
  66. 湖南省衛生廳, 湖南省人力資源和社會保障廳, 湖南省民政廳, 等. 湖南省關於將部分醫療康復項目納入基本醫療保障範圍的實施方案(湘殘聯字〔2012〕48 號)[S]. 湖南省人民政府門戶網站, 2012. (訪問於 2026-10-02). 依據衛農衛發〔2010〕80 號制定,附 9 項醫療康復項目表。引用於:認知能力訓練、日常生活活動能力訓練、康復與干預方法
  67. 衛生部辦公廳. 新生兒訪視技術規範(《新生兒訪視等兒童保健技術規範》附件 1,衛辦婦社發〔2012〕49 號)[S]. 衛生部, 2012. (訪問於 2026-10-08).
  68. 衛生部辦公廳. 兒童孤獨症診療康復指南(衛辦醫政發〔2010〕123 號)[S]. 衛生部, 2010. (訪問於 2026-09-07).引用於:孤獨症譜系障礙(自閉症)、感覺統合與感覺處理困難、融合教育、行為矯正訓練、感覺統合訓練、應用行為分析(ABA)、回合式教學(DTT)、語言行為與 VB-MAPP、問題行為的功能評估與正向行為支持(PBS)、地板時光(DIR)、結構化教學(TEACCH)、社交技能小組訓練、人際關係發展干預(RDI)、認知能力訓練、輔助與替代溝通(AAC)、圖片交換溝通系統(PECS)、感覺統合治療(ASI)、聽覺統合訓練(AIT)、孤獨症(自閉症)的干預方法、評估量表一覽、術語表
  69. 衛生部. 全國兒童保健工作規範(試行)[S]. 衛生部, 2009. (訪問於 2026-10-08).
  70. 中華人民共和國衛生部. 新生兒疾病篩查管理辦法(衛生部令第 64 號)[S]. 中國政府網, 2009. (訪問於 2026-09-10). 全國統一篩查先天性甲狀腺功能減低症、苯丙酮尿症等新生兒遺傳代謝病和聽力障礙。引用於:脊髓性肌萎縮症、苯丙酮尿症、21-羥化酶缺乏症、原發性生長激素缺乏症、罕見病政策與保障、新生兒篩查結果異常、遺傳代謝病
  71. 國家發展和改革委員會, 衛生部, 國家中醫藥管理局. 《全國醫療服務價格項目規範》新增和修訂項目(2007 年)[S]. 國家發展和改革委員會, 2007. (訪問於 2026-10-02).引用於:物理因子治療、康復與干預方法

指南與專家共識191

  1. 中華醫學會罕見病分會, 中華醫學會兒科學分會內分泌遺傳代謝學組, 中國優生優育協會出生缺陷防控專業委員會新生兒遺傳代謝病篩查學組. 21-羥化酶缺乏症臨床管理指南(2026)[J]. 中華兒科雜誌, 2026, 64(6): 590-600. DOI: 10.3760/cma.j.cn112140-20251204-01073.引用於:21-羥化酶缺乏症
  2. Alves I, Fredwall SO, Hughes M, 等. An overview of the International Consensus Statement on achondroplasia[J]. Orphanet Journal of Rare Diseases, 2026, 21(1): 34. DOI: 10.1186/s13023-025-04189-y.引用於:軟骨發育不全
  3. Ni W, Su J, Fei Y, 等. Chinese expert consensus on the treatment and diagnosis of moyamoya disease and moyamoya syndrome (2024)[J]. Stroke and vascular neurology, 2026, 11(4): 406-414. DOI: 10.1136/svn-2024-003925. 我國 20 餘家中心神經外科專家的 2024 年共識英文版:國內流行病學數據、診斷標準、手術指徵與時機、兒童術式選擇和圍手術期併發症的處理。引用於:煙霧病
  4. He Y, Tang J, Zhang M, 等. Clinical practice guideline for the diagnosis and treatment of neonatal arterial ischemic stroke (2026)[J]. Chinese Medical Journal, 2026, 139(18): 2687-2689. DOI: 10.1097/CM9.0000000000004227.
  5. Erdemir G, Rao CK, Pino AF, 等. Diagnosis and management guidelines for infantile epileptic spasms syndrome around the world: A scoping review and comparative study of international approaches[J]. Epilepsia, 2026, 67(9): 4600–4617. DOI: 10.1002/epi.70329.引用於:West 綜合徵
  6. Wakeling E, Davies JH, Giabicani E, 等. Diagnosis and management of Silver-Russell syndrome: second international consensus statement[J]. Nature Reviews Endocrinology, 2026. DOI: 10.1038/s41574-026-01303-3. 2026 年 9 月 23 日在線發表。引用於:Silver-Russell 綜合徵
  7. Thompson Stone R, White AL, Rubin JP, 等. Expert Recommendations for Rapid Response to Positive Newborn Screen for Infantile Krabbe Disease[J]. Neurology Genetics, 2026, 12(3): e200383. DOI: 10.1212/nxg.0000000000200383. 美國專家建議:新生兒篩查陽性後的確認檢查、分型、造血幹細胞移植的時間窗與侷限,以及支持治療的範圍。引用於:Krabbe 病
  8. Grünert SC, Bhattacharya K, Karall D, 等. International Guideline on the Diagnosis, Treatment, and Monitoring of Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)[J]. Journal of Inherited Metabolic Disease, 2026, 49(5): e70251. DOI: 10.1002/jimd.70251. 長鏈脂肪酸氧化障礙的國際指南:診斷流程、飲食與空腹管理、運動前的能量補充、生病預案,以及心臟、眼與周圍神經的長期監測。多數推薦基於專家共識。引用於:極長鏈酰基輔酶 A 脫氫酶缺乏症、長鏈 3-羥酰基輔酶 A 脫氫酶缺乏症
  9. Hermans C, Auerswald G, Berrueco R, 等. Normalization of Haemostasis in People with Haemophilia A: Expert Consensus on Unmet Needs and a Framework for Advancing Towards Health Equity[J]. TH Open, 2026, 10: a28557618. DOI: 10.1055/a-2855-7618. 專家共識,文中對照了預防治療谷濃度目標的歷史做法與現行世界血友病聯盟指南的主張。引用於:血友病
  10. Candler TP, Ali K, Bewick E, 等. UK consensus guidelines for multidisciplinary care of children and young people with achondroplasia: a modified Delphi process[J]. Archives of Disease in Childhood, 2026, 111(6): 545–557. DOI: 10.1136/archdischild-2025-329829.引用於:軟骨發育不全
  11. 唐婉秋, 羅小鴻, 張雨平. 《先天性肌性斜頸的物理治療管理:美國物理治療協會兒科物理治療學會2024年循證臨床實踐指南》解讀[J]. 中國當代兒科雜誌, 2025, 27(9): 1045-1049. DOI: 10.7499/j.issn.1008-8830.2502066.
  12. 中國醫師協會新生兒科醫師分會早產兒專業委員會, 中華兒科雜誌編輯委員會. 早產兒出院後隨訪與健康管理專家共識(2025)[J]. 中華兒科雜誌, 2025, 63(7): 721-736. DOI: 10.3760/cma.j.cn112140-20250117-00050.
  13. 中華預防醫學會兒童保健分會, 等. 兒童發育性協調障礙的篩查、評估和診斷指南(2025)[J]. 中華兒科雜誌, 2025, 63(5): 444-453. DOI: 10.3760/cma.j.cn112140-20250122-00065.引用於:書寫與精細動作訓練
  14. 中華醫學會兒科學分會新生兒學組, 《中國當代兒科雜誌》編輯委員會. 基層醫療衛生機構常見新生兒疾病診療指南:新生兒黃疸(2025年)[J]. 中國當代兒科雜誌, 2025, 27(12): 1433-1443. DOI: 10.7499/j.issn.1008-8830.2505012. 適用於胎齡 35 周及以上的新生兒。
  15. 中華醫學會物理醫學與康復學分會言語語言康復學組, 中國康復醫學會言語康復專業委員會, 中華醫學會兒科學分會康復學組. 發展性語言障礙早期識別專家建議(2025)[J]. 中華兒科雜誌, 2025, 63(6): 600-605. DOI: 10.3760/cma.j.cn112140-20250115-00038.引用於:語言發育遲緩與構音障礙、言語認知訓練、語言發育遲緩、語言發育遲緩與構音障礙的訓練方法、評估量表一覽、術語表
  16. 首都兒童醫學中心, 中華預防醫學會兒童保健分會, 中國婦幼保健協會兒童早期發展專業委員會, 等. 學習困難門診的規範化建設專家共識[J]. 中國兒童保健雜誌, 2025, 33(4): 349-354. DOI: 10.11852/zgetbjzz2025-0286.引用於:學習困難與學習障礙、作業訓練、學習困難與學習障礙的干預方法、術語表
  17. Russo S, Milani D, Meossi C, 等. Beckwith-Wiedemann spectrum (BWSp): an update on diagnosis, management, and follow-up from the scientific committee of the Italian BWSp association[J]. Italian Journal of Pediatrics, 2025, 51(1): 287. DOI: 10.1186/s13052-025-02131-3. 意大利患者協會科學委員會在 2018 年國際共識基礎上的更新:腫瘤篩查、舌減容手術的時機、下肢不等長的骨科處理,以及認知與心理社會隨訪。引用於:Beckwith-Wiedemann 綜合徵
  18. Wilson JL, Soo AKS, Gregory A, 等. Consensus Clinical Management Guideline for PLA2G6-Associated Neurodegeneration (PLAN)[J]. Journal of Child Neurology, 2025, 40(6): 415-432. DOI: 10.1177/08830738251323649. 由臨床專家與患兒家屬共同制定的國際共識管理指南,多數建議屬專家意見;本頁的對症處理、康復、輔具、餵養與舒適照護據此寫。引用於:嬰兒神經軸索營養不良
  19. Alshehri AM, Alanazy MH, Alabdali M, 等. Consensus guidelines on the diagnosis and management of myasthenia gravis by the Saudi Arabia Neuromuscular and Electrodiagnostic Medicine and neuromuscular specialists from the Gulf Cooperation Council region[J]. Therapeutic Advances in Neurological Disorders, 2025, 18: 17562864251346333. DOI: 10.1177/17562864251346333.引用於:全身型重症肌無力
  20. Chateau AV, Blackbeard D, Hlela C, 等. Consensus statements for the biopsychosocial care of patients with epidermolysis bullosa South Africa: Part 2[J]. Health SA Gesondheid, 2025, 30: 2964. DOI: 10.4102/hsag.v30i0.2964.引用於:遺傳性大皰性表皮鬆解症
  21. van Voorst RJ, Schoenmakers DH, Bonkowsky JL, 等. Consensus-Based Expert Recommendations for Diagnosis and Clinical Management of Vanishing White Matter[J]. Neurology, 2025, 105(11): e214320. DOI: 10.1212/wnl.0000000000214320. 國際專家共識,43 條建議:影像與基因的診斷標準、病程預測、發熱與頭部外傷等誘因的預防、疫苗、手術與麻醉、急性惡化的處理、癲癇、營養與卵巢功能。引用於:白質消融性白質腦病
  22. Dahan-Oliel N, Cachecho S, Araujo C, 等. Consensus-based recommendations for the rehabilitation of children with arthrogryposis multiplex congenita: an integrated knowledge translation approach[J]. Orphanet Journal of Rare Diseases, 2025, 20(1): 168. DOI: 10.1186/s13023-025-03671-x. 10 個國家的治療師、醫生與患者經兩輪德爾菲形成的 16 條兒童康復建議,涵蓋早期干預、牽伸與力量、支具、移動、自理與參與、疼痛、圍手術期。引用於:先天性多發性關節攣縮
  23. Ledinger D, Nussbaumer-Streit B, Piso B, 等. Diagnosis and management of cystinosis: systematic review for a clinical practice guideline[J]. Orphanet Journal of Rare Diseases, 2025, 20(1): 463. DOI: 10.1186/s13023-025-03974-z. 為臨床實踐指南所做的系統評價:診斷、半胱胺口服與滴眼、電解質補充與隨訪的證據梳理。引用於:胱氨酸貯積症
  24. Kuypers AM, Das AM, Maiorana A, 等. Overview of European Practices for Management of Tyrosinemia Type 1: Towards European Guidelines[J]. Journal of Inherited Metabolic Disease, 2025, 48(5): e70089. DOI: 10.1002/jimd.70089. 歐洲各中心酪氨酸血症Ⅰ型管理實踐的橫斷面調查,為統一的歐洲指南做準備。引用於:原發性酪氨酸血症
  25. Cattarinussi L, Bregou A, Newman CJ, 等. Radiological Screening of Atlantoaxial Instability in Children with Trisomy 21: A Systematic Review and Evidence-Based Recommendations[J]. Children (Basel), 2025, 12(4): 421. DOI: 10.3390/children12040421.引用於:21 三體綜合徵
  26. Zhong Y, Lin X, Yang Y, 等. Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers[J]. BMC Ophthalmology, 2025, 25(1): 3. DOI: 10.1186/s12886-024-03836-5. 全國七中心隊列。正文列出我國 2014 年指南的篩查對象(胎齡小於 32 周或出生體重低於 2000 g,或有嚴重全身疾病、長期吸氧等風險)與首次篩查時間(矯正胎齡 31–32 周或生後 4–6 周)。引用於:早產兒視網膜病變
  27. Mokhtar G, El-Beshlawy A, Alfy ME, 等. Updated Egyptian national guidelines for management of hemophilia A in children & adolescents[J]. Annals of Hematology, 2025, 104(10): 5463–5473. DOI: 10.1007/s00277-025-06557-x.引用於:血友病
  28. 國家兒童醫學中心, 首都醫科大學附屬北京兒童醫院保健中心, 等. 中國全面發育遲緩診斷指南(2024)[J]. 中華實用兒科臨床雜誌, 2024, 39(7): 481-489. DOI: 10.3760/cma.j.cn101070-20240426-00262.引用於:全面發育遲緩、兒童發育與行為評估、全面發育遲緩、腦性癱瘓的鑑別與病因評估:何時需要進一步檢查、全面發育遲緩:病因評估與後續管理、發育遲緩的康復訓練方法、評估量表一覽、術語表
  29. 《中國杜氏肌營養不良攜帶者篩查的臨床實踐指南》制訂組. 中國杜氏肌營養不良攜帶者篩查的臨床實踐指南[J]. 國際神經病學神經外科學雜誌, 2024, 51(1): 1-6. DOI: 10.16636/j.cnki.jinn.1673-2642.2024.01.001.引用於:杜氏肌營養不良
  30. 中華醫學會兒科學分會內分泌遺傳代謝學組. 中國兒童生長激素缺乏症診治指南[J]. 中華兒科雜誌, 2024, 62(1): 5-11. DOI: 10.3760/cma.j.cn112140-20230914-00183.引用於:原發性生長激素缺乏症
  31. Colovic H, Zlatanovic D, Zivkovic V, 等. A Review of Current Perspectives on Motoric Insufficiency Rehabilitation following Pediatric Stroke[J]. Healthcare (Basel, Switzerland), 2024, 12(2): 149. DOI: 10.3390/healthcare12020149. 兒童卒中後運動康復的綜述:彙總澳大利亞、英國與美國幾份指南對偏癱訓練的建議(目標導向、重複與強度、雙手訓練、限制—誘導運動療法)及其證據等級。引用於:煙霧病
  32. Dollfus H, Lilien MR, Maffei P, 等. Bardet-Biedl syndrome improved diagnosis criteria and management: Inter European Reference Networks consensus statement and recommendations[J]. European Journal of Human Genetics, 2024, 32(11): 1347–1360. DOI: 10.1038/s41431-024-01634-7.引用於:Bardet-Biedl 綜合徵
  33. Zarate YA, Bosanko K, Andres A, 等. Bone health in SATB2-associated syndrome: Results from a large prospective cohort and recommendations for surveillance[J]. American Journal of Medical Genetics Part A, 2024, 194(2): 203–210. DOI: 10.1002/ajmg.a.63421.引用於:SATB2 相關障礙
  34. Úbeda F, Santander S, Luesma MJ. Clinical Practice Guidelines for the Diagnosis and Management of Hereditary Fructose Intolerance[J]. Diseases, 2024, 12(3): 44. DOI: 10.3390/diseases12030044. 按 PRISMA 做的系統綜述,彙總 35 項研究並提出診斷流程:厭惡甜食與少齲齒作為線索、撤除果糖後的好轉時間、與半乳糖血症和酪氨酸血症的先後排查。引用於:遺傳性果糖不耐受症
  35. Adang LA, Bonkowsky JL, Boelens JJ, 等. Consensus guidelines for the monitoring and management of metachromatic leukodystrophy in the United States[J]. Cytotherapy, 2024, 26(7): 739–748. DOI: 10.1016/j.jcyt.2024.03.487.引用於:異染性腦白質營養不良
  36. AlSayed M, Arafa D, Al-Khawajha H, 等. Consensus-based expert recommendations on the management of MPS IVa and VI in Saudi Arabia[J]. Orphanet Journal of Rare Diseases, 2024, 19(1): 269. DOI: 10.1186/s13023-024-03237-3.引用於:黏多糖貯積症
  37. Lacombe D, Bloch-Zupan A, Bredrup C, 等. Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement[J]. Journal of Medical Genetics, 2024, 61(6): 503-519. DOI: 10.1136/jmg-2023-109438. 多國專家與患者組織共同制定的診斷與管理共識,含臨床評分標準。引用於:Rubinstein-Taybi 綜合徵
  38. Dixon M, Millington C, Bernstein L, 等. Dietary management for pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency, a follow-on from the international consortium guidelines[J]. JIMD Reports, 2024, 65(3): 188-203. DOI: 10.1002/jmd2.12418. 國際協作組的飲食管理建議:逐條列出 2021 年共識關於賴氨酸減量治療、監測與生病期處理的條文,並給出限賴氨酸飲食的實施辦法。引用於:吡哆醇依賴性癲癇
  39. Sargent B, Coulter C, Cannoy J, 等. Physical therapy management of congenital muscular torticollis: a 2024 evidence-based clinical practice guideline from the American Physical Therapy Association Academy of Pediatric Physical Therapy[J]. Pediatric Physical Therapy, 2024, 36(4): 370-421. DOI: 10.1097/PEP.0000000000001114.
  40. Parenti G, Fecarotta S, Alagia M, 等. The European reference network for metabolic diseases (MetabERN) clinical pathway recommendations for Pompe disease (acid maltase deficiency, glycogen storage disease type II)[J]. Orphanet Journal of Rare Diseases, 2024, 19(1): 408. DOI: 10.1186/s13023-024-03373-w.引用於:糖原累積病Ⅱ型
  41. Perrino MR, Das A, Scollon SR, 等. Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies[J]. Clinical Cancer Research, 2024, 30(21): 4834-4843. DOI: 10.1158/1078-0432.CCR-24-1611. 源自美國癌症研究協會 2023 年兒童腫瘤易感研討會、2024 年發表的腫瘤監測更新建議,含 Costello 綜合徵的腹盆腔超聲與膀胱腫瘤篩查時間表。引用於:Costello 綜合徵
  42. 中華醫學會兒科學分會內分泌遺傳代謝學組, 中華兒科雜誌編輯委員會. 中樞性性早熟診斷與治療專家共識(2022)[J]. 中華兒科雜誌, 2023, 61(1): 16-22. DOI: 10.3760/cma.j.cn112140-20220802-00693.引用於:餵養困難與兒童營養諮詢、術語表
  43. 中國醫師協會新生兒科醫師分會循證專業委員會. 早產兒和低出生體重兒袋鼠式護理臨床實踐指南(2022)[J]. 中國循證醫學雜誌, 2023, 23(3): 249-264. DOI: 10.7507/1672-2531.202209145.引用於:高危兒與早產兒早期干預、早期綜合訓練、袋鼠式護理(KMC)
  44. 靜進, 歐萍, 徐海青, 等. 兒童心理行為專科建設專家共識[J]. 中國兒童保健雜誌, 2023, 31(9): 929-934. DOI: 10.11852/zgetbjzz2023-0679.引用於:兒童發育與行為評估
  45. 中華醫學會兒科學分會康復學組. 兒童康復臨床中餵養障礙的評估及管理專家共識[J]. 中國實用兒科雜誌, 2023, 38(8): 561-566. DOI: 10.19538/j.ek2023080601.引用於:餵養困難與兒童營養諮詢、言語認知訓練、餵養與吞嚥治療、口部運動治療與口肌訓練、小兒推拿、餵養困難與吞嚥問題的干預方法、訓練器材與教具、術語表
  46. 兒童鐵缺乏和缺鐵性貧血防治專家共識[J]. 中國實用兒科雜誌, 2023, 38(3): 161-167. DOI: 10.19538/j.ek2023030601.引用於:餵養困難與兒童營養諮詢
  47. 中華預防醫學會兒童保健分會, 中國疾病預防控制中心婦幼保健中心, 中國婦幼保健協會高危兒童健康管理專委會. 高危兒規範化健康管理專家共識[J]. 中國兒童保健雜誌, 2023, 31(6): 581-585. DOI: 10.11852/zgetbjzz2023-0347.
  48. 中華醫學會兒科學分會新生兒學組, 中華兒科雜誌編輯委員會. 高危新生兒分類分級管理專家共識(2023)[J]. 中華兒科雜誌, 2023, 61(10): 869-873. DOI: 10.3760/cma.j.cn112140-20230630-00434.引用於:高危兒與早產兒早期干預、兒童發育與行為評估、家庭育兒指導課程、早期綜合訓練、運動訓練、肌張力低下、粗大運動發育落後、高危兒早期干預、高危兒與早產兒的早期干預方法、0~1 歲神經運動 20 項檢查、術語表
  49. 中華醫學會兒科學分會新生兒學組, 中國醫藥教育協會新生兒專業委員會. 新生兒重症監護病房家庭參與式照護實踐指南[J]. 中華兒科雜誌, 2023, 61(4): 292-300. DOI: 10.3760/cma.j.cn112140-20230113-00031.引用於:康復與干預方法
  50. 王久菊, 孟祥芝, 李虹, 等. 漢語發展性閱讀障礙診斷與干預的專家意見[J]. 中國心理衛生雜誌, 2023, 37(3). DOI: 10.3969/j.issn.1000-6729.2023.03.001.引用於:注意力與認知訓練、學習困難與學習障礙的干預方法、康復與干預方法
  51. Mustillo PJ, Sullivan KE, Chinn IK, 等. Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development[J]. Journal of Clinical Immunology, 2023, 43(2): 247–270. DOI: 10.1007/s10875-022-01418-y.引用於:22q11.2 缺失綜合徵
  52. Mushtaq T, Ali SR, Boulos N, 等. Emergency and perioperative management of adrenal insufficiency in children and young people: British Society for Paediatric Endocrinology and Diabetes consensus guidance[J]. Archives of Disease in Childhood, 2023, 108(11): 871-878. DOI: 10.1136/archdischild-2022-325156. 英國兒科內分泌與糖尿病學會的共識:腎上腺皮質功能不全(含垂體原因)的兒童在患病、嘔吐腹瀉、外傷與手術時如何加用氫化可的松,以及腎上腺危象的識別與處理。引用於:21-羥化酶缺乏症、原發性生長激素缺乏症、視隔發育不良
  53. Carton C, Evans DG, Blanco I, 等. ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1[J]. EClinicalMedicine, 2023, 56: 101818. DOI: 10.1016/j.eclinm.2022.101818.引用於:神經纖維瘤病
  54. Carter MT, Srour M, Au PYB, et al. Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists (CCMG)[J]. Journal of Medical Genetics, 2023, 60(6): 523-532. DOI: 10.1136/jmg-2022-108962.
  55. Stepien KM, Broomfield A, Cole D, 等. Management of pain in Fabry disease in the UK clinical setting: consensus findings from an expert Delphi panel[J]. Orphanet Journal of Rare Diseases, 2023, 18(1): 203. DOI: 10.1186/s13023-023-02796-1. 法佈雷病疼痛管理的專家德爾菲共識,含誘因管理與分級處理的原則。引用於:法佈雷病
  56. Care of Preterm or Low Birthweight Infants Group. New World Health Organization recommendations for care of preterm or low birth weight infants: health policy[J]. EClinicalMedicine, 2023, 63: 102155. DOI: 10.1016/j.eclinm.2023.102155.引用於:袋鼠式護理(KMC)
  57. Boy N, Mühlhausen C, Maier EM, 等. Recommendations for diagnosing and managing individuals with glutaric aciduria type 1: Third revision[J]. Journal of Inherited Metabolic Disease, 2023, 46(3): 482–519. DOI: 10.1002/jimd.12566.引用於:戊二酸血症Ⅰ型、Lesch-Nyhan 綜合徵
  58. Shaikh MG, Lucas-Herald AK, Dastamani A, 等. Standardised practices in the networked management of congenital hyperinsulinism: a UK national collaborative consensus[J]. Frontiers in Endocrinology, 2023, 14: 1231043. DOI: 10.3389/fendo.2023.1231043. 英國全國協作共識:先天性高胰島素血症的識別、血糖目標、轉診與長期隨訪的統一做法。引用於:先天性高胰島素性低血糖血症
  59. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG. Technical guidelines for seasonal influenza vaccination in China (2023-2024)[J]. 中華流行病學雜誌, 2023, 44(10): 1507–1530. DOI: 10.3760/cma.j.cn112338-20230908-00139. 中文期刊,題名與署名按 PubMed 的英文著錄。引用於:脊髓性肌萎縮症
  60. Jones JM, Fleming-Dutra KE, Prill MM, 等. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023[J]. MMWR. Morbidity and Mortality Weekly Report, 2023, 72(34): 920–925. DOI: 10.15585/mmwr.mm7234a4.引用於:Menkes 病
  61. Fujimura M, Tominaga T, Kuroda S, 等. 2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society[J]. Neurologia medico-chirurgica, 2022, 62(4): 165-170. DOI: 10.2176/jns-nmc.2021-0382. 日本煙霧病研究委員會與日本卒中學會的 2021 年診療指南英文版:手術、藥物與出血型的處理建議,以及兒童避免過度換氣、哭鬧與脫水的生活指導。引用於:煙霧病
  62. Isselbacher EM, Preventza O, Hamilton Black J 3rd, 等. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines[J]. Journal of the American College of Cardiology, 2022, 80(24): e223–e393. DOI: 10.1016/j.jacc.2022.08.004.引用於:馬凡綜合徵
  63. 中華醫學會兒科學分會發育行為學組, 中國醫師協會兒科分會兒童保健學組. 中國低齡孤獨症譜系障礙患兒家庭干預專家共識[J]. 中華兒科雜誌, 2022, 60(5): 395-400. DOI: 10.3760/cma.j.cn112140-20220112-00045.引用於:日常生活活動能力訓練
  64. 張建奎, 李曉捷, 唐久來, 等. 中國腦性癱瘓康復指南(2022)核心內容解讀[J]. 中華實用兒科臨床雜誌, 2022, 37(24): 1841-1853. DOI: 10.3760/cma.j.cn101070-20221118-01309.引用於:小兒推拿
  65. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第一章:概論[J]. 中華實用兒科臨床雜誌, 2022, 37(12): 887-892.引用於:兒童腦癱康復、運動訓練、術語表
  66. 中國康復醫學會兒童康復專業委員會, 中國殘疾人康復協會小兒腦性癱瘓康復專業委員會, 中國醫師協會康復醫師分會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第七章:康復途徑及管理[J]. 中華實用兒科臨床雜誌, 2022, 37(20): 1521-1526. DOI: 10.3760/cma.j.cn101070-20220919-01094.
  67. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第二章:腦性癱瘓高危兒的評定與干預[J]. 中華實用兒科臨床雜誌, 2022, 37(13): 974-982. DOI: 10.3760/cma.j.cn101070-20220519-00574.引用於:兒童腦癱康復、早期綜合訓練、術語表
  68. 中國康復醫學會兒童康復專業委員會, 中國殘疾人康復協會小兒腦性癱瘓康復專業委員會, 中國醫師協會康復醫師分會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第三章:ICF-CY框架下的兒童腦癱評定[J]. 中華實用兒科臨床雜誌, 2022, 37(15): 1121-1141. DOI: 10.3760/cma.j.cn101070-20220621-00746.
  69. 中國康復醫學會兒童康復專業委員會, 中國殘疾人康復協會小兒腦性癱瘓康復專業委員會, 中國醫師協會康復醫師分會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第四章:康復治療(上)[J]. 中華實用兒科臨床雜誌, 2022, 37(16): 1201-1229. DOI: 10.3760/cma.j.cn101070-20220711-00850.
  70. 中國康復醫學會兒童康復專業委員會, 中國殘疾人康復協會小兒腦性癱瘓康復專業委員會, 中國醫師協會康復醫師分會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第四章:康復治療(下)[J]. 中華實用兒科臨床雜誌, 2022, 37(17): 1281-1309. DOI: 10.3760/cma.j.cn101070-20220718-00875.
  71. 中華醫學會兒科學分會神經學組, 張慈柳, 洪思琦, 等. 兒童神經系統疾病糖皮質激素治療專家系列建議之六——進行性假肥大型肌營養不良的治療[J]. 中國實用兒科雜誌, 2022, 37(5): 343-346. DOI: 10.19538/j.ek2022050607.引用於:杜氏肌營養不良
  72. 中華醫學會兒科學分會康復學組. 兒童康復相關發育性疾病的命名現狀與建議[J]. 中國全科醫學, 2022, 25(8): 899-904. DOI: 10.12114/j.issn.1007-9572.2022.01.301.引用於:語言發育遲緩與構音障礙、全面發育遲緩、感覺統合與感覺處理困難、學習困難與學習障礙、遺傳性痙攣性截癱、語言發育遲緩、全面發育遲緩、全面發育遲緩:病因評估與後續管理、發育遲緩的康復訓練方法、術語表
  73. 中國優生優育協會嬰幼兒發育專業委員會. 高危新生兒行為神經發育早期干預專家共識[J]. 中國兒童保健雜誌, 2022, 30(3): 233-236. DOI: 10.11852/zgetbjzz2021-0625.引用於:高危兒與早產兒早期干預、高危兒早期干預、袋鼠式護理(KMC)、嬰兒撫觸與被動操、小兒推拿、高危兒與早產兒的早期干預方法、康復與干預方法、NBNA 方法頁
  74. Duis J, Nespeca M, Summers J, 等. A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome[J]. Molecular Genetics & Genomic Medicine, 2022, 10(3): e1843. DOI: 10.1002/mgg3.1843.引用於:Angelman 綜合徵、癲癇發作、共濟失調、日間嗜睡與睡眠節律紊亂、染色體與基因組印記異常、神經發育障礙與癲癇性腦病
  75. Douzgou S, Rawson M, Baselga E, 等. A standard of care for individuals with PIK3CA-related disorders: An international expert consensus statement[J]. Clinical Genetics, 2022, 101(1): 32-47. DOI: 10.1111/cge.14027. 2019 年曼徹斯特專家會議形成的國際共識,覆蓋基因檢測取樣、頭顱影像隨訪、癲癇、神經發育、內分泌與血栓風險。引用於:PIK3CA 相關過度生長綜合徵
  76. Gibson N, Wynter M, Thomason P, 等. Australian hip surveillance guidelines at 10 years: New evidence and implementation[J]. Journal of Pediatric Rehabilitation Medicine, 2022, 15(1): 31-37. DOI: 10.3233/PRM-220017.引用於:康復與干預方法
  77. Kemper AR, Newman TB, Slaughter JL, 等. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation[J]. Pediatrics, 2022, 150(3): e2022058859. DOI: 10.1542/peds.2022-058859.
  78. Leaf JB, Cihon JH, Leaf R, 等. Concerns About ABA-Based Intervention: An Evaluation and Recommendations[J]. Journal of Autism and Developmental Disorders, 2022, 52(6): 2838-2853. DOI: 10.1007/s10803-021-05137-y.引用於:問題行為的功能評估與正向行為支持(PBS)
  79. Specchio N, Wirrell E C, Scheffer I E, 等. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE Task Force on Nosology and Definitions[J]. Epilepsia, 2022, 63(6): 1398-1442. DOI: 10.1111/epi.17241. Lennox-Gastaut 綜合徵列為兒童期起病的五個發育性和/或癲癇性腦病之一。引用於:Lennox-Gastaut 綜合徵、Landau-Kleffner 綜合徵
  80. Engelen M, van Ballegoij WJC, Mallack EJ, 等. International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy: A Consensus-Based Approach[J]. Neurology, 2022, 99(21): 940–951. DOI: 10.1212/WNL.0000000000201374.引用於:X-連鎖腎上腺腦白質營養不良
  81. Jackman M, Sakzewski L, Morgan C, 等. Interventions to improve physical function for children and young people with cerebral palsy: international clinical practice guideline[J]. Developmental Medicine and Child Neurology, 2022, 64(5): 536-549. DOI: 10.1111/dmcn.15055.引用於:目標導向與任務導向訓練、強制性誘導運動療法與雙手強化訓練(CIMT)、減重步行與跑臺訓練、引導式教育(CE)、腦癱(腦性癱瘓)的康復訓練方法
  82. Abraham MB, Karges B, Dovc K, 等. ISPAD Clinical Practice Consensus Guidelines 2022: Assessment and management of hypoglycemia in children and adolescents with diabetes[J]. Pediatric Diabetes, 2022, 23(8): 1322-1340. DOI: 10.1111/pedi.13443. 國際兒童青少年糖尿病學會(ISPAD)的低血糖指南:兒童低血糖的表現、誘因,以及運動前測血糖、向老師和看護人交代早期表現的建議。引用於:新生兒糖尿病
  83. Greeley SAW, Polak M, Njølstad PR, 等. ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents[J]. Pediatric Diabetes, 2022, 23(8): 1188-1211. DOI: 10.1111/pedi.13426. 國際兒童青少年糖尿病學會(ISPAD)的單基因糖尿病指南:新生兒糖尿病的基因檢測時機、各亞型的病程、鉀通道型的神經系統表現與磺脲類治療。引用於:新生兒糖尿病
  84. Dai Y L, Zou C C, 等. Recommendations for the diagnosis and management of childhood Prader-Willi syndrome in China[J]. Orphanet Journal of Rare Diseases, 2022, 17: 221. DOI: 10.1186/s13023-022-02302-z. 中華醫學會兒科學分會罕見病學組等聯合發佈的中國診治建議。引用於:Prader-Willi 綜合徵
  85. Muschol N, Giugliani R, Jones SA, 等. Sanfilippo syndrome: consensus guidelines for clinical care[J]. Orphanet Journal of Rare Diseases, 2022, 17(1): 391. DOI: 10.1186/s13023-022-02484-6.引用於:黏多糖貯積症
  86. Moon RY, Carlin RF, Hand I; Task Force on Sudden Infant Death Syndrome and the Committee on Fetus and Newborn. Sleep-Related Infant Deaths: Updated 2022 Recommendations for Reducing Infant Deaths in the Sleep Environment[J]. Pediatrics, 2022, 150(1): e2022057990. DOI: 10.1542/peds.2022-057990.引用於:軟骨發育不全、遺傳性大皰性表皮鬆解症
  87. Plotkin SR, Messiaen L, Legius E, 等. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation[J]. Genetics in Medicine, 2022, 24(9): 1967–1977. DOI: 10.1016/j.gim.2022.05.007.引用於:神經纖維瘤病
  88. 中華醫學會兒科學分會康復學組. 2021年JAMA Pediatrics《0~2歲腦性癱瘓及其高危兒的早期干預:基於系統評價的國際臨床實踐指南》中國專家解讀[J]. 中華實用兒科臨床雜誌, 2021, 36(19): 1446-1451. DOI: 10.3760/cma.j.cn101070-20210729-00904.
  89. Coughlin CR, Tseng LA, Abdenur JE, 等. Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency[J]. Journal of Inherited Metabolic Disease, 2021, 44(1): 178-192. DOI: 10.1002/jimd.12332. 國際吡哆醇依賴性癲癇協作組的診斷與管理共識,16 個國家 29 家機構參與制定;把限賴氨酸飲食與精氨酸補充列為吡哆醇之外的輔助治療。引用於:吡哆醇依賴性癲癇
  90. Sabeti S, Ball KL, Bhattacharya SK, 等. Consensus Statement for the Management and Treatment of Sturge-Weber Syndrome: Neurology, Neuroimaging, and Ophthalmology Recommendations[J]. Pediatric Neurology, 2021, 121: 59–66. DOI: 10.1016/j.pediatrneurol.2021.04.013.引用於:Sturge-Weber 綜合徵
  91. Morgan C, Fetters L, Adde L, 等. Early intervention for children aged 0 to 2 years with or at high risk of cerebral palsy: international clinical practice guideline based on systematic reviews[J]. JAMA Pediatrics, 2021, 175(8): 846-858. DOI: 10.1001/jamapediatrics.2021.0878.引用於:兒童腦癱康復、運動訓練、高危兒早期干預、嬰兒撫觸與被動操、目標導向與任務導向訓練、強制性誘導運動療法與雙手強化訓練(CIMT)、腦癱(腦性癱瘓)的康復訓練方法
  92. Van den Bergh PYK, van Doorn PA, Hadden RDM, 等. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision[J]. Journal of the Peripheral Nervous System, 2021, 26(3): 242-268. DOI: 10.1111/jns.12455. 歐洲神經病學學會與周圍神經學會聯合工作組的第二次修訂版,是慢性炎性脫髓鞘性多發性神經根神經病診治的國際參考。引用於:慢性炎性脫髓鞘性多發性神經根神經病
  93. Manickam K, McClain MR, Demmer LA, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)[J]. Genetics in Medicine, 2021, 23(11): 2029-2037. DOI: 10.1038/s41436-021-01242-6.
  94. Manickam K, McClain MR, Demmer LA, 等. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)[J]. Genetics in Medicine, 2021, 23(11): 2029–2037. DOI: 10.1038/s41436-021-01242-6.引用於:SYNGAP1 相關智力障礙、全面發育遲緩:病因評估與後續管理
  95. Ijsselstijn H, Schiller RM, Holder C, 等. Extracorporeal Life Support Organization (ELSO) Guidelines for Follow-up After Neonatal and Pediatric Extracorporeal Membrane Oxygenation[J]. ASAIO Journal, 2021, 67(9): 955-963. DOI: 10.1097/MAT.0000000000001525. 體外生命支持組織的隨訪指南:做過體外膜肺氧合的新生兒與兒童,結構化隨訪從出院前開始,延續到青春期。引用於:新生兒持續肺動脈高壓
  96. Forny P, Hörster F, Ballhausen D, 等. Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First revision[J]. Journal of Inherited Metabolic Disease, 2021, 44(3): 566–592. DOI: 10.1002/jimd.12370.引用於:甲基丙二酸血症、丙酸血症
  97. Mole S E, Schulz A, Badoe E, 等. Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients[J]. Orphanet Journal of Rare Diseases, 2021, 16(1): 185. DOI: 10.1186/s13023-021-01813-5. 21 名國際專家以德爾菲法制定的 CLN2 病指南,共 53 條推薦。引用於:神經元蠟樣脂褐質沉積症
  98. Nosadini M, Thomas T, Eyre M, 等. International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis[J]. Neurology: Neuroimmunology & Neuroinflammation, 2021, 8(5): e1052. DOI: 10.1212/NXI.0000000000001052.引用於:自身免疫性腦炎
  99. 中國醫師協會兒科醫師分會兒童保健學組. NICU出院高危兒0~3歲生長發育隨訪管理技術的專家共識[J]. 中國兒童保健雜誌, 2021, 29(8): 809-814. DOI: 10.11852/zgetbjzz2020-2035.
  100. Weisman A, Chan JM, LaPointe C, 等. Physiotherapy for epidermolysis bullosa: clinical practice guidelines[J]. Orphanet Journal of Rare Diseases, 2021, 16(1): 406. DOI: 10.1186/s13023-021-01997-w. DEBRA International 的物理治療臨床實踐指南:攣縮預防、關節活動度維持、體位與轉移的禁忌與做法。引用於:遺傳性大皰性表皮鬆解症、其他系統與多系統受累
  101. Legius E, Messiaen L, Wolkenstein P, 等. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation[J]. Genetics in Medicine, 2021, 23(8): 1506–1513. DOI: 10.1038/s41436-021-01170-5.引用於:神經纖維瘤病
  102. Mathijssen IMJ, Working Group Guideline Craniosynostosis. Updated Guideline on Treatment and Management of Craniosynostosis[J]. The Journal of Craniofacial Surgery, 2021, 32(1): 371-450. DOI: 10.1097/scs.0000000000007035. 荷蘭顱縫早閉診療指南的修訂版(2020 年獲各學會批准):轉診與影像、手術時機,以及顱壓、睡眠呼吸、聽力、言語語言、認知行為與心理社會各項的篩查安排。引用於:綜合徵性顱縫早閉
  103. 中國兒童 OSA 診斷與治療指南制訂工作組, 中華醫學會耳鼻咽喉頭頸外科學分會小兒學組, 中華醫學會兒科學分會呼吸學組, 等. 中國兒童阻塞性睡眠呼吸暫停診斷與治療指南(2020)[J]. 中華耳鼻咽喉頭頸外科雜誌, 2020, 55(8): 729-747. DOI: 10.3760/cma.j.cn115330-20200521-00431.引用於:兒童注意力不集中、家庭育兒指導課程
  104. 中華醫學會醫學遺傳學分會遺傳病臨床實踐指南撰寫組, 譚虎, 梁德生, 等. 杜氏進行性肌營養不良的臨床實踐指南[J]. 中華醫學遺傳學雜誌, 2020, 37(3): 258-262. DOI: 10.3760/cma.j.issn.1003-9406.2020.03.006.引用於:杜氏肌營養不良、兒童罕見病、發育倒退、粗大運動發育落後、血清肌酸激酶升高、腦性癱瘓的鑑別與病因評估:何時需要進一步檢查、神經肌肉病
  105. 中華醫學會兒科學分會康復學組. 兒童腦性癱瘓運動障礙的康復建議[J]. 中華兒科雜誌, 2020, 58(2): 91-95. DOI: 10.3760/cma.j.issn.0578-1310.2020.02.005.引用於:目標導向與任務導向訓練、強制性誘導運動療法與雙手強化訓練(CIMT)、減重步行與跑臺訓練、腦癱(腦性癱瘓)的康復訓練方法、康復與干預方法
  106. 中華醫學會兒科學分會發育行為學組. 注意缺陷多動障礙早期識別、規範診斷和治療的兒科專家共識[J]. 中華兒科雜誌, 2020, 58(3): 188-193. DOI: 10.3760/cma.j.issn.0578-1310.2020.03.006.引用於:感覺統合與感覺處理困難、兒童注意力不集中、注意缺陷多動障礙(多動症)、學習困難與學習障礙、家長行為管理培訓(PMT)、神經反饋、術語表
  107. 北京醫學會醫學遺傳學分會, 北京罕見病診療與保障學會. 脊髓性肌萎縮症遺傳學診斷專家共識[J]. 中華醫學雜誌, 2020, 100(40): 3130-3140. DOI: 10.3760/cma.j.cn112137-20200803-02267.引用於:脊髓性肌萎縮症、杜氏肌營養不良、Prader-Willi 綜合徵、兒童罕見病、肌張力低下、餵養困難、神經肌肉病
  108. Cellucci T, Van Mater H, Graus F, 等. Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient[J]. Neurology: Neuroimmunology & Neuroinflammation, 2020, 7(2): e663. DOI: 10.1212/NXI.0000000000000663. 兒童自身免疫性腦炎的國際共識性診斷路徑:可能與確診的判據、必須排除的感染與其他病因。引用於:自身免疫性腦炎、神經發育障礙與癲癇性腦病
  109. Messner AH, Walsh J, Rosenfeld RM, 等. Clinical consensus statement: ankyloglossia in children[J]. Otolaryngology–Head and Neck Surgery, 2020, 162(5): 597-611. DOI: 10.1177/0194599820915457.
  110. Michigami T, Ohata Y, Fujiwara M, 等. Clinical Practice Guidelines for Hypophosphatasia[J]. Clinical Pediatric Endocrinology, 2020, 29(1): 9–24. DOI: 10.1297/cpe.29.9.引用於:低鹼性磷酸酶血症
  111. Opladen T, López-Laso E, Cortès-Saladelafont E, 等. Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies[J]. Orphanet Journal of Rare Diseases, 2020, 15(1): 126. DOI: 10.1186/s13023-020-01379-8. 國際神經遞質相關疾病工作組(iNTD)制定的共識指南。引用於:四氫生物蝶呤缺乏症
  112. Fu C, Armstrong D, Marsh E, 等. Consensus guidelines on managing Rett syndrome across the lifespan[J]. BMJ Paediatrics Open, 2020, 4(1): e000717. DOI: 10.1136/bmjpo-2020-000717.引用於:Rett 綜合徵
  113. Jung BK, Yun IS. Diagnosis and treatment of positional plagiocephaly[J]. Archives of Craniofacial Surgery, 2020, 21(2): 80-86. DOI: 10.7181/acfs.2020.00059. 體位性斜頭的成因、變化過程與處理的綜述,本頁用它交代體位性頭型與顱縫早閉的區別。引用於:綜合徵性顱縫早閉
  114. Klepper J, Akman C, Armeno M, 等. Glut1 Deficiency Syndrome (Glut1DS): state of the art in 2020 and recommendations of the international Glut1DS study group[J]. Epilepsia Open, 2020, 5(3): 354-365. DOI: 10.1002/epi4.12414. 國際 GLUT1 缺乏綜合徵研究組的診斷與治療共識。引用於:GLUT1 缺乏綜合徵
  115. Bachmann-Gagescu R, Dempsey JC, Bulgheroni S, 等. Healthcare recommendations for Joubert syndrome[J]. American Journal of Medical Genetics Part A, 2020, 182(1): 229–249. DOI: 10.1002/ajmg.a.61399.引用於:Joubert 綜合徵
  116. Mantovani G, Bastepe M, Monk D, 等. Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients[J]. Hormone Research in Paediatrics, 2020, 93(3): 182-196. DOI: 10.1159/000508985. 2018 年國際共識的更新與精簡版,文獻檢索補到 2019 年底;認知、睡眠與肥胖幾節補充了共識之後發表的研究。引用於:假性甲狀旁腺功能減退症
  117. 中華醫學會醫學遺傳學分會遺傳病臨床實踐指南撰寫組, 關榮偉, 李秋炎, 等. Rett 綜合徵的臨床實踐指南[J]. 中華醫學遺傳學雜誌, 2020, 37(3): 308-312.引用於:Rett 綜合徵
  118. 北京醫學會罕見病分會, 北京醫學會神經內科分會神經肌肉病學組, 中國肌萎縮側索硬化協作組. 脊髓性肌萎縮症多學科管理專家共識[J]. 中華醫學雜誌, 2019, 99(19): 1460-1467. DOI: 10.3760/cma.j.issn.0376-2491.2019.19.006.引用於:脊髓性肌萎縮症、兒童罕見病、肌張力低下、粗大運動發育落後、餵養困難、血清肌酸激酶升高、神經肌肉病
  119. Javaid MK, Boyce A, Appelman-Dijkstra N, 等. Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium[J]. Orphanet Journal of Rare Diseases, 2019, 14(1): 139. DOI: 10.1186/s13023-019-1102-9. FD/MAS 國際協作組的最佳實踐共識:定義與分型、分期評估、各系統的處理,以及運動、康復與術後恢復的建議。引用於:低磷性佝僂病、McCune-Albright 綜合徵
  120. Wolraich ML, Hagan JF, Allan C, 等. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents[J]. Pediatrics, 2019, 144(4): e20192528.引用於:感覺統合與感覺處理困難、兒童注意力不集中、注意缺陷多動障礙(多動症)、學習困難與學習障礙、家庭育兒指導課程、家長介導干預、家長實施的語言干預、家長行為管理培訓(PMT)、神經反饋、多動症(ADHD)與注意力問題的非藥物干預方法、康復與干預方法、術語表
  121. Haffner D, Emma F, Eastwood DM, 等. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia[J]. Nature Reviews Nephrology, 2019, 15(7): 435–455. DOI: 10.1038/s41581-019-0152-5.引用於:低磷性佝僂病
  122. Germain DP, Fouilhoux A, Decramer S, 等. Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients[J]. Clinical Genetics, 2019, 96(2): 107-117. DOI: 10.1111/cge.13546. 兒童法佈雷病的共識建議:兒童期症狀構成(疼痛、少汗、不耐熱與運動、胃腸道)、基線與隨訪評估項目。引用於:法佈雷病
  123. Gripp KW, Morse LA, Axelrad M, 等. Costello syndrome: Clinical phenotype, genotype, and management guidelines[J]. American Journal of Medical Genetics Part A, 2019, 179(9): 1725-1744. DOI: 10.1002/ajmg.a.61270. 國際專家組制定的 Costello 綜合徵管理指南,按專科逐項列出確診時與隨訪中的檢查、餵養、骨科、神經認知與腫瘤篩查建議;屬專家意見。引用於:Costello 綜合徵
  124. Altassan R, Péanne R, Jaeken J, 等. International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up[J]. Journal of Inherited Metabolic Disease, 2019, 42(1): 5-28. DOI: 10.1002/jimd.12024. 多國專家在系統綜述基礎上撰寫的國際診療指南,按系統給出確診後的評估與管理建議。引用於:PMM2-CDG
  125. Blank R, Barnett AL, Cairney J, 等. International clinical practice recommendations on the definition, diagnosis, assessment, intervention, and psychosocial aspects of developmental coordination disorder[J]. Developmental Medicine and Child Neurology, 2019, 61(3): 242-285. DOI: 10.1111/dmcn.14132.引用於:目標導向與任務導向訓練、書寫與精細動作訓練、感覺處理困難(感統失調)的干預方法、康復與干預方法
  126. Dahan-Oliel N, Cachecho S, Barnes D, 等. International multidisciplinary collaboration toward an annotated definition of arthrogryposis multiplex congenita[J]. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2019, 181(3): 288-299. DOI: 10.1002/ajmg.c.31721. 8 個國家 25 位專家形成的共識定義及其逐句註釋:定義、病因、攣縮的演變、脊柱、其他系統、認知與功能。引用於:先天性多發性關節攣縮
  127. Hohenfellner K, Rauch F, Ariceta G, 等. Management of bone disease in cystinosis: Statement from an international conference[J]. Journal of Inherited Metabolic Disease, 2019, 42(5): 1019-1029. DOI: 10.1002/jimd.12134. 國際會議聲明:胱氨酸貯積症的骨病超出常規腎性骨營養不良範疇,需要多學科長期隨訪。引用於:胱氨酸貯積症
  128. Srivastava S, Love-Nichols JA, Dies KA, et al. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders[J]. Genetics in Medicine, 2019, 21(11): 2413-2421. DOI: 10.1038/s41436-019-0554-6.
  129. Chan JM, Weisman A, King A, 等. Occupational therapy for epidermolysis bullosa: clinical practice guidelines[J]. Orphanet Journal of Rare Diseases, 2019, 14(1): 129. DOI: 10.1186/s13023-019-1059-8. DEBRA International 的作業治療臨床實踐指南:手部畸形的預防與支具、自理與書寫的適配、環境與輔具改造。引用於:遺傳性大皰性表皮鬆解症
  130. Deignan JL, Chung WK, Kearney HM, et al. Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG)[J]. Genetics in Medicine, 2019, 21(6): 1267-1270. DOI: 10.1038/s41436-019-0478-1.
  131. Wasserstein M, Dionisi-Vici C, Giugliani R, 等. Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD)[J]. Molecular Genetics and Metabolism, 2019, 126(2): 98–105. DOI: 10.1016/j.ymgme.2018.11.014.引用於:尼曼匹克病
  132. Beygo J, Buiting K, Ramsden SC, 等. Update of the EMQN/ACGS best practice guidelines for molecular analysis of Prader-Willi and Angelman syndromes[J]. European Journal of Human Genetics, 2019, 27(9): 1326–1340. DOI: 10.1038/s41431-019-0435-0.引用於:Prader-Willi 綜合徵
  133. 中華醫學會兒科學分會神經學組, 中國醫師協會神經內科分會兒童神經疾病專業委員會. 兒童智力障礙或全面發育遲緩病因診斷策略專家共識[J]. 中華兒科雜誌, 2018, 56(11): 806-810. DOI: 10.3760/cma.j.issn.0578-1310.2018.11.003.引用於:全面發育遲緩、全面發育遲緩、腦性癱瘓的鑑別與病因評估:何時需要進一步檢查、孤獨症譜系障礙的鑑別與病因評估、全面發育遲緩:病因評估與後續管理、發育遲緩的康復訓練方法
  134. 中國醫師協會神經修復學分會兒童神經修復學專業委員會. 嬰幼兒腦損傷神經修復治療專家共識[J]. 中國當代兒科雜誌, 2018, 20(10): 785-792. DOI: 10.7499/j.issn.1008-8830.2018.10.001.引用於:姿勢管理與體位擺放、認知能力訓練、日常生活活動能力訓練、物理因子治療、康復與干預方法
  135. Mueller B, Engelbert R, Baratta-Ziska F, 等. Consensus statement on physical rehabilitation in children and adolescents with osteogenesis imperfecta[J]. Orphanet Journal of Rare Diseases, 2018, 13(1): 158. DOI: 10.1186/s13023-018-0905-4.引用於:成骨不全症
  136. Kline AD, Moss JF, Selicorni A, 等. Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement[J]. Nature Reviews Genetics, 2018, 19(10): 649–666. DOI: 10.1038/s41576-018-0031-0.引用於:Cornelia de Lange 綜合徵
  137. Mantovani G, Bastepe M, Monk D, 等. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement[J]. Nature Reviews Endocrinology, 2018, 14(8): 476-500. DOI: 10.1038/s41574-018-0042-0. 13 個國家 37 位專家與患者組織代表制定的首個國際共識,共 67 條推薦,涵蓋臨床診斷、分子診斷、遺傳諮詢與各系統的隨訪管理。引用於:假性甲狀旁腺功能減退症
  138. Mercuri E, Finkel R S, Muntoni F, 等. Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care[J]. Neuromuscular Disorders, 2018, 28(2): 103-115. DOI: 10.1016/j.nmd.2017.11.005.引用於:脊髓性肌萎縮症
  139. Brioude F, Kalish JM, Mussa A, 等. Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement[J]. Nature Reviews Endocrinology, 2018, 14(4): 229-249. DOI: 10.1038/nrendo.2017.166. 首份國際共識,72 條建議:提出 Beckwith-Wiedemann 譜系的概念與臨床評分,並就分子檢測、巨舌、下肢不等長、低血糖和腫瘤篩查給出處理建議。引用於:Beckwith-Wiedemann 綜合徵
  140. Kaplan SL, Coulter C, Sargent B. Physical therapy management of congenital muscular torticollis: a 2018 evidence-based clinical practice guideline from the APTA Academy of Pediatric Physical Therapy[J]. Pediatric Physical Therapy, 2018, 30(4): 240-290. DOI: 10.1097/PEP.0000000000000544.
  141. Bilgen H, Kültürsay N, Türkyılmaz C. Turkish Neonatal Society guideline on nutrition of the healthy term newborn[J]. Turk Pediatri Arsivi, 2018, 53(Suppl 1): S128-S137. DOI: 10.5152/turkpediatriars.2018.01813. 健康足月新生兒餵養指南:生後第二天起尿少、尿色深並帶粉紅色尿酸鹽結晶,是奶量不足的可靠徵象之一。引用於:Lesch-Nyhan 綜合徵
  142. 中華醫學會兒科學分會發育行為學組, 中國醫師協會兒科分會兒童保健專業委員會, 兒童孤獨症診斷與防治技術和標準研究項目專家組. 孤獨症譜系障礙兒童早期識別篩查和早期干預專家共識[J]. 中華兒科雜誌, 2017, 55(12): 890-897. DOI: 10.3760/cma.j.issn.0578-1310.2017.12.004.引用於:孤獨症譜系障礙(自閉症)、語言發育遲緩與構音障礙、應用行為分析(ABA)、自然發展行為干預(NDBI)、關鍵反應訓練(PRT)、早期介入丹佛模式(ESDM)、問題行為的功能評估與正向行為支持(PBS)、家長介導干預、地板時光(DIR)、結構化教學(TEACCH)、社交技能小組訓練、人際關係發展干預(RDI)、康復與干預方法
  143. 中華醫學會兒科學分會新生兒學組, 《中華兒科雜誌》編輯委員會. 新生兒肺動脈高壓診治專家共識[J]. 中華兒科雜誌, 2017, 55(3): 163-168. DOI: 10.3760/cma.j.issn.0578-1310.2017.03.002. 國內現行的專家共識:定義與發生率、相關因素、臨床表現、導管前後血氧差與超聲診斷標準、治療原則、體外膜肺氧合的指徵與禁忌,以及早產兒支氣管肺發育不良併發肺動脈高壓的區分。引用於:新生兒持續肺動脈高壓
  144. 中華醫學會兒科學分會康復學組. 新生兒重症監護病房神經行為發育評估方法專家指導意見[J]. 中國實用兒科雜誌, 2017, 32(11): 801-806. DOI: 10.19538/j.ek2017110601.引用於:高危兒與早產兒早期干預、鮑秀蘭教授、NBNA 方法頁
  145. 中國醫師協會新生兒科醫師分會神經專業委員會. 新生兒動脈缺血性腦卒中臨床診治專家共識[J]. 中國當代兒科雜誌, 2017, 19(6): 611-613. DOI: 10.7499/j.issn.1008-8830.2017.06.001.引用於:術語表
  146. Hogarth P, Kurian MA, Gregory A, 等. Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN)[J]. Molecular Genetics and Metabolism, 2017, 120(3): 278-287. DOI: 10.1016/j.ymgme.2016.11.004. 泛酸激酶相關神經變性的國際臨床管理共識指南:診斷、對症用藥、肌張力障礙持續狀態、運動與輔具、進食、口腔、溝通、教育與應急預案。引用於:泛酸激酶相關神經變性
  147. Wassenberg T, Molero-Luis M, Jeltsch K, 等. Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency[J]. Orphanet Journal of Rare Diseases, 2017, 12(1): 12. DOI: 10.1186/s13023-016-0522-z. 國際神經遞質相關疾病工作組的共識指南:症狀構成、識別信號、確診路徑與治療原則。引用於:芳香族 L-氨基酸脫羧酶缺乏症
  148. Wakeling E L, Brioude F, Lokulo-Sodipe O, 等. Diagnosis and management of Silver-Russell syndrome: first international consensus statement[J]. Nature Reviews Endocrinology, 2017, 13(2): 105-124. DOI: 10.1038/nrendo.2016.138.引用於:Silver-Russell 綜合徵
  149. Chinsky JM, Singh R, Ficicioglu C, 等. Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations[J]. Genetics in Medicine, 2017, 19(12). DOI: 10.1038/gim.2017.101. 美加共識:以琥珀酰丙酮為新生兒篩查指標、尼替西農聯合飲食限制的管理方案,以及確診後的隨訪時間表。引用於:原發性酪氨酸血症
  150. Huemer M, Diodato D, Schwahn B, 等. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency[J]. Journal of Inherited Metabolic Disease, 2017, 40(1): 21–48. DOI: 10.1007/s10545-016-9991-4.引用於:甲基丙二酸血症
  151. Morris AA, Kožich V, Santra S, 等. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency[J]. Journal of Inherited Metabolic Disease, 2017, 40(1): 49–74. DOI: 10.1007/s10545-016-9979-0.引用於:同型半胱氨酸血症
  152. Welling L, Bernstein LE, Berry GT, 等. International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up[J]. Journal of Inherited Metabolic Disease, 2017, 40(2): 171–176. DOI: 10.1007/s10545-016-9990-5.引用於:半乳糖血症
  153. Boy N, Mühlhausen C, Maier EM, 等. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision[J]. Journal of Inherited Metabolic Disease, 2017, 40(1): 75–101. DOI: 10.1007/s10545-016-9999-9.引用於:戊二酸血症Ⅰ型、腦性癱瘓的鑑別與病因評估:何時需要進一步檢查、遺傳代謝病
  154. Adang LA, Sherbini O, Ball L, 等. Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies[J]. Molecular Genetics and Metabolism, 2017, 122(1-2): 18-32. DOI: 10.1016/j.ymgme.2017.08.006. 腦白質營養不良預防性與對症照護的國際共識:痙攣、髖與脊柱、骨量、餵養與胃造瘻、溝通、疼痛與易激惹的處理。引用於:Krabbe 病、白質消融性白質腦病
  155. Zarate YA, Fish JL. SATB2-associated syndrome: Mechanisms, phenotype, and practical recommendations[J]. American Journal of Medical Genetics Part A, 2017, 173(2): 327–337. DOI: 10.1002/ajmg.a.38022.引用於:SATB2 相關障礙
  156. van Wegberg AMJ, MacDonald A, Ahring K, 等. The complete European guidelines on phenylketonuria: diagnosis and treatment[J]. Orphanet Journal of Rare Diseases, 2017, 12(1): 162. DOI: 10.1186/s13023-017-0685-2.引用於:苯丙酮尿症
  157. Engelbert RH, Juul-Kristensen B, Pacey V, 等. The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers Danlos syndrome[J]. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2017, 175(1): 158-167. DOI: 10.1002/ajmg.c.31545. 國際聯盟的物理治療指南:物理治療在多學科管理中的位置、以功能—活動—參與為框架的評估,以及現有證據的侷限。引用於:Ehlers-Danlos 綜合徵
  158. 《中華兒科雜誌》編輯委員會, 中華醫學會兒科學分會兒童保健學組, 中華醫學會兒科學分會新生兒學組. 早產、低出生體重兒出院後餵養建議[J]. 中華兒科雜誌, 2016, 54(1): 6-12. DOI: 10.3760/cma.j.issn.0578-1310.2016.01.003.引用於:餵養困難與兒童營養諮詢
  159. Breugem CC, Evans KN, Poets CF, 等. Best Practices for the Diagnosis and Evaluation of Infants With Robin Sequence: A Clinical Consensus Report[J]. JAMA Pediatrics, 2016, 170(9): 894-902. DOI: 10.1001/jamapediatrics.2016.0796. 國際多學科共識:以小下頜、舌後墜與上氣道梗阻定義本病,建議做睡眠監測。支持本頁的定義與診斷路徑。引用於:Pierre Robin 序列徵
  160. Bornstein SR, Allolio B, Arlt W, 等. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline[J]. The Journal of Clinical Endocrinology and Metabolism, 2016, 101(2): 364–389. DOI: 10.1210/jc.2015-1710.引用於:X-連鎖腎上腺腦白質營養不良
  161. Fietz M, AlSayed M, Burke D, 等. Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis[J]. Molecular Genetics and Metabolism, 2016, 119(1–2): 160–167. DOI: 10.1016/j.ymgme.2016.07.011.引用於:神經元蠟樣脂褐質沉積症
  162. Munns CF, Shaw N, Kiely M, 等. Global consensus recommendations on prevention and management of nutritional rickets[J]. The Journal of Clinical Endocrinology & Metabolism, 2016, 101(2): 394-415. DOI: 10.1210/jc.2015-2175.
  163. Politei JM, Bouhassira D, Germain DP, 等. Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment[J]. CNS Neuroscience & Therapeutics, 2016, 22(7): 568–576. DOI: 10.1111/cns.12542.引用於:法佈雷病
  164. Paruthi S, Brooks L J, D’Ambrosio C, 等. Recommended amount of sleep for pediatric populations: a consensus statement of the American Academy of Sleep Medicine[J]. Journal of Clinical Sleep Medicine, 2016, 12(6): 785-786. DOI: 10.5664/jcsm.5866.引用於:兒童注意力不集中、家庭育兒指導課程
  165. 中華醫學會兒科學分會內分泌遺傳代謝學組, 等. 中國 Prader-Willi 綜合徵診治專家共識(2015)[J]. 中華兒科雜誌, 2015, 53(6): 419-424. DOI: 10.3760/cma.j.issn.0578-1310.2015.06.006.引用於:Prader-Willi 綜合徵、兒童罕見病、肌張力低下、餵養困難、身材矮小、日間嗜睡與睡眠節律紊亂、染色體與基因組印記異常、術語表
  166. 中國康復醫學會兒童康復專業委員會, 中國殘疾人康復協會小兒腦性癱瘓康復專業委員會, 《中國腦性癱瘓康復指南》編委會. 中國腦性癱瘓康復指南(2015):第一部分[J]. 中國康復醫學雜誌, 2015, 30(7): 747-754. DOI: 10.3969/j.issn.1001-1242.2015.07.028.引用於:兒童腦癱康復、運動訓練、小兒推拿
  167. Parikh S, Goldstein A, Koenig MK, 等. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society[J]. Genetics in Medicine, 2015, 17(9): 689–701. DOI: 10.1038/gim.2014.177.引用於:線粒體腦肌病
  168. Thornton PS, Stanley CA, De Leon DD, 等. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children[J]. The Journal of Pediatrics, 2015, 167(2): 238–245. DOI: 10.1016/j.jpeds.2015.03.057.引用於:先天性高胰島素性低血糖血症
  169. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genetics in Medicine, 2015, 17(5): 405-424. DOI: 10.1038/gim.2015.30.
  170. North KN, Wang CH, Clarke N, 等. Approach to the diagnosis of congenital myopathies[J]. Neuromuscular Disorders, 2014, 24(2): 97-116. DOI: 10.1016/j.nmd.2013.11.003. 先天性肌病國際照護標準委員會的診斷共識:共同特徵、鑑別診斷,以及臨床、活檢、肌肉磁共振與基因各自提示什麼。引用於:先天性肌病
  171. Pierpont ME, Magoulas PL, Adi S, 等. Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines[J]. Pediatrics, 2014, 134(4): e1149-62. DOI: 10.1542/peds.2013-3189. 2012 年國際共識會議形成的管理建議:按心臟、皮膚、神經、認知行為、胃腸、內分泌、骨骼、眼、耳等系統逐項列出確診時與隨訪中的安排。引用於:心-面-皮膚綜合徵
  172. Kishnani PS, Austin SL, Abdenur JE, 等. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics[J]. Genetics in Medicine, 2014, 16(11): e1. DOI: 10.1038/gim.2014.128.引用於:糖原累積病Ⅰ型
  173. Narayanaswami P, Weiss M, Selcen D, 等. Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies: report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine[J]. Neurology, 2014, 83(16): 1453-1463. DOI: 10.1212/WNL.0000000000000892. 美國神經病學學會與美國神經肌肉和電診斷醫學會的循證指南摘要:各分型的心臟與呼吸受累、多學科隨訪、運動的安全範圍與過度訓練的警示信號。學會現已將這份指南標註為退役(RETIRED)。引用於:肢帶型肌營養不良
  174. 中華醫學會兒科學分會免疫學組, 中華醫學會兒科學分會兒童保健學組, 中華醫學會兒科學分會消化學組, 等. 中國嬰幼兒牛奶蛋白過敏診治循證建議[J]. 中華兒科雜誌, 2013, 51(3): 183-186.引用於:餵養困難與兒童營養諮詢、術語表
  175. Deal C L, Tony M, Höybye C, 等. Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome[J]. The Journal of Clinical Endocrinology & Metabolism, 2013, 98(6): E1072-E1087. DOI: 10.1210/jc.2012-3888.引用於:Prader-Willi 綜合徵
  176. Krueger DA, Northrup H, International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference[J]. Pediatric Neurology, 2013, 49(4): 255–265. DOI: 10.1016/j.pediatrneurol.2013.08.002.引用於:結節性硬化症
  177. 中國醫師協會新生兒專業委員會. 早產兒腦損傷診斷與防治專家共識[J]. 中國當代兒科雜誌, 2012, 14(12): 883-884.
  178. Wang CH, Dowling JJ, North K, 等. Consensus statement on standard of care for congenital myopathies[J]. Journal of Child Neurology, 2012, 27(3): 363-382. DOI: 10.1177/0883073812436605. 同一委員會的照護共識,分神經、呼吸、骨科與康復、消化營養與口腔五部分;本頁的隨訪、麻醉、運動與支具安排以它為依據。引用於:先天性肌病
  179. Häberle J, Boddaert N, Burlina A, 等. Suggested guidelines for the diagnosis and management of urea cycle disorders[J]. Orphanet Journal of Rare Diseases, 2012, 7: 32. DOI: 10.1186/1750-1172-7-32.引用於:鳥氨酸氨甲酰基轉移酶缺乏症、精氨酸酶缺乏症、HHH 綜合徵
  180. Kölker S, Christensen E, Leonard JV, 等. Diagnosis and management of glutaric aciduria type I – revised recommendations[J]. Journal of Inherited Metabolic Disease, 2011, 34(3): 677–694. DOI: 10.1007/s10545-011-9289-5.引用於:戊二酸血症Ⅰ型
  181. Bassett AS, McDonald-McGinn DM, Devriendt K, 等. Practical guidelines for managing patients with 22q11.2 deletion syndrome[J]. The Journal of Pediatrics, 2011, 159(2): 332–339.e1. DOI: 10.1016/j.jpeds.2011.02.039.引用於:22q11.2 缺失綜合徵
  182. Laughlin J, Luerssen TG, Dias MS, 等. Prevention and management of positional skull deformities in infants[J]. Pediatrics, 2011, 128(6): 1236-1241. DOI: 10.1542/peds.2011-2220.
  183. Speiser PW, Azziz R, Baskin LS, 等. A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency[J]. International Journal of Pediatric Endocrinology, 2010, 2010: 494173. DOI: 10.1155/2010/494173.引用於:21-羥化酶缺乏症
  184. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. American Journal of Human Genetics, 2010, 86(5): 749-764. DOI: 10.1016/j.ajhg.2010.04.006.
  185. Miller DT, Adam MP, Aradhya S, 等. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. American Journal of Human Genetics, 2010, 86(5): 749–764. DOI: 10.1016/j.ajhg.2010.04.006.引用於:ADNP 綜合徵、染色體與基因組印記異常
  186. Nuorti JP, Whitney CG, Centers for Disease Control and Prevention (CDC). Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP)[J]. MMWR Recommendations and Reports, 2010, 59(RR-11): 1–18.引用於:脊髓性肌萎縮症
  187. Neul J L, Kaufmann W E, Glaze D G, 等. Rett syndrome: revised diagnostic criteria and nomenclature[J]. Annals of Neurology, 2010, 68(6): 944-950. DOI: 10.1002/ana.22124. RettSearch 國際聯盟修訂的診斷標準,國內指南據此制定中文版標準。引用於:Rett 綜合徵、Angelman 綜合徵、發育倒退、語言發育遲緩、手部刻板動作、孤獨症譜系障礙的鑑別與病因評估
  188. 中華醫學會兒科學分會內分泌遺傳代謝學組. 矮身材兒童診治指南[J]. 中華兒科雜誌, 2008, 46(6): 428-430.引用於:餵養困難與兒童營養諮詢、身材矮小、骨骼與結締組織、內分泌與生長、術語表
  189. 中華醫學會兒科學分會內分泌遺傳代謝學組, 《中華兒科雜誌》編輯委員會. 矮身材兒童診治指南[J]. 中華兒科雜誌, 2008, 46(6): 428-430.引用於:原發性生長激素缺乏症
  190. Arnold GL, Koeberl DD, Matern D, 等. A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency[J]. Molecular Genetics and Metabolism, 2008, 93(4): 363-370. DOI: 10.1016/j.ymgme.2007.11.002. 15 位遺傳代謝專家以 Delphi 法形成的診療共識方案,覆蓋篩查陽性嬰兒及其母親的初評、診斷與管理,各條建議屬專家意見層級。引用於:3-甲基巴豆酰輔酶 A 羧化酶缺乏症
  191. ACMG Work Group on Management of Pompe Disease, Kishnani PS, Steiner RD, Bali D, 等. Pompe disease diagnosis and management guideline[J]. Genetics in Medicine, 2006, 8(5): 267–288. DOI: 10.1097/01.gim.0000218152.87434.f3.引用於:糖原累積病Ⅱ型

研究論文982

  1. 劉昆, 趙海青, 張淇, 等. 13 例 2 型神經元蠟樣脂褐質沉積病患兒的臨床特徵分析[J]. 中華醫學雜誌, 2026, 106(15): 1493-1496. DOI: 10.3760/cma.j.cn112137-20260129-00328. 解放軍總醫院兒科醫學部 2018 至 2023 年確診並隨訪的 13 例。引用於:神經元蠟樣脂褐質沉積症
  2. Wang Y, Hui KY, Lu SF, 等. A double-blind randomized controlled trial of personalized upper-alpha neurofeedback in children with ADHD[J]. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 2026. DOI: 10.1111/jcpp.70188.引用於:神經反饋
  3. Abtahi-Naeini B, Heidari-Beni M, Rostampour N, 等. Acrodermatitis Dysmetabolica as a Cutaneous Manifestation of Isoleucine Deficiency in Maple Syrup Urine Disease: A Systematic Review of Reported Cases[J]. Health Science Reports, 2026, 9(10): e73230. DOI: 10.1002/hsr2.73230.引用於:楓糖尿症
  4. Xing SX, Hyman N, Kim DK, 等. Adherence to Pediatric Ophthalmology Follow-Up After Completion of Retinopathy of Prematurity: A Retrospective Review[J]. Patient Preference and Adherence, 2026, 20: 582716. DOI: 10.2147/PPA.S582716. 研究完成早產兒視網膜病變篩查後小兒眼科隨訪的實際完成情況。引用於:早產兒視網膜病變
  5. Jin JL, Wu D, Ding Y. Analysis of the clinical phenotype and genotype features of 5 cases of beta-ketothiolase deficiency[J]. BMC Pediatrics, 2026, 26(1): 183. DOI: 10.1186/s12887-026-06563-6. 北京兒童醫院 5 例患兒的臨床與基因分析:誘因、急性期血糖的兩種走向、與糖尿病酮症酸中毒的分辨、緩解期飲食與隨訪。引用於:β-酮硫解酶缺乏症
  6. Seneor D, Barile J, Mendes P, 等. Arthrogryposis Multiplex Congenita: Comprehensive Review from a Neuromuscular Standpoint[J]. Genes, 2026, 17(6): 675. DOI: 10.3390/genes17060675. 綜述:按中樞、前角細胞、周圍神經、神經肌肉接頭、肌肉、代謝與結締組織逐層梳理病因,並給出產前超聲表現與測序的診斷率。引用於:先天性多發性關節攣縮
  7. Doppler K, Sommer C. Autoimmune nodopathies: a clinical review[J]. Clinical Neurophysiology, 2026, 191: 2112341. DOI: 10.1016/j.clinph.2026.2112341.引用於:慢性炎性脫髓鞘性多發性神經根神經病
  8. González de Aledo-Castillo JM, Casado-Río M, Pajares S, 等. Classical Homocystinuria Incidentally Diagnosed Following a Normal Newborn Screening Result[J]. International Journal of Neonatal Screening, 2026, 12(3): 73. DOI: 10.3390/ijns12030073.引用於:同型半胱氨酸血症
  9. Wang S Q, Wu S N, Wei H Y, 等. Clinical and genetic characteristics of and diagnostic insights on KBG syndrome in Chinese patients: a retrospective study and literature review[J]. Orphanet Journal of Rare Diseases, 2026. DOI: 10.1186/s13023-026-04305-6. 鄭州大學附屬兒童醫院:65 例中國患者與 519 例非中國患者的比較。引用於:KBG 綜合徵
  10. Dong H, Li M, Ma M, 等. Clinical Characteristics of Childhood-Onset Myasthenia Gravis in a Large Chinese Cohort[J]. Pediatric Neurology, 2026, 179: 98–104. DOI: 10.1016/j.pediatrneurol.2026.03.014.引用於:先天性肌無力綜合徵、全身型重症肌無力
  11. Farsana MK, Holla VV, Dhar D, 等. Clinical, Radiological, and Therapeutic Profiles of Patients With DYT-TOR1A: A Single-Center Study in India and Literature Review of the Asian MDSGene Cohort[J]. Journal of Movement Disorders, 2026, 19(2): 192-198. DOI: 10.14802/jmd.25256. 印度一家中心 12 例基因確診患者的回顧,並與數據庫中的亞洲病例對比:起病部位、泛化所需時間與脊柱畸形的比例。引用於:DYT-TOR1A 肌張力障礙
  12. Chauvet-Piat E, François-Heude MC, Manes G, 等. CTNNB1-related disorders: clinical and radiological contributions from a French cohort[J]. Frontiers in Neurology, 2026, 17: 1754143. DOI: 10.3389/fneur.2026.1754143.引用於:CTNNB1 相關神經發育障礙
  13. Bruni G, Zuvadelli J, Bernabei SM, 等. Current Dietary Practices in Hereditary Fructose Intolerance: Results from a National Survey Across 15 Italian Metabolic Centres[J]. Nutrients, 2026, 18(16): 2609. DOI: 10.3390/nu18162609. 意大利 15 家代謝中心的飲食管理調查:糖醇與甜味劑的歸類、維生素補充、便秘的處理,各中心做法的一致與分歧。引用於:遺傳性果糖不耐受症
  14. Capurro C, Parodi S, Buttiglieri S, 等. Dental Management of Self-Injurious Behavior in Lesch-Nyhan Disease: A Patient- and Caregiver-Reported Outcome Study[J]. Children (Basel), 2026, 13(8): 1000. DOI: 10.3390/children13081000. 意大利 24 例的問卷調查:自傷的部位分佈、口內防護裝置與拔牙各自的使用情況,以及家庭一方的感受。引用於:Lesch-Nyhan 綜合徵
  15. Meng R, Kong L, Who Cst Team, 等. Development and Preliminary Findings of a Modified WHO Caregiver Skills Training Program for Children with Autism in Mainland China[J]. Behavioral Sciences (Basel, Switzerland), 2026, 16(7). DOI: 10.3390/bs16071159.引用於:家長介導干預
  16. Samanta D. Developmental and/or Epileptic Encephalopathy with Spike-Wave Activation in Sleep: From Thalamocortical Mechanisms to Precision Therapy[J]. Children (Basel), 2026, 13(8): 993. DOI: 10.3390/children13080993. 伴睡眠期棘慢波激活的發育性和/或癲癇性腦病的綜述:命名沿革、腦電圖特徵、檢查流程、鑑別診斷與各類治療的構成。引用於:Landau-Kleffner 綜合徵
  17. Yuan K, Zhu Y, Chen Y, 等. Diagnostic delay, misdiagnosis, and patient-reported psychosocial burden among Chinese individuals with McCune-Albright syndrome: a national cross-sectional survey[J]. Orphanet Journal of Rare Diseases, 2026. DOI: 10.1186/s13023-026-04507-y. 2024 年 11 月至 2025 年 6 月面向國內患者的問卷調查(152 例):首發症狀、確診所需時間,以及對上學與日常生活的影響。引用於:McCune-Albright 綜合徵
  18. Blair HA. Doxecitine and Doxribtimine: First Approval[J]. Paediatric Drugs, 2026, 28(2): 209–215. DOI: 10.1007/s40272-025-00734-1.引用於:線粒體腦肌病
  19. Gu L, Zhao J, Gong L, 等. Dried blood spot quality in newborn inherited metabolic disease screening in Beijing, 2020-2024: a retrospective analysis of incidence, causes, and improvement strategies[J]. BMC Pediatrics, 2026, 26(1). DOI: 10.1186/s12887-026-07116-7.引用於:苯丙酮尿症
  20. Wan Q, Ding Y, Liu W, 等. Effects of exercise training on skeletal muscle function in patients with mitochondrial myopathy: a systematic review[J]. Frontiers in Sports and Active Living, 2026, 8: 1710264. DOI: 10.3389/fspor.2026.1710264.引用於:線粒體腦肌病
  21. Hirano M, Garone C, Haas R, 等. Efficacy and safety of pyrimidine nucleos(t)ide therapy in thymidine kinase 2 deficiency[J]. Brain Communications, 2026, 8(3): fcag201. DOI: 10.1093/braincomms/fcag201.引用於:線粒體腦肌病
  22. Ju Y, Ji TY. Electro-clinical features of Mowat-Wilson syndrome: A retrospective study of 31 children in mainland China[J]. Epileptic Disorders, 2026, 28(2): 344–358. DOI: 10.1002/epd2.70149.引用於:Mowat-Wilson 綜合徵
  23. Plug BC, Man JHK, Breur M, 等. Endogenous Repair in Vanishing White Matter[J]. Annals of Neurology, 2026, 99(3): 737–747. DOI: 10.1002/ana.78083.引用於:腦性癱瘓的鑑別與病因評估:何時需要進一步檢查
  24. Jones C, Amendum P, DelVecchio M, 等. Etiologies of Acute Ataxia in Children: A Systematic Review of 1167 Subjects[J]. Journal of Child Neurology, 2026, 41(7): 933–938. DOI: 10.1177/08830738251396192.引用於:異染性腦白質營養不良
  25. Ta D, Downs J, Baynam G, 等. Functional skills in MECP2 duplication syndrome: developmental dynamics and regression[J]. Orphanet Journal of Rare Diseases, 2026, 21(1): 16. DOI: 10.1186/s13023-025-04008-4.引用於:MECP2 重複綜合徵
  26. Proepper CR, Schwarz LM, Schuetz SM, 等. Gene-specific long-term course, neurodevelopmental outcome and quality of life in patients with LIS1/PAFAH1B1-, DCX-, DYNC1H1-, TUBA1A- and TUBG1-related lissencephaly[J]. Orphanet Journal of Rare Diseases, 2026, 21(1): 206. DOI: 10.1186/s13023-026-04398-z.引用於:無腦回畸形
  27. Liu R Y, Wu Y J, Zou C C. Genetic and clinical characteristics of chromosome 15q11-q13 duplication syndrome in Chinese children[J]. American Journal of Medical Genetics Part A, 2026, 200(7): 1498-1514. DOI: 10.1002/ajmg.a.70100. 浙江大學醫學院附屬兒童醫院:22 例中國患兒。引用於:15q11.2-q13.1 重複綜合徵
  28. Hubert M, Gawęcki M. Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHADD)-Associated Ocular Pathology-A Narrative Review[J]. Diagnostics (Basel), 2026, 16(2): 295. DOI: 10.3390/diagnostics16020295. 本病眼部表現的綜述:脈絡膜視網膜病變的分期與進展、進行性近視、黃斑新生血管的發生率。引用於:長鏈 3-羥酰基輔酶 A 脫氫酶缺乏症
  29. Alashwal AA, Al-Fattani A, Ramzan K, 等. Long-Term Treatment for Laron Syndrome with IGF-1 Injection over 22 Years in Saudi Arabia: A Cohort Study[J]. Hormone Research in Paediatrics, 2026, 99(4): 469-479. DOI: 10.1159/000543047. 沙特 28 例隊列:首診年齡、嬰幼兒期低血糖、家系與近親婚配情況,以及治療期間記錄到的不良事件。引用於:萊倫氏綜合徵
  30. Servais A, Abi-Wardé MT, Arnoux JB, 等. Management of acute metabolic decompensation in maple syrup urine disease: guidance based on international clinical practice[J]. Orphanet Journal of Rare Diseases, 2026, 21(1). DOI: 10.1186/s13023-026-04418-y.引用於:楓糖尿症
  31. Shang Y, Xu J. Management of Lower-Extremity Deformity in Arthrogryposis Multiplex Congentia: A Narrative Review[J]. Medical Science Monitor, 2026, 32: e951581. DOI: 10.12659/MSM.951581. 敘述性綜述:髖、膝、足畸形按部位的處理原則與手術時機,以及按年齡段劃分的康復重點。題名中的拼寫照原文。引用於:先天性多發性關節攣縮
  32. Hopkin RJ, Byrne BJ, Dimachkie MM, 等. Miglustat: a first-in-class enzyme stabilizer for cipaglucosidase alfa for the treatment of late-onset Pompe disease[J]. Therapeutic Advances in Rare Disease, 2026, 7: 26330040261425686. DOI: 10.1177/26330040261425686.引用於:糖原累積病Ⅱ型
  33. Hu AC, George AM, Viswanathan A, 等. Patient-Reported Speech Outcomes in Patients with Beckwith-Wiedemann Syndrome[J]. Plastic and Reconstructive Surgery, 2026. DOI: 10.1097/prs.0000000000013004. 36 名 4 至 18 歲患者自評的言語、進食與呼吸情況,以及接受言語治療和舌減容手術的比例。引用於:Beckwith-Wiedemann 綜合徵
  34. Yang Y, Song A, Du H, 等. Pattern of height and weight development in a large cohort of underage Chinese pseudohypoparathyroidism patients from a single center[J]. Endocrine Connections, 2026, 15(6): e250865. DOI: 10.1530/ec-25-0865. 北京協和醫院 92 例經分子分型的Ⅰ型患者的身高、體重發育規律,是我國數據的來源。引用於:假性甲狀旁腺功能減退症
  35. Li T, Wang J, Li H, 等. Pediatric Extremity Vascular Malformations: Diagnosis, Referral, and Limb Management from a Pediatric Orthopedic Perspective[J]. Journal of Clinical Medicine, 2026, 15(10): 3833. DOI: 10.3390/jcm15103833. 從小兒骨科角度寫的綜述:高低流量的區分、凝血篩查、雙下肢不等長的判斷與隨訪,以及壓力衣、矯形器、鞋墊與步態訓練的位置。引用於:PIK3CA 相關過度生長綜合徵
  36. Mitchell JJ, Abdenur JE, de Boer F, 等. Phase 3 Randomized Trial Results of DTX401 AAV Gene Therapy for the Treatment of GSDIa[J]. Journal of Inherited Metabolic Disease, 2026, 49(5): e70241. DOI: 10.1002/jimd.70241. Ⅰa 型基因治療的Ⅲ期隨機雙盲安慰劑對照試驗,納入 8 歲及以上患者。引用於:糖原累積病Ⅰ型
  37. Kaempfen S, Cooper C, Schulzke SM, 等. Physical activity programmes for promoting bone mineralisation and growth in preterm infants[J]. Cochrane Database of Systematic Reviews, 2026, 9(9): CD005387. DOI: 10.1002/14651858.CD005387.pub4.引用於:嬰兒撫觸與被動操
  38. Vinciguerra C, Leale I, Rini N, 等. Physical Exercise in Myasthenia Gravis: A Systematic Review[J]. Healthcare (Basel), 2026, 14(8): 1100. DOI: 10.3390/healthcare14081100.引用於:全身型重症肌無力
  39. de Souza VG, Santos MS, Panno L, 等. Prevalence of motor development delay in children with craniosynostosis: a systematic review and meta-analysis[J]. European Journal of Pediatrics, 2026, 185(5): 331. DOI: 10.1007/s00431-026-06980-w. 8 項研究、510 名顱縫早閉兒童術前運動發育的系統綜述與薈萃分析,樣本以非綜合徵性為主。引用於:綜合徵性顱縫早閉
  40. Zhou Y, Hao Z, Zhuang Q, 等. Real-World Effectiveness and Safety of Eliglustat in Adult Patients with Gaucher Disease Type 1: A Multicenter Retrospective Study in China[J]. Journal of Clinical Medicine, 2026, 15(6): 2323. DOI: 10.3390/jcm15062323.引用於:戈謝病
  41. Klintö K, Schaar Johansson M, Brunnegård K, 等. Speech Outcomes in 5-Year-Olds Born With Cleft Palate With and Without Robin Sequence-A Swedish Registry Study[J]. The Cleft Palate-Craniofacial Journal, 2026, 63(10): 3247-3257. DOI: 10.1177/10556656251387538. 瑞典唇顎裂登記庫 433 名 5 歲兒童的言語結局,按是否伴本病及其他問題分四組比較。引用於:Pierre Robin 序列徵
  42. Watanabe D, Hasebe Y, Maebayashi Y, 等. Sudden Release of a Fixed Contracture as a Clue to Occult Humeral Fracture in a Neonate With Arthrogryposis Multiplex Congenita[J]. Cureus, 2026, 18(7): e112944. DOI: 10.7759/cureus.112944. 病例報告:新生兒在清洗腋窩後發生肱骨幹骨折,最早的表現是原本固定的姿勢突然鬆開;文中給出日常護理的托扶要點。引用於:先天性多發性關節攣縮
  43. Qu L, Colombi C, Chen W, 等. The Efficacy of a Culturally-Adapted Group-based Parent Coaching Program for Autistic Children in China via Telehealth: A Randomized Controlled Trial[J]. Journal of Autism and Developmental Disorders, 2026, 56(1): 26-44. DOI: 10.1007/s10803-024-06543-8.引用於:家長介導干預
  44. Lan D, Zhang S, Li J, 等. (Epi)genotype-phenotype correlations of Beckwith-Wiedemann syndrome in China[J]. Italian Journal of Pediatrics, 2025, 51(1): 276. DOI: 10.1186/s13052-025-02122-4. 復旦大學附屬兒科醫院 2013 至 2022 年 242 例患兒的回顧性研究:各項表現的比例、分子分型構成與分型和表現的對應關係。引用於:Beckwith-Wiedemann 綜合徵
  45. 王琳. 兒童語言障礙早期特徵及干預[J]. 中國實用兒科雜誌, 2025, 40(7): 545-548. DOI: 10.19538/j.ek2025070604.引用於:語言發育遲緩與構音障礙、家長實施的語言干預
  46. Bess J, Brown T, Bhala S, 等. A literature review and pooled case analysis of cardiofaciocutaneous syndrome to estimate cancer risk[J]. Genetics in Medicine, 2025, 27(7): 101423. DOI: 10.1016/j.gim.2025.101423. 彙總 198 篇文獻共 690 例的系統綜述,估計本病的腫瘤發生比例與年齡分佈。引用於:心-面-皮膚綜合徵
  47. Fabiano GA, Schatz NK, Merrill BM, 等. A randomized, controlled trial to evaluate the efficacy of a daily report card intervention to enhance the efficacy of individualized education programs for children with attention-deficit/hyperactivity disorder[J]. Journal of Consulting and Clinical Psychology, 2025, 93(7): 484-499. DOI: 10.1037/ccp0000959.引用於:康復與干預方法
  48. Harutyunyan L, D'Incal CP, Jansen AC, 等. A Systematic Review Illustrates the Expanding Clinical and Molecular Landscape of Helsmoortel-Van der Aa Syndrome[J]. Brain Sciences, 2025, 16(1): 4. DOI: 10.3390/brainsci16010004.引用於:ADNP 綜合徵
  49. Gil CB, Paz D, Pinales BE, 等. A Zebrafish Seizure Model of cblX Syndrome Reveals a Dose-Dependent Response to mTor Inhibition[J]. Journal of Developmental Biology, 2025, 14(1). DOI: 10.3390/jdb14010002.引用於:同型半胱氨酸血症
  50. Simpson AJ, McLellan A, Behl KE, 等. Alternating Hemiplegia of Childhood and ATP1A3-Related Diseases: Insights From a Decade of Discovery and Collaboration[J]. Neurology Genetics, 2025, 11(5): e200308. DOI: 10.1212/NXG.0000000000200308. 基因發現十週年專題會議的綜述:氟桂利嗪的使用與停藥、多系統受累、多學科照護與病名的討論。引用於:兒童交替性偏癱
  51. Yu X, Zhang X, Qiu S, 等. Analysis of clinical features and genetic variants in Chinese children with pyridoxine-dependent epilepsy: a case series study[J]. Frontiers in Neurology, 2025, 16: 1609600. DOI: 10.3389/fneur.2025.1609600. 國內 6 名患兒的病例系列:圍產期表現、熱敏感的發作、開始規律用藥的時間與發育結局,以及中國患兒的熱點變異。引用於:吡哆醇依賴性癲癇
  52. Wagner M, Berecki G, Fazeli W, 等. Antisense oligonucleotide treatment in a preterm infant with early-onset SCN2A developmental and epileptic encephalopathy[J]. Nature Medicine, 2025, 31(7): 2174-2178. DOI: 10.1038/s41591-025-03656-0. 一例功能增強型變異的早產兒經擴展使用項目接受反義寡核苷酸 elsunersen 鞘內給藥的個案報告;文中列出本病各表型的 OMIM 編號。引用於:SCN2A 相關疾病
  53. Pauluka E, Ceolin LS, Fontanela LC, 等. Aquatic Compared With Land-Based Exercises on Gross Motor Function of Children/Adolescents With Cerebral Palsy: A Systematic Review With Meta-Analysis[J]. Child: Care, Health and Development, 2025, 51(1): e70023. DOI: 10.1111/cch.70023.引用於:康復與干預方法
  54. Burlina A, Ardissone A, Battini R, 等. Arginase 1 deficiency: a treatable form of spastic paraplegia[J]. Neurological Sciences, 2025, 46(9): 4219–4228. DOI: 10.1007/s10072-025-08153-3.引用於:精氨酸酶缺乏症
  55. Liu H, Yi S, Li Y, 等. Association between screen exposure and language development delay during the COVID-19 pandemic for 18-72 months children in China: evidence from a cross-sectional study[J]. BMC Public Health, 2025, 25(1): 3889. DOI: 10.1186/s12889-025-25050-8. S-S 法各階段及其對應年齡見該文補充材料表 S1。引用於:S-S 法、構音與語音訓練
  56. Woo H, Lee SU, Yun D, 等. Attention-deficit/hyperactivity disorder in children with a history of febrile seizures: a systematic review and meta-analysis[J]. European Journal of Pediatrics, 2025, 184(7): 442. DOI: 10.1007/s00431-025-06285-4.引用於:亞歷山大病
  57. Wright B, Blackwell JE, Bell KJ, 等. Autism Spectrum Social Stories in Schools Trial 2 (ASSSIST-2): a pragmatic randomised controlled trial of the Social Stories™ intervention to address the social and emotional health of autistic children in UK primary schools[J]. Child and Adolescent Mental Health, 2025, 30(1): 4-12. DOI: 10.1111/camh.12740.引用於:社交故事
  58. Yuill N, Elphick C, Marshall J, 等. Behavioral profiles and social relationships in Wiedemann-Steiner syndrome: parent reports on 25 cases[J]. Orphanet Journal of Rare Diseases, 2025, 20(1): 154. DOI: 10.1186/s13023-025-03643-1. 25 位英美家長的深度訪談:社交動機強而不設防、與照料者關係緊密、換環節困難與衝動、感覺敏感,以及家長在家裡用過的應對辦法。引用於:Wiedemann-Steiner 綜合徵
  59. Rogers DJ, Hudock RL, Dimian AF, 等. Characterisation of Challenging Behaviours and Associated Genetic and Neurological Features in Cardiofaciocutaneous Syndrome[J]. Journal of Intellectual Disability Research, 2025, 69(8): 682-692. DOI: 10.1111/jir.13247. 61 例照護者問卷:自傷、攻擊等挑戰行為的比例、年齡分佈、行為功能,以及與睡眠、疼痛和感覺調節的關係。引用於:心-面-皮膚綜合徵
  60. Yang RM, Feng T, Cai W, 等. Chinese Multidisciplinary Expert Consensus on Orphan/Anticopper Drugs and Other Non-drug Management of Hepatolenticular Degeneration[J]. Current Neuropharmacology, 2025, 23(13): 1683–1708. DOI: 10.2174/011570159X349587250311072553.引用於:肝豆狀核變性
  61. Zhang M J, Zhang S M, Zhang Q P, 等. Clinical and genetic characteristics of glucose transporter 1 deficiency syndrome in a large cohort of Chinese patients[J]. World Journal of Pediatrics, 2025, 21(3): 274-283. DOI: 10.1007/s12519-025-00884-9. 北京大學第一醫院兒科:90 例中國患者。引用於:GLUT1 缺乏綜合徵
  62. Zhao P, Tan L, Meng Q, 等. Clinical and genetic characterization of congenital disorders of glycosylation in 20 Chinese patients[J]. Orphanet Journal of Rare Diseases, 2025, 20(1): 625. DOI: 10.1186/s13023-025-04075-7. 武漢兒童醫院 2018–2025 年經全外顯子組測序確診的 20 例先天性糖基化障礙,其中 PMM2-CDG 3 例。引用於:PMM2-CDG
  63. Ngoh A, Clark M, Greenaway R, 等. Clinical and Molecular Genetic Characterization of Landau Kleffner Syndrome: An Observational Cohort and Experimental Study[J]. Annals of Neurology, 2025, 98(5): 951-966. DOI: 10.1002/ana.27306. 英國一家兒童神經專科中心 52 例患兒的隊列:起病年齡、伴隨表現、語言與成年期結局,以及 GRIN2A 變異的比例與功能研究。引用於:Landau-Kleffner 綜合徵
  64. Ladd JM, Pyle-Eilola AL, Mamilly L, 等. Clinical Presentation of Congenital Hypopituitarism: Lessons From a Large Academic Centre[J]. Clinical Endocrinology, 2025, 102(6): 649–655. DOI: 10.1111/cen.15213.引用於:原發性生長激素缺乏症
  65. Kahraman AB, Yıldız Y, Dursun A, 等. Comparison of Ketogenesis and Ketolysis Defects: A Retrospective Single-Center Study of 30 Patients[J]. Turkish Archives of Pediatrics, 2025, 60(5): 491-499. DOI: 10.5152/turkarchpediatr.2025.25156. 酮體生成障礙與酮體利用障礙的單中心對照:兩類病在起病年齡、酸中毒程度與生化特徵上的差別。引用於:β-酮硫解酶缺乏症
  66. da Silva NN, Cavalcante WA, Tertuliano ALO, 等. Conductive Education for Children With Cerebral Palsy: A Systematic Review of Outcomes, Practice Time and Motor Performance Assessment[J]. Child: Care, Health and Development, 2025, 51(5): e70149. DOI: 10.1111/cch.70149.引用於:引導式教育(CE)
  67. Grabala P. Congenital Scoliosis: A Comprehensive Review of Diagnosis, Management, and Surgical Decision-Making in Pediatric Spinal Deformity-An Expanded Narrative Review[J]. Journal of Clinical Medicine, 2025, 14(22): 8085. DOI: 10.3390/jcm14228085.引用於:先天性脊柱側凸
  68. Romeo DJ, Wagner CS, Banala M, 等. Conservative Management of Macroglossia in Beckwith-Wiedemann Syndrome[J]. Pediatrics, 2025, 155(4): e2024068618. DOI: 10.1542/peds.2024-068618. 320 例巨舌患兒的回顧:3 歲以內未做手術者的比例,以及這部分孩子的阻塞性睡眠呼吸暫停與巨舌分級隨年齡的變化。引用於:Beckwith-Wiedemann 綜合徵
  69. Ocampo-Navia MI, Perez-Mendez W, Rodriguez-Alvarez MP, 等. Dandy-Walker syndrome: an updated literature review[J]. Child's Nervous System, 2025, 41(1): 194. DOI: 10.1007/s00381-025-06842-0.引用於:Dandy-Walker 畸形
  70. Goad BS, Rodda J, Allen M, 等. Development and Adaptive Function in Individuals With SCN2A-Related Disorders[J]. Neurology, 2025, 105(3): e213868. DOI: 10.1212/WNL.0000000000213868. 國際自然史研究 100 例:各表型亞組達到的運動與語言里程碑、功能分級、適應行為,以及發育停滯或倒退的時間與誘因。引用於:SCN2A 相關疾病
  71. Gragnaniello V, Puma A, Gueraldi D, 等. Diagnosis of glutaric aciduria type I based on neuroradiological findings: when neonatal screening fails[J]. Italian Journal of Pediatrics, 2025, 51(1): 137. DOI: 10.1186/s13052-025-01975-z.引用於:亞歷山大病、Canavan 病
  72. Tan Z, Wang J, Feng J, 等. Differential item functioning in neonatal behavioral neurological assessment in high-risk full-term infants in NICU based on a machine learning approach[J]. Frontiers in Neuroscience, 2025, 19: 1681152. DOI: 10.3389/fnins.2025.1681152.引用於:NBNA 方法頁
  73. Laron Z. Disabilities and Handicaps of Patients with Laron Syndrome[J]. Children (Basel), 2025, 12(9): 1271. DOI: 10.3390/children12091271. 以色列 76 例隨訪隊列從嬰兒期到成年的功能受限:肌力與活動、髖關節、視聽、學校環境與心理社會適應。引用於:萊倫氏綜合徵
  74. Zhu L, Tang Z, Hu J, 等. Disease burden and health-related quality of life among children with X-linked hypophosphataemia in China: a national cross-sectional survey[J]. BMJ Paediatrics Open, 2025, 9(1): e003165. DOI: 10.1136/bmjpo-2024-003165.引用於:低磷性佝僂病
  75. Almuhanna SM, 等. Effectiveness of early intervention programs for young children with global developmental delay: a systematic review[J]. Galen Medical Journal, 2025, 14: e3906.引用於:全面發育遲緩
  76. Huang CH, Chen CY, Lin HW, 等. Effects of Whole-Body Vibration Therapy on Physical Function in Children With Cerebral Palsy: A Systematic Review and Meta-Analysis of Randomized Clinical Trials[J]. Physical Therapy, 2025, 105(6). DOI: 10.1093/ptj/pzaf052.引用於:康復與干預方法
  77. Aukes R, Albersen M, Boelen A, 等. Evaluation of Newborn Screening for Diseases Using C5-OH as a Marker: Systematic Review of the Literature and Evaluation of 17 Years of C5-OH Screening in the Netherlands[J]. Journal of Inherited Metabolic Disease, 2025, 48(5): e70088. DOI: 10.1002/jimd.70088. 荷蘭 17 年 C5OH 篩查數據與 58 篇文獻的系統綜述:陽性預測值、同一指標升高的各種疾病、母源性陽性與各國篩查政策。引用於:3-甲基巴豆酰輔酶 A 羧化酶缺乏症
  78. Mole SE, Gissen P, Nordstrom S, 等. Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United Kingdom[J]. Orphanet Journal of Rare Diseases, 2025, 20(1): 223. DOI: 10.1186/s13023-025-03747-8.引用於:神經元蠟樣脂褐質沉積症
  79. Lopez RD, Hall CE, Sussman JH, 等. Evolution of discrepancies in limb asymmetry in Beckwith-Wiedemann spectrum[J]. Journal of Children’s Orthopaedics, 2025, 19(6): 463-472. DOI: 10.1177/18632521251384575. 142 例分子確診患兒的肢體圍度與手足長度隨訪:兩側差異的變化速度,以及分型對差異大小的影響。引用於:Beckwith-Wiedemann 綜合徵
  80. Sartor BCP, de Oliveira BM, Teruya KI, 等. Feeding Difficulties in Children with Hepatic Glycogen Storage Diseases Identified by a Brazilian Portuguese Validated Screening Tool[J]. Nutrients, 2025, 17(11): 1758. DOI: 10.3390/nu17111758. 29 名 6 月齡至 7 歲以下肝型糖原累積病患兒(Ⅰa 型 15 名、Ⅰb 型 5 名)的進食困難調查。引用於:糖原累積病Ⅰ型
  81. Comper F, Miranda CJ, Liou B, 等. FLT201, a novel liver-directed AAV gene therapy candidate for Gaucher disease type 1[J]. Molecular Therapy, 2025, 33(8): 3789–3807. DOI: 10.1016/j.ymthe.2025.05.003.引用於:戈謝病
  82. Rodan LH, Stoler J, Chen E, et al. Genetic evaluation of the child with intellectual disability or global developmental delay: clinical report[J]. Pediatrics, 2025, 156(1): e2025072219. DOI: 10.1542/peds.2025-072219.
  83. Yang T, Fang D, Zhu W, 等. Genotype-phenotype correlations in 9q34.3 microdeletion syndrome: a study of 35 Mainland Chinese patients[J]. Orphanet Journal of Rare Diseases, 2025, 21(1): 22. DOI: 10.1186/s13023-025-04076-6. 上海交通大學醫學院附屬新華醫院等:2020 至 2024 年收集的 35 例中國大陸患者。引用於:Kleefstra 綜合徵
  84. Zhang Y, Shi X, Huang J, 等. Genotypic and phenotypic characteristics of pediatric X-adrenoleukodystrophy in a Chinese cohort[J]. Neuropsychiatric Disease and Treatment, 2025, 21: 677-687. DOI: 10.2147/NDT.S507632. 14 例中國男孩,全部為兒童腦型。引用於:X-連鎖腎上腺腦白質營養不良
  85. Roy SM, Trejo A, McReynolds J, 等. High Rates of Dysphagia and Silent Aspiration in Infants With Prader-Willi Syndrome[J]. American Journal of Medical Genetics Part A, 2025, 197(10): e64121. DOI: 10.1002/ajmg.a.64121.引用於:Prader-Willi 綜合徵
  86. Xie H, He P, Sheng Q, 等. Highlighting cardiovascular manifestations of kleefstra syndrome: literature review and clinical insights[J]. BMC Cardiovascular Disorders, 2025, 25(1): 175. DOI: 10.1186/s12872-025-04610-1.引用於:Kleefstra 綜合徵
  87. Evans DG, Blakeley JO, Plotkin SR. History and clinical epidemiology of NF2-related schwannomatosis[J]. Familial Cancer, 2025, 24(4): 79. DOI: 10.1007/s10689-025-00504-5.引用於:神經纖維瘤病
  88. Ting SL, Yakob Y, Sani HA, 等. Holocarboxylase Synthetase Deficiency: Clinical, Biochemical and Molecular Findings in Five Malaysian Patients Including a Newborn Presenting as Collodion Baby[J]. JIMD Reports, 2025, 66(2): e70006. DOI: 10.1002/jmd2.70006. 5 例病例系列,隨訪最長至 30 歲:皮疹先於急性發作、感染誘發失代償、同胞出生後即篩查,以及按症狀調整生物素劑量的做法。引用於:全羧化酶合成酶缺乏症
  89. Beales PL, Cetiner M, Haqq AM, 等. Hyperphagia in Bardet-Biedl syndrome: Pathophysiology, burden, and management[J]. Obesity Reviews, 2025, 26(7): e13915. DOI: 10.1111/obr.13915.引用於:Bardet-Biedl 綜合徵
  90. Huang H, Geng J, Long Y, 等. Improving variant interpretation and diagnosis in Koolen-de Vries syndrome through a curated genotype-phenotype repository[J]. Molecular Genetics and Genomics, 2025, 301(1): 10. DOI: 10.1007/s00438-025-02322-x. 四川大學華西醫院:用基因型-表型數據庫篩查國內罕見病隊列。引用於:Koolen-de Vries 綜合徵
  91. Edmondson AC, Honzík T, Lam C, 等. Incidence and prevalence of phosphomannomutase 2-congenital disorder of glycosylation: Past, present, and future[J]. Molecular Genetics and Metabolism, 2025, 146(1-2): 109188. DOI: 10.1016/j.ymgme.2025.109188.引用於:PMM2-CDG
  92. Huang S, Yao Q, Kong F, 等. Incidence of Organic Acid Disorders in 13 Million Chinese Newborns: A Systematic Review and Meta-Analysis[J]. International Journal of Neonatal Screening, 2025, 11(4): 113. DOI: 10.3390/ijns11040113. 國內 57 項串聯質譜新生兒篩查研究的彙總,共 13,314,056 名新生兒,列出各種有機酸代謝病的檢出例數。引用於:全羧化酶合成酶缺乏症
  93. Huang S, Yao Q, Kong F, 等. Incidence of Organic Acid Disorders in 13 Million Chinese Newborns: A Systematic Review and Meta-Analysis[J]. International Journal of Neonatal Screening, 2025, 11(4): 113. DOI: 10.3390/ijns11040113. 彙總我國 57 項新生兒篩查研究、1331 萬名新生兒的薈萃分析,給出各種有機酸代謝病的發生率與構成。引用於:3-甲基巴豆酰輔酶 A 羧化酶缺乏症
  94. Nishimura A, Tamura A, Fujikawa T, 等. KMT2A-CBL fusion gene in the first reported case of T-cell acute lymphoblastic leukemia associated with Wiedemann-Steiner syndrome[J]. International Journal of Hematology, 2025, 122(1): 153-158. DOI: 10.1007/s12185-025-03975-5. 1 例 17 歲患者發生 T 細胞急性淋巴細胞白血病的個案報告;作者指出本病與白血病的關係有待進一步研究。引用於:Wiedemann-Steiner 綜合徵
  95. Low KJ, Walker M, Treneman-Evans G, 等. Life Beyond Childhood: Insight Into the Lived Experience of 91 Adults With KBG Syndrome Through an Online Patient/Caregiver-Reported Co-Produced Questionnaire[J]. Brain and Behavior, 2025, 15(5): e70553. DOI: 10.1002/brb3.70553.引用於:KBG 綜合徵
  96. Schoen SA, Balderrama R, Dopheide E, 等. Methodological Components for Evaluating Intervention Effectiveness of SOS Feeding Approach: A Feasibility Study[J]. Children (Basel, Switzerland), 2025, 12(3). DOI: 10.3390/children12030373.引用於:餵養與吞嚥治療
  97. Tenenbaum A, Yaakov AB, Peled Y, 等. Middle Ear Disorders in Children with Down Syndrome: The Detrimental Effect on Speech and Language Development[J]. Children (Basel), 2025, 12(5): 558. DOI: 10.3390/children12050558.引用於:21 三體綜合徵
  98. Al Ojaimi M, Banimortada BJ, Alragheb A, 等. Molecular and clinical aspects of histone-related disorders[J]. Human Genomics, 2025, 19(1): 47. DOI: 10.1186/s40246-025-00734-9.引用於:Sotos 綜合徵
  99. Dweikat IM, Abdul-Hafez HA, Zayed A, 等. Molecular characterization, clinical phenotype, and neurological outcome of twelve Palestinian children with beta-ketothiolase deficiency: report of two novel variants in the ACAT1 gene[J]. BMC Medical Genomics, 2025, 18(1): 106. DOI: 10.1186/s12920-025-02175-8. 12 例患兒的逐例記錄:發作時的表現與誘因、急性期處理、發作次數隨年齡的變化與神經系統轉歸。引用於:β-酮硫解酶缺乏症
  100. Schwantje M, van Brussel M, Takken T, 等. Myopathic Symptoms and Exercise Tolerance in Adolescent Patients With Long-Chain Fatty Acid Oxidation Disorders[J]. Journal of Inherited Metabolic Disease, 2025, 48(5): e70070. DOI: 10.1002/jimd.70070. 荷蘭 14 名青少年患者(其中本病 4 名)的運動試驗與肌肉症狀調查:嚴重肌痛出現的年齡與誘因,進食充分條件下的運動耐受情況。引用於:長鏈 3-羥酰基輔酶 A 脫氫酶缺乏症
  101. Biscarini F, Barateau L, Pizza F, 等. Narcolepsy and rapid eye movement sleep[J]. Journal of Sleep Research, 2025, 34(2): e14277. DOI: 10.1111/jsr.14277.引用於:發作性睡病
  102. Chakkarapani E, de Vries LS, Ferriero DM, 等. Neonatal encephalopathy and hypoxic-ischemic encephalopathy: the state of the art[J]. Pediatric Research, 2025, 98(7): 2444-2458. DOI: 10.1038/s41390-025-03986-2.
  103. Weixel T, Adedipe D, Muldoon G, 等. Neurodevelopmental profiles of 14 individuals with phosphomannomutase deficiency (PMM2-CDG)[J]. Journal of Inherited Metabolic Disease, 2025, 48(1): e12782. DOI: 10.1002/jimd.12782. 14 名 2–33 歲患者的前瞻性評估:認知與適應行為、運動和語言里程碑的獲得月齡,以及周圍神經、眼與聽力的受累情況。引用於:PMM2-CDG
  104. Gaudet I, Gagnon SP, Hamel S, 等. Neuropsychological and behavioral outcomes in childhood-onset myotonic dystrophy type 1 through lifespan: a scoping review[J]. Neuromuscular Disorders, 2025, 56-57: 106263. DOI: 10.1016/j.nmd.2025.106263.引用於:肌強直性營養不良
  105. Zhang S, Li X, Ye S, 等. Newborn screening for fatty acid oxidation disorders: epidemiological and genetic findings in Southeastern China[J]. BMC Pediatrics, 2025, 25(1): 863. DOI: 10.1186/s12887-025-06250-y. 我國東南沿海 21 萬餘名新生兒的脂肪酸氧化障礙篩查:各病種的檢出率、本病召回複查時酰基肉鹼回落的比例與隨訪所見。引用於:多種酰基輔酶 A 脫氫酶缺乏症
  106. Zhang S, Li X, Ye S, 等. Newborn screening for fatty acid oxidation disorders: epidemiological and genetic findings in Southeastern China[J]. BMC Pediatrics, 2025, 25(1): 863. DOI: 10.1186/s12887-025-06250-y. 我國東南沿海一個地區 21 萬餘名新生兒的脂肪酸氧化障礙篩查結果,含各病種的例數。引用於:長鏈 3-羥酰基輔酶 A 脫氫酶缺乏症
  107. Han D, Tao Y, Li J, 等. Newborn screening for inherited metabolic disorders in central China: a retrospective study of 153,956 infants using non-derivatized tandem mass spectrometry[J]. Scientific Reports, 2025, 16(1): 645. DOI: 10.1038/s41598-025-33087-3.引用於:苯丙酮尿症
  108. Pereira D, Santos T, Janeiro P, 等. Palliative Care Approach in a Case of Severe Nonketotic Hyperglycinemia With Long Survival: A Case Report[J]. Cureus, 2025, 17(9): e91636. DOI: 10.7759/cureus.91636. 一例重型患兒存活至 7 歲的病例報告,記錄了多學科與兒童舒緩醫療團隊的照護安排、家用輔具與呼吸支持。引用於:非酮性高甘氨酸血症
  109. Trucco F, Albamonte E, Pane M, 等. Parental diagnostic delay and developmental outcomes in congenital and childhood-onset myotonic dystrophy type 1[J]. Developmental Medicine and Child Neurology, 2025, 67(3): 365–373. DOI: 10.1111/dmcn.16079.引用於:肌強直性營養不良
  110. Chałupka-Borowska A, Sobieska M. Peabody Developmental Motor Scales-Second Edition: A Reliable Tool for Assessing Motor Development in Children[J]. Journal of Clinical Medicine, 2025, 14(24): 8936. DOI: 10.3390/jcm14248936.引用於:糖原累積病Ⅱ型、戈謝病、面肩肱型肌營養不良症、法佈雷病
  111. Crisafulli O, Diotti D, Negro M, 等. Physical exercise in metabolic myopathies at risk of rhabdomyolysis: a feasible approach or an unavoidable hazard?[J]. European Journal of Applied Physiology, 2025, 125(11): 3039-3064. DOI: 10.1007/s00421-025-05922-y. 有橫紋肌溶解風險的代謝性肌病能不能運動、怎麼運動的系統梳理,逐病列出已發表的訓練方案與樣本量。引用於:極長鏈酰基輔酶 A 脫氫酶缺乏症
  112. Todhunter-Brown A, Sellers CE, Baer GD, 等. Physical rehabilitation approaches for the recovery of function and mobility following stroke[J]. Cochrane Database of Systematic Reviews, 2025, 2(2): CD001920. DOI: 10.1002/14651858.CD001920.pub4.引用於:Bobath 療法(NDT)、康復與干預方法
  113. Gragnaniello V, Gaiga G, Cazzorla C, 等. Psychological Impact of Newborn Screening for 3-Methylcrotonyl-CoA Carboxylase Deficiency: The Parental Experience[J]. International Journal of Neonatal Screening, 2025, 11(4): 115. DOI: 10.3390/ijns11040115. 意大利東北部十餘年的篩查與隨訪:確診流程、應急方案與年度隨訪的做法、肉鹼補充,以及家長在確診前後的心理感受。引用於:3-甲基巴豆酰輔酶 A 羧化酶缺乏症
  114. Xu J, Zhao W, Yan Z, 等. REM Density, Leg Movements, and REM Sleep without Atonia: Differentiating Type 1 from Type 2 Narcolepsy Through Polysomnographic Analysis, a Preliminary Study[J]. Nature and Science of Sleep, 2025, 17: 2079–2089. DOI: 10.2147/NSS.S535919. 方法部分列出《睡眠障礙國際分類》第 3 版對 1 型與 2 型發作性睡病的診斷標準。引用於:發作性睡病
  115. Kuok MCI, Chan WKY. Rhabdomyolysis in Children: A State-of-the-Art Review[J]. Children, 2025, 12(4): 492. DOI: 10.3390/children12040492.引用於:血清肌酸激酶升高
  116. Pope L, Light J, Laubscher E. The Effect of Naturalistic Developmental Behavioral Interventions and Aided AAC on the Language Development of Children on the Autism Spectrum with Minimal Speech: A Systematic Review and Meta-analysis[J]. Journal of Autism and Developmental Disorders, 2025, 55(9): 3078-3099. DOI: 10.1007/s10803-024-06382-7.引用於:輔助與替代溝通(AAC)
  117. van Buuren S, Dusseldorp E, Doove L, 等. The Global Scales for Early Development (GSED): metric and measurement properties[J]. International Journal of Behavioral Development, 2025. DOI: 10.1177/01650254241294033. 世界衛生組織全球早期發展量表的條目難度參照(D-score),七國樣本含中國站點;參照人群不等於中國常模引用於:高危兒與早產兒早期干預、全面發育遲緩、兒童發育與行為評估、寶秀蘭兒童神經發育綜合評估系統、評估量表一覽
  118. Wang Q, Duan J, Zhao X, 等. The incidence rate and gene mutation characteristics of hyperphenylalaninemia in Yunnan Province, Southwest China[J]. Orphanet Journal of Rare Diseases, 2025, 20(1): 606. DOI: 10.1186/s13023-025-04114-3.引用於:苯丙酮尿症
  119. Dang C, Zhu Y, Luo X, 等. The promoting effects of digital targeted cognitive training in medication treatment for children with ADHD: a randomized controlled trial[J]. BMC Medicine, 2025, 23(1): 371. DOI: 10.1186/s12916-025-04192-x.引用於:注意力與認知訓練
  120. Zhang M J, Zhang S M, Zhang Q P, 等. The relationship between genotype and phenotype in Chinese children with glucose transporter type 1 deficiency syndrome[J]. Frontiers in Neurology, 2025, 16: 1638549. DOI: 10.3389/fneur.2025.1638549. 同一團隊對 93 例患兒的基因型-表型分析。引用於:GLUT1 缺乏綜合徵
  121. Anitha V, Nallasamy N, Christy JS, 等. Understanding Keratoconus in Down Syndrome: From Etiology to Management - A Narrative Review[J]. Clinical Ophthalmology, 2025, 19: 4925–4939. DOI: 10.2147/OPTH.S556378.引用於:21 三體綜合徵
  122. Wilkinson NR, Cervi E, Wagner B, 等. Vascular Ehlers-Danlos syndrome in children: evaluating the importance of diagnosis and follow-up during childhood[J]. European Journal of Human Genetics, 2025, 33(3): 368-376. DOI: 10.1038/s41431-024-01773-x. 英國倫敦 Ehlers-Danlos 綜合徵服務中心 63 名兒童期確診血管型患者的隊列:確診途徑、兒童期可見的體徵與隨訪安排。引用於:Ehlers-Danlos 綜合徵
  123. Benifla M, Serey-Gaut M, Bois E, 等. Vestibular Deficit in Patients with Waardenburg Syndrome[J]. Biomedicines, 2025, 13(8): 2021. DOI: 10.3390/biomedicines13082021. 法國兩家兒科中心 34 例基因確診並有聽力損失的患兒,逐例做前庭功能、聽力與內耳影像檢查,並記錄獨走年齡。引用於:Waardenburg 綜合徵
  124. Menderes D, Serdaroğlu E, Hırfanoğlu T, 等. What is the impact of etiology, lead time to treatment, and parental awareness on outcomes in infantile epileptic spasm syndrome?[J]. Epilepsy & Behavior, 2025, 163: 110178. DOI: 10.1016/j.yebeh.2024.110178.引用於:West 綜合徵
  125. Wang Y, Li H, Huang Z, 等. A novel variant in a Chinese boy with lysinuric protein intolerance: A case report and literature review[J]. Heliyon, 2024, 10(5): e27044. DOI: 10.1016/j.heliyon.2024.e27044. 廣州 1 例以間質性肺病就診的患兒,並按大洲彙總了 108 例已報道患者的臨床與基因特點。引用於:賴氨酸尿蛋白不耐受症
  126. Schust LF, Burke J, SanInocencio C, 等. A patient organization perspective: charting the course to a cure for SCN2A-related disorders[J]. Therapeutic Advances in Rare Disease, 2024, 5: 26330040241292645. DOI: 10.1177/26330040241292645. FamilieSCN2A Foundation 的自述:成立經過、患者登記與自然史研究,以及本病常見的共患問題。引用於:SCN2A 相關疾病
  127. Nizami FM, Trivedi S, Kalita J. A systematic review of electroencephalographic findings in Lennox-Gastaut syndrome[J]. Epilepsy Research, 2024, 205: 107406. DOI: 10.1016/j.eplepsyres.2024.107406.引用於:Lennox-Gastaut 綜合徵
  128. Lao U, Li Y, Bai W, 等. Adaptation and Feasibility of the Mandarin Version of PEERS(®) for Autistic Adolescents[J]. Journal of Autism and Developmental Disorders, 2024, 54(9): 3387-3399. DOI: 10.1007/s10803-023-06056-w.引用於:社交技能小組訓練
  129. Feng X, Yuan K, Lu H, 等. Analysis of clinical features of 193 Chinese patients with McCune-Albright syndrome through a literature review[J]. 中華醫學遺傳學雜誌, 2024, 41(7): 776-782. DOI: 10.3760/cma.j.cn511374-20230425-00242. 中文論文,題名為 PubMed 收錄的英文題名。彙總 1990 年 1 月至 2022 年 11 月國內報道的 193 例:性別構成、首診原因與各項表現的比例。引用於:McCune-Albright 綜合徵
  130. Zhu Y, Hu J, Ye W, 等. Assessment of the measurement properties of the Peabody Developmental Motor Scales-2 by applying the COSMIN methodology[J]. Italian Journal of Pediatrics, 2024, 50(1): 87. DOI: 10.1186/s13052-024-01645-6.引用於:Angelman 綜合徵、共濟失調毛細血管擴張症
  131. Karachaliou CE, Livaniou E. Biotin Homeostasis and Human Disorders: Recent Findings and Perspectives[J]. International Journal of Molecular Sciences, 2024, 25(12): 6578. DOI: 10.3390/ijms25126578. 生物素循環與相關疾病的綜述:全羧化酶合成酶與生物素酶各自的位置、本病的產前診斷與影像所見、大劑量生物素對免疫檢驗的干擾。引用於:全羧化酶合成酶缺乏症
  132. Sarli C, van der Laan L, Reilly J, 等. Blepharophimosis with intellectual disability and Helsmoortel-Van Der Aa Syndrome share episignature and phenotype[J]. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2024, 196(4): e32089. DOI: 10.1002/ajmg.c.32089.引用於:ADNP 綜合徵
  133. Romand X, Gastaldi R, Pérennou D, 等. Bone mineral density in adults with arthrogryposis multiplex congenita: a retrospective cohort analysis[J]. Scientific Reports, 2024, 14(1): 8206. DOI: 10.1038/s41598-024-58083-x. 法國參考中心 51 例成人的回顧性隊列:髖部骨密度、骨折史與維生素 D 水平;引言綜述了新生兒期的骨量與圍產期骨折。引用於:先天性多發性關節攣縮
  134. Araneda R, Ebner-Karestinos D, Paradis J, 等. Changes Induced by Early Hand-Arm Bimanual Intensive Therapy Including Lower Extremities in Young Children With Unilateral Cerebral Palsy: A Randomized Clinical Trial[J]. JAMA Pediatrics, 2024, 178(1): 19-28. DOI: 10.1001/jamapediatrics.2023.4809.引用於:強制性誘導運動療法與雙手強化訓練(CIMT)
  135. Kavanaugh BC, Elacio J, Best CR, 等. Christianson syndrome across the lifespan: genetic mutations and longitudinal study in children, adolescents, and adults[J]. Journal of Medical Genetics, 2024, 61(11): 1031-1039. DOI: 10.1136/jmg-2024-109973. 跨年齡段的縱向自然史研究:運動、語言與適應行為隨年齡的變化軌跡,以及成年期出現的退行。引用於:Christianson 綜合徵
  136. He Y, Qiu Y, Xiong Y, 等. Clinical and genetic characteristics of myotonia congenita in Chinese population[J]. Channels (Austin), 2024, 18(1): 2349823. DOI: 10.1080/19336950.2024.2349823. 中國人群先天性肌強直的臨床與基因特點:起病年齡、症狀構成與 CLCN1 變異譜。引用於:先天性肌強直
  137. Zhao T, Wu S, Shen Y, 等. Clinical and genetic characterization of 47 Chinese pediatric patients with Pitt-Hopkins syndrome: a retrospective study[J]. Orphanet Journal of Rare Diseases, 2024, 19(1): 51. DOI: 10.1186/s13023-024-03055-7. 上海交通大學醫學院附屬上海兒童醫院:47 例中國患兒。引用於:Pitt-Hopkins 綜合徵
  138. Zhong H, Zeng L, Yu X, 等. Clinical features and genetic spectrum of a multicenter Chinese cohort with myotonic dystrophy type 1[J]. Orphanet Journal of Rare Diseases, 2024, 19(1): 103. DOI: 10.1186/s13023-024-03114-z.引用於:肌強直性營養不良
  139. Wang D, Zhang BH, Wen X, 等. Clinical features and surgical treatments of scoliosis in neurofibromatosis type 1: a systemic review and meta-analysis[J]. European Spine Journal, 2024, 33(7): 2646–2665. DOI: 10.1007/s00586-024-08194-w.引用於:神經纖維瘤病
  140. Ge C, Tian Y, Hu C, 等. Clinical impact and in vitro characterization of ADNP variants in pediatric patients[J]. Molecular Autism, 2024, 15(1): 5. DOI: 10.1186/s13229-024-00584-7. 15 例中國患兒,國內首個成組報告的隊列。引用於:ADNP 綜合徵
  141. Ouyang Y, Feng J, Wang T, 等. Comparison of the efficacy of parent-mediated NDBIs on developmental skills in children with ASD and fidelity in parents: a systematic review and network meta-analysis[J]. BMC Pediatrics, 2024, 24(1): 270. DOI: 10.1186/s12887-024-04752-9.引用於:家長介導干預
  142. Ramdas S, Beeson D, Dong YY. Congenital myasthenic syndromes: increasingly complex[J]. Current Opinion in Neurology, 2024, 37(5): 493–501. DOI: 10.1097/WCO.0000000000001300.引用於:先天性肌無力綜合徵
  143. Khabyeh-Hasbani N, Lu YH, Baumgartner W, 等. Contemporary Management of the Upper Limb in Apert Syndrome: A Review[J]. Plastic and Reconstructive Surgery. Global Open, 2024, 12(8): e6067. DOI: 10.1097/gox.0000000000006067. Apert 綜合徵上肢的綜述:並指的 Upton 分型、分指手術的先後與年齡,以及肩、肘受限的表現與隨訪。引用於:綜合徵性顱縫早閉
  144. Peng S, Meng L, Fang R, 等. Current state of research on exercise for the treatment of myasthenia gravis: A scoping review[J]. Complementary Therapies in Medicine, 2024, 81: 103033. DOI: 10.1016/j.ctim.2024.103033.引用於:全身型重症肌無力
  145. Izquierdo-García E, Lázaro-Cebas A, Montero Pastor B, 等. Design of mobile and website health application devices for drug tolerability in hereditary fructose intolerance[J]. Orphanet Journal of Rare Diseases, 2024, 19(1): 12. DOI: 10.1186/s13023-023-03011-x. 逐項評估 555 種藥用輔料對本病患者是否適用,並整理了歐洲藥品說明書對果糖、山梨醇、蔗糖等輔料的警示要求。引用於:遺傳性果糖不耐受症
  146. Orton J, Doyle LW, Tripathi T, 等. Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants[J]. Cochrane Database of Systematic Reviews, 2024, 2(2): CD005495. DOI: 10.1002/14651858.CD005495.pub5.引用於:高危兒早期干預、袋鼠式護理(KMC)、嬰兒撫觸與被動操、目標導向與任務導向訓練
  147. Yang X, Meng Y, Chen J, 等. Electroencephalogram and phenotype patterns in neuronopathic Gaucher disease patients - ten years of experience in a single center[J]. Acta Epileptologica, 2024, 6(1): 30. DOI: 10.1186/s42494-024-00168-1.引用於:戈謝病
  148. Kenney-Jung DL, Collazo-Lopez JE, Rogers DJ, 等. Epilepsy in cardiofaciocutaneous syndrome: Clinical burden and response to anti-seizure medication[J]. American Journal of Medical Genetics Part A, 2024, 194(2): 301-310. DOI: 10.1002/ajmg.a.63428. 多國 138 例照護者問卷結合病歷的隊列,描述癲癇的發作類型、住院與用藥負擔。引用於:心-面-皮膚綜合徵
  149. Berg AT, Thompson CH, Myers LS, 等. Expanded clinical phenotype spectrum correlates with variant function in SCN2A-related disorders[J]. Brain, 2024, 147(8): 2761-2774. DOI: 10.1093/brain/awae125. 81 例:按起病年齡分組的發作類型、運動與溝通受限、管飼、皮質性視覺損害、脊柱側彎的比例,以及與變異功能分類的關係。引用於:SCN2A 相關疾病
  150. Jang DH, Kim J, Schwabe AL, 等. Genetics of Cerebral Palsy: Diagnosis, Differential Diagnosis, and Beyond[J]. Annals of Rehabilitation Medicine, 2024, 48(6): 369-376. DOI: 10.5535/arm.240081. 腦癱遺傳學綜述:腦癱患兒基因檢測中常見的致病基因裡包括 ATP1A3,並討論與腦癱表現相近的遺傳病如何區分。引用於:兒童交替性偏癱
  151. Arun A, Nath AR, Thankachan B, 等. Hutchinson-Gilford progeria syndrome: unraveling the genetic basis, symptoms, and advancements in therapeutic approaches[J]. Therapeutic Advances in Rare Disease, 2024, 5: 26330040241305144. DOI: 10.1177/26330040241305144. 早老症的綜述:LMNA 變異與早老蛋白的機制、各系統表現的出現次序、洛那法尼的獲批情況。引用於:早老症
  152. Pîrlog LM, Pătrășcanu AA, Militaru MS, 等. Insights into Clinical Disorders in Cowden Syndrome: A Comprehensive Review[J]. Medicina, 2024, 60(5): 767. DOI: 10.3390/medicina60050767.引用於:PTEN 錯構瘤腫瘤綜合徵
  153. Demaret T, Joyal JS, Karalis A, 等. Insulin therapy in acute decompensation of holocarboxylase synthetase deficiency with hyperglycemia and ketoacidosis[J]. Molecular Genetics and Metabolism Reports, 2024, 39: 101073. DOI: 10.1016/j.ymgmr.2024.101073. 一例晚髮型患兒 8 歲時急性失代償的處理經過:嘔吐後出現嚴重乳酸與酮症酸中毒,併發高血糖。引用於:全羧化酶合成酶缺乏症
  154. Gowda GG, Tigga MP, Sreenath RH. Management of Renal Angiomyolipomas in Tuberous Sclerosis: A Case Series[J]. Vascular Specialist International, 2024, 40: 40. DOI: 10.5758/vsi.240039.引用於:結節性硬化症
  155. Bossier C, Stark C, Martakis K, 等. Motor improvement in children with PMM2-CDG syndrome following a six-month rehabilitation treatment utilising whole-body vibration; a retrospective study[J]. Journal of Musculoskeletal & Neuronal Interactions, 2024, 24(1): 12-21. 13 名患兒參加間歇式康復項目的回顧性記錄,無對照組;本頁引用其中對運動表現、訓練目標與研究現狀的描述。引用於:PMM2-CDG
  156. Garone G, Innocenti A, Grasso M, 等. Movement disorder phenotype in CTNNB1-syndrome: A complex but recognizable phenomenology[J]. Parkinsonism & Related Disorders, 2024, 126: 107057. DOI: 10.1016/j.parkreldis.2024.107057.引用於:CTNNB1 相關神經發育障礙
  157. Zhou Z, Cai Y, Li X, 等. Natural history and outcome of nonketotic hyperglycinemia in China[J]. Frontiers in Neurology, 2024, 15: 1440883. DOI: 10.3389/fneur.2024.1440883. 廣州一家中心的 5 例加 2017–2023 年中國大陸報道的 15 例,共 20 例的臨床表現、基因構成與轉歸。引用於:非酮性高甘氨酸血症
  158. Bayat A, Grimes H, de Boer E, 等. Natural history of adults with KBG syndrome: A physician-reported experience[J]. Genetics in Medicine, 2024, 26(8): 101170. DOI: 10.1016/j.gim.2024.101170.引用於:KBG 綜合徵
  159. Rissardo JP, Vora NM, Singh Y, 等. Navigating the Complexity of Alternating Hemiplegia in Childhood: A Comprehensive Review[J]. Rambam Maimonides Medical Journal, 2024, 15(3). DOI: 10.5041/RMMJ.10529. 綜述:病程三個階段、誘因、各隊列的臨床數據、鑑別診斷與多學科管理。引用於:兒童交替性偏癱
  160. Litwin T, Antos A, Bembenek J, 等. Neurological Deterioration in Wilson's Disease-Types, Etiology, Course, and Management[J]. Discovery Medicine, 2024, 36(183): 646–654. DOI: 10.24976/Discov.Med.202436183.61.引用於:肝豆狀核變性
  161. Lin W, Wang K, Chen Y, 等. Newborn screening and genetic diagnosis of 3-methylcrotonyl-CoA carboxylase deficiency in Quanzhou,China[J]. Molecular Genetics and Metabolism Reports, 2024, 40: 101127. DOI: 10.1016/j.ymgmr.2024.101127. 福建泉州 64 萬新生兒的篩查結果:發生率、生化與基因特點、成人患者,以及國內各地發生率的範圍。引用於:3-甲基巴豆酰輔酶 A 羧化酶缺乏症
  162. Schleiss MR. Newborn Screening for Congenital Cytomegalovirus (cCMV) Infection: Universal, Targeted, Expanded-Targeted, or None-of-the-Above?[J]. Neonatology Today, 2024, 19(8): 3–12.引用於:Usher 綜合徵
  163. Sowa M, Boyer M, Green J, 等. Nutrition Management in Children Less than 5 Years of Age with Glycogen Storage Disease Type I: Survey Results[J]. Nutrients, 2024, 16(19): 3244. DOI: 10.3390/nu16193244.引用於:糖原累積病Ⅰ型
  164. Peña-Quintana L, Correcher-Medina P. Nutritional Management of Patients with Fatty Acid Oxidation Disorders[J]. Nutrients, 2024, 16(16): 2707. DOI: 10.3390/nu16162707. 脂肪酸氧化障礙的營養管理綜述,逐類寫明飲食原則;本病部分涉及脂肪與蛋白質限制以及中鏈甘油三酯的禁用。引用於:中鏈酰基輔酶 A 脫氫酶缺乏症、多種酰基輔酶 A 脫氫酶缺乏症
  165. Cornwall HL, Lam CM, Chaudhry D, 等. Outcomes of cochlear implantation in Usher syndrome: a systematic review[J]. European Archives of Oto-Rhino-Laryngology, 2024, 281(3): 1115-1129. DOI: 10.1007/s00405-023-08304-2. 系統綜述:33 項研究、187 名植入人工耳蝸的患者,含植入年齡、術後聽覺言語訓練的內容與溝通方式。引用於:Usher 綜合徵
  166. Mikami-Saito Y, Wada Y, Arai-Ichinoi N, 等. Phenotypic and genetic spectra of galactose mutarotase deficiency: A nationwide survey conducted in Japan[J]. Genetics in Medicine, 2024, 26(8): 101165. DOI: 10.1016/j.gim.2024.101165.引用於:半乳糖血症
  167. Zhang X, Xu K, Shi J, 等. Phenotypic variability observed in a Chinese patient cohort with biallelic variants in the CLN genes[J]. Molecular Vision, 2024, 30: 175-187. 首都醫科大學附屬北京同仁醫院北京市眼科研究所:14 例。引用於:神經元蠟樣脂褐質沉積症
  168. Santos BV, de Souza J, Zeny MS, 等. Phenotypic/Genotypic Profile of Children with Neuronal Ceroid Lipofuscinosis in Southern Brazil[J]. Neuropediatrics, 2024, 55(5): 303–310. DOI: 10.1055/s-0044-1787706.引用於:神經元蠟樣脂褐質沉積症
  169. Luo X, Niu H, Zhou F, 等. Prenatal diagnosis, ultrasound findings and pregnancy outcome of 7q11.23 deletion and duplication syndromes: what are the fetal features?[J]. BMC Pregnancy and Childbirth, 2024, 24(1): 727. DOI: 10.1186/s12884-024-06920-2. 深圳市龍崗區婦幼保健院 2017 至 2024 年的產前診斷病例。引用於:7q11.23 重複綜合徵
  170. Boronat S, Turon-Viñas E, Mac Manus N, 等. Response to amoxicillin and perampanel in infantile Alexander disease[J]. Epilepsia Open, 2024, 9(6): 2505–2509. DOI: 10.1002/epi4.13077.引用於:亞歷山大病
  171. 楊聖海, 劉浩然, 李佳一, 等. Rubinstein-Taybi 綜合徵患兒 21 例臨床及基因變異譜系特點[J]. 中華兒科雜誌, 2024, 62(4): 351-356. DOI: 10.3760/cma.j.cn112140-20230822-00122. 首都兒科研究所附屬兒童醫院 2013 年 1 月至 2022 年 7 月就診的 21 例。引用於:Rubinstein-Taybi 綜合徵
  172. 楊蕾, 方方, 金洪, 伍妘. SLC6A8 基因變異相關肌酸轉運蛋白缺乏症的臨床特徵分析[J]. 中華兒科雜誌, 2024, 62(12): 1202-1207. DOI: 10.3760/cma.j.cn112140-20240715-00485. 首都醫科大學附屬北京兒童醫院 2016 年 1 月至 2024 年 6 月確診的 5 例。引用於:腦肌酸缺乏綜合徵
  173. Zheng L, Wang W, Sun Q. Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA[J]. Signal Transduction and Targeted Therapy, 2024, 9(1): 46. DOI: 10.1038/s41392-024-01770-y.引用於:Alagille 綜合徵
  174. Ingersoll B, Frost KM, Straiton D, 等. Telehealth coaching in Project ImPACT indirectly affects children's expressive language ability through parent intervention strategy use and child intentional communication: An RCT[J]. Autism Research : Official Journal of the International Society for Autism Research, 2024, 17(10): 2177-2187. DOI: 10.1002/aur.3230.引用於:家長介導干預
  175. Van Hirtum LDFM, Van Damme T, Van Hove JLK, 等. The behavioral phenotype of children and adolescents with attenuated non-ketotic hyperglycinemia, intermediate to good subtype[J]. Orphanet Journal of Rare Diseases, 2024, 19(1): 150. DOI: 10.1186/s13023-024-03172-3. 12 名 6–21 歲輕型患者的家長問卷研究:運動、溝通、適應行為、社交與多動表現的輪廓。引用於:非酮性高甘氨酸血症
  176. Mayston MJ, Saloojee GM, Foley SE. The Bobath Clinical Reasoning Framework: A systems science approach to the complexity of neurodevelopmental conditions, including cerebral palsy[J]. Developmental Medicine and Child Neurology, 2024, 66(5): 564-572. DOI: 10.1111/dmcn.15748.引用於:Bobath 療法(NDT)
  177. Fan Q, Ding M, Cheng W, 等. The clinical effects of Orff music therapy on children with autism spectrum disorder: a comprehensive evaluation[J]. Frontiers in Neurology, 2024, 15: 1387060. DOI: 10.3389/fneur.2024.1387060.引用於:康復與干預方法
  178. Adiguzel H, Kirmaci ZIK, Gogremis M, 等. The effect of proprioceptive neuromuscular facilitation on functional skills, muscle strength, and trunk control in children with cerebral palsy: A randomized controlled trial[J]. Early Human Development, 2024, 192: 106010. DOI: 10.1016/j.earlhumdev.2024.106010.引用於:康復與干預方法
  179. Yanchik A, Vietze P, Lax LE. The Effects of Discrete Trial and Natural Environment Teaching on Adaptive Behavior in Toddlers With Autism Spectrum Disorder[J]. American Journal on Intellectual and Developmental Disabilities, 2024, 129(4): 263-278. DOI: 10.1352/1944-7558-129.4.263.引用於:自然發展行為干預(NDBI)、回合式教學(DTT)
  180. Wiener-Vacher SR, Campi M, Caldani S, 等. Vestibular Impairment and Postural Development in Children With Bilateral Profound Hearing Loss[J]. JAMA Network Open, 2024, 7(5): e2412846. DOI: 10.1001/jamanetworkopen.2024.12846. 592 名雙側極重度耳聾兒童的隊列:按耳聾病因統計前庭功能受損的比例,以及前庭受損與豎頭、獨坐、扶站、獨走年齡推遲的關係。引用於:Usher 綜合徵
  181. Fontaine M, Dhooge I, Dhondt C, 等. Vestibular Infant Screening-Rehabilitation (VIS-REHAB): protocol for a randomised controlled trial on Vestibular Rehabilitation Therapy (VRT) in vestibular-impaired children[J]. BMJ Open, 2024, 14(12): e085575. DOI: 10.1136/bmjopen-2024-085575. 隨機對照試驗的方案:前庭功能受損兒童的前庭康復由哪幾類練習組成,以及聽障兒童在佩戴助聽器或人工耳蝸的狀態下訓練。引用於:Usher 綜合徵
  182. Nordon DG, Passone CGB, da Silva CAA, 等. W-Sitting In Childhood: A Systematic Review[J]. Acta Ortopedica Brasileira, 2024, 32(6): e279277. DOI: 10.1590/1413-785220243206e279277. PMID 39802577(2026-11-13 經 PubMed 核對題錄)。只用結論:未找到反對 W 型坐姿的科學依據,現有研究證據級別多數較低。
  183. Downs J, Ludwig NN, Wojnaroski M, 等. What does better look like in individuals with severe neurodevelopmental impairments? A qualitative descriptive study on SCN2A-related developmental and epileptic encephalopathy[J]. Quality of Life Research, 2024, 33(2): 519-528. DOI: 10.1007/s11136-023-03543-6. 對 10 個家庭的訪談:家長眼裡在粗大運動、手功能、溝通與日常生活四個方面有意義的功能進步各是什麼。引用於:SCN2A 相關疾病
  184. Dai LZ, Lin C, Lei R, 等. A Case of Pseudohypoparathyroidism Misdiagnosed as Idiopathic Epilepsy for 5 Years: Clinical Analysis and Follow-up Outcomes[J]. The Journal of International Medical Research, 2023, 51(11): 3000605231215202. DOI: 10.1177/03000605231215202. 國內一例Ⅰb 型的病例報告:15 歲女孩按特發性癲癇用藥 5 年,查電解質與甲狀旁腺激素後明確診斷。引用於:假性甲狀旁腺功能減退症
  185. Ma M, Li Y, Dai S, 等. A meta-analysis on the prevalence of Charcot-Marie-Tooth disease and related inherited peripheral neuropathies[J]. Journal of Neurology, 2023, 270(5): 2468-2482. DOI: 10.1007/s00415-023-11559-8.引用於:腓骨肌萎縮症
  186. Murro V, Banfi S, Testa F, 等. A multidisciplinary approach to inherited retinal dystrophies from diagnosis to initial care: a narrative review with inputs from clinical practice[J]. Orphanet Journal of Rare Diseases, 2023, 18(1): 223. DOI: 10.1186/s13023-023-02798-z. 遺傳性視網膜營養不良從診斷到初始照護的多學科路徑,含兒童的功能性視覺評估與定向行走訓練。引用於:視網膜色素變性、Usher 綜合徵
  187. Alkhayal FA, Al Haddad S, Bakraa RM, 等. Acrodermatitis dysmetabolica secondary to isoleucine deficiency in infant with maple syrup urine disease[J]. Dermatology Reports, 2023, 15(4): 9750. DOI: 10.4081/dr.2023.9750.引用於:楓糖尿症
  188. Ng R, Bjornsson HT, Fahrner JA, 等. Anxiety in Wiedemann-Steiner syndrome[J]. American Journal of Medical Genetics Part A, 2023, 191(2): 437-444. DOI: 10.1002/ajmg.a.63040. 18 名 8 至 33 歲患者的焦慮篩查:分離焦慮最常被報告,家長評定的焦慮總分隨年齡升高。引用於:Wiedemann-Steiner 綜合徵
  189. Pavuluri H, Jose M, Fasaludeen A, 等. Arginase deficiency-An unheralded cause of developmental epileptic encephalopathy[J]. Epileptic Disorders, 2023, 25(4): 556–561. DOI: 10.1002/epd2.20081.引用於:精氨酸酶缺乏症
  190. Sandbank M, Bottema-Beutel K, Crowley LaPoint S, 等. Autism intervention meta-analysis of early childhood studies (Project AIM): updated systematic review and secondary analysis[J]. BMJ (Clinical Research Ed.), 2023, 383: e076733. DOI: 10.1136/bmj-2023-076733.引用於:結構化教學(TEACCH)
  191. Malloy J, Berry E, Correia A, 等. Baseline Range of Motion, Strength, Motor Function, and Participation in Youth with Hutchinson-Gilford Progeria Syndrome[J]. Physical & Occupational Therapy in Pediatrics, 2023, 43(4): 482–501. DOI: 10.1080/01942638.2022.2158054.引用於:早老症
  192. Qiu X, Zhao P, Luo J, 等. Biochemical and molecular features of tetrahydrobiopterin deficiency in Fujian Province, southeastern China[J]. Frontiers in Genetics, 2023, 14: 1250568. DOI: 10.3389/fgene.2023.1250568.引用於:苯丙酮尿症
  193. Astiazaran-Symonds E, Ney GM, Higgs C, 等. Cancer in Costello syndrome: a systematic review and meta-analysis[J]. British Journal of Cancer, 2023, 128(11): 2089-2096. DOI: 10.1038/s41416-023-02229-7. 彙總 234 篇文獻、621 例患者的系統綜述:各類腫瘤的構成、20 歲前的累積發生率,以及不同 HRAS 變異的腫瘤比例。引用於:Costello 綜合徵
  194. Blair HA. Cipaglucosidase Alfa: First Approval[J]. Drugs, 2023, 83(8): 739–745. DOI: 10.1007/s40265-023-01886-5.引用於:糖原累積病Ⅱ型
  195. Wang J, Fang F, Ding C, 等. Clinical and genetic spectrum of hereditary spastic paraplegia in Chinese children[J]. Developmental Medicine & Child Neurology, 2023, 65(3): 416-423. DOI: 10.1111/dmcn.15390.引用於:遺傳性痙攣性截癱
  196. Ling S, Qiu W, Zhang H, 等. Clinical, biochemical, and genetic analysis of 28 Chinese patients with holocarboxylase synthetase deficiency[J]. Orphanet Journal of Rare Diseases, 2023, 18(1): 48. DOI: 10.1186/s13023-023-02656-y. 上海 28 例中國患兒 2006 至 2021 年的回顧性隊列:起病年齡、症狀構成、血尿代謝指標、變異譜與隨訪結局。引用於:全羧化酶合成酶缺乏症
  197. Carraro L, Iosca A, Dainesi MI, 等. Cognitive function in DMD carriers: personal case series and literature review[J]. Acta Myologica, 2023, 42(2-3): 53–59. DOI: 10.36185/2532-1900-354.引用於:杜氏肌營養不良
  198. Huang W, Lee GT, Zhang X. Current Dimensions of Applied Behavior Analysis in Mainland China: A Review of 20 Years of Research[J]. Behavior Analysis in Practice, 2023, 16(2): 437-449. DOI: 10.1007/s40617-022-00751-3.引用於:應用行為分析(ABA)、關鍵反應訓練(PRT)、語言行為與 VB-MAPP、問題行為的功能評估與正向行為支持(PBS)
  199. Schön M, Lapunzina P, Nevado J, 等. Definition and clinical variability of SHANK3-related Phelan-McDermid syndrome[J]. European Journal of Medical Genetics, 2023, 66(7): 104754. DOI: 10.1016/j.ejmg.2023.104754.引用於:Phelan-McDermid 綜合徵
  200. Uzan GS, Günay Ç, Kurul SH, 等. Double Trouble: A Case of DYT-TOR1A Diagnosed in the Postoperative Period[J]. Annals of Indian Academy of Neurology, 2023, 26(4): 578-580. DOI: 10.4103/aian.aian_39_23. 病例報告:9 歲女孩因左腿發緊先做了椎管內囊腫手術,術後症狀擴展才確診本病。引用於:DYT-TOR1A 肌張力障礙
  201. Sun J, Liu M, Li X, 等. Effectiveness of Group Parent-Child Interaction Therapy on Problem Behaviors in Chinese Kindergartners[J]. International Journal of Environmental Research and Public Health, 2023, 20(4). DOI: 10.3390/ijerph20043446.引用於:家長行為管理培訓(PMT)
  202. Liu G, Chen Y, Ou P, 等. Effects of Parent-Child Sandplay Therapy for preschool children with autism spectrum disorder and their mothers: A randomized controlled trial[J]. Journal of Pediatric Nursing, 2023, 71: 6-13. DOI: 10.1016/j.pedn.2023.02.006.引用於:遊戲治療與沙盤遊戲
  203. Chen Z, Huang Z, Li X, 等. Effects of traditional Chinese medicine combined with modern rehabilitation therapies on motor function in children with cerebral palsy: A systematic review and meta-analysis[J]. Frontiers in Neuroscience, 2023, 17: 1097477. DOI: 10.3389/fnins.2023.1097477.引用於:小兒推拿
  204. Wang SH, Zhang HT, Zou YY, 等. Efficacy and moderating factors of the Early Start Denver Model in Chinese toddlers with autism spectrum disorder: a longitudinal study[J]. World Journal of Pediatrics : WJP, 2023, 19(8): 741-752. DOI: 10.1007/s12519-022-00555-z.引用於:早期介入丹佛模式(ESDM)
  205. Quan J, Liu XF, Hu K, 等. Enteral nutrition support for lysinuric protein intolerance: a case report and literature review[J]. 中國當代兒科雜誌(Zhongguo Dang Dai Er Ke Za Zhi), 2023, 25(12): 1270-1275. DOI: 10.7499/j.issn.1008-8830.2306148. 中文原題《賴氨酸尿性蛋白耐受不良患兒的腸內營養支持 1 例並文獻複習》。中南大學湘雅醫院的病例與 92 例患兒的文獻複習,講營養治療的構成。引用於:賴氨酸尿蛋白不耐受症
  206. Irving M, AlSayed M, Arundel P, 等. European Achondroplasia Forum guiding principles for the detection and management of foramen magnum stenosis[J]. Orphanet Journal of Rare Diseases, 2023, 18(1): 219. DOI: 10.1186/s13023-023-02795-2.引用於:軟骨發育不全
  207. Nomakuchi TT, Danowitz M, Stewart B, 等. Expanding the reproductive organ phenotype of CHD7-spectrum disorder[J]. American Journal of Medical Genetics Part A, 2023, 191(5): 1418–1424. DOI: 10.1002/ajmg.a.63148.引用於:CHARGE 綜合徵
  208. St John M, van Reyk O, Koolen DA, 等. Expanding the speech and language phenotype in Koolen-de Vries syndrome: late onset and periodic stuttering a novel feature[J]. European Journal of Human Genetics, 2023, 31(5): 531–540. DOI: 10.1038/s41431-022-01230-7.引用於:Koolen-de Vries 綜合徵
  209. Degrassi I, Leonardi I, Di Profio E, 等. Fat-Soluble Vitamins Deficiency in Pediatric Cholestasis: A Scoping Review[J]. Nutrients, 2023, 15(11): 2491. DOI: 10.3390/nu15112491.引用於:Alagille 綜合徵
  210. Sun W, Wang Y, Wu M, 等. Fourteen cases of cerebral creatine deficiency syndrome in children: a cohort study in China[J]. Translational Pediatrics, 2023, 12(5): 927-937. DOI: 10.21037/tp-23-164. 復旦大學附屬兒科醫院 2017 至 2022 年的發育遲緩兒童隊列。引用於:腦肌酸缺乏綜合徵
  211. Szafranski P, Garimella RP, Mani H, 等. Further refinement of the differentially methylated distant lung-specific FOXF1 enhancer in a neonate with alveolar capillary dysplasia[J]. Clinical Epigenetics, 2023, 15(1): 169. DOI: 10.1186/s13148-023-01587-6.引用於:新生兒持續肺動脈高壓
  212. Wright M, Cortina-Borja M, Knowles R, 等. Global birth prevalence of Robin sequence in live-born infants: a systematic review and meta-analysis[J]. European Respiratory Review, 2023, 32(170): 230133. DOI: 10.1183/16000617.0133-2023. 34 項研究、22 個國家的出生患病率薈萃分析。支持本頁的流行病學數據。引用於:Pierre Robin 序列徵
  213. Ng R, Harris J, Fahrner JA, 等. Individuals with Wiedemann-Steiner syndrome show nonverbal reasoning and visuospatial defects with relative verbal skill sparing[J]. Journal of the International Neuropsychological Society, 2023, 29(5): 512-518. DOI: 10.1017/s1355617722000467. 10 名 6 至 17 歲患兒的神經心理評估病例系列:言語類能力相對保留,非言語推理、視覺空間、視覺記憶、注意、工作記憶與計算是弱項。引用於:Wiedemann-Steiner 綜合徵
  214. Pavone P, Marino L, Cacciaguerra G, 等. Klippel-Trenaunay Syndrome, Segmental/Focal Overgrowth Malformations: A Review[J]. Children (Basel), 2023, 10(8): 1421. DOI: 10.3390/children10081421. Klippel-Trenaunay 綜合徵的綜述:命名由來、三聯徵各自出現的時間、併發症與保守處理。引用於:PIK3CA 相關過度生長綜合徵
  215. Bouchard C, Tremblay JP. Limb-Girdle Muscular Dystrophies Classification and Therapies[J]. Journal of Clinical Medicine, 2023, 12(14): 4769. DOI: 10.3390/jcm12144769. 分類沿革的綜述:從 19 世紀的臨床分型到 2018 年的新命名與新定義,逐一列出各分型的基因與表現。引用於:肢帶型肌營養不良
  216. Nokelainen P, Perez-Macias JM, Himanen SL, 等. Methods for Detecting Abnormal Ventilation in Children - the Case Study of 13-Years old Pitt-Hopkins Girl[J]. Child Neurology Open, 2023, 10: 2329048X231151361. DOI: 10.1177/2329048X231151361.引用於:Pitt-Hopkins 綜合徵
  217. Feng B, Li X, Zhang Q, 等. Molecular and phenotypic spectrum of cardio-facio-cutaneous syndrome in Chinese patients[J]. Orphanet Journal of Rare Diseases, 2023, 18(1): 284. DOI: 10.1186/s13023-023-02878-0. 上海兒童醫學中心等報告的 20 例中國患兒的基因型與表型,並與 186 例非中國患者比較。引用於:心-面-皮膚綜合徵
  218. Vandriel SM, Li LT, She H, 等. Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study[J]. Hepatology, 2023, 77(2): 512-529. DOI: 10.1002/hep.32761. 全球 Alagille 聯盟(GALA)隊列:1433 例兒童肝病的自然史,膽汁淤積、瘙癢與黃瘤的出現比例與轉歸。引用於:Alagille 綜合徵
  219. Del Sindaco G, Berkenou J, Pagnano A, 等. Neonatal and Early Infancy Features of Patients With Inactivating PTH/PTHrP Signaling Disorders/Pseudohypoparathyroidism[J]. The Journal of Clinical Endocrinology and Metabolism, 2023, 108(11): 2961-2969. DOI: 10.1210/clinem/dgad236. 法國與意大利兩個中心 136 例患者的回顧性隊列,描述新生兒期併發症與 1 歲以內出現的線索。引用於:假性甲狀旁腺功能減退症
  220. Enokizono M, Aida N, Yagishita A, et al. Neuroimaging findings of inborn errors of metabolism: urea cycle disorders, aminoacidopathies, and organic acidopathies[J]. Japanese Journal of Radiology, 2023, 41: 683-702. DOI: 10.1007/s11604-023-01396-0.
  221. Tanizaki R, Miyamatsu Y. Nocturnal Leg Cramping Caused by Carnitine Deficiency Due to Long-Term Pivalate Antibiotics Administration in a Patient With Chronic Kidney Disease[J]. Cureus, 2023, 15(11): e48927. DOI: 10.7759/cureus.48927.引用於:原發性肉鹼缺乏症
  222. Sibley MH, Bruton AM, Zhao X, 等. Non-pharmacological interventions for attention-deficit hyperactivity disorder in children and adolescents[J]. Lancet. Child & Adolescent Health, 2023, 7(6): 415-428. DOI: 10.1016/S2352-4642(22)00381-9.引用於:注意力與認知訓練、神經反饋、康復與干預方法
  223. van der Plas PPJM, van Heesch GGM, Koudstaal MJ, 等. Non-Surgical Respiratory Management in Relation to Feeding and Growth in Patients with Robin Sequence; a Prospective Longitudinal Study[J]. The Cleft Palate-Craniofacial Journal, 2023. DOI: 10.1177/10556656231199840. 36 例非手術處理患兒第一年的前瞻隨訪:呼吸接近正常後,餵養困難與體重落後仍可持續。引用於:Pierre Robin 序列徵
  224. Lin Y, Chen X, Xie B, 等. Novel variants and phenotypic heterogeneity in a cohort of 11 Chinese children with Wiedemann-Steiner syndrome[J]. Frontiers in Genetics, 2023, 14: 1085210. DOI: 10.3389/fgene.2023.1085210. 廣州、廣西與武漢三家醫院的 11 例患兒,並彙總此前報道的 41 例,給出 52 例中國患者各項表現的比例;另記錄了生長激素治療期間骨齡的變化。引用於:Wiedemann-Steiner 綜合徵
  225. Lachmann RH, Diaz GA, Wasserstein MP, 等. Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adults[J]. Orphanet Journal of Rare Diseases, 2023, 18(1): 94. DOI: 10.1186/s13023-023-02700-x.引用於:尼曼匹克病
  226. Greene Z, O'Donnell CP, Walshe M. Oral stimulation for promoting oral feeding in preterm infants[J]. Cochrane Database of Systematic Reviews, 2023, 6(6): CD009720. DOI: 10.1002/14651858.CD009720.pub3.引用於:餵養與吞嚥治療、口部運動治療與口肌訓練
  227. Lin Y, Kuang Q, Li H, 等. Outcome and clinical features in juvenile myasthenia gravis: A systematic review and meta-analysis[J]. Frontiers in Neurology, 2023, 14: 1119294. DOI: 10.3389/fneur.2023.1119294.引用於:先天性肌無力綜合徵、全身型重症肌無力
  228. Lovett A, Eastwood M, Metcalfe C, 等. Outcomes of Cochlear implantation in early-deafened patients with Waardenburg syndrome: A systematic review and narrative synthesis[J]. Laryngoscope Investigative Otolaryngology, 2023, 8(4): 1094-1107. DOI: 10.1002/lio2.1110. 系統綜述,納入 16 項研究、179 例植入人工耳蝸的患者,彙總術前影像、併發症、溝通方式與就學情況,以及與結果相關的因素。引用於:Waardenburg 綜合徵
  229. Tofts LJ, Simmonds J, Schwartz SB, 等. Pediatric joint hypermobility: a diagnostic framework and narrative review[J]. Orphanet Journal of Rare Diseases, 2023, 18(1): 104. DOI: 10.1186/s13023-023-02717-2. 國際聯盟兒科工作組的兒童關節過度活動診斷框架:5 歲起評估、Beighton 評分 6 分及以上為界、8 個亞組,以及兒童期常見的伴隨問題。引用於:Ehlers-Danlos 綜合徵
  230. Elbeltagi R, Al-Beltagi M, Saeed NK, 等. Play therapy in children with autism: Its role, implications, and limitations[J]. World Journal of Clinical Pediatrics, 2023, 12(1): 1-22. DOI: 10.5409/wjcp.v12.i1.1.引用於:地板時光(DIR)、遊戲治療與沙盤遊戲
  231. Sreedevi N, Swapna N, Maruthy S, 等. PMM2-CDG T237M Mutation in a Patient with Cerebral Palsy-Like Phenotypes Reported from South India[J]. Global Medical Genetics, 2023, 10(2): 105-108. DOI: 10.1055/s-0043-1769494. 一名兒童期診斷為腦癱的 12 歲女孩經全外顯子組測序查出 PMM2 純合致病變異的病例報告。引用於:PMM2-CDG
  232. Wu S, Zhao J, de Villiers J, 等. Prevalence, co-occurring difficulties, and risk factors of developmental language disorder: first evidence for Mandarin-speaking children in a population-based study[J]. The Lancet Regional Health – Western Pacific, 2023, 34: 100713.引用於:語言發育遲緩與構音障礙
  233. Coughlin CR, Gospe SM. Pyridoxine-dependent epilepsy: Current perspectives and questions for future research[J]. Annals of the Child Neurology Society, 2023, 1(1): 24-37. DOI: 10.1002/cns3.20016. 綜述:三種吡哆醇依賴性癲癇的由來、自然病程、腦發育異常、生物標誌物與按年齡的用藥框架。引用於:吡哆醇依賴性癲癇
  234. Variane GFT, Dahlen A, Pietrobom RFR, 等. Remote Monitoring for Seizures During Therapeutic Hypothermia in Neonates With Hypoxic-Ischemic Encephalopathy[J]. JAMA Network Open, 2023, 6(11): e2343429. DOI: 10.1001/jamanetworkopen.2023.43429.引用於:KCNQ2 相關障礙
  235. Nguyen XT, Moekotte L, Plomp AS, 等. Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies[J]. International Journal of Molecular Sciences, 2023, 24(8): 7481. DOI: 10.3390/ijms24087481. 視網膜色素變性的臨床管理綜述:夜盲與視野收窄的病程、檢查手段、併發症隨訪與低視力支持。引用於:視網膜色素變性
  236. Dauvilliers Y, Lecendreux M, Lammers GJ, 等. Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: a double-blind, randomised, placebo-controlled trial[J]. The Lancet Neurology, 2023, 22(4): 303–311. DOI: 10.1016/S1474-4422(23)00036-4.引用於:發作性睡病
  237. Janssens K, Amesz P, Nuvelstijn Y, 等. School Problems and School Support for Children with Narcolepsy: Parent, Teacher, and Child Reports[J]. International Journal of Environmental Research and Public Health, 2023, 20(6): 5175. DOI: 10.3390/ijerph20065175. 荷蘭三家睡眠中心的問卷研究:家長、教師與孩子分別報告的校園困難,以及課堂內可落實的安排。引用於:發作性睡病
  238. Penn R, Harrar D, Sun LR. Seizures, Epilepsy, and Electroencephalography Findings in Pediatric Moyamoya Arteriopathy: A Scoping Review[J]. Pediatric Neurology, 2023, 142: 95–103.e2. DOI: 10.1016/j.pediatrneurol.2022.11.016.引用於:煙霧病
  239. Mastromauro C, Giannini C, Chiarelli F. Short stature related to Growth Hormone Insensitivity (GHI) in childhood[J]. Frontiers in Endocrinology, 2023, 14: 1141039. DOI: 10.3389/fendo.2023.1141039. 生長激素不敏感的綜述:生長激素受體的結構與變異分佈、各類原發與繼發病因的分辨、治療構成。引用於:萊倫氏綜合徵
  240. Lodewyckx P, Issa J, Gaschignard M, 等. Systemic primary carnitine deficiency induces severe arrhythmia due to shortening of QT interval[J]. Molecular Genetics and Metabolism, 2023, 140(4): 107733. DOI: 10.1016/j.ymgme.2023.107733.引用於:原發性肉鹼缺乏症
  241. Onesimo R, Sforza E, Giorgio V, 等. The "FEEDS (FEeding Eating Deglutition Skills)" over Time Study in Cardiofaciocutaneous Syndrome[J]. Genes, 2023, 14(7): 1338. DOI: 10.3390/genes14071338. 意大利一家罕見病中心 26 例基因確診患者(1.5 至 38 歲)的餵養、咀嚼與吞嚥能力隨年齡的變化。引用於:心-面-皮膚綜合徵
  242. Asadi-Pooya AA. The new International League Against Epilepsy (ILAE) definition of Lennox-Gastaut syndrome: Practical implications and limitations[J]. Journal of Clinical Neuroscience, 2023, 115: 43–46. DOI: 10.1016/j.jocn.2023.07.014.引用於:Lennox-Gastaut 綜合徵
  243. Collin-Histed T, Rosenberg A, Hopman N, 等. Understanding patient and parent/caregiver perceptions on gene therapy in Gaucher disease: an international survey[J]. Orphanet Journal of Rare Diseases, 2023, 18(1): 5. DOI: 10.1186/s13023-022-02576-3.引用於:戈謝病
  244. Ramos BCF, Aranda CS, Cardona RSB, 等. Vaccination strategies for people living with inborn errors of metabolism in Brazil[J]. Jornal de Pediatria, 2023, 99 Suppl 1: S70–S80. DOI: 10.1016/j.jped.2022.12.001.引用於:戊二酸血症Ⅰ型
  245. 潘虹地, 張悅, 李一辰, 等. 2020年中國15省嬰幼兒大運動發育進程研究[J]. 中國兒童保健雜誌, 2022, 30(10): 1053-1057. DOI: 10.11852/zgetbjzz2022-0342. 照養人報告的橫斷面調查,1~36 月齡正常兒童;只用各里程碑的第 50 百分位月齡。
  246. 馬丹, 張文麗, 曹玲, 等. 發育性口吃的機制、評估和干預進展[J]. 中國兒童保健雜誌, 2022, 30(7): 750-754. DOI: 10.11852/zgetbjzz2021-0665.
  247. Wong PW, Lam YY, Lau JS, 等. Adapting and pretesting the World Health Organization's Caregiver Skills Training Program for children with autism and developmental disorders or delays in Hong Kong[J]. Scientific Reports, 2022, 12(1): 16932. DOI: 10.1038/s41598-022-21343-9.引用於:家長介導干預
  248. Du X, Wang Y, Zhang W, 等. An analysis of phenotype and genotype in a large cohort of Chinese children with Angelman syndrome[J]. Genes, 2022, 13(8): 1447. DOI: 10.3390/genes13081447. 復旦大學附屬兒科醫院 695 例,中國目前規模較大的單中心隊列。引用於:Angelman 綜合徵
  249. Coughlin CR, Tseng LA, Bok LA, 等. Association Between Lysine Reduction Therapies and Cognitive Outcomes in Patients With Pyridoxine-Dependent Epilepsy[J]. Neurology, 2022, 99(23): e2627-e2636. DOI: 10.1212/WNL.0000000000201222. 國際患者登記的觀察性隊列(100 名參與者):起病年齡、發育落後的比例,以及發育結局與發作控制之間的關係。引用於:吡哆醇依賴性癲癇
  250. Agar G, Bissell S, Wilde L, 等. Caregivers' experience of sleep management in Smith-Magenis syndrome: a mixed-methods study[J]. Orphanet Journal of Rare Diseases, 2022, 17(1): 35. DOI: 10.1186/s13023-021-02159-8.引用於:Smith-Magenis 綜合徵
  251. Infantino I, Tocchioni F, Ghionzoli M, 等. Case Report: Gut and spleen anomalies associated with DYRK1A syndrome[J]. Frontiers in Pediatrics, 2022, 10: 936732. DOI: 10.3389/fped.2022.936732.引用於:DYRK1A 綜合徵
  252. Parker LE, Wallace K, Thevathasan A, 等. Characterization of sedation and anesthesia complications in patients with alternating hemiplegia of childhood[J]. European Journal of Paediatric Neurology, 2022, 38: 47-52. DOI: 10.1016/j.ejpn.2022.03.007. 34 例患者 129 次鎮靜或麻醉操作的併發症分析。引用於:兒童交替性偏癱
  253. Li L, Qiao X, Liu F, 等. Description of the Molecular and Phenotypic Spectrum of Lesch-Nyhan Disease in Eight Chinese Patients[J]. Frontiers in Genetics, 2022, 13: 868942. DOI: 10.3389/fgene.2022.868942. 浙江大學醫學院附屬兒童醫院 2018–2021 年確診的 8 例:就診與確診年齡、此前得到的診斷、尿酸與腎臟情況、防護用具的使用。引用於:Lesch-Nyhan 綜合徵
  254. Howells M, Hamby T, Honeycutt J, 等. Detethering of MRI-Demonstrated Tethered Cord Syndrome[J]. Pediatric Neurosurgery, 2022, 57(2): 85–92. DOI: 10.1159/000522135.引用於:先天性脊柱側凸
  255. Kuroda S, Fujimura M, Takahashi J, 等. Diagnostic Criteria for Moyamoya Disease - 2021 Revised Version[J]. Neurologia medico-chirurgica, 2022, 62(7): 307-312. DOI: 10.2176/jns-nmc.2022-0072. 2021 年修訂的診斷標準全文:血管造影與磁共振的判定條件、單側病變的處理、煙霧綜合徵(類煙霧病)的基礎病清單,以及歷次修訂的沿革。引用於:煙霧病
  256. Lee YC, Chen CR, Lin KC. Effects of Mindfulness-Based Interventions in Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Randomized Controlled Trials[J]. International Journal of Environmental Research and Public Health, 2022, 19(22). DOI: 10.3390/ijerph192215198.引用於:康復與干預方法
  257. Sun W, Yu M, Zhou X. Effects of physical exercise on attention deficit and other major symptoms in children with ADHD: A meta-analysis[J]. Psychiatry Research, 2022, 311: 114509. DOI: 10.1016/j.psychres.2022.114509.引用於:康復與干預方法
  258. Cortés-Pérez I, González-González N, Peinado-Rubia AB, 等. Efficacy of Robot-Assisted Gait Therapy Compared to Conventional Therapy or Treadmill Training in Children with Cerebral Palsy: A Systematic Review with Meta-Analysis[J]. Sensors (Basel, Switzerland), 2022, 22(24). DOI: 10.3390/s22249910.引用於:減重步行與跑臺訓練、康復與干預方法
  259. Li S, Wang Y, Zhang W, 等. Epilepsy and molecular phenotype affect the neurodevelopment of pediatric Angelman syndrome patients in China[J]. Frontiers in Psychiatry, 2022, 13: 886028. DOI: 10.3389/fpsyt.2022.886028.引用於:Angelman 綜合徵
  260. Heussen N, Häusler M. Equine-Assisted Therapies for Children With Cerebral Palsy: A Meta-analysis[J]. Pediatrics, 2022, 150(1). DOI: 10.1542/peds.2021-055229.引用於:康復與干預方法
  261. Farjoun N, Mayston M, Florencio LL, 等. Essence of the Bobath concept in the treatment of children with cerebral palsy. A qualitative study of the experience of Spanish therapists[J]. Physiotherapy Theory and Practice, 2022, 38(1): 151-163. DOI: 10.1080/09593985.2020.1725943.引用於:Bobath 療法(NDT)、姿勢管理與體位擺放
  262. Tang M, Chen X, Ni Q, 等. Estimation of hereditary fructose intolerance prevalence in the Chinese population[J]. Orphanet Journal of Rare Diseases, 2022, 17(1): 326. DOI: 10.1186/s13023-022-02487-3. 復旦大學附屬兒科醫院基於中國兒童遺傳病檢測隊列的估算:中國人群的患病率、ALDOB 常見變異,以及 68 例患者的表現彙總。引用於:遺傳性果糖不耐受症
  263. Zubler JM, Wiggins LD, Macias MM, 等. Evidence-Informed Milestones for Developmental Surveillance Tools[J]. Pediatrics, 2022, 149(3): e2021052138. DOI: 10.1542/peds.2021-052138. PMID 35132439。確立「多數兒童(≥75%)在該月齡前可達成」的里程碑納入判據引用於:高危兒與早產兒早期干預、全面發育遲緩、兒童發育與行為評估、寶秀蘭兒童神經發育綜合評估系統、評估量表一覽、術語表
  264. Itoh S, Okada H, Koyano K, 等. Fetal and neonatal bilirubin metabolism[J]. Frontiers in Pediatrics, 2022, 10: 1002408. DOI: 10.3389/fped.2022.1002408.
  265. Goldberg L, Laron Z, Kornreich L, 等. Focal Epilepsy in Individuals with Laron Syndrome[J]. Hormone Research in Paediatrics, 2022, 95(3): 286-290. DOI: 10.1159/000524350. 以色列 75 例隊列中 4 例局灶性癲癇的報告,發作時血糖正常;同時交代了這一隊列的智力分佈。引用於:萊倫氏綜合徵
  266. McIntyre S, Goldsmith S, Webb A, 等. Global prevalence of cerebral palsy: A systematic analysis[J]. Developmental Medicine & Child Neurology, 2022, 64(12): 1494–1506. DOI: 10.1111/dmcn.15346.引用於:Phelan-McDermid 綜合徵
  267. Fan W, Ni K, Chen F, 等. Hearing characteristics and cochlear implant effects in children with Waardenburg syndrome: a case series[J]. Translational Pediatrics, 2022, 11(7): 1234-1241. DOI: 10.21037/tp-22-271. 上海市兒童醫院 5 例患兒的病例系列:出生時聽力篩查情況、顳骨影像,以及按聽覺發展四個階段設計的術後聽覺與言語評估。引用於:Waardenburg 綜合徵
  268. Singh SK, Sarma MS. Hereditary fructose intolerance: A comprehensive review[J]. World Journal of Clinical Pediatrics, 2022, 11(4): 321-329. DOI: 10.5409/wjcp.v11.i4.321. 兒科綜述:代謝後果、餵養問題與厭惡甜食、床旁尿檢線索、容易混淆的診斷,以及飲食管理中的未決問題。引用於:遺傳性果糖不耐受症
  269. Wang J, Yu Q, Ma X, 等. Hutchinson-Gilford progeria syndrome complicated with stroke: A report of 2 cases and literature review[J]. Frontiers in Pediatrics, 2022, 10: 1056225. DOI: 10.3389/fped.2022.1056225.引用於:早老症
  270. Zou Y, Luo H, Yuan H, 等. Identification of a Novel Nonsense Mutation in PLA2G6 and Prenatal Diagnosis in a Chinese Family With Infantile Neuroaxonal Dystrophy[J]. Frontiers in Neurology, 2022, 13: 904027. DOI: 10.3389/fneur.2022.904027. 國內一個家系的報告:兄弟二人的影像演變過程,以及致病變異明確後的產前診斷。引用於:嬰兒神經軸索營養不良
  271. Kenney-Jung DL, Rogers DJ, Kroening SJ, 等. Infantile epileptic spasms syndrome in children with cardiofaciocutanous syndrome: Clinical presentation and associations with genotype[J]. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2022, 190(4): 501-509. DOI: 10.1002/ajmg.c.32022. 兩個臨床隊列共 180 例中嬰兒痙攣的比例、起病月齡與基因型。引用於:心-面-皮膚綜合徵
  272. Wirrell EC, Hood V, Knupp KG, 等. International consensus on diagnosis and management of Dravet syndrome[J]. Epilepsia, 2022, 63(7): 1761–1777. DOI: 10.1111/epi.17274.引用於:嬰兒嚴重肌陣攣性癲癇
  273. Li T, Lu D, Yao C, 等. Kansl1 haploinsufficiency impairs autophagosome-lysosome fusion and links autophagic dysfunction with Koolen-de Vries syndrome in mice[J]. Nature Communications, 2022, 13(1): 931. DOI: 10.1038/s41467-022-28613-0. 國家生物醫學分析中心(北京)團隊的小鼠研究。引用於:Koolen-de Vries 綜合徵
  274. Dekkers TJ, Hornstra R, van der Oord S, 等. Meta-analysis: Which Components of Parent Training Work for Children With Attention-Deficit/Hyperactivity Disorder?[J]. Journal of the American Academy of Child and Adolescent Psychiatry, 2022, 61(4): 478-494. DOI: 10.1016/j.jaac.2021.06.015.引用於:問題行為的功能評估與正向行為支持(PBS)、家長行為管理培訓(PMT)
  275. Leoni C, Viscogliosi G, Tartaglia M, 等. Multidisciplinary Management of Costello Syndrome: Current Perspectives[J]. Journal of Multidisciplinary Healthcare, 2022, 15: 1277-1296. DOI: 10.2147/JMDH.S291757. 多學科管理綜述:從兒童期到成年期各專科的隨訪時間表,以及餵養、物理治療、矯形器與骨健康的安排。引用於:Costello 綜合徵
  276. Geretsegger M, Fusar-Poli L, Elefant C, 等. Music therapy for autistic people[J]. Cochrane Database of Systematic Reviews, 2022, 5(5): CD004381. DOI: 10.1002/14651858.CD004381.pub4.引用於:康復與干預方法
  277. Xie K, Zeng B, Zhang L, 等. Mutation spectrum of PTS gene in patients with tetrahydrobiopterin deficiency from jiangxi province[J]. Frontiers in Genetics, 2022, 13: 1077729. DOI: 10.3389/fgene.2022.1077729.引用於:苯丙酮尿症
  278. Stamberger H, Crosiers D, Balagura G, 等. Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood[J]. Neurology, 2022, 99(3): e221–e233. DOI: 10.1212/WNL.0000000000200715.引用於:STXBP1 相關發育性癲癇性腦病
  279. Kalinousky AJ, Rapp T, Hijazi H, 等. Neurobehavioral phenotype of Kabuki syndrome: Anxiety is a common feature[J]. Frontiers in Genetics, 2022, 13: 1007046. DOI: 10.3389/fgene.2022.1007046.引用於:Kabuki 綜合徵
  280. Naros A, Steiner-Wilke I, Kaiser N, 等. Neurocognitive development in isolated Robin sequence treated with the Tuebingen palatal plate[J]. Clinical Oral Investigations, 2022, 26(7): 4817-4823. DOI: 10.1007/s00784-022-04448-3. 孤立型患兒 5 至 6 歲時的智力測驗與發育里程碑,對照組為單純顎裂兒童。引用於:Pierre Robin 序列徵
  281. Pierpont EI, Kenney-Jung DL, Shanley R, 等. Neurologic and neurodevelopmental complications in cardiofaciocutaneous syndrome are associated with genotype: A multinational cohort study[J]. Genetics in Medicine, 2022, 24(7): 1556-1566. DOI: 10.1016/j.gim.2022.04.004. 多國 138 例隊列:智力障礙與癲癇的總體比例,以及它們與致病基因的關係。引用於:心-面-皮膚綜合徵
  282. Nowak M, Chuchra P, Paprocka J. Nonketotic Hyperglycinemia: Insight into Current Therapies[J]. Journal of Clinical Medicine, 2022, 11(11): 3027. DOI: 10.3390/jcm11113027. 治療綜述:降甘氨酸藥物、受體拮抗劑、抗癲癇藥、生酮飲食與迷走神經刺激的使用情況,以及併發症與多學科照護。引用於:非酮性高甘氨酸血症
  283. Keam SJ. Olipudase Alfa: First Approval[J]. Drugs, 2022, 82(8): 941–947. DOI: 10.1007/s40265-022-01727-x.引用於:尼曼匹克病
  284. Chen SC, Yu J, Wang HS, 等. Parent-administered pediatric Tuina for attention deficit/hyperactivity disorder symptoms in preschool children: A pilot randomized controlled trial embedded with a process evaluation[J]. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 2022, 102: 154191. DOI: 10.1016/j.phymed.2022.154191.引用於:小兒推拿
  285. Chung IH, Chin WC, Huang YS, 等. Pediatric Narcolepsy—A Practical Review[J]. Children (Basel), 2022, 9(7): 974. DOI: 10.3390/children9070974. 兒童發作性睡病的實用綜述:症狀構成、誤判原因、評估與診斷工具、藥物與行為干預,含亞洲地區可及性的說明。引用於:發作性睡病、日間嗜睡與睡眠節律紊亂
  286. Thomas AT, Waite J, Williams CA, 等. Phenotypic characteristics and variability in CHARGE syndrome: a PRISMA compliant systematic review and meta-analysis[J]. Journal of Neurodevelopmental Disorders, 2022, 14(1): 49. DOI: 10.1186/s11689-022-09459-5.引用於:CHARGE 綜合徵
  287. Santos de Assis G, Schlichting T, Rodrigues Mateus B, 等. Physical therapy with hippotherapy compared to physical therapy alone in children with cerebral palsy: systematic review and meta-analysis[J]. Developmental Medicine and Child Neurology, 2022, 64(2): 156-161. DOI: 10.1111/dmcn.15042.引用於:康復與干預方法
  288. Wu L, Wang J, Wang L, 等. Physical, language, neurodevelopment and phenotype-genotype correlation of Chinese patients with Mowat-Wilson syndrome[J]. Frontiers in Genetics, 2022, 13: 1016677. DOI: 10.3389/fgene.2022.1016677. 首都兒科研究所:國內最大的一組 22 例。引用於:Mowat-Wilson 綜合徵
  289. Butti N, Castagna A, Montirosso R. Psychosocial Difficulties in Preschool-Age Children with Beckwith-Wiedemann Syndrome: An Exploratory Study[J]. Children (Basel), 2022, 9(4): 551. DOI: 10.3390/children9040551. 30 名 1.5 至 6 歲患兒的家長問卷研究:粗大運動、語言理解與社交發展各領域處於邊緣或異常範圍的比例。引用於:Beckwith-Wiedemann 綜合徵
  290. Tseng LA, Teela L, Janssen MC, 等. Pyridoxine-dependent epilepsy (PDE-ALDH7A1) in adulthood: A Dutch pilot study exploring clinical and patient-reported outcomes[J]. Molecular Genetics and Metabolism Reports, 2022, 31: 100853. DOI: 10.1016/j.ymgmr.2022.100853. 荷蘭 10 名成年患者的發作控制、神經系統體徵、智力、受教育程度與就業情況。引用於:吡哆醇依賴性癲癇
  291. Zeng Q, Yang Y, Duan J, 等. SCN2A-Related Epilepsy: The Phenotypic Spectrum, Treatment and Prognosis[J]. Frontiers in Molecular Neuroscience, 2022, 15: 809951. DOI: 10.3389/fnmol.2022.809951. 北京大學第一醫院與深圳市兒童醫院的 72 例中國患兒:起病年齡、發作類型、腦電圖與磁共振、遺傳來源、用藥反應與轉歸。引用於:SCN2A 相關疾病
  292. Rapp T, Kalinousky AJ, Johnson J, 等. Sleep disturbance is a common feature of Kabuki syndrome[J]. American Journal of Medical Genetics Part A, 2022, 188(10): 3041–3048. DOI: 10.1002/ajmg.a.62921.引用於:Kabuki 綜合徵
  293. Ng R, Bjornsson HT, Fahrner JA, 等. Sleep disturbances correlate with behavioral problems among individuals with Wiedemann-Steiner syndrome[J]. Frontiers in Genetics, 2022, 13: 950082. DOI: 10.3389/fgene.2022.950082. 24 名患者家長填寫的睡眠與行為問卷:睡眠問題的類型與比例、多動與情緒問題的比例,以及睡眠與行為問題之間的關聯。引用於:Wiedemann-Steiner 綜合徵
  294. Morison LD, Braden RO, Amor DJ, 等. Social motivation a relative strength in DYRK1A syndrome on a background of significant speech and language impairments[J]. European Journal of Human Genetics, 2022, 30(7): 800–811. DOI: 10.1038/s41431-022-01079-w.引用於:DYRK1A 綜合徵
  295. Cui B, Wei L, Sun LY, 等. The effect of liver transplantation for argininemia-the largest experiences in a single center[J]. Translational Pediatrics, 2022, 11(4): 495–504. DOI: 10.21037/tp-21-576.引用於:精氨酸酶缺乏症
  296. Castiglione A, Möller C. Usher Syndrome[J]. Audiology Research, 2022, 12(1): 42-65. DOI: 10.3390/audiolres12010005. 敘述性綜述:命名由來、基因與蛋白複合體、各型的聽力、平衡與視力表現,以及聽覺、視覺與平衡三方面的康復安排。引用於:Usher 綜合徵
  297. Yıldız Bölükbaşı E, Karolak JA, Szafranski P, 等. Variable expressivity in a four-generation ACDMPV family with a non-coding hypermorphic SNV in trans to the frameshifting FOXF1 variant[J]. European Journal of Human Genetics, 2022, 30(10): 1182–1186. DOI: 10.1038/s41431-022-01159-x.引用於:新生兒持續肺動脈高壓
  298. Maudoux A, Vitry S, El-Amraoui A. Vestibular Deficits in Deafness: Clinical Presentation, Animal Modeling, and Treatment Solutions[J]. Frontiers in Neurology, 2022, 13: 816534. DOI: 10.3389/fneur.2022.816534. 綜述:耳聾合併前庭功能受損的臨床表現、檢查方法、代償機制與前庭康復。引用於:Usher 綜合徵
  299. 陳蝶, 李軒, 唐孟言, 等. 0~3歲嬰幼兒前囟遲閉的影響因素研究[J]. 中國兒童保健雜誌, 2021, 29(2): 226-229. DOI: 10.11852/zgetbjzz2020-0043. 單中心研究,只讀到摘要。
  300. 王荻蘭, 楊玉, 楊利, 等. 2 例德朗熱綜合徵的臨床表現及遺傳學特徵分析[J]. 南昌大學學報(醫學版), 2021, 61(6). 中文文獻裡使用「德朗熱綜合徵」這一譯名的來源之一。引用於:Cornelia de Lange 綜合徵
  301. 車鳳玉, 賀春霞, 張李鈺, 等. 一個 Smith-Lemli-Opitz 綜合徵家系的臨床特徵和基因變異分析[J]. 中華醫學遺傳學雜誌, 2021, 38(11): 1114-1119. DOI: 10.3760/cma.j.cn511374-20201207-00852. 西安市兒童醫院陝西省兒科疾病研究所。引用於:Smith-Lemli-Opitz 綜合徵
  302. 嶽曉晶, 杜琳, 賈飛勇. 嬰幼兒餵養困難的研究進展[J]. 中國兒童保健雜誌, 2021, 29(7): 738-741.引用於:餵養困難與兒童營養諮詢
  303. Rossi A, Hoogeveen IJ, Lubout CMA, 等. A generic emergency protocol for patients with inborn errors of metabolism causing fasting intolerance: A retrospective, single-center study and the generation of www.emergencyprotocol.net[J]. Journal of Inherited Metabolic Disease, 2021, 44(5): 1124-1135. DOI: 10.1002/jimd.12386. 禁食不耐受類遺傳代謝病的通用急症方案:按年齡的禁食上限、含糖口服液的配製與升級處理的次序。引用於:中鏈酰基輔酶 A 脫氫酶缺乏症、極長鏈酰基輔酶 A 脫氫酶缺乏症
  304. Huang K, Bi FF, Yang H. A Systematic Review and Meta-Analysis of the Prevalence of Congenital Myopathy[J]. Frontiers in Neurology, 2021, 12: 761636. DOI: 10.3389/fneur.2021.761636. 納入 11 項研究的患病率薈萃分析,含香港地區的兒童數據;合併患病率按 2022 年的更正採用。引用於:先天性肌病
  305. Cheung MS, Irving M, Cocca A, 等. Achondroplasia Foramen Magnum Score: screening infants for stenosis[J]. Archives of Disease in Childhood, 2021, 106(2): 180–184. DOI: 10.1136/archdischild-2020-319625.引用於:軟骨發育不全
  306. Uchitel J, Wallace K, Tran L, 等. Alternating hemiplegia of childhood: evolution over time and mouse model corroboration[J]. Brain Communications, 2021, 3(3): fcab128. DOI: 10.1093/braincomms/fcab128. 美國 42 例與法國 52 例的隨訪研究:非發作性的功能障礙隨年齡緩慢加重,發作性的障礙沒有隨年齡變化。引用於:兒童交替性偏癱
  307. Casertano A, Rossi A, Fecarotta S, 等. An Overview of Hypoglycemia in Children Including a Comprehensive Practical Diagnostic Flowchart for Clinical Use[J]. Frontiers in Endocrinology, 2021, 12: 684011. DOI: 10.3389/fendo.2021.684011.引用於:先天性高胰島素性低血糖血症
  308. Liu MX, Hua J, Ke L, 等. Analysis of developmental coordination disorder in Chinese children[J]. 中華兒科雜誌, 2021, 59(11): 928-934. DOI: 10.3760/cma.j.cn112140-20210331-00277. 原文為中文引用於:書寫與精細動作訓練
  309. Dhillon S. Avalglucosidase alfa: First Approval[J]. Drugs, 2021, 81(15): 1803–1809. DOI: 10.1007/s40265-021-01600-3.引用於:糖原累積病Ⅱ型
  310. Lin Y, Yang Z, Yang C, 等. C4OH is a potential newborn screening marker-a multicenter retrospective study of patients with beta-ketothiolase deficiency in China[J]. Orphanet Journal of Rare Diseases, 2021, 16(1): 224. DOI: 10.1186/s13023-021-01859-5. 我國 18 個省市 1608 萬餘名新生兒的篩查數據與 29 例患兒的回顧:篩查指標、誘因、轉歸與變異譜。引用於:β-酮硫解酶缺乏症
  311. Park J E, Lee T, Ha K, Ki C S. Carrier frequency and incidence estimation of Smith-Lemli-Opitz syndrome in East Asian populations by Genome Aggregation Database (gnomAD) based analysis[J]. Orphanet Journal of Rare Diseases, 2021, 16(1): 166. DOI: 10.1186/s13023-021-01789-2. 用 gnomAD 中 9197 名東亞人的外顯子組數據推算攜帶率與發病率。引用於:Smith-Lemli-Opitz 綜合徵
  312. Lin S, He Z, Huang L, 等. Case report: low-level maternal mosaicism of a novel CREBBP variant causes recurrent Rubinstein-Taybi syndrome in two siblings of a Chinese family[J]. Frontiers in Genetics, 2021, 12: 640992. DOI: 10.3389/fgene.2021.640992. 中山大學附屬第一醫院報告的同胞再發家系。引用於:Rubinstein-Taybi 綜合徵
  313. Canavero I, Vetrano IG, Zedde M, 等. Clinical Management of Moyamoya Patients[J]. Journal of Clinical Medicine, 2021, 10(16): 3628. DOI: 10.3390/jcm10163628.引用於:煙霧病
  314. Huang Q, Xiong H, Tao Z, 等. Clinical phenotypes and molecular findings in ten Chinese patients with Kleefstra Syndrome Type 1 due to EHMT1 defects[J]. European Journal of Medical Genetics, 2021, 64(9): 104289. DOI: 10.1016/j.ejmg.2021.104289. 重慶醫科大學附屬兒童醫院報告的 10 例。引用於:Kleefstra 綜合徵
  315. Gowda VK, Vegda H, Nagarajan BB, 等. Clinical Profile and Outcome of Indian Children with Aromatic L-Amino Acid Decarboxylase Deficiency: A primary CSF Neurotransmitter Disorder Mimicking as Dyskinetic Cerebral Palsy[J]. Journal of Pediatric Genetics, 2021, 10(2): 85–91. DOI: 10.1055/s-0040-1714690.引用於:芳香族 L-氨基酸脫羧酶缺乏症
  316. Gong Z, Liang L, Qiu W, 等. Clinical, Biochemical, and Molecular Analyses of Medium-Chain Acyl-CoA Dehydrogenase Deficiency in Chinese Patients[J]. Frontiers in Genetics, 2021, 12: 577046. DOI: 10.3389/fgene.2021.577046.引用於:中鏈酰基輔酶 A 脫氫酶缺乏症
  317. van der Meulen I, Pangalila RF, van de Sandt-Koenderman WME. Cognitive linguistic Treatment in Landau Kleffner Syndrome: Improvement in Daily Life Communication[J]. Child Neurology Open, 2021, 8: 2329048X211022196. DOI: 10.1177/2329048x211022196. 一名慢性期青少年患者的言語語言訓練個案:訓練內容怎麼選、怎麼排,以及聽覺言語失認在訓練後的變化。引用於:Landau-Kleffner 綜合徵
  318. Kinaan M, Hamidi O, Yau H, 等. Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer[J]. Journal of the Endocrine Society, 2021, 5(1): bvaa158. DOI: 10.1210/jendso/bvaa158.引用於:21-羥化酶缺乏症
  319. Zhao Y, Li Y, Bian Y, 等. Congenital myasthenic syndrome in China: genetic and myopathological characterization[J]. Annals of Clinical and Translational Neurology, 2021, 8(4): 898-907. DOI: 10.1002/acn3.51346.引用於:先天性肌無力綜合徵
  320. Padilla KL, Akers JS. Content Validity Evidence for the Verbal Behavior Milestones Assessment and Placement Program[J]. Journal of Autism and Developmental Disorders, 2021, 51(11): 4054-4066. DOI: 10.1007/s10803-020-04864-y.引用於:應用行為分析(ABA)、語言行為與 VB-MAPP
  321. Timmer MA, Blokzijl J, Schutgens REG, 等. Coordinating physiotherapy care for persons with haemophilia[J]. Haemophilia, 2021, 27(6): 1051-1061. DOI: 10.1111/hae.14404. 血友病物理治療的組織與協作:關節出血後的分期處理、關節健康監測、與血液科的銜接。引用於:血友病、其他系統與多系統受累
  322. Zhang Y, Liu X, Gao H, 等. Copy number variations of chromosome 17p11.2 region in children with development delay and in fetuses with abnormal imaging findings[J]. BMC Medical Genomics, 2021, 14(1): 215. DOI: 10.1186/s12920-021-01065-z. 中國醫科大學附屬盛京醫院:7077 例發育遲緩或智力障礙兒童的 17p11.2 拷貝數篩查。引用於:Potocki-Lupski 綜合徵
  323. Deng J, Zhou L, Zhang J, 等. Correlation Between Genotype and Age of Onset in Leukoencephalopathy With Vanishing White Matter[J]. Frontiers in Genetics, 2021, 12: 729777. DOI: 10.3389/fgene.2021.729777. 彙總文獻與北京大學第一醫院共 341 例患者,分析基因型與起病年齡的關係;引言交代了本病的發現與致病基因確認的年份。引用於:白質消融性白質腦病
  324. Panseri S, Pavlovic R, Castrica M, 等. Determination of Carbohydrates in Lactose-Free Dairy Products to Support Food Labelling[J]. Foods, 2021, 10(6): 1219. DOI: 10.3390/foods10061219.引用於:半乳糖血症
  325. Mooneyham GC, Ferrafiat V, Stolte E, 等. Developing Consensus in the Assessment and Treatment Pathways for Autoimmune Encephalitis in Child and Adolescent Psychiatry[J]. Frontiers in Psychiatry, 2021, 12: 638901. DOI: 10.3389/fpsyt.2021.638901. 兒童青少年精神科視角下的自身免疫性腦炎:以精神行為改變起病時的評估與處理路徑,含恢復期的康復與復學。引用於:自身免疫性腦炎
  326. Accogli A, Geraldo AF, Piccolo G, 等. Diagnostic Approach to Macrocephaly in Children[J]. Frontiers in Pediatrics, 2021, 9: 794069. DOI: 10.3389/fped.2021.794069.引用於:PIK3CA 相關過度生長綜合徵
  327. Neurofeedback Collaborative Group. Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up[J]. Journal of the American Academy of Child and Adolescent Psychiatry, 2021, 60(7): 841-855. DOI: 10.1016/j.jaac.2020.07.906.引用於:神經反饋
  328. Norcia G, Lucibello S, Coratti G, 等. Early Gross Motor Milestones in Duchenne Muscular Dystrophy[J]. Journal of Neuromuscular Diseases, 2021, 8(4): 453–456. DOI: 10.3233/JND-210640.引用於:杜氏肌營養不良
  329. Zeng H, Liu S, Huang R, 等. Effect of the TEACCH program on the rehabilitation of preschool children with autistic spectrum disorder: A randomized controlled trial[J]. Journal of Psychiatric Research, 2021, 138: 420-427. DOI: 10.1016/j.jpsychires.2021.04.025.引用於:回合式教學(DTT)、結構化教學(TEACCH)
  330. Bang P, Woelfle J, Perrot V, 等. Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome[J]. European Journal of Endocrinology, 2021, 184(2): 267-276. DOI: 10.1530/eje-20-0325. 歐洲十國重組人 IGF-1 治療登記研究(242 例;初治的青春期前患兒中,報告基因診斷為萊倫氏綜合徵的 21 例):治療前自發低血糖史的比例與治療中的不良事件。引用於:萊倫氏綜合徵
  331. Mailloux Z, Grady-Dominguez P, Petersen J, 等. Evaluation in Ayres Sensory Integration® (EASI) Vestibular and Proprioceptive Tests: Construct Validity and Internal Reliability[J]. American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association, 2021, 75(6). DOI: 10.5014/ajot.2021.043166.引用於:康復與干預方法
  332. Hume K, Steinbrenner JR, Odom SL, 等. Evidence-Based Practices for Children, Youth, and Young Adults with Autism: Third Generation Review[J]. Journal of Autism and Developmental Disorders, 2021, 51(11): 4013-4032. DOI: 10.1007/s10803-020-04844-2.引用於:應用行為分析(ABA)、回合式教學(DTT)、關鍵反應訓練(PRT)、語言行為與 VB-MAPP、問題行為的功能評估與正向行為支持(PBS)、感覺統合治療(ASI)、孤獨症(自閉症)的干預方法、康復與干預方法
  333. Shuai L, Wang Y, Li W, 等. Executive Function Training for Preschool Children With ADHD: A Randomized Controlled Trial[J]. Journal of Attention Disorders, 2021, 25(14): 2037-2047. DOI: 10.1177/1087054720956723.引用於:注意力與認知訓練
  334. Sheppard SE, Campbell IM, Harr MH, 等. Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann-Steiner syndrome[J]. American Journal of Medical Genetics Part A, 2021, 185(6): 1649-1665. DOI: 10.1002/ajmg.a.62124. 來自五大洲 104 例患者的多中心隊列:各項表現的比例、發育里程碑的中位年齡、成年患者的學業與就業、變異類型與表現的關係,以及修訂後的臨床管理建議。引用於:Wiedemann-Steiner 綜合徵
  335. Hei M, Gao X, Li Y, 等. Family Integrated Care for Preterm Infants in China: A Cluster Randomized Controlled Trial[J]. Journal of Pediatrics, 2021, 228: 36-43.e2. DOI: 10.1016/j.jpeds.2020.09.006.引用於:袋鼠式護理(KMC)、康復與干預方法
  336. Zhou J, Li S, Gu L, 等. General movement assessment is correlated with neonatal behavior neurological assessment/cerebral magnetic resonance imaging in preterm infants[J]. Medicine, 2021, 100(37): e27262. DOI: 10.1097/MD.0000000000027262.引用於:NBNA 方法頁
  337. Savatt JM, Myers SM. Genetic Testing in Neurodevelopmental Disorders[J]. Frontiers in Pediatrics, 2021, 9: 526779. DOI: 10.3389/fped.2021.526779.引用於:孤獨症譜系障礙的鑑別與病因評估、全面發育遲緩:病因評估與後續管理
  338. Xie Y, Lin Z, Liu L, 等. Genotype and phenotype distribution of 435 patients with Charcot-Marie-Tooth disease from central south China[J]. European Journal of Neurology, 2021, 28(11): 3774-3783. DOI: 10.1111/ene.15024. 中國中南部 435 例隊列,目前可查的較大規模中國人群基因型構成數據。引用於:腓骨肌萎縮症
  339. Cheng S S W, Luk H M, Mok M T, 等. Genotype and phenotype in 18 Chinese patients with Coffin-Siris syndrome[J]. American Journal of Medical Genetics Part A, 2021, 185(7): 2250-2261. DOI: 10.1002/ajmg.a.62187. 香港 18 例中國患者。引用於:Coffin-Siris 綜合徵
  340. Derks TGJ, Rodriguez-Buritica DF, Ahmad A, 等. Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs[J]. Nutrients, 2021, 13(11): 3828. DOI: 10.3390/nu13113828. Ⅰa 型的管理綜述:生玉米澱粉與夜間餵養的做法、血糖監測的時機、運動與進食對日常生活的影響。引用於:糖原累積病Ⅰ型
  341. Li R, Gong F, Pan H, 等. Identification and In Vitro Functional Verification of Two Novel Mutations of GHR Gene in the Chinese Children with Laron Syndrome[J]. Frontiers in Endocrinology, 2021, 12: 605736. DOI: 10.3389/fendo.2021.605736. 北京協和醫院 2012 至 2017 年收治的 4 例中國患兒:身高、激素水平、GHR 基因變異,以及當時國內藥物可及的情況。引用於:萊倫氏綜合徵
  342. WHO Immediate KMC Study Group, Arya S, Naburi H, 等. Immediate "Kangaroo Mother Care" and Survival of Infants with Low Birth Weight[J]. New England Journal of Medicine, 2021, 384(21): 2028-2038. DOI: 10.1056/NEJMoa2026486.引用於:袋鼠式護理(KMC)
  343. Narayanaswami P, Sanders DB, Wolfe G, 等. International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update[J]. Neurology, 2021, 96(3): 114–122. DOI: 10.1212/WNL.0000000000011124.引用於:全身型重症肌無力
  344. Dhillon S. Lonafarnib: First Approval[J]. Drugs, 2021, 81(2): 283–289. DOI: 10.1007/s40265-020-01464-z.引用於:早老症
  345. Leoni C, Romeo DM, Pelliccioni M, 等. Musculo-skeletal phenotype of Costello syndrome and cardio-facio-cutaneous syndrome: insights on the functional assessment status[J]. Orphanet Journal of Rare Diseases, 2021, 16(1): 43. DOI: 10.1186/s13023-021-01674-y. 17 例 Costello 綜合徵與 17 例心麵皮膚綜合徵的骨骼肌肉表現與功能評估(6 分鐘步行試驗與兒童結局數據收集量表)。引用於:Costello 綜合徵
  346. Muzetti JH, do Valle DA, Santos MLSF, 等. Neurological Characteristics of Pediatric Glycogen Storage Disease[J]. Frontiers in Endocrinology, 2021, 12: 685272. DOI: 10.3389/fendo.2021.685272. 12 名肝型糖原累積病患兒的橫斷面研究,比較Ⅰ型與Ⅸ型的頭顱磁共振所見及其與代謝控制的關係。引用於:糖原累積病Ⅰ型
  347. Mütze U, Henze L, Gleich F, 等. Newborn screening and disease variants predict neurological outcome in isovaleric aciduria[J]. Journal of Inherited Metabolic Disease, 2021, 44(4): 857–870. DOI: 10.1002/jimd.12364.引用於:異戊酸血症
  348. Sjøstrand Å, Kefalianos E, Hofslundsengen H, 等. Non-pharmacological interventions for stuttering in children six years and younger[J]. Cochrane Database of Systematic Reviews, 2021, 9(9): CD013489. DOI: 10.1002/14651858.CD013489.pub2.引用於:康復與干預方法
  349. Zanella LW, Valentini NC, Copetti F, 等. Peabody Developmental Motor Scales - Second Edition (PDMS-2): Reliability, content and construct validity evidence for Brazilian children[J]. Research in Developmental Disabilities, 2021, 111: 103871. DOI: 10.1016/j.ridd.2021.103871.引用於:嬰兒嚴重肌陣攣性癲癇、Angelman 綜合徵、Joubert 綜合徵、CTNNB1 相關神經發育障礙、Dandy-Walker 畸形
  350. Alvarez G, Krentzel A, Vova J, 等. Pharmacologic Treatment and Early Rehabilitation Outcomes in Pediatric Patients With Anti-NMDA Receptor Encephalitis[J]. Archives of Physical Medicine and Rehabilitation, 2021, 102(3): 406–412. DOI: 10.1016/j.apmr.2020.09.381.引用於:自身免疫性腦炎
  351. Zhang H, Yang L, Duan J, 等. Phenotypes in children with SYNGAP1 encephalopathy in China[J]. Frontiers in Neuroscience, 2021, 15: 761473. DOI: 10.3389/fnins.2021.761473. 深圳市兒童醫院 7 例,合併既往報道共 13 例。引用於:SYNGAP1 相關智力障礙
  352. Keller SR, Mallack EJ, Rubin JP, 等. Practical Approaches and Knowledge Gaps in the Care for Children With Leukodystrophies[J]. Journal of Child Neurology, 2021, 36(1): 65-78. DOI: 10.1177/0883073820946154. 腦白質營養不良患兒神經系統照護的實踐建議:睡眠、疼痛、癲癇、語言與認知四個方面按病情階段給出篩查、評估與處理辦法,其中單列了本病發熱時的處理。引用於:白質消融性白質腦病
  353. Ryll UC, Krumlinde-Sundholm L, Verhage CH, 等. Predictive validity of the Hand Assessment for Infants in infants at risk of unilateral cerebral palsy[J]. Developmental Medicine and Child Neurology, 2021, 63(4): 436-443. DOI: 10.1111/dmcn.14739.
  354. Namasivayam AK, Huynh A, Granata F, 等. PROMPT intervention for children with severe speech motor delay: a randomized control trial[J]. Pediatric Research, 2021, 89(3): 613-621. DOI: 10.1038/s41390-020-0924-4.引用於:康復與干預方法
  355. Zhu YY, Sun GL, Yang ZL. SATB2-associated syndrome caused by a novel SATB2 mutation in a Chinese boy: A case report and literature review[J]. World Journal of Clinical Cases, 2021, 9(21): 6081–6090. DOI: 10.12998/wjcc.v9.i21.6081.引用於:SATB2 相關障礙
  356. Zarate YA, Bosanko KA, Caffrey AR. SATB2-associated syndrome in adolescents and adults[J]. American Journal of Medical Genetics Part A, 2021, 185(8): 2391–2398. DOI: 10.1002/ajmg.a.62258.引用於:SATB2 相關障礙
  357. Society for Maternal-Fetal Medicine (SMFM), Prabhu M, Kuller JA, 等. Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013)[J]. American Journal of Obstetrics and Gynecology, 2021, 225(4): B2–B15. DOI: 10.1016/j.ajog.2021.06.079.引用於:21 三體綜合徵
  358. Moretti L, Bizzoca D, Buono C, 等. Sports and Children with Hemophilia: Current Trends[J]. Children (Basel), 2021, 8(11): 1064. DOI: 10.3390/children8111064.引用於:血友病
  359. Serrano M. Stroke-Like Episodes in PMM2-CDG: When the Lack of Other Evidence Is the Only Evidence[J]. Frontiers in Pediatrics, 2021, 9: 717864. DOI: 10.3389/fped.2021.717864. 卒中樣發作的臨床定義、常見表現與誘因的文獻回顧,以及急診處理中需要排除的其他急症。引用於:PMM2-CDG
  360. Song EJ, Lee EJ, Kwon HY. The effects of sling exercise program on balance and body activities in children with spastic cerebral palsy[J]. Journal of Exercise Rehabilitation, 2021, 17(6): 410-417. DOI: 10.12965/jer.2142608.304.引用於:減重步行與跑臺訓練、懸吊訓練(SET)
  361. Guenzel AJ, Hall PL, Scott AI, 等. The low excretor phenotype of glutaric acidemia type I is a source of false negative newborn screening results and challenging diagnoses[J]. JIMD Reports, 2021, 60(1): 67–74. DOI: 10.1002/jmd2.12217.引用於:亞歷山大病、Canavan 病
  362. Lim A, Ngeow J. The Skin in Cowden Syndrome[J]. Frontiers in Medicine, 2021, 8: 658842. DOI: 10.3389/fmed.2021.658842.引用於:PTEN 錯構瘤腫瘤綜合徵
  363. Grünert SC, Eckenweiler M, Haas D, 等. The spectrum of peripheral neuropathy in disorders of the mitochondrial trifunctional protein[J]. Journal of Inherited Metabolic Disease, 2021, 44(4): 893-902. DOI: 10.1002/jimd.12372. 8 例本病與 11 例三功能蛋白缺乏症患者的神經系統檢查與電生理:周圍神經病變的比例、起病年齡與類型。引用於:長鏈 3-羥酰基輔酶 A 脫氫酶缺乏症
  364. Hoytema van Konijnenburg EMM, Wortmann SB, Koelewijn MJ, et al. Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app[J]. Orphanet Journal of Rare Diseases, 2021, 16(1): 170. DOI: 10.1186/s13023-021-01727-2.
  365. Wafa TT, Faridi R, King KA, 等. Vestibular phenotype-genotype correlation in a cohort of 90 patients with Usher syndrome[J]. Clinical Genetics, 2021, 99(2): 226-235. DOI: 10.1111/cge.13868. 90 名患者的前庭功能檢查與基因型對照:Ⅰ型裡有保留部分前庭反應的,Ⅱ型裡也有前庭檢查異常的。引用於:Usher 綜合徵
  366. Chandrasekharan P, Lakshminrusimha S, Abman SH. When to say no to inhaled nitric oxide in neonates?[J]. Seminars in Fetal & Neonatal Medicine, 2021, 26(2): 101200. DOI: 10.1016/j.siny.2021.101200.引用於:新生兒持續肺動脈高壓
  367. Kozel BA, Barak B, Kim CA, 等. Williams syndrome[J]. Nature Reviews Disease Primers, 2021, 7(1): 42. DOI: 10.1038/s41572-021-00276-z.引用於:威廉姆斯綜合徵
  368. Grünert SC, Sass JO. 2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways[J]. Orphanet Journal of Rare Diseases, 2020, 15(1): 106. DOI: 10.1186/s13023-020-01357-0. 對文獻中 244 例患者的系統回顧:起病年齡、發作次數、神經系統轉歸、頭顱影像、飲食與左卡尼汀的使用情況。引用於:β-酮硫解酶缺乏症
  369. 高超, 段佳麗, 張沛, 等. 一個 Smith-Lemli-Opitz 綜合徵家系的臨床表型和遺傳學分析[J]. 中華醫學遺傳學雜誌, 2020, 37(11): 1272-1275. DOI: 10.3760/cma.j.cn511374-20190929-00502. 鄭州大學附屬兒童醫院(河南省兒童醫院)康復醫學科。引用於:Smith-Lemli-Opitz 綜合徵
  370. 黃麗萍, 曾佩佩, 陳玲, 等. 不同年齡段兒童功能性構音障礙臨床特徵分析[J]. 中國兒童保健雜誌, 2020, 28(9): 1024-1027. DOI: 10.11852/zgetbjzz2020-0596.
  371. Gu J, Liang SZ, Shi BJ, 等. 支氣管肺發育不良早產兒生後1年內神經行為發育的臨床分析[J]. 中國當代兒科雜誌, 2020, 22(6): 583-588. DOI: 10.7499/j.issn.1008-8830.2002145.引用於:NBNA 方法頁
  372. 汲嶽芝, 阮文華. 嬰幼兒舌繫帶過短的診斷及治療[J]. 華西口腔醫學雜誌, 2020, 38(4).
  373. Tong Y R, Geng C, Guan Y Z, 等. A comprehensive analysis of 2013 dystrophinopathies in China: a report from national rare disease center[J]. Frontiers in Neurology, 2020, 11: 572006. DOI: 10.3389/fneur.2020.572006. 北京協和醫院國家罕見病中心 2013 例登記病例。引用於:杜氏肌營養不良
  374. Kollins SH, DeLoss DJ, Cañadas E, 等. A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial[J]. Lancet. Digital Health, 2020, 2(4): e168-e178. DOI: 10.1016/S2589-7500(20)30017-0.引用於:注意力與認知訓練
  375. Ayoub MD, Kamath BM. Alagille Syndrome: Diagnostic Challenges and Advances in Management[J]. Diagnostics (Basel), 2020, 10(11): 907. DOI: 10.3390/diagnostics10110907.引用於:Alagille 綜合徵
  376. Dai W, Lu D, Gu X, 等. Aromatic L-amino acid decarboxylase deficiency in 17 Mainland China patients: Clinical phenotype, molecular spectrum, and therapy overview[J]. Molecular Genetics & Genomic Medicine, 2020, 8(3): e1143. DOI: 10.1002/mgg3.1143. 17 例中國大陸患者的臨床表型與基因譜:剪接位點變異 IVS6+4A>T 佔 58.8%,是國內檢測策略的依據。引用於:芳香族 L-氨基酸脫羧酶缺乏症
  377. Roche L, Sigafoos J, Trembath D. Augmentative and alternative communication intervention for people with Angelman syndrome: a systematic review[J]. Current Developmental Disorders Reports, 2020, 7(1): 28-34. DOI: 10.1007/s40474-020-00187-w.引用於:Angelman 綜合徵、語言發育遲緩
  378. Zhang J, Wang Y, Ma D, 等. Carrier screening and prenatal diagnosis for spinal muscular atrophy in 13 069 Chinese pregnant women[J]. The Journal of Molecular Diagnostics, 2020, 22(6): 817-822. DOI: 10.1016/j.jmoldx.2020.03.001.引用於:脊髓性肌萎縮症
  379. Uggenti C, Lepelley A, Depp M, 等. cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing[J]. Nature Genetics, 2020, 52(12): 1364–1372. DOI: 10.1038/s41588-020-00737-3.引用於:Aicardi-Goutières 綜合徵
  380. Jiao X, Xue J, Gong P, 等. Clinical and genetic features in pyridoxine-dependent epilepsy: a Chinese cohort study[J]. Developmental Medicine and Child Neurology, 2020, 62(3): 315-321. DOI: 10.1111/dmcn.14385. 國內單中心 31 個家系 33 名患兒的發作類型、腦電圖與基因變異。引用於:吡哆醇依賴性癲癇
  381. James AC, Reardon T, Soler A, 等. Cognitive behavioural therapy for anxiety disorders in children and adolescents[J]. Cochrane Database of Systematic Reviews, 2020, 11(11): CD013162. DOI: 10.1002/14651858.CD013162.pub2.引用於:康復與干預方法
  382. Messina V, Karlsson L, Hirvikoski T, 等. Cognitive Function of Children and Adolescents With Congenital Adrenal Hyperplasia: Importance of Early Diagnosis[J]. The Journal of Clinical Endocrinology and Metabolism, 2020, 105(3): e683–e691. DOI: 10.1210/clinem/dgaa016.引用於:21-羥化酶缺乏症
  383. Gimeno H, Polatajko HJ, Lin JP, 等. Cognitive Strategy Training in Childhood-Onset Movement Disorders: Replication Across Therapists[J]. Frontiers in Pediatrics, 2020, 8: 600337. DOI: 10.3389/fped.2020.600337. 兒童期起病的運動障礙在腦深部電刺激之後做任務導向作業治療的研究,描述了目標怎麼選、課程怎麼排。引用於:DYT-TOR1A 肌張力障礙
  384. An Y, Zhang L, Liu W, 等. De novo variants in the Helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth[J]. Human Genetics, 2020, 139(4): 499-512. DOI: 10.1007/s00439-020-02115-9. 中國孤獨症隊列中的 4 例 CHD8 新發變異。引用於:CHD8 相關神經發育障礙
  385. Bozano A, Schiaffino A, Spessa A, 等. Description of the Lesch-Nyhan neurobehavioral disorder and its management through participant observation of three young individuals[J]. JIMD Reports, 2020, 52(1): 63-71. DOI: 10.1002/jmd2.12100. 對 3 名患兒 60 次、共 90 多小時的參與式觀察:自傷等行為的誘因、孩子事後的反應,以及照護者各種應對方式與行為是否中止的關係。引用於:Lesch-Nyhan 綜合徵
  386. Strand EA. Dynamic Temporal and Tactile Cueing: A Treatment Strategy for Childhood Apraxia of Speech[J]. American Journal of Speech-language Pathology, 2020, 29(1): 30-48. DOI: 10.1044/2019_AJSLP-19-0005.引用於:構音與語音訓練、康復與干預方法
  387. Poffenberger CN, Inati S, Tayebi N, 等. EEG abnormalities in patients with chronic neuronopathic Gaucher disease: A retrospective review[J]. Molecular Genetics and Metabolism, 2020, 131(3): 358–363. DOI: 10.1016/j.ymgme.2020.10.010.引用於:戈謝病
  388. Cerbone M, Güemes M, Wade A, 等. Endocrine morbidity in midline brain defects: Differences between septo-optic dysplasia and related disorders[J]. EClinicalMedicine, 2020, 19: 100224. DOI: 10.1016/j.eclinm.2019.11.017. 一家兒科內分泌中心 259 例患兒(其中視隔發育不良 171 例)的回顧性縱向隊列:各項垂體激素缺乏出現的年齡、青春期與體重的表現、磁共振所見與激素缺乏的關係。引用於:原發性生長激素缺乏症、視隔發育不良
  389. O'Shea R, Jones M, Lightfoot K. Examining Conductive Education: Linking Science, Theory, and Intervention[J]. Archives of Rehabilitation Research and Clinical Translation, 2020, 2(4): 100077. DOI: 10.1016/j.arrct.2020.100077.引用於:Bobath 療法(NDT)、引導式教育(CE)
  390. Crisafulli S, Sultana J, Fontana A, 等. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis[J]. Orphanet Journal of Rare Diseases, 2020, 15: 141. DOI: 10.1186/s13023-020-01430-8.引用於:杜氏肌營養不良
  391. Stępień A, Maślanko K, Krawczyk M, 等. Gross Motor Function Disorders in Patients with Alternating Hemiplegia of Childhood[J]. Journal of Mother and Child, 2020, 24(1): 24-32. DOI: 10.34763/jmotherandchild.2020241.1935.000003. 10 例患者與 30 名對照的發作間期粗大運動評估,逐項列出受累最明顯的動作,供製定物理治療方案參考。引用於:兒童交替性偏癱
  392. Frost KM, Brian J, Gengoux GW, 等. Identifying and measuring the common elements of naturalistic developmental behavioral interventions for autism spectrum disorder: Development of the NDBI-Fi[J]. Autism : the International Journal of Research and Practice, 2020, 24(8): 2285-2297. DOI: 10.1177/1362361320944011.引用於:自然發展行為干預(NDBI)、早期介入丹佛模式(ESDM)
  393. Chen J, Tian DC, Zhang C, 等. Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study[J]. The Lancet Regional Health. Western Pacific, 2020, 5: 100063. DOI: 10.1016/j.lanwpc.2020.100063.引用於:全身型重症肌無力
  394. Riikonen R. Infantile Spasms: Outcome in Clinical Studies[J]. Pediatric Neurology, 2020, 108: 54–64. DOI: 10.1016/j.pediatrneurol.2020.01.015.引用於:West 綜合徵
  395. Scheiman M, Kulp MT, Cotter SA, 等. Interventions for convergence insufficiency: a network meta-analysis[J]. Cochrane Database of Systematic Reviews, 2020, 12(12): CD006768. DOI: 10.1002/14651858.CD006768.pub3.引用於:康復與干預方法
  396. Ma J, Han W, Jiang L. Japanese encephalitis-induced anti-N-methyl-d-aspartate receptor encephalitis: A hospital-based prospective study[J]. Brain & Development, 2020, 42(2): 179–184. DOI: 10.1016/j.braindev.2019.09.003.引用於:自身免疫性腦炎
  397. Hu P, Lin L, Wu Z, 等. Kayser-Fleischer ring with keratoconus: a coincidence? A case report[J]. BMC Ophthalmology, 2020, 20(1): 190. DOI: 10.1186/s12886-020-01463-4.引用於:肝豆狀核變性
  398. Alqarajeh F, Omorodion J, Bosfield K, 等. Lysinuric protein intolerance: Pearls to detect this otherwise easily missed diagnosis[J]. Translational Science of Rare Diseases, 2020, 5(1-2): 81-86. DOI: 10.3233/trd-190035. 延遲確診的 1 例報告:營養不良時血、尿氨基酸可以不典型,曾先按遺傳性果糖不耐受症處理。引用於:賴氨酸尿蛋白不耐受症
  399. Self JE, Dunn MJ, Erichsen JT, 等. Management of nystagmus in children: a review of the literature and current practice in UK specialist services[J]. Eye, 2020, 34(9): 1515-1534. DOI: 10.1038/s41433-019-0741-3. 兒童眼球震顫的處理綜述:嬰兒型眼球震顫的起病時間、代償性頭位、檢查要點與低視力支持。引用於:眼皮膚白化病
  400. Ho S, Luk H M, Chung B H, 等. Mowat-Wilson syndrome in a Chinese population: a case series[J]. American Journal of Medical Genetics Part A, 2020, 182(6): 1336-1341. DOI: 10.1002/ajmg.a.61557. 香港 15 例中國患者。引用於:Mowat-Wilson 綜合徵
  401. Wan N, Chen Z, Wan L, 等. MR Imaging of SCA3/MJD[J]. Frontiers in Neuroscience, 2020, 14: 749. DOI: 10.3389/fnins.2020.00749. SCA3/馬查多-約瑟夫病的影像學綜述:小腦與腦幹萎縮的分佈與隨病程的演變。引用於:脊髓小腦性共濟失調
  402. Sawamoto K, Álvarez González JV, Piechnik M, 等. Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management[J]. International Journal of Molecular Sciences, 2020, 21(4): 1517. DOI: 10.3390/ijms21041517.引用於:黏多糖貯積症
  403. Chang X, Zhang J, Jiang Y, 等. Natural history and genotype-phenotype correlation of pantothenate kinase-associated neurodegeneration[J]. CNS Neuroscience & Therapeutics, 2020, 26(7): 754-761. DOI: 10.1111/cns.13294. 北京大學第一醫院兒科彙總中英文文獻與該中心病例共 248 例的自然史分析,給出各症狀出現的比例與時間。引用於:泛酸激酶相關神經變性
  404. Krieg SI, Krägeloh-Mann I, Groeschel S, 等. Natural history of Krabbe disease - a nationwide study in Germany using clinical and MRI data[J]. Orphanet Journal of Rare Diseases, 2020, 15(1): 243. DOI: 10.1186/s13023-020-01489-3. 德國全國性隊列(38 例):各型的構成、首發症狀、里程碑的獲得與丟失,以及不同類型的磁共振受累模式。引用於:Krabbe 病
  405. Wang X, Wang Y, Ma D, 等. Neonatal screening and genotype-phenotype correlation of 21-hydroxylase deficiency in the Chinese population[J]. Frontiers in Genetics, 2020, 11: 623125. DOI: 10.3389/fgene.2020.623125. 南京地區 2000 至 2019 年 121 萬餘名新生兒篩查隊列。引用於:21-羥化酶缺乏症
  406. de Bruijn MAAM, Bruijstens AL, Bastiaansen AEM, 等. Pediatric autoimmune encephalitis: Recognition and diagnosis[J]. Neurology: Neuroimmunology & Neuroinflammation, 2020, 7(3): e682. DOI: 10.1212/NXI.0000000000000682. 荷蘭全國隊列:兒童自身免疫性腦炎的起病表現、抗體分佈與識別要點。引用於:自身免疫性腦炎
  407. Szugye HS. Pediatric Rhabdomyolysis[J]. Pediatrics in Review, 2020, 41(6): 265–275. DOI: 10.1542/pir.2018-0300.引用於:血清肌酸激酶升高
  408. Liang SB, Lai BY, Cao HJ, 等. Pediatric tuina for the treatment of anorexia in children under 14 years: a systematic review and meta-analysis of randomized controlled trials[J]. Complementary Therapies in Medicine, 2020, 51: 102411. DOI: 10.1016/j.ctim.2020.102411.引用於:小兒推拿
  409. Wu H, Li H, Bai T, 等. Phenotype-to-genotype approach reveals head-circumference-associated genes in an autism spectrum disorder cohort[J]. Clinical Genetics, 2020, 97(2): 338-346. DOI: 10.1111/cge.13665. 中南大學醫學遺傳學研究中心:67 個伴頭圍異常的孤獨症家系做外顯子組測序。引用於:CHD8 相關神經發育障礙、PTEN 錯構瘤腫瘤綜合徵
  410. Zhou H, Xu X, Yan W, 等. Prevalence of autism spectrum disorder in China: a nationwide multi-center population-based study among children aged 6 to 12 years[J]. Neuroscience Bulletin, 2020, 36(9): 961-971.引用於:孤獨症譜系障礙(自閉症)
  411. Sandbank M, Bottema-Beutel K, Crowley S, 等. Project AIM: autism intervention meta-analysis for studies of young children[J]. Psychological Bulletin, 2020, 146(1): 1-29.引用於:孤獨症譜系障礙(自閉症)、融合教育、行為矯正訓練、地板時光(DIR)、結構化教學(TEACCH)、術語表
  412. Lipkin PH, Macias MM. Promoting optimal development: identifying infants and young children with developmental disorders through developmental surveillance and screening[J]. Pediatrics, 2020, 145(1): e20193449.引用於:兒童發育與行為評估、術語表
  413. Lim J, Greenspoon D, Hunt A, 等. Rehabilitation interventions in Rett syndrome: a scoping review[J]. Developmental Medicine & Child Neurology, 2020, 62(8): 906-916. DOI: 10.1111/dmcn.14565. 納入 62 篇文獻的範圍綜述:大運動、精細動作與溝通三類干預均有獲益報告。引用於:Rett 綜合徵、發育倒退、神經發育障礙與癲癇性腦病
  414. Roeper M, Salimi Dafsari R, Hoermann H, 等. Risk Factors for Adverse Neurodevelopment in Transient or Persistent Congenital Hyperinsulinism[J]. Frontiers in Endocrinology, 2020, 11: 580642. DOI: 10.3389/fendo.2020.580642. 一過性與持續性先天性高胰島素血症的神經發育結局及其危險因素分析。引用於:先天性高胰島素性低血糖血症
  415. S-S 語言發育遲緩檢查法評估語言發育遲緩兒童發育特徵的相關性研究[J]. 中國兒童保健雜誌, 2020. DOI: 10.11852/zgetbjzz2019-0898.引用於:語言發育遲緩與構音障礙、學習困難與學習障礙、兒童發育與行為評估、言語認知訓練、S-S 法、評估量表一覽
  416. De Vries MC, Brown DA, Allen ME, 等. Safety of drug use in patients with a primary mitochondrial disease: An international Delphi-based consensus[J]. Journal of Inherited Metabolic Disease, 2020, 43(4): 800–818. DOI: 10.1002/jimd.12196.引用於:線粒體腦肌病
  417. Maiorana A, Sabia A, Corsetti T, 等. Safety of vaccines administration in hereditary fructose intolerance[J]. Orphanet Journal of Rare Diseases, 2020, 15(1): 274. DOI: 10.1186/s13023-020-01552-z. 羅馬 Bambino Gesù 兒童醫院逐種核對歐洲常用兒童疫苗的蔗糖、山梨醇含量,列出哪些可以接種、哪些不能。引用於:遺傳性果糖不耐受症
  418. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics, Committee on Genetics, Society for Maternal-Fetal Medicine. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226[J]. Obstetrics and Gynecology, 2020, 136(4): e48–e69. DOI: 10.1097/AOG.0000000000004084.引用於:21 三體綜合徵
  419. Dowdall N, Melendez-Torres GJ, Murray L, 等. Shared Picture Book Reading Interventions for Child Language Development: A Systematic Review and Meta-Analysis[J]. Child Development, 2020, 91(2): e383-e399. DOI: 10.1111/cdev.13225.引用於:家長實施的語言干預
  420. Novak I, Morgan C, Fahey M, 等. State of the evidence traffic lights 2019: systematic review of interventions for preventing and treating children with cerebral palsy[J]. Current Neurology and Neuroscience Reports, 2020, 20(2): 3.引用於:兒童腦癱康復、運動訓練、作業訓練、減重步行與跑臺訓練、康復與干預方法、訓練器材與教具、術語表
  421. Choi JY, Rha DW, Kim SA, 等. The Dynamic Thumb-in-Palm Pattern in Children with Spastic Cerebral Palsy and Its Effects on Upper Limb Function[J]. Children (Basel), 2020, 8(1): 17. DOI: 10.3390/children8010017.引用於:L1 綜合徵
  422. Deb SS, Retzer A, Roy M, 等. The effectiveness of parent training for children with autism spectrum disorder: a systematic review and meta-analyses[J]. BMC Psychiatry, 2020, 20(1): 583. DOI: 10.1186/s12888-020-02973-7.引用於:家長介導干預、地板時光(DIR)
  423. Fuller EA, Oliver K, Vejnoska SF, 等. The Effects of the Early Start Denver Model for Children with Autism Spectrum Disorder: A Meta-Analysis[J]. Brain Sciences, 2020, 10(6). DOI: 10.3390/brainsci10060368.引用於:早期介入丹佛模式(ESDM)
  424. Atwal PS, Midei M, Adams D, 等. The infantile neuroaxonal dystrophy rating scale (INAD-RS)[J]. Orphanet Journal of Rare Diseases, 2020, 15(1): 195. DOI: 10.1186/s13023-020-01479-5. 針對本病的評定量表,按六個方面共 40 項記錄病情,供專科隨訪使用。引用於:嬰兒神經軸索營養不良
  425. Altuame FD, Foskett G, Atwal PS, 等. The natural history of infantile neuroaxonal dystrophy[J]. Orphanet Journal of Rare Diseases, 2020, 15(1): 109. DOI: 10.1186/s13023-020-01355-2. 28 例經基因證實患兒的回顧性自然史研究:起疑年齡、各項能力丟失的先後與月齡、體徵、影像、電生理與化驗。引用於:嬰兒神經軸索營養不良
  426. Li C, Geng Y, Zhu X, 等. The prevalence of spinal muscular atrophy carrier in China: evidences from epidemiological surveys[J]. Medicine, 2020, 99(5): e18975. DOI: 10.1097/MD.0000000000018975.引用於:脊髓性肌萎縮症
  427. McWilliam RA, Boavida T, Bull K, 等. The Routines-Based Model Internationally Implemented[J]. International Journal of Environmental Research and Public Health, 2020, 17(22). DOI: 10.3390/ijerph17228308.引用於:康復與干預方法
  428. Shirley M. Triheptanoin: First Approval[J]. Drugs, 2020, 80(15): 1595–1600. DOI: 10.1007/s40265-020-01399-5.引用於:極長鏈酰基輔酶 A 脫氫酶缺乏症
  429. Toms M, Pagarkar W, Moosajee M. Usher syndrome: clinical features, molecular genetics and advancing therapeutics[J]. Therapeutic Advances in Ophthalmology, 2020, 12: 2515841420952194. DOI: 10.1177/2515841420952194. 綜述:三型的臨床特徵、聾兒何時該懷疑本病、視網膜電圖在嬰兒期的用途、聽力康復與在研治療。引用於:Usher 綜合徵
  430. 張悅. 我國兒童保健工作中高危兒管理內涵和外延的探析[J]. 中國兒童保健雜誌, 2019, 27(2): 123-125. DOI: 10.11852/zgetbjzz2018-1853.
  431. 夏倩倩, 侯新琳. 圍產期腦卒中的臨床表現、治療與結局[J]. 中華新生兒科雜誌, 2019, 34(2): 159-160. DOI: 10.3760/cma.j.issn.2096-2932.2019.02.019.引用於:術語表
  432. Liu GH, Huang LS, Qian QF, 等. 階梯式融合性箱庭療法對學齡前輕中度孤獨症譜系障礙患兒核心症狀及睡眠管理的效果評價[J]. 中國當代兒科雜誌, 2019, 21(8): 743-748. DOI: 10.7499/j.issn.1008-8830.2019.08.002.引用於:遊戲治療與沙盤遊戲
  433. Wang YX, Lu GB, Ge P, 等. 學齡前期孤獨症譜系障礙兒童交叉式團體與個體沙盤干預的療效比較[J]. 中國當代兒科雜誌, 2019, 21(4): 342-347. DOI: 10.7499/j.issn.1008-8830.2019.04.008.引用於:遊戲治療與沙盤遊戲
  434. Rogers SJ, Estes A, Lord C, 等. A Multisite Randomized Controlled Two-Phase Trial of the Early Start Denver Model Compared to Treatment as Usual[J]. Journal of the American Academy of Child and Adolescent Psychiatry, 2019, 58(9): 853-865. DOI: 10.1016/j.jaac.2019.01.004.引用於:應用行為分析(ABA)、自然發展行為干預(NDBI)、早期介入丹佛模式(ESDM)
  435. Gengoux GW, Abrams DA, Schuck R, 等. A Pivotal Response Treatment Package for Children With Autism Spectrum Disorder: An RCT[J]. Pediatrics, 2019, 144(3). DOI: 10.1542/peds.2019-0178.引用於:關鍵反應訓練(PRT)
  436. Yakoreva M, Kahre T, Žordania R, 等. A retrospective analysis of the prevalence of imprinting disorders in Estonia from 1998 to 2016[J]. European Journal of Human Genetics, 2019, 27(11): 1649–1658. DOI: 10.1038/s41431-019-0446-x.引用於:Silver-Russell 綜合徵
  437. Schoen SA, Lane SJ, Mailloux Z, 等. A systematic review of Ayres Sensory Integration intervention for children with autism[J]. Autism Research, 2019, 12(1): 6-19.引用於:感覺統合與感覺處理困難、感覺統合訓練、感覺統合治療(ASI)
  438. Pauli RM. Achondroplasia: a comprehensive clinical review[J]. Orphanet Journal of Rare Diseases, 2019, 14(1): 1. DOI: 10.1186/s13023-018-0972-6.引用於:軟骨發育不全
  439. Roberts MY, Curtis PR, Sone BJ, 等. Association of parent training with child language development: a systematic review and meta-analysis[J]. JAMA Pediatrics, 2019, 173(7): 671-680. DOI: 10.1001/jamapediatrics.2019.1197.引用於:語言發育遲緩與構音障礙、家庭育兒指導課程、言語認知訓練、S-S 法、家長實施的語言干預、家長行為管理培訓(PMT)、語言發育遲緩與構音障礙的訓練方法、訓練器材與教具
  440. Xie Z, Hou Y, Yu M, 等. Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of Chinese patients[J]. Orphanet Journal of Rare Diseases, 2019, 14(1): 43. DOI: 10.1186/s13023-019-1021-9. 我國 25 例肌聚糖相關型患者的起病年齡、首發症狀、體徵、肌酸激酶與肌肉活檢結果,是本頁兒童期起病一型的主要依據。引用於:肢帶型肌營養不良
  441. Yu S, Wu B, Qian Y, 等. Clinical exome sequencing identifies novel CREBBP variants in 18 Chinese Rubinstein-Taybi Syndrome kids with high frequency of polydactyly[J]. Molecular Genetics & Genomic Medicine, 2019, 7(12): e1009. DOI: 10.1002/mgg3.1009. 復旦大學附屬兒科醫院 2014 至 2018 年確診的 18 例。引用於:Rubinstein-Taybi 綜合徵
  442. Van Dijck A, Vulto-van Silfhout AT, Cappuyns E, 等. Clinical Presentation of a Complex Neurodevelopmental Disorder Caused by Mutations in ADNP[J]. Biological Psychiatry, 2019, 85(4): 287–297. DOI: 10.1016/j.biopsych.2018.02.1173.引用於:ADNP 綜合徵
  443. Bartholomay KL, Lee CH, Bruno JL, 等. Closing the Gender Gap in Fragile X Syndrome: Review on Females with FXS and Preliminary Research Findings[J]. Brain Sciences, 2019, 9(1): 11. DOI: 10.3390/brainsci9010011.引用於:脆性 X 綜合徵
  444. Pescosolido MF, Kavanaugh BC, Pochet N, 等. Complex Neurological Phenotype in Female Carriers of NHE6 Mutations[J]. Molecular Neuropsychiatry, 2019, 5(2): 98–108. DOI: 10.1159/000496341.引用於:Christianson 綜合徵
  445. Dietrich ML, Schieffelin JS. Congenital Cytomegalovirus Infection[J]. Ochsner Journal, 2019, 19(2): 123–130. DOI: 10.31486/toj.18.0095.引用於:Usher 綜合徵
  446. Finsterer J. Congenital myasthenic syndromes[J]. Orphanet Journal of Rare Diseases, 2019, 14(1): 57. DOI: 10.1186/s13023-019-1025-5.引用於:先天性肌無力綜合徵
  447. Hoare BJ, Wallen MA, Thorley MN, 等. Constraint-induced movement therapy in children with unilateral cerebral palsy[J]. Cochrane Database of Systematic Reviews, 2019, (4): CD004149. DOI: 10.1002/14651858.CD004149.pub3.引用於:兒童腦癱康復、作業訓練、強制性誘導運動療法與雙手強化訓練(CIMT)、術語表
  448. Olivieri G, Pro S, Diodato D, 等. Corticospinal tract damage in HHH syndrome: a metabolic cause of hereditary spastic paraplegia[J]. Orphanet Journal of Rare Diseases, 2019, 14(1): 208. DOI: 10.1186/s13023-019-1181-7. 九例患者的神經系統系統評估,說明 HHH 綜合徵以皮質脊髓束受累為主,表型與複雜型遺傳性痙攣性截癱重疊。引用於:HHH 綜合徵
  449. Okano Y, Ohura T, Sakamoto O, 等. Current treatment for citrin deficiency during NICCD and adaptation/compensation stages: Strategy to prevent CTLN2[J]. Molecular Genetics and Metabolism, 2019, 127(3): 175–183. DOI: 10.1016/j.ymgme.2019.06.004.引用於:瓜氨酸血症
  450. Di Dato F, Spadarella S, Puoti MG, 等. Daily Fructose Traces Intake and Liver Injury in Children with Hereditary Fructose Intolerance[J]. Nutrients, 2019, 11(10): E2397. DOI: 10.3390/nu11102397. 48 例患兒平均隨訪 10.3 年的隊列:飲食控制下的生長、神經發育、轉氨酶與肝臟超聲。引用於:遺傳性果糖不耐受症
  451. Salomone E, Pacione L, Shire S, 等. Development of the WHO Caregiver Skills Training Program for Developmental Disorders or Delays[J]. Frontiers in Psychiatry, 2019, 10: 769. DOI: 10.3389/fpsyt.2019.00769.引用於:家長介導干預
  452. Marshall RD, Collins A, Escolar ML, 等. Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration[J]. Orphanet Journal of Rare Diseases, 2019, 14(1): 174. DOI: 10.1186/s13023-019-1142-1. 對 39 名患者及其照護者的訪談研究,記錄確診路徑、就診與治療師訪視次數、在校困難與照護負擔。引用於:泛酸激酶相關神經變性
  453. Beltran-Quintero ML, Bascou NA, Poe MD, 等. Early progression of Krabbe disease in patients with symptom onset between 0 and 5 months[J]. Orphanet Journal of Rare Diseases, 2019, 14(1): 46. DOI: 10.1186/s13023-019-1018-4. 88 例 0–5 月齡起病患兒的前瞻性自然史研究:首發症狀、各月齡段的症狀出現率、電生理與影像、生存時間。引用於:Krabbe 病
  454. Novak I, Honan I. Effectiveness of paediatric occupational therapy for children with disabilities: A systematic review[J]. Australian Occupational Therapy Journal, 2019, 66(3): 258-273. DOI: 10.1111/1440-1630.12573.引用於:書寫與精細動作訓練
  455. MacLennan AH, Lewis S, Moreno-De-Luca A, 等. Genetic or Other Causation Should Not Change the Clinical Diagnosis of Cerebral Palsy[J]. Journal of Child Neurology, 2019, 34(8): 472–476. DOI: 10.1177/0883073819840449. 遺傳學病因與符合定義的腦癱臨床診斷可以並存;病因發現本身不應自動取消原臨床診斷。引用於:腦性癱瘓的鑑別與病因評估:何時需要進一步檢查
  456. Madsen KL, Preisler N, Buch AE, 等. Impaired fat oxidation during exercise in multiple acyl-CoA dehydrogenase deficiency[J]. JIMD Reports, 2019, 46(1): 79-84. DOI: 10.1002/jmd2.12024. 兩名成年晚髮型患者的運動代謝研究:用穩定同位素示蹤測量次極量運動中脂肪與糖的氧化。引用於:多種酰基輔酶 A 脫氫酶缺乏症
  457. Shum KK, Cho WK, Lam LMO, 等. Learning How to Make Friends for Chinese Adolescents with Autism Spectrum Disorder: A Randomized Controlled Trial of the Hong Kong Chinese Version of the PEERS® Intervention[J]. Journal of Autism and Developmental Disorders, 2019, 49(2): 527-541. DOI: 10.1007/s10803-018-3728-1.引用於:社交技能小組訓練
  458. Kang Q, Hu J, Yang N, 等. Marketing of drugs for rare diseases is speeding up in China: Looking at the example of drugs for mucopolysaccharidosis[J]. Intractable & Rare Diseases Research, 2019, 8(3): 165–171. DOI: 10.5582/irdr.2019.01090.引用於:黏多糖貯積症
  459. Hakami WS, Hundallah KJ, Tabarki BM. Metabolic and genetic disorders mimicking cerebral palsy[J]. Neurosciences (Riyadh), 2019, 24(3): 155-163. 表現類似腦性癱瘓的代謝與遺傳病綜述,列出病史、查體與影像上提示應另查病因的線索。引用於:泛酸激酶相關神經變性
  460. Li X, Yao R, Tan X, 等. Molecular and phenotypic spectrum of Noonan syndrome in Chinese patients[J]. Clinical Genetics, 2019, 96(4): 290-299. DOI: 10.1111/cge.13588. 103 例中國患者的二代測序結果,是目前可查的較大規模中國人群基因構成數據。引用於:Noonan 綜合徵
  461. Abdelkreem E, Harijan RK, Yamaguchi S, 等. Mutation update on ACAT1 variants associated with mitochondrial acetoacetyl-CoA thiolase (T2) deficiency[J]. Human Mutation, 2019, 40(10): 1641-1663. DOI: 10.1002/humu.23831. ACAT1 變異綜述,附酶的兩項功能、生化診斷的注意點、各地發生率與臨床意義(含不伴酮症酸中毒的錐體外系表現)。引用於:β-酮硫解酶缺乏症
  462. Ganau M, Huet S, Syrmos N, 等. Neuro-Ophthalmological Manifestations Of Septo-Optic Dysplasia: Current Perspectives[J]. Eye and Brain, 2019, 11: 37-47. DOI: 10.2147/eb.s186307. 敘述性綜述:各地區的發生率研究、眼科與神經系統表現、磁共振的讀片順序、內分泌檢查項目與眼科處理。引用於:視隔發育不良
  463. Kaplan K, McCool C, Lupski JR, 等. Objective measures of sleep disturbances in children with Potocki-Lupski syndrome[J]. American Journal of Medical Genetics Part A, 2019, 179(10): 1982–1986. DOI: 10.1002/ajmg.a.61307.引用於:Potocki-Lupski 綜合徵
  464. Goday PS, Huh SY, Silverman A, 等. Pediatric Feeding Disorder: Consensus Definition and Conceptual Framework[J]. Journal of Pediatric Gastroenterology and Nutrition, 2019, 68(1): 124-129. DOI: 10.1097/MPG.0000000000002188.引用於:餵養與吞嚥治療、餵養困難與吞嚥問題的干預方法
  465. Guo C, Luo M, Wang X, 等. Reliability and validity of the Chinese version of Modified Checklist for Autism in Toddlers, Revised, with Follow-Up (M-CHAT-R/F)[J]. Journal of Autism and Developmental Disorders, 2019, 49(1). DOI: 10.1007/s10803-018-3682-y.引用於:孤獨症譜系障礙(自閉症)、感覺統合與感覺處理困難、兒童發育與行為評估、評估量表一覽
  466. Wang J, Zhang Q, Chen Y, 等. Rett and Rett-like syndrome: expanding the genetic spectrum to KIF1A and GRIN1 gene[J]. Molecular Genetics & Genomic Medicine, 2019, 7(11): e968. DOI: 10.1002/mgg3.968. 北京大學第一醫院兒科:44 例 MECP2、CDKL5、FOXG1 陰性的 Rett 或 Rett 樣患兒。引用於:神經元蠟樣脂褐質沉積症
  467. Martins J, Darling A, Garrido C, 等. Sensory Tricks in Pantothenate Kinase-Associated Neurodegeneration: Video-Analysis of 43 Patients[J]. Movement Disorders Clinical Practice, 2019, 6(8): 704-707. DOI: 10.1002/mdc3.12842. 43 名基因確診患者的錄像分析,描述用手壓下巴等緩解肌張力障礙的「感覺詭計」。引用於:泛酸激酶相關神經變性
  468. Zhang Y, Xu Q, Lu P, 等. Skill Training for Parents with ASD Children in China[J]. Pediatric Medicine, 2019, 2: 47. DOI: 10.21037/pm.2019.08.02.引用於:自然發展行為干預(NDBI)、早期介入丹佛模式(ESDM)
  469. Storebø OJ, Elmose Andersen M, Skoog M, 等. Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years[J]. Cochrane Database of Systematic Reviews, 2019, 6(6): CD008223. DOI: 10.1002/14651858.CD008223.pub3.引用於:康復與干預方法
  470. Iodice A, Pisani F. Status dystonicus: management and prevention in children at high risk[J]. Acta Bio-Medica: Atenei Parmensis, 2019, 90(3): 207-212. DOI: 10.23750/abm.v90i3.7207. 兒童肌張力障礙持續狀態的綜述:高危病因、誘因與早期識別的體徵。引用於:泛酸激酶相關神經變性、DYT-TOR1A 肌張力障礙
  471. Vlaskamp D R M, Shaw B J, Burgess R, 等. SYNGAP1 encephalopathy: a distinctive generalized developmental and epileptic encephalopathy[J]. Neurology, 2019, 92(2): e96-e107. DOI: 10.1212/WNL.0000000000006729. 57 例國際多中心隊列,北京大學第一醫院兒科參與。引用於:SYNGAP1 相關智力障礙
  472. Rubio-Gozalbo ME, Haskovic M, Bosch AM, 等. The natural history of classic galactosemia: lessons from the GalNet registry[J]. Orphanet Journal of Rare Diseases, 2019, 14(1): 86. DOI: 10.1186/s13023-019-1047-z.引用於:半乳糖血症
  473. Yu L, Zhu X, Shek DTL, 等. Validation of the Simplified Chinese Psychoeducational Profile Third Edition in mainland China[J]. Journal of Autism and Developmental Disorders, 2019, 49(4): 1599-1612.引用於:孤獨症譜系障礙(自閉症)、兒童發育與行為評估、結構化教學(TEACCH)、評估量表一覽
  474. Carr JJ, Lalara J, Lalara G, 等. What is the best way to keep walking and moving around for individuals with Machado-Joseph disease? A scoping review through the lens of Aboriginal families with Machado-Joseph disease in the Top End of Australia[J]. BMJ Open, 2019, 9(9): e032092. DOI: 10.1136/bmjopen-2019-032092. SCA3/馬查多-約瑟夫病維持行走與移動能力的範圍綜述:運動與平衡訓練、輔具與環境改造的證據梳理。引用於:脊髓小腦性共濟失調
  475. 李曉捷, 邱洪斌, 姜志梅, 等. 中國十二省市小兒腦性癱瘓流行病學特徵[J]. 中華實用兒科臨床雜誌, 2018, 33(5): 378-383.引用於:兒童腦癱康復
  476. 唐久來, 王寶田, 李曉捷. 腦性癱瘓早期診斷和腦性癱瘓高風險兒診斷及早期干預進展[J]. 中華實用兒科臨床雜誌, 2018, 33(15): 1121-1125. DOI: 10.3760/cma.j.issn.2095-428X.2018.15.001.
  477. 黃椿棚, 劉顯, 包崇雲. 嬰幼兒舌繫帶過短的臨床診療新進展[J]. 國際口腔醫學雜誌, 2018, 45(4).
  478. Sonuga-Barke EJS, Barton J, Daley D, 等. A comparison of the clinical effectiveness and cost of specialised individually delivered parent training for preschool attention-deficit/hyperactivity disorder and a generic, group-based programme: a multi-centre, randomised controlled trial of the New Forest Parenting Programme versus Incredible Years[J]. European Child & Adolescent Psychiatry, 2018, 27(6): 797-809. DOI: 10.1007/s00787-017-1054-3.引用於:家長行為管理培訓(PMT)
  479. Domniz N, Ries-Levavi L, Cohen Y, 等. Absence of AGG Interruptions Is a Risk Factor for Full Mutation Expansion Among Israeli FMR1 Premutation Carriers[J]. Frontiers in Genetics, 2018, 9: 606. DOI: 10.3389/fgene.2018.00606.引用於:脆性 X 綜合徵
  480. Singh SP, Pati GK. Alagille Syndrome and the Liver: Current Insights[J]. Euroasian Journal of Hepato-Gastroenterology, 2018, 8(2): 140–147. DOI: 10.5005/jp-journals-10018-1280.引用於:Alagille 綜合徵
  481. Sankar MJ, Sankar J, Chandra P. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity[J]. Cochrane Database of Systematic Reviews, 2018, 1(1): CD009734. DOI: 10.1002/14651858.CD009734.pub3. 本頁只引其中對 1 型病變的定義。引用於:早產兒視網膜病變
  482. Feng Y, Huang Y, Zhao X, 等. Clinical and molecular characteristics of 11 Chinese probands with GM1 gangliosidosis[J]. Metabolic Brain Disease, 2018, 33(6): 2051-2057. DOI: 10.1007/s11011-018-0315-2. 11 例中國先證者:5 例嬰兒型、6 例晚嬰或青少年型。引用於:神經節苷脂貯積症
  483. Dong E L, Wang C, Wu S, 等. Clinical spectrum and genetic landscape for hereditary spastic paraplegias in China[J]. Molecular Neurodegeneration, 2018, 13(1): 36. DOI: 10.1186/s13024-018-0269-1.引用於:遺傳性痙攣性截癱
  484. Morgan L, Hooker JL, Sparapani N, 等. Cluster randomized trial of the classroom SCERTS intervention for elementary students with autism spectrum disorder[J]. Journal of Consulting and Clinical Psychology, 2018, 86(7): 631-644. DOI: 10.1037/ccp0000314.引用於:康復與干預方法
  485. Perez KM, Lee EB, Kahanda S, 等. Cognitive and behavioral phenotype of children with pseudohypoparathyroidism type 1A[J]. American Journal of Medical Genetics Part A, 2018, 176(2): 283-289. DOI: 10.1002/ajmg.a.38534. 16 名Ⅰa 型兒童與未患病同胞、匹配對照的前瞻性比較,評估智力、執行功能與行為。引用於:假性甲狀旁腺功能減退症
  486. Hamed SA, Metwalley KA, Farghaly HS. Cognitive function in children with classic congenital adrenal hyperplasia[J]. European Journal of Pediatrics, 2018, 177(11): 1633–1640. DOI: 10.1007/s00431-018-3226-7.引用於:21-羥化酶缺乏症
  487. Kronenburg A, van den Berg E, van Schooneveld MM, 等. Cognitive Functions in Children and Adults with Moyamoya Vasculopathy: A Systematic Review and Meta-Analysis[J]. Journal of stroke, 2018, 20(3): 332-341. DOI: 10.5853/jos.2018.01550. 認知功能的系統綜述與薈萃分析(11 項兒童研究、281 例):認知受損的比例與受影響的領域。引用於:煙霧病
  488. Ma P, Zhang S, Zhang H, 等. Comprehensive genetic characteristics of dystrophinopathies in China[J]. Orphanet Journal of Rare Diseases, 2018, 13: 109. DOI: 10.1186/s13023-018-0853-z.引用於:杜氏肌營養不良
  489. Engel C, Lillie K, Zurawski S, 等. Curriculum-Based Handwriting Programs: A Systematic Review With Effect Sizes[J]. American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association, 2018, 72(3): 7203205010p1-7203205010p8. DOI: 10.5014/ajot.2018.027110.引用於:書寫與精細動作訓練
  490. Li N, Wang Y, Yang Y, 等. Description of the molecular and phenotypic spectrum of Wiedemann-Steiner syndrome in Chinese patients[J]. Orphanet Journal of Rare Diseases, 2018, 13(1): 178. DOI: 10.1186/s13023-018-0909-0. 上海兒童醫學中心等五家醫院的 14 例中國患者,與法國 33 例隊列的表型比較;CXXC 結構域錯義變異與較重神經發育表現的關係。引用於:Wiedemann-Steiner 綜合徵
  491. Birnkrant D J, Bushby K, Bann C M, 等. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management[J]. The Lancet Neurology, 2018, 17(3): 251-267. DOI: 10.1016/S1474-4422(18)30024-3.引用於:杜氏肌營養不良、血清肌酸激酶升高、神經肌肉病
  492. Birnkrant D J, Bushby K, Bann C M, 等. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management[J]. The Lancet Neurology, 2018, 17(4): 347-361. DOI: 10.1016/S1474-4422(18)30025-5.引用於:杜氏肌營養不良、神經肌肉病
  493. Birnkrant D J, Bushby K, Bann C M, 等. Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan[J]. The Lancet Neurology, 2018, 17(5): 445-455. DOI: 10.1016/S1474-4422(18)30026-7.引用於:杜氏肌營養不良
  494. Finkel R S, Mercuri E, Meyer O H, 等. Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics[J]. Neuromuscular Disorders, 2018, 28(3): 197-207. DOI: 10.1016/j.nmd.2017.11.004.引用於:脊髓性肌萎縮症
  495. Reichow B, Hume K, Barton EE, 等. Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD)[J]. Cochrane Database of Systematic Reviews, 2018, 5(5): CD009260. DOI: 10.1002/14651858.CD009260.pub3.引用於:應用行為分析(ABA)、回合式教學(DTT)、早期介入丹佛模式(ESDM)、康復與干預方法
  496. Morgan A T, van Haaften L, van Hulst K, 等. Early speech development in Koolen de Vries syndrome limited by oral praxis and hypotonia[J]. European Journal of Human Genetics, 2018, 26(1): 75-84. DOI: 10.1038/s41431-017-0035-9.引用於:Koolen-de Vries 綜合徵
  497. Wang J, Lang YB, DU JH, 等. Effect of suspension exercise training on motor and balance functions in children with spastic cerebral palsy[J]. 中國當代兒科雜誌, 2018, 20(6): 465-469. DOI: 10.7499/j.issn.1008-8830.2018.06.007. 原文為中文引用於:懸吊訓練(SET)
  498. Myrhaug HT, Odgaard-Jensen J, Østensjø S, 等. Effects of a conductive education course in young children with cerebral palsy:A randomized controlled trial[J]. Developmental Neurorehabilitation, 2018, 21(8): 481-489. DOI: 10.1080/17518423.2017.1360961.引用於:引導式教育(CE)
  499. Zhou B, Xu Q, Li H, 等. Effects of Parent-Implemented Early Start Denver Model Intervention on Chinese Toddlers with Autism Spectrum Disorder: A Non-Randomized Controlled Trial[J]. Autism Research : Official Journal of the International Society for Autism Research, 2018, 11(4): 654-666. DOI: 10.1002/aur.1917.引用於:自然發展行為干預(NDBI)、早期介入丹佛模式(ESDM)
  500. Liu X, Wang XM, Ge JJ, 等. Effects of the portage early education program on Chinese children with global developmental delay[J]. Medicine, 2018, 97(41): e12202. DOI: 10.1097/MD.0000000000012202.引用於:康復與干預方法
  501. Schaaf RC, Dumont RL, Arbesman M, 等. Efficacy of Occupational Therapy Using Ayres Sensory Integration(®): A Systematic Review[J]. American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association, 2018, 72(1): 7201190010p1-7201190010p10. DOI: 10.5014/ajot.2018.028431.引用於:感覺統合治療(ASI)
  502. Bélanger SA, Caron J. Evaluation of the child with global developmental delay and intellectual disability[J]. Paediatrics & Child Health, 2018, 23(6): 403-410. DOI: 10.1093/pch/pxy093.
  503. Hay K, Nelin M, Carey H, 等. Hammersmith Infant Neurological Examination Asymmetry Score Distinguishes Hemiplegic Cerebral Palsy From Typical Development[J]. Pediatric Neurology, 2018, 87: 70-74. DOI: 10.1016/j.pediatrneurol.2018.07.002.
  504. Liu Y, Liu YP, Zhang Y, 等. Heterogeneous phenotypes, genotypes, treatment and prevention of 1 003 patients with methylmalonic acidemia in the mainland of China[J]. 中華兒科雜誌, 2018, 56(6): 414–420. DOI: 10.3760/cma.j.issn.0578-1310.2018.06.003. 1998 至 2017 年我國 26 個省、市、自治區 1003 例:單純型 29.5%,合併同型半胱氨酸血症 70.5%;合併型獲基因診斷者中 94.7% 為 MMACHC 基因變異。引用於:甲基丙二酸血症
  505. Wyatt KEK, Lam SK, Gadgil N. Indirect revascularization for moyamoya disease: A pediatric neuroanesthesiology perspective[J]. Surgical neurology international, 2018, 9: 224. DOI: 10.4103/sni.sni_151_18. 兒童神經麻醉視角的綜述:血二氧化碳下降怎樣使腦血流減少,以及兒童腦氧代謝高、更易缺血的原因。引用於:煙霧病
  506. Sims A, Chounthirath T, Yang J, 等. Infant walker-related injuries in the United States[J]. Pediatrics, 2018, 142(4): e20174332. DOI: 10.1542/peds.2017-4332.
  507. Mailloux Z, Parham LD, Roley SS, 等. Introduction to the Evaluation in Ayres Sensory Integration(®) (EASI)[J]. American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association, 2018, 72(1): 7201195030p1-7201195030p7. DOI: 10.5014/ajot.2018.028241.引用於:康復與干預方法
  508. Zhao S, Zhan X, Wang Y, 等. Large-scale study of clinical and biochemical characteristics of Chinese patients diagnosed with Krabbe disease[J]. Clinical Genetics, 2018, 93(2): 248-254. DOI: 10.1111/cge.13071. 22 例無親緣關係中國患者的分型構成、血漿半乳糖鞘氨醇水平與 GALC 變異譜。引用於:Krabbe 病
  509. Funaki T, Takahashi JC, Miyamoto S. Late Cerebrovascular Events and Social Outcome after Adolescence: Long-term Outcome of Pediatric Moyamoya Disease[J]. Neurologia medico-chirurgica, 2018, 58(6): 240-246. DOI: 10.2176/nmc.ra.2018-0026. 兒童期起病者成年後的長期結局綜述:遲發出血、就學就業與社會適應,以及學校與醫院配合的教育支持。引用於:煙霧病
  510. Jahngir M U, Ahmad M Q, Jahangir M. Lennox-Gastaut syndrome: in a nutshell[J]. Cureus, 2018, 10(8): e3134. DOI: 10.7759/cureus.3134. 開放獲取綜述,含流行病學、發作類型、腦電圖與治療選擇。引用於:Lennox-Gastaut 綜合徵
  511. Nevill RE, Lecavalier L, Stratis EA. Meta-analysis of parent-mediated interventions for young children with autism spectrum disorder[J]. Autism : the International Journal of Research and Practice, 2018, 22(2): 84-98. DOI: 10.1177/1362361316677838.引用於:社交技能小組訓練
  512. Hamilton EMC, van der Lei HDW, Vermeulen G, 等. Natural History of Vanishing White Matter[J]. Annals of Neurology, 2018, 84(2): 274-288. DOI: 10.1002/ana.25287. 296 例基因確診患者的國際多中心自然史研究:起病年齡分佈、首發表現與誘因、各項神經系統體徵的比例、急性惡化之後的恢復情況、就學情況。引用於:白質消融性白質腦病
  513. Peterson B, Coda A, Pacey V, 等. Physical and mechanical therapies for lower limb symptoms in children with Hypermobility Spectrum Disorder and Hypermobile Ehlers-Danlos Syndrome: a systematic review[J]. Journal of Foot and Ankle Research, 2018, 11: 59. DOI: 10.1186/s13047-018-0302-1. 兒童下肢症狀物理治療的系統評價,納入兩項隨機對照試驗共 86 名 7 至 16 歲兒童;本頁康復一節的課程形態與證據現狀以它為依據。引用於:Ehlers-Danlos 綜合徵
  514. Sanders SJ, Campbell AJ, Cottrell JR, 等. Progress in Understanding and Treating SCN2A-Mediated Disorders[J]. Trends in Neurosciences, 2018, 41(7): 442-456. DOI: 10.1016/j.tins.2018.03.011. 綜述:Nav1.2 的分佈與隨年齡的變化、三類主要表型、功能增強與功能喪失的模型、各表型的估算發生率與現有治療。引用於:SCN2A 相關疾病
  515. American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, 等. Screening Examination of Premature Infants for Retinopathy of Prematurity[J]. Pediatrics, 2018, 142(6). DOI: 10.1542/peds.2018-3061. 修訂 2013 年版政策聲明,說明有效的篩查與治療體系應具備的要素,包括初次與隨訪檢查的時機。引用於:早產兒視網膜病變
  516. Freitas DA, Chaves GS, Santino TA, 等. Standard (head-down tilt) versus modified (without head-down tilt) postural drainage in infants and young children with cystic fibrosis[J]. The Cochrane Database of Systematic Reviews, 2018, 3(3): CD010297. DOI: 10.1002/14651858.CD010297.pub3.引用於:無腦回畸形
  517. Izquierdo-Serra M, Martínez-Monseny AF, López L, 等. Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG): Evidence for Hypoglycosylation-Driven Channelopathy[J]. International Journal of Molecular Sciences, 2018, 19(2): 619. DOI: 10.3390/ijms19020619. 西班牙 43 名患者中 9 次卒中樣發作的逐例記錄:誘因、無症狀間隔、表現、影像與恢復時間,以及與凝血指標的對照。引用於:PMM2-CDG
  518. Eliasson AC, Nordstrand L, Ek L, 等. The effectiveness of Baby-CIMT in infants younger than 12 months with clinical signs of unilateral-cerebral palsy; an explorative study with randomized design[J]. Research in Developmental Disabilities, 2018, 72: 191-201. DOI: 10.1016/j.ridd.2017.11.006.引用於:強制性誘導運動療法與雙手強化訓練(CIMT)
  519. Booth ATC, Buizer AI, Meyns P, 等. The efficacy of functional gait training in children and young adults with cerebral palsy: a systematic review and meta-analysis[J]. Developmental Medicine and Child Neurology, 2018, 60(9): 866-883. DOI: 10.1111/dmcn.13708.引用於:減重步行與跑臺訓練、懸吊訓練(SET)
  520. 鮑秀蘭, 劉維民. 新生兒行為神經測定和觀察在早產兒及小嬰兒腦發育評估和早期干預中的應用[J]. 中國實用兒科雜誌, 2017, 32(11): 820-822. DOI: 10.19538/j.ek2017110605.引用於:鮑秀蘭教授、NBNA 方法頁
  521. 劉亞楠, 劉建軍. 輔助溝通系統在孤獨症兒童交流訓練中的應用[J]. 中國康復理論與實踐, 2017, 23(4). DOI: 10.3969/j.issn.1006-9771.2017.04.010.引用於:輔助與替代溝通(AAC)、圖片交換溝通系統(PECS)
  522. Blackburn P R, Williams M, Cousin M A, 等. A novel de novo frameshift deletion in EHMT1 in a patient with Kleefstra Syndrome results in decreased H3K9 dimethylation[J]. Molecular Genetics & Genomic Medicine, 2017, 5(2): 141-146. DOI: 10.1002/mgg3.268.引用於:Kleefstra 綜合徵
  523. Wassif CA, Kratz L, Sparks SE, 等. A placebo-controlled trial of simvastatin therapy in Smith-Lemli-Opitz syndrome[J]. Genetics in Medicine, 2017, 19(3): 297–305. DOI: 10.1038/gim.2016.102.引用於:Smith-Lemli-Opitz 綜合徵
  524. Serrano NL, De Diego V, Cuadras D, 等. A quantitative assessment of the evolution of cerebellar syndrome in children with phosphomannomutase-deficiency (PMM2-CDG)[J]. Orphanet Journal of Rare Diseases, 2017, 12(1): 155. DOI: 10.1186/s13023-017-0707-0. 14 名 5–18 歲患兒間隔 20 個月以上的兩次共濟失調量表評估:小腦功能的變化與影像上小腦萎縮進展的對照。引用於:PMM2-CDG
  525. Sharp WG, Volkert VM, Scahill L, 等. A Systematic Review and Meta-Analysis of Intensive Multidisciplinary Intervention for Pediatric Feeding Disorders: How Standard Is the Standard of Care?[J]. Journal of Pediatrics, 2017, 181: 116-124.e4. DOI: 10.1016/j.jpeds.2016.10.002.引用於:餵養與吞嚥治療
  526. Fisher EL. A systematic review and meta-analysis of predictors of expressive-language outcomes among late talkers[J]. Journal of Speech, Language, and Hearing Research, 2017, 60(10): 2935-2948.引用於:語言發育遲緩與構音障礙
  527. Landmeier KA, Lanning M, Carmody D, 等. ADHD, learning difficulties and sleep disturbances associated with KCNJ11-related neonatal diabetes[J]. Pediatric Diabetes, 2017, 18(7): 518-523. DOI: 10.1111/pedi.12428. 30 例 KCNJ11 相關新生兒糖尿病與 25 名同胞對照的家長問卷:注意缺陷多動障礙、學業、睡眠、社交,以及接受作業治療與言語治療的比例。引用於:新生兒糖尿病
  528. Ferre CL, Brandão M, Surana B, 等. Caregiver-directed home-based intensive bimanual training in young children with unilateral spastic cerebral palsy: a randomized trial[J]. Developmental Medicine and Child Neurology, 2017, 59(5): 497-504. DOI: 10.1111/dmcn.13330.引用於:強制性誘導運動療法與雙手強化訓練(CIMT)
  529. Ito M, Fukuda M, Suzuki Y, 等. Carnitine-related hypoglycemia caused by 3 days of pivalate antibiotic therapy in a patient with severe muscular dystrophy: a case report[J]. BMC Pediatrics, 2017, 17(1): 73. DOI: 10.1186/s12887-017-0835-7.引用於:原發性肉鹼缺乏症
  530. Lane C, Milne E, Freeth M. Characteristics of Autism Spectrum Disorder in Sotos Syndrome[J]. Journal of Autism and Developmental Disorders, 2017, 47(1): 135–143. DOI: 10.1007/s10803-016-2941-z.引用於:Sotos 綜合徵
  531. Reierson G, Bernstein J, Froehlich-Santino W, 等. Characterizing regression in Phelan McDermid Syndrome (22q13 deletion syndrome)[J]. Journal of Psychiatric Research, 2017, 91: 139–144. DOI: 10.1016/j.jpsychires.2017.03.010.引用於:Phelan-McDermid 綜合徵
  532. Earl RK, Turner TN, Mefford HC, 等. Clinical phenotype of ASD-associated DYRK1A haploinsufficiency[J]. Molecular Autism, 2017, 8: 54. DOI: 10.1186/s13229-017-0173-5.引用於:DYRK1A 綜合徵
  533. Cassandrini D, Trovato R, Rubegni A, 等. Congenital myopathies: clinical phenotypes and new diagnostic tools[J]. Italian Journal of Pediatrics, 2017, 43(1): 101. DOI: 10.1186/s13052-017-0419-z. 意大利先天性肌病協作網的綜述:各型的臨床表現、活檢與磁共振特點、基因檢測策略。引用於:先天性肌病
  534. Liu Y, Li H, Zhang YQ, 等. Development of anterior fontanelle in Chinese children in 2015[J]. Zhonghua Er Ke Za Zhi, 2017, 55(8): 602-607. DOI: 10.3760/cma.j.issn.0578-1310.2017.08.011. 中華兒科雜誌;PubMed 只給英文題名。只讀到摘要,只用前囟閉合月齡的群體數字。
  535. Novak I, Morgan C, Adde L, 等. Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment[J]. JAMA Pediatrics, 2017, 171(9): 897-907. DOI: 10.1001/jamapediatrics.2017.1689.引用於:高危兒與早產兒早期干預、兒童腦癱康復、兒童發育與行為評估、高危兒與早產兒的早期干預方法、0~1 歲神經運動 20 項檢查、評估量表一覽
  536. Bieleninik L, Geretsegger M, Mössler K, 等. Effects of Improvisational Music Therapy vs Enhanced Standard Care on Symptom Severity Among Children With Autism Spectrum Disorder: The TIME-A Randomized Clinical Trial[J]. JAMA, 2017, 318(6): 525-535. DOI: 10.1001/jama.2017.9478.引用於:康復與干預方法
  537. DeSouza AA, Akers JS, Fisher WW. Empirical Application of Skinner's Verbal Behavior to Interventions for Children with Autism: A Review[J]. Analysis of Verbal Behavior, 2017, 33(2): 229-259. DOI: 10.1007/s40616-017-0093-7.引用於:應用行為分析(ABA)、語言行為與 VB-MAPP、問題行為的功能評估與正向行為支持(PBS)
  538. Azoury SC, Reddy S, Shukla V, 等. Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation Related Syndromic Craniosynostosis[J]. International Journal of Biological Sciences, 2017, 13(12): 1479-1488. DOI: 10.7150/ijbs.22373. FGFR2 相關顱縫早閉綜合徵的綜述:顱縫早閉的發生率與構成、各條顱縫早閉對應的頭型、受體信號增強導致顱縫過早骨化的機制。引用於:綜合徵性顱縫早閉
  539. Wolff M, Johannesen KM, Hedrich UBS, 等. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders[J]. Brain, 2017, 140(5): 1316-1336. DOI: 10.1093/brain/awx054. 71 例新病例與 130 例既往病例:起病年齡(三月齡前後)、對鈉通道阻滯劑的反應與變異功能方向三者的對應關係。引用於:SCN2A 相關疾病
  540. Paes EC, de Vries IAC, Penris WM, 等. Growth and prevalence of feeding difficulties in children with Robin sequence: a retrospective cohort study[J]. Clinical Oral Investigations, 2017, 21(6): 2063-2076. DOI: 10.1007/s00784-016-1996-8. 69 例本病與 64 例單純顎裂的對照隊列,並附餵養困難的系統綜述。支持本頁的餵養困難、鼻胃管與體重增長數據。引用於:Pierre Robin 序列徵
  541. Day JO, Flanagan SE, Shepherd MH, 等. Hyperglycaemia-related complications at the time of diagnosis can cause permanent neurological disability in children with neonatal diabetes[J]. Diabetic Medicine, 2017, 34(7): 1000-1004. DOI: 10.1111/dme.13328. 兩例以嚴重酮症酸中毒起病、腦水腫後遺留痙攣性四肢癱的新生兒糖尿病病例報告,並與帶同一變異、起病時無酮症酸中毒的家庭成員對照。引用於:新生兒糖尿病
  542. Yeung K S, Tso W W Y, Ip J J K, 等. Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and/or autism[J]. Molecular Autism, 2017, 8: 66. DOI: 10.1186/s13229-017-0182-4. 香港 21 例巨頭伴發育遲緩或孤獨症的患兒,PI3K-AKT-mTOR 通路檢出率近一半。引用於:PTEN 錯構瘤腫瘤綜合徵
  543. Williams F, Griffiths PD. In utero MR imaging in fetuses at high risk of lissencephaly[J]. The British Journal of Radiology, 2017, 90(1072): 20160902. DOI: 10.1259/bjr.20160902.引用於:無腦回畸形
  544. Weihbrecht K, Goar WA, Pak T, 等. Keeping an Eye on Bardet-Biedl Syndrome: A Comprehensive Review of the Role of Bardet-Biedl Syndrome Genes in the Eye[J]. Medical Research Archives, 2017, 5(9). DOI: 10.18103/mra.v5i9.1526.引用於:Bardet-Biedl 綜合徵
  545. Droms RJ, Rork JF, McLean R, 等. Menkes Disease Mimicking Child Abuse[J]. Pediatric Dermatology, 2017, 34(3): e132–e134. DOI: 10.1111/pde.13106.引用於:Menkes 病
  546. Bikic A, Reichow B, McCauley SA, 等. Meta-analysis of organizational skills interventions for children and adolescents with Attention-Deficit/Hyperactivity Disorder[J]. Clinical Psychology Review, 2017, 52: 108-123. DOI: 10.1016/j.cpr.2016.12.004.引用於:注意力與認知訓練、康復與干預方法
  547. Masoud M, Gordon K, Hall A, 等. Motor function domains in alternating hemiplegia of childhood[J]. Developmental Medicine and Child Neurology, 2017, 59(8): 822-828. DOI: 10.1111/dmcn.13443. 23 例患者的粗大運動、上肢功能、運動性言語與吞嚥的標準化評估,比較各功能區受累的輕重。引用於:兒童交替性偏癱
  548. Yu M, Zheng Y, Jin S, 等. Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing[J]. PLoS One, 2017, 12(4): e0175343. DOI: 10.1371/journal.pone.0175343. 北京大學第一醫院 180 例疑診患者的二代測序結果:105 例基因確診者的分型構成、起病年齡與肌酸激酶水平。引用於:肢帶型肌營養不良
  549. Thomas R, Abell B, Webb HJ, 等. Parent-Child Interaction Therapy: A Meta-analysis[J]. Pediatrics, 2017, 140(3). DOI: 10.1542/peds.2017-0352.引用於:遊戲治療與沙盤遊戲
  550. Vogel CB. Pediatric portal hypertension: A review for primary care[J]. The Nurse Practitioner, 2017, 42(5): 35–42. DOI: 10.1097/01.NPR.0000515427.91649.91.引用於:肝豆狀核變性
  551. Mathew B, Lakshminrusimha S. Persistent Pulmonary Hypertension in the Newborn[J]. Children (Basel), 2017, 4(8): E63. DOI: 10.3390/children4080063. 綜述:病理生理、新生兒低氧血症的鑑別表(肺實質疾病、發紺型先天性心臟病與本病)、治療,以及出院後神經發育、聽力與呼吸問題的比例。引用於:新生兒持續肺動脈高壓
  552. Steurer MA, Jelliffe-Pawlowski LL, Baer RJ, 等. Persistent Pulmonary Hypertension of the Newborn in Late Preterm and Term Infants in California[J]. Pediatrics, 2017, 139(1): e20161165. DOI: 10.1542/peds.2016-1165. 美國加利福尼亞州 2007–2011 年的人群數據:發生率、病因構成、1 年病死率與獨立危險因素。引用於:新生兒持續肺動脈高壓
  553. Legendre M, Abadie V, Attié-Bitach T, 等. Phenotype and genotype analysis of a French cohort of 119 patients with CHARGE syndrome[J]. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2017, 175(4): 417–430. DOI: 10.1002/ajmg.c.31591.引用於:CHARGE 綜合徵
  554. Wang T, Liu K, Li Z, 等. Prevalence of attention deficit/hyperactivity disorder among children and adolescents in China: a systematic review and meta-analysis[J]. BMC Psychiatry, 2017, 17(1): 32.引用於:注意缺陷多動障礙(多動症)
  555. Verhaart I E C, Robertson A, Wilson I J, 等. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy: a literature review[J]. Orphanet Journal of Rare Diseases, 2017, 12(1): 124. DOI: 10.1186/s13023-017-0671-8.引用於:脊髓性肌萎縮症
  556. Rosewich H, Sweney MT, DeBrosse S, 等. Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders[J]. Neurology Genetics, 2017, 3(2): e139. DOI: 10.1212/NXG.0000000000000139. 國際工作組的會議紀要:發作的描述與記錄、腦電圖的用法、基因檢測建議,以及症狀波動給標準化評估帶來的困難。引用於:兒童交替性偏癱
  557. Hannah-Shmouni F, Morissette R, Sinaii N, 等. Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians[J]. Genetics in Medicine, 2017, 19(11): 1276–1279. DOI: 10.1038/gim.2017.46.引用於:21-羥化酶缺乏症
  558. Forsythe E, Sparks K, Best S, 等. Risk Factors for Severe Renal Disease in Bardet-Biedl Syndrome[J]. Journal of the American Society of Nephrology, 2017, 28(3): 963–970. DOI: 10.1681/ASN.2015091029.引用於:Bardet-Biedl 綜合徵
  559. Norrish G, Cantarutti N, Pissaridou E, 等. Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis[J]. European Journal of Preventive Cardiology, 2017, 24(11): 1220–1230. DOI: 10.1177/2047487317702519.引用於:Costello 綜合徵
  560. Cohen SM, Greathouse ST, Rabbani CC, 等. Robin sequence: what the multidisciplinary approach can do[J]. Journal of Multidisciplinary Healthcare, 2017, 10: 121-132. DOI: 10.2147/jmdh.s98967. 多學科綜述:產前、新生兒科、睡眠、餵養、顱面外科、耳鼻喉與正畸各科從出生到骨骼成熟的處理。支持本頁的信號、診斷、治療與隨訪。引用於:Pierre Robin 序列徵
  561. O'Callaghan FJ, Edwards SW, Alber FD, 等. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial[J]. The Lancet Neurology, 2017, 16(1): 33–42. DOI: 10.1016/S1474-4422(16)30294-0.引用於:West 綜合徵
  562. Salehi P, Stafford HJ, Glass RP, 等. Silent aspiration in infants with Prader-Willi syndrome identified by videofluoroscopic swallow study[J]. Medicine, 2017, 96(50): e9256. DOI: 10.1097/MD.0000000000009256.引用於:Prader-Willi 綜合徵
  563. Harvey LA, Katalinic OM, Herbert RD, 等. Stretch for the treatment and prevention of contractures[J]. Cochrane Database of Systematic Reviews, 2017, 1(1): CD007455. DOI: 10.1002/14651858.CD007455.pub3.引用於:HHH 綜合徵
  564. Kang L, Zhan X, Gu X, 等. Successful newborn screening for Gaucher disease using fluorometric assay in China[J]. Journal of Human Genetics, 2017, 62(8): 763–768. DOI: 10.1038/jhg.2017.36.引用於:戈謝病
  565. Murias K, Moir A, Myers KA, et al. Systematic review of MRI findings in children with developmental delay or cognitive impairment[J]. Brain and Development, 2017, 39(8): 644-655. DOI: 10.1016/j.braindev.2017.04.006.
  566. Malfait F, Francomano C, Byers P, 等. The 2017 international classification of the Ehlers-Danlos syndromes[J]. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2017, 175(1): 8-26. DOI: 10.1002/ajmg.c.31552. 國際 Ehlers-Danlos 綜合徵聯盟的 2017 年分類:分為 13 型,除過度活動型外確診均需分子證據,並修訂了過度活動型的臨床標準。引用於:Ehlers-Danlos 綜合徵
  567. Bertsch M, Floyd M, Kehoe T, 等. The clinical evaluation of infantile nystagmus: What to do first and why[J]. Ophthalmic Genetics, 2017, 38(1): 22–33. DOI: 10.1080/13816810.2016.1266667.引用於:視隔發育不良
  568. Badihian S, Adihian N, Yaghini O. The effect of baby walker on child development: a systematic review[J]. Iranian Journal of Child Neurology, 2017, 11(4): 1-6.
  569. Huang S, Huang B, Wang G, 等. The relationship between the GJB3 c.538C>T variant and hearing phenotype in the Chinese population[J]. International Journal of Pediatric Otorhinolaryngology, 2017, 102: 67–70. DOI: 10.1016/j.ijporl.2017.09.001.引用於:非綜合徵型耳聾
  570. Valentín-Gudiol M, Mattern-Baxter K, Girabent-Farrés M, 等. Treadmill interventions in children under six years of age at risk of neuromotor delay[J]. Cochrane Database of Systematic Reviews, 2017, 7(7): CD009242. DOI: 10.1002/14651858.CD009242.pub3.引用於:減重步行與跑臺訓練
  571. Mauhin W, Habarou F, Gobin S, 等. Update on Lysinuric Protein Intolerance, a Multi-faceted Disease Retrospective cohort analysis from birth to adulthood[J]. Orphanet Journal of Rare Diseases, 2017, 12(1): 3. DOI: 10.1186/s13023-016-0550-8. 法國一家醫院 1977–2015 年 16 例患者從出生到成年的回顧性隊列:起病表現、各系統受累的比例與治療構成。引用於:賴氨酸尿蛋白不耐受症
  572. Jung MW, Landenberger M, Jung T, 等. Vojta therapy and neurodevelopmental treatment in children with infantile postural asymmetry: a randomised controlled trial[J]. Journal of Physical Therapy Science, 2017, 29(2): 301-306. DOI: 10.1589/jpts.29.301.引用於:Bobath 療法(NDT)、Vojta 療法
  573. Frank MC, Braginsky M, Yurovsky D, Marchman VA. Wordbank: an open repository for developmental vocabulary data[J]. Journal of Child Language, 2017, 44(3): 677-694. DOI: 10.1017/S0305000916000209. PMID 27189114。普通話(北京)MB-CDI 詞彙量分位來自該庫引用於:寶秀蘭兒童神經發育綜合評估系統
  574. Peterson KM, Piazza CC, Volkert VM. A comparison of a modified sequential oral sensory approach to an applied behavior-analytic approach in the treatment of food selectivity in children with autism spectrum disorder[J]. Journal of Applied Behavior Analysis, 2016, 49(3): 485-511.引用於:餵養困難與兒童營養諮詢、餵養與吞嚥治療、術語表
  575. Santangelo T, Graham S. A Comprehensive Meta-analysis of Handwriting Instruction[J]. Educational Psychology Review, 2016, 28(2): 225-265. DOI: 10.1007/s10648-015-9335-1.引用於:書寫與精細動作訓練
  576. Frohlich J, Senturk D, Saravanapandian V, 等. A quantitative electrophysiological biomarker of duplication 15q11.2-q13.1 syndrome[J]. PLoS One, 2016, 11(12): e0167179. DOI: 10.1371/journal.pone.0167179.引用於:15q11.2-q13.1 重複綜合徵
  577. Chang YC, Locke J. A systematic review of peer-mediated interventions for children with autism spectrum disorder[J]. Research in Autism Spectrum Disorders, 2016, 27: 1-10. DOI: 10.1016/j.rasd.2016.03.010.引用於:社交技能小組訓練、遊戲治療與沙盤遊戲、康復與干預方法
  578. Caffarelli M, Kimia AA, Torres AR. Acute Ataxia in Children: A Review of the Differential Diagnosis and Evaluation in the Emergency Department[J]. Pediatric Neurology, 2016, 65: 14–30. DOI: 10.1016/j.pediatrneurol.2016.08.025.引用於:白質消融性白質腦病
  579. Kowalczyk B, Feluś J. Arthrogryposis: an update on clinical aspects, etiology, and treatment strategies[J]. Archives of Medical Science, 2016, 12(1): 10-24. DOI: 10.5114/aoms.2016.57578. 綜述:命名沿革、胎兒運動減少的機制、肌發育不良型各關節的典型姿勢,以及上肢、脊柱、髖、膝、足的矯形治療。引用於:先天性多發性關節攣縮
  580. Whyte MP, Rockman-Greenberg C, Ozono K, 等. Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia[J]. The Journal of Clinical Endocrinology and Metabolism, 2016, 101(1): 334–342. DOI: 10.1210/jc.2015-3462.引用於:低鹼性磷酸酶血症
  581. Rothblum-Oviatt C, Wright J, Lefton-Greif MA, 等. Ataxia telangiectasia: a review[J]. Orphanet Journal of Rare Diseases, 2016, 11(1): 159. DOI: 10.1186/s13023-016-0543-7.引用於:共濟失調毛細血管擴張症、脊髓小腦性共濟失調
  582. Hale CL, Niederriter AN, Green GE, 等. Atypical phenotypes associated with pathogenic CHD7 variants and a proposal for broadening CHARGE syndrome clinical diagnostic criteria[J]. American Journal of Medical Genetics Part A, 2016, 170A(2): 344–354. DOI: 10.1002/ajmg.a.37435.引用於:CHARGE 綜合徵
  583. Liu Z, Li X, Zhang J T, 等. Autism-like behaviours and germline transmission in transgenic monkeys overexpressing MeCP2[J]. Nature, 2016, 530(7588): 98-102. DOI: 10.1038/nature16533. 中國科學院神經科學研究所:過表達 MeCP2 的轉基因食蟹猴。引用於:MECP2 重複綜合徵
  584. Roussel J, Labarthe F, Thireau J, 等. Carnitine deficiency induces a short QT syndrome[J]. Heart Rhythm, 2016, 13(1): 165–174. DOI: 10.1016/j.hrthm.2015.07.027.引用於:原發性肉鹼缺乏症
  585. Yi Z, Pan H, Li L, 等. Chromosome Xq28 duplication encompassing MECP2: clinical and molecular analysis of 16 new patients from 10 families in China[J]. European Journal of Medical Genetics, 2016, 59(6-7): 347-353. DOI: 10.1016/j.ejmg.2016.05.004. 北京大學第一醫院:國內首個較大的病例系列。引用於:MECP2 重複綜合徵
  586. Huemer M, Carvalho DR, Brum JM, 等. Clinical phenotype, biochemical profile, and treatment in 19 patients with arginase 1 deficiency[J]. Journal of Inherited Metabolic Disease, 2016, 39(3): 331–340. DOI: 10.1007/s10545-016-9928-y.引用於:精氨酸酶缺乏症
  587. Elmonem MA, Veys KR, Soliman NA, 等. Cystinosis: a review[J]. Orphanet Journal of Rare Diseases, 2016, 11: 47. DOI: 10.1186/s13023-016-0426-y.引用於:胱氨酸貯積症
  588. van Bon BW, Coe BP, Bernier R, 等. Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID[J]. Molecular Psychiatry, 2016, 21(1): 126–132. DOI: 10.1038/mp.2015.5.引用於:DYRK1A 綜合徵
  589. Morgan C, Darrah J, Gordon AM, 等. Effectiveness of motor interventions in infants with cerebral palsy: a systematic review[J]. Developmental Medicine and Child Neurology, 2016, 58(9): 900-9. DOI: 10.1111/dmcn.13105.引用於:Bobath 療法(NDT)
  590. Cao B, Gong C, Wu D, 等. Genetic Analysis and Follow-Up of 25 Neonatal Diabetes Mellitus Patients in China[J]. Journal of Diabetes Research, 2016, 2016: 6314368. DOI: 10.1155/2016/6314368. 北京兒童醫院等三家兒童醫院 2001 至 2013 年 25 例新生兒糖尿病的基因分析與 1 至 13 年隨訪。引用於:新生兒糖尿病
  591. Song J, Feng Y, Acke FR, 等. Hearing loss in Waardenburg syndrome: a systematic review[J]. Clinical Genetics, 2016, 89(4): 416-425. DOI: 10.1111/cge.12631. 系統綜述,彙總 73 篇文獻、417 例患者的聽力表型,按臨床分型與致病基因分別給出聽力損失的比例。引用於:Waardenburg 綜合徵
  592. Donti TR, Blackburn PR, Atwal PS. Holocarboxylase synthetase deficiency pre and post newborn screening[J]. Molecular Genetics and Metabolism Reports, 2016, 7: 40-44. DOI: 10.1016/j.ymgmr.2016.03.007. 5 例病例系列:新生兒篩查正常或被當作別的病的個例、停服生物素後的反覆,以及從發育正常到重度殘疾的結局差別。引用於:全羧化酶合成酶缺乏症
  593. Sanders DB, Wolfe GI, Benatar M, 等. International consensus guidance for management of myasthenia gravis: Executive summary[J]. Neurology, 2016, 87(4): 419–425. DOI: 10.1212/WNL.0000000000002790.引用於:全身型重症肌無力
  594. Sugden E, Baker E, Munro N, 等. Involvement of parents in intervention for childhood speech sound disorders: a review of the evidence[J]. International Journal of Language & Communication Disorders, 2016, 51(6): 597-625. DOI: 10.1111/1460-6984.12247.引用於:構音與語音訓練
  595. White KK, Parnell SE, Kifle Y, 等. Is there a correlation between sleep disordered breathing and foramen magnum stenosis in children with achondroplasia?[J]. American Journal of Medical Genetics Part A, 2016, 170A(1): 32–41. DOI: 10.1002/ajmg.a.37385.引用於:軟骨發育不全
  596. Conde-Agudelo A, Díaz-Rossello JL. Kangaroo mother care to reduce morbidity and mortality in low birthweight infants[J]. Cochrane Database of Systematic Reviews, 2016, 2016(8): CD002771. DOI: 10.1002/14651858.CD002771.pub4.引用於:高危兒早期干預、袋鼠式護理(KMC)、嬰兒撫觸與被動操
  597. Sun L, Li X, Shi J, 等. Molecular etiology and genotype-phenotype correlation of Chinese Han deaf patients with type I and type II Waardenburg Syndrome[J]. Scientific Reports, 2016, 6: 35498. DOI: 10.1038/srep35498. 36 例中國漢族聾人先證者及其家系成員的基因與表型分析,給出各基因的佔比、新發變異的比例與雀斑表型。引用於:Waardenburg 綜合徵
  598. Kim JS. Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis[J]. Journal of stroke, 2016, 18(1): 2-11. DOI: 10.5853/jos.2015.01627. 東亞各國的流行病學數據與臨床表現綜述:兒童以短暫性腦缺血發作為主、發作的誘因、頭痛、癲癇與不自主運動的比例。引用於:煙霧病
  599. Forsyth R, Vockley CW, Edick MJ, 等. Outcomes of cases with 3-methylcrotonyl-CoA carboxylase (3-MCC) deficiency - Report from the Inborn Errors of Metabolism Information System[J]. Molecular Genetics and Metabolism, 2016, 118(1): 15-20. DOI: 10.1016/j.ymgme.2016.02.002. 美國遺傳代謝病登記系統中經篩查確診病例的轉歸:發育落後與代謝異常的比例,篩查 C5OH 水平不能預測結局。引用於:3-甲基巴豆酰輔酶 A 羧化酶缺乏症
  600. Carmody D, Pastore AN, Landmeier KA, 等. Patients with KCNJ11-related diabetes frequently have neuropsychological impairments compared with sibling controls[J]. Diabetic Medicine, 2016, 33(10): 1380-1386. DOI: 10.1111/dme.13159. 23 例 KCNJ11 相關新生兒糖尿病與 20 名同胞對照的神經心理與行為評估:智力、學業、執行功能與日常生活技能。引用於:新生兒糖尿病
  601. Carr J B, Yang S, Lather L A. Pediatric pes planus: a state-of-the-art review[J]. Pediatrics, 2016, 137(3): e20151230. DOI: 10.1542/peds.2015-1230.
  602. de Winter CF, Baas M, Bijlsma EK, 等. Phenotype and natural history in 101 individuals with Pitt-Hopkins syndrome through an internet questionnaire system[J]. Orphanet Journal of Rare Diseases, 2016, 11: 37. DOI: 10.1186/s13023-016-0422-2.引用於:Pitt-Hopkins 綜合徵
  603. Morgan C, Novak I, Dale RC, 等. Single blind randomised controlled trial of GAME (Goals - Activity - Motor Enrichment) in infants at high risk of cerebral palsy[J]. Research in Developmental Disabilities, 2016, 55: 256-67. DOI: 10.1016/j.ridd.2016.04.005.引用於:目標導向與任務導向訓練、康復與干預方法
  604. D'Antonio F, Khalil A, Garel C, 等. Systematic review and meta-analysis of isolated posterior fossa malformations on prenatal imaging (part 2): neurodevelopmental outcome[J]. Ultrasound in Obstetrics & Gynecology, 2016, 48(1): 28–37. DOI: 10.1002/uog.15755.引用於:Dandy-Walker 畸形
  605. D'Antonio F, Khalil A, Garel C, 等. Systematic review and meta-analysis of isolated posterior fossa malformations on prenatal ultrasound imaging (part 1): nomenclature, diagnostic accuracy and associated anomalies[J]. Ultrasound in Obstetrics & Gynecology, 2016, 47(6): 690–697. DOI: 10.1002/uog.14900.引用於:Dandy-Walker 畸形
  606. Gaastra GF, Groen Y, Tucha L, 等. The Effects of Classroom Interventions on Off-Task and Disruptive Classroom Behavior in Children with Symptoms of Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review[J]. PloS One, 2016, 11(2): e0148841. DOI: 10.1371/journal.pone.0148841.引用於:康復與干預方法
  607. Hobson JA, Tarver L, Beurkens N, 等. The Relation between Severity of Autism and Caregiver-Child Interaction: a Study in the Context of Relationship Development Intervention[J]. Journal of Abnormal Child Psychology, 2016, 44(4): 745-55. DOI: 10.1007/s10802-015-0067-y.引用於:人際關係發展干預(RDI)
  608. Jordan V K, Zaveri H P, Scott D A. 1p36 deletion syndrome: an update[J]. The Application of Clinical Genetics, 2015, 8: 189-200. DOI: 10.2147/TACG.S65698. 開放獲取綜述。引用於:1p36 缺失綜合徵
  609. McDonald-McGinn DM, Sullivan KE, Marino B, 等. 22q11.2 deletion syndrome[J]. Nature Reviews Disease Primers, 2015, 1: 15071. DOI: 10.1038/nrdp.2015.71.引用於:22q11.2 缺失綜合徵
  610. 劉維民, 鮑秀蘭, 馬磊, 等. 早期干預降低極低出生體重兒腦癱發生率的臨床研究[J]. 中國兒童保健雜誌, 2015, 23(4): 360-363. DOI: 10.11852/zgetbjzz2015-23-04-08.引用於:嬰兒撫觸與被動操
  611. 鍾晨, 楊紅, 等. 兩種評估方法對高危兒粗大運動發育結局和腦性癱瘓預測效度的比較[J]. 中國兒童保健雜誌, 2015, 23(8): 856-858. DOI: 10.11852/zgetbjzz2015-23-08-23.引用於:高危兒與早產兒早期干預、兒童腦癱康復、兒童發育與行為評估、評估量表一覽
  612. Trinka E, Cock H, Hesdorffer D, 等. A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus[J]. Epilepsia, 2015, 56(10): 1515–1523. DOI: 10.1111/epi.13121.引用於:癲癇發作、神經發育障礙與癲癇性腦病
  613. Lin Y, Bratton SC. A Meta‐Analytic Review of Child‐Centered Play Therapy Approaches[J]. Journal of Counseling & Development, 2015, 93(1): 45-58. DOI: 10.1002/j.1556-6676.2015.00180.x.引用於:遊戲治療與沙盤遊戲
  614. Kubo Y, Nishio H, Saito K. A new method for SMN1 and hybrid SMN gene analysis in spinal muscular atrophy using long-range PCR followed by sequencing[J]. Journal of Human Genetics, 2015, 60(5): 233–239. DOI: 10.1038/jhg.2015.16.引用於:脊髓性肌萎縮症
  615. Kerzner B, Milano K, MacLean WC, 等. A practical approach to classifying and managing feeding difficulties[J]. Pediatrics, 2015, 135(2): 344-353.引用於:餵養困難與兒童營養諮詢、餵養困難、評估量表一覽、術語表
  616. Murray E, McCabe P, Ballard KJ. A Randomized Controlled Trial for Children With Childhood Apraxia of Speech Comparing Rapid Syllable Transition Treatment and the Nuffield Dyspraxia Programme-Third Edition[J]. Journal of Speech, Language, and Hearing Research : JSLHR, 2015, 58(3): 669-86. DOI: 10.1044/2015_JSLHR-S-13-0179.引用於:康復與干預方法
  617. Case-Smith J, Weaver LL, Fristad MA. A systematic review of sensory processing interventions for children with autism spectrum disorders[J]. Autism : the International Journal of Research and Practice, 2015, 19(2): 133-48. DOI: 10.1177/1362361313517762.引用於:感覺統合治療(ASI)、感覺處理困難(感統失調)的干預方法、康復與干預方法
  618. Kimber E. AMC: amyoplasia and distal arthrogryposis[J]. Journal of Children’s Orthopaedics, 2015, 9(6): 427-432. DOI: 10.1007/s11832-015-0689-1. 綜述並報告瑞典 131 例的全國性研究:肌發育不良型與遠端關節攣縮的特點、臨床分組、肌力與運動功能的關係。引用於:先天性多發性關節攣縮
  619. Swanson MA, Coughlin CR, Scharer GH, 等. Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia[J]. Annals of Neurology, 2015, 78(4): 606-618. DOI: 10.1002/ana.24485. 124 例按發育結局分層的隊列:重型與輕型的劃分、起病時間、腦結構異常、抗癲癇藥數量與殘餘酶活性的關係。引用於:非酮性高甘氨酸血症
  620. Crow YJ, Chase DS, Lowenstein Schmidt J, 等. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1[J]. American Journal of Medical Genetics Part A, 2015, 167A(2): 296–312. DOI: 10.1002/ajmg.a.36887.引用於:Aicardi-Goutières 綜合徵
  621. Panagiotakaki E, De Grandis E, Stagnaro M, 等. Clinical profile of patients with ATP1A3 mutations in Alternating Hemiplegia of Childhood-a study of 155 patients[J]. Orphanet Journal of Rare Diseases, 2015, 10: 123. DOI: 10.1186/s13023-015-0335-5. 九個國家 155 例患者的國際隊列:Aicardi 臨床標準、ATP1A3 變異的檢出率與三個熱點變異各自的臨床輪廓。引用於:兒童交替性偏癱
  622. Shim KW, Park EK, Kim JS, 等. Cognitive Outcome of Pediatric Moyamoya Disease[J]. Journal of Korean Neurosurgical Society, 2015, 57(6): 440-444. DOI: 10.3340/jkns.2015.57.6.440. 兒童煙霧病認知結局的綜述:受影響的認知領域、與起病年齡和梗死的關係,以及缺課對學業的影響。引用於:煙霧病
  623. Cortese S, Ferrin M, Brandeis D, 等. Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials[J]. Journal of the American Academy of Child and Adolescent Psychiatry, 2015, 54(3): 164-74. DOI: 10.1016/j.jaac.2014.12.010.引用於:注意力與認知訓練
  624. Jiang L, Liang X, Li Y, 等. Comprehensive molecular diagnosis of 67 Chinese Usher syndrome probands: high rate of ethnicity specific mutations in Chinese USH patients[J]. Orphanet Journal of Rare Diseases, 2015, 10: 110. DOI: 10.1186/s13023-015-0329-3. 在北京協和醫院入組的 67 箇中國家系的基因檢測結果:各基因的佔比與中國人群的常見變異。引用於:Usher 綜合徵
  625. Burnei G, Gavriliu S, Vlad C, 等. Congenital scoliosis: an up-to-date[J]. Journal of Medicine and Life, 2015, 8(3): 388-397. 先天性脊柱側彎的綜述:椎體形成障礙與分節障礙的分型、伴發畸形的篩查與手術時機。引用於:先天性脊柱側凸
  626. Shepard PJ, Barshop BA, Baumgartner MR, 等. Consanguinity and rare mutations outside of MCCC genes underlie nonspecific phenotypes of MCCD[J]. Genetics in Medicine, 2015, 17(8): 660-667. DOI: 10.1038/gim.2014.157. 33 例患者的外顯子測序研究:只有非特異表現的 10 例中,5 例在其他疾病基因上查到很可能解釋症狀的純合變異。引用於:3-甲基巴豆酰輔酶 A 羧化酶缺乏症
  627. Ji J, Lee H, Argiropoulos B, 等. DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies[J]. European Journal of Human Genetics, 2015, 23(11): 1473-1481. DOI: 10.1038/ejhg.2015.71. 14 例隊列,本病被確立為一個可識別綜合徵的研究。引用於:DYRK1A 綜合徵
  628. Spittle A, Orton J, Anderson PJ, 等. Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants[J]. Cochrane Database of Systematic Reviews, 2015, (11): CD005495. DOI: 10.1002/14651858.CD005495.pub4.引用於:高危兒與早產兒早期干預、家庭育兒指導課程、早期綜合訓練、術語表
  629. Roberts MY, Kaiser AP. Early intervention for toddlers with language delays: a randomized controlled trial[J]. Pediatrics, 2015, 135(4): 686-93. DOI: 10.1542/peds.2014-2134.引用於:自然發展行為干預(NDBI)、家長實施的語言干預
  630. Knight V, Sartini E, Spriggs AD. Evaluating visual activity schedules as evidence-based practice for individuals with autism spectrum disorders[J]. Journal of Autism and Developmental Disorders, 2015, 45(1): 157-78. DOI: 10.1007/s10803-014-2201-z.引用於:結構化教學(TEACCH)、社交故事、康復與干預方法
  631. Zhang H, Dai L, Chen N, 等. Fifteen novel EIF2B1-5 mutations identified in Chinese children with leukoencephalopathy with vanishing white matter and a long term follow-up[J]. PLoS One, 2015, 10(3): e0118001. DOI: 10.1371/journal.pone.0118001. 北京大學第一醫院 34 例基因確診患兒的基因型與隨訪:起病年齡與方式、EIF2B3 變異的比例與始祖變異、發作性加重與癲癇的比例。引用於:白質消融性白質腦病
  632. Gharesouran J, Khalili AF, Azari NS, 等. First case report of Rett syndrome in the Azeri Turkish population and brief review of the literature[J]. Epilepsy & Behavior Case Reports, 2015, 3: 15–19. DOI: 10.1016/j.ebcr.2014.11.001.引用於:Rett 綜合徵
  633. Nolin SL, Glicksman A, Ersalesi N, 等. Fragile X full mutation expansions are inhibited by one or more AGG interruptions in premutation carriers[J]. Genetics in Medicine, 2015, 17(5): 358–364. DOI: 10.1038/gim.2014.106.引用於:脆性 X 綜合徵
  634. Wirrell EC, Shellhaas RA, Joshi C, 等. How should children with West syndrome be efficiently and accurately investigated? Results from the National Infantile Spasms Consortium[J]. Epilepsia, 2015, 56(4): 617–625. DOI: 10.1111/epi.12951.引用於:West 綜合徵
  635. Landreth H, Malow BA, Shoemaker AH. Increased Prevalence of Sleep Apnea in Children with Pseudohypoparathyroidism Type 1a[J]. Hormone Research in Paediatrics, 2015, 84(1): 1-5. DOI: 10.1159/000381452. Ⅰa 型兒童睡眠呼吸暫停患病情況的前瞻性問卷調查與回顧性病歷分析。引用於:假性甲狀旁腺功能減退症
  636. Shimada S, Shimojima K, Okamoto N, 等. Microarray analysis of 50 patients reveals the critical chromosomal regions responsible for 1p36 deletion syndrome-related complications[J]. Brain & Development, 2015, 37(5): 515–526. DOI: 10.1016/j.braindev.2014.08.002.引用於:1p36 缺失綜合徵
  637. Kim SH, Kim AR, Choi HS, 等. Molecular Etiology of Hereditary Single-Side Deafness: Its Association With Pigmentary Disorders and Waardenburg Syndrome[J]. Medicine, 2015, 94(43): e1817. DOI: 10.1097/MD.0000000000001817. 韓國 50 例單側聾兒童的病因研究:有家族聚集的 4 個家系都帶色素異常,其中 2 個家系查到 PAX3 或 MITF 變異。引用於:Waardenburg 綜合徵
  638. Siciliano G, Simoncini C, Giannotti S, 等. Muscle exercise in limb girdle muscular dystrophies: pitfall and advantages[J]. Acta Myologica, 2015, 34(1): 3-8. 專講肢帶型肌營養不良與運動的綜述:肌膜不穩與離心收縮損傷的關係,以及幾項有氧訓練與抗阻訓練小樣本研究的做法和退出原因。引用於:肢帶型肌營養不良
  639. Schreibman L, Dawson G, Stahmer AC, 等. Naturalistic Developmental Behavioral Interventions: Empirically Validated Treatments for Autism Spectrum Disorder[J]. Journal of Autism and Developmental Disorders, 2015, 45(8): 2411-28. DOI: 10.1007/s10803-015-2407-8.引用於:應用行為分析(ABA)、自然發展行為干預(NDBI)、回合式教學(DTT)、關鍵反應訓練(PRT)、早期介入丹佛模式(ESDM)、家長介導干預、地板時光(DIR)、結構化教學(TEACCH)、遊戲治療與沙盤遊戲、人際關係發展干預(RDI)、家長實施的語言干預、孤獨症(自閉症)的干預方法、康復與干預方法
  640. Lee AS, Gibbon FE. Non-speech oral motor treatment for children with developmental speech sound disorders[J]. Cochrane Database of Systematic Reviews, 2015, 2015(3): CD009383. DOI: 10.1002/14651858.CD009383.pub2.引用於:構音與語音訓練、口部運動治療與口肌訓練
  641. Sharma V, Berkelhamer S, Lakshminrusimha S. Persistent pulmonary hypertension of the newborn[J]. Maternal Health, Neonatology and Perinatology, 2015, 1: 14. DOI: 10.1186/s40748-015-0015-4. 綜述:胎兒循環與出生時的轉換、分類、診斷與鑑別、各項治療的構成、吸入一氧化氮的獲批時間、遠期結局。引用於:新生兒持續肺動脈高壓
  642. von Kodolitsch Y, De Backer J, Schüler H, 等. Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome[J]. The Application of Clinical Genetics, 2015, 8: 137–155. DOI: 10.2147/TACG.S60472.引用於:馬凡綜合徵
  643. Serrano M, de Diego V, Muchart J, 等. Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment[J]. Orphanet Journal of Rare Diseases, 2015, 10: 138. DOI: 10.1186/s13023-015-0358-y. 13 名患兒的小腦綜合徵評估:小腦受累的構成、出生時的小腦影像,以及共濟失調與影像、智商的關係。引用於:PMM2-CDG
  644. Keppler-Noreuil KM, Rios JJ, Parker VE, 等. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation[J]. American Journal of Medical Genetics Part A, 2015, 167A(2): 287-295. DOI: 10.1002/ajmg.a.36836. 2013 年美國國立衛生研究院研討會的紀要:傘名的由來、臨床診斷標準與基因檢測的送檢條件。引用於:PIK3CA 相關過度生長綜合徵
  645. Kasari C, Gulsrud A, Paparella T, 等. Randomized comparative efficacy study of parent-mediated interventions for toddlers with autism[J]. Journal of Consulting and Clinical Psychology, 2015, 83(3): 554-63. DOI: 10.1037/a0039080.引用於:自然發展行為干預(NDBI)
  646. Beltrand J, Elie C, Busiah K, 等. Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations[J]. Diabetes Care, 2015, 38(11): 2033-2041. DOI: 10.2337/dc15-0837. 19 例鉀通道型新生兒糖尿病的前瞻性單中心研究;本頁引用其摘要中的基線所見:肌張力低下、動作構想與執行困難、注意障礙,以及肌電與神經傳導正常、頭顱磁共振有病灶。引用於:新生兒糖尿病
  647. Wu N, Ming X, Xiao J, 等. TBX6 null variants and a common hypomorphic allele in congenital scoliosis[J]. The New England Journal of Medicine, 2015, 372(4): 341–350. DOI: 10.1056/NEJMoa1406829.引用於:先天性脊柱側凸
  648. American Academy of Pediatrics Committee on Fetus and Newborn, American College of Obstetricians and Gynecologists Committee on Obstetric Practice. The Apgar score[J]. Pediatrics, 2015, 136(4): 819-822. DOI: 10.1542/peds.2015-2651.
  649. Martinelli D, Diodato D, Ponzi E, 等. The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome[J]. Orphanet Journal of Rare Diseases, 2015, 10: 29. DOI: 10.1186/s13023-015-0242-9.引用於:鳥氨酸氨甲酰基轉移酶缺乏症、HHH 綜合徵
  650. Rudloe T, Prabhu SP, Gorman MP, 等. The Yield of Neuroimaging in Children Presenting to the Emergency Department With Acute Ataxia in the Post-Varicella Vaccine Era[J]. Journal of Child Neurology, 2015, 30(10): 1333–1339. DOI: 10.1177/0883073814561300.引用於:白質消融性白質腦病
  651. Fehr S, Leonard H, Ho G, 等. There is variability in the attainment of developmental milestones in the CDKL5 disorder[J]. Journal of Neurodevelopmental Disorders, 2015, 7(1): 2. DOI: 10.1186/1866-1955-7-2.引用於:CDKL5 缺乏症
  652. Klouwer FC, Berendse K, Ferdinandusse S, 等. Zellweger spectrum disorders: clinical overview and management approach[J]. Orphanet Journal of Rare Diseases, 2015, 10: 151. DOI: 10.1186/s13023-015-0368-9.引用於:Zellweger 譜系障礙
  653. 吳衛紅, 鮑秀蘭, 席冰玉, 等. 0~1 歲 52 項神經運動檢查和簡化 20 項相關性研究[J]. 中國兒童保健雜誌, 2014, 22(3): 310-311.引用於:高危兒與早產兒早期干預、兒童腦癱康復、兒童發育與行為評估、0~1 歲神經運動 20 項檢查、評估量表一覽、術語表
  654. 李曉捷, 唐久來, 馬丙祥, 等. 腦性癱瘓的定義、診斷標準及臨床分型[J]. 中華實用兒科臨床雜誌, 2014, 29(19): 1520. DOI: 10.3760/cma.j.issn.2095-428X.2014.19.024.引用於:兒童腦癱康復、脊髓性肌萎縮症、杜氏肌營養不良、腓骨肌萎縮症、肌強直性營養不良、遺傳性痙攣性截癱、Rett 綜合徵、嬰兒嚴重肌陣攣性癲癇、Angelman 綜合徵、Silver-Russell 綜合徵、糖原累積病Ⅱ型、甲基丙二酸血症、異染性腦白質營養不良、軟骨發育不全、低磷性佝僂病、Phelan-McDermid 綜合徵、CHARGE 綜合徵、發育倒退、共濟失調、腦性癱瘓的鑑別與病因評估:何時需要進一步檢查、評估量表一覽、術語表
  655. 李靜, 黃彥紅, 董穎, 等. 應用愛飯達工具對兒童不良飲食行為問題干預效果評價[J]. 中國兒童保健雜誌, 2014, 22(3): 333-336.引用於:餵養困難與兒童營養諮詢、評估量表一覽
  656. Lugowska A, Mierzewska H, Bekiesińska-Figatowska M, 等. A homozygote for the c.459+1G>A mutation in the ARSA gene presents with cerebellar ataxia as the only first clinical sign of metachromatic leukodystrophy[J]. Journal of the Neurological Sciences, 2014, 338(1–2): 214–217. DOI: 10.1016/j.jns.2013.12.030.引用於:異染性腦白質營養不良
  657. Mohammadzaheri F, Koegel LK, Rezaee M, 等. A randomized clinical trial comparison between pivotal response treatment (PRT) and structured applied behavior analysis (ABA) intervention for children with autism[J]. Journal of Autism and Developmental Disorders, 2014, 44(11): 2769-77. DOI: 10.1007/s10803-014-2137-3.引用於:關鍵反應訓練(PRT)
  658. Chacko A, Bedard AC, Marks DJ, 等. A randomized clinical trial of Cogmed Working Memory Training in school-age children with ADHD: a replication in a diverse sample using a control condition[J]. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 2014, 55(3): 247-55. DOI: 10.1111/jcpp.12146.引用於:注意力與認知訓練
  659. Yoo HJ, Bahn G, Cho IH, 等. A randomized controlled trial of the Korean version of the PEERS(®) parent-assisted social skills training program for teens with ASD[J]. Autism Research : Official Journal of the International Society for Autism Research, 2014, 7(1): 145-61. DOI: 10.1002/aur.1354.引用於:社交技能小組訓練
  660. Helsmoortel C, Vulto-van Silfhout A T, Coe B P, 等. A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP[J]. Nature Genetics, 2014, 46(4): 380-384. DOI: 10.1038/ng.2899. 首次報告本病,估計 ADNP 變異至少佔孤獨症病例的 0.17%。引用於:ADNP 綜合徵
  661. Schaaf RC, Benevides T, Mailloux Z, 等. An intervention for sensory difficulties in children with autism: a randomized trial[J]. Journal of Autism and Developmental Disorders, 2014, 44(7): 1493-1506.引用於:感覺統合與感覺處理困難、感覺統合訓練、感覺統合治療(ASI)、康復與干預方法、術語表
  662. Chen L, Su M, Ren SG, 等. Analysis of Current Status and Strategies of Retinopathy of Prematurity Screening during 6 Years in Local Regions of China: Implication and Caution[J]. Journal of Ophthalmology, 2014, 2014: 756059. DOI: 10.1155/2014/756059. 河北 5651 例篩查資料:重症病例均在生後 4–6 周的首次篩查時間檢出。引用於:早產兒視網膜病變
  663. Amlie-Lefond C, Gill JC. Approach to acute ischemic stroke in childhood[J]. Current Treatment Options in Cardiovascular Medicine, 2014, 16(1): 276. DOI: 10.1007/s11936-013-0276-z.引用於:神經發育障礙與癲癇性腦病
  664. Yang X, Gao H, Zhang J, 等. ATP1A3 mutations and genotype-phenotype correlation of alternating hemiplegia of childhood in Chinese patients[J]. PLoS One, 2014, 9(5): e97274. DOI: 10.1371/journal.pone.0097274. 國內 47 例典型患兒與 4 例不典型患兒的基因研究:起病月齡、首發症狀、ATP1A3 變異檢出率與新發比例。引用於:兒童交替性偏癱
  665. Brennan-Jones CG, White J, Rush RW, 等. Auditory-verbal therapy for promoting spoken language development in children with permanent hearing impairments[J]. Cochrane Database of Systematic Reviews, 2014, 2014(3): CD010100. DOI: 10.1002/14651858.CD010100.pub2.引用於:構音與語音訓練、康復與干預方法
  666. Daley D, van der Oord S, Ferrin M, 等. Behavioral interventions in attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials across multiple outcome domains[J]. Journal of the American Academy of Child and Adolescent Psychiatry, 2014, 53(8): 835-847.引用於:兒童注意力不集中、注意缺陷多動障礙(多動症)、家庭育兒指導課程、融合教育、家長介導干預、術語表
  667. Grünert SC. Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency[J]. Orphanet Journal of Rare Diseases, 2014, 9: 117. DOI: 10.1186/s13023-014-0117-5. 彙總 1979 至 2014 年文獻中 350 例晚髮型:起病年齡、急性與慢性表現的比例、診斷延遲與致病基因的分佈。引用於:多種酰基輔酶 A 脫氫酶缺乏症
  668. Xi J, Wen B, Lin J, 等. Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency[J]. Journal of Inherited Metabolic Disease, 2014, 37(3): 399-404. DOI: 10.1007/s10545-013-9671-6. 90 例我國晚髮型患者的 ETFDH 變異譜,三個常見變異及其南北分佈。引用於:多種酰基輔酶 A 脫氫酶缺乏症
  669. Kasari C, Kaiser A, Goods K, 等. Communication interventions for minimally verbal children with autism: a sequential multiple assignment randomized trial[J]. Journal of the American Academy of Child and Adolescent Psychiatry, 2014, 53(6): 635-46. DOI: 10.1016/j.jaac.2014.01.019.引用於:輔助與替代溝通(AAC)
  670. Moeschler JB, Shevell M. Comprehensive evaluation of the child with intellectual disability or global developmental delays[J]. Pediatrics, 2014, 134(3): e903-e918.引用於:全面發育遲緩、肌張力低下、發育倒退、粗大運動發育落後、全面發育遲緩、癲癇發作、頭圍增長異常、咖啡牛奶斑、色素脫失斑與鮮紅斑痣、急性代謝危象、腦性癱瘓的鑑別與病因評估:何時需要進一步檢查、孤獨症譜系障礙的鑑別與病因評估、全面發育遲緩:病因評估與後續管理、遺傳代謝病
  671. Deng D, Xu C, Sun P, 等. Crystal structure of the human glucose transporter GLUT1[J]. Nature, 2014, 510(7503): 121-125. DOI: 10.1038/nature13306. 清華大學團隊解析的人 GLUT1 晶體結構。引用於:GLUT1 缺乏綜合徵
  672. Brazil A, Stanford K, Smolarek T, 等. Delineating the phenotype of 1p36 deletion in adolescents and adults[J]. American Journal of Medical Genetics Part A, 2014, 164A(10): 2496–2503. DOI: 10.1002/ajmg.a.36657.引用於:1p36 缺失綜合徵
  673. Paul SM, Gabor LR, Rudzinski S, 等. Disease severity and functional factors associated with walking performance in polyostotic fibrous dysplasia[J]. Bone, 2014, 60: 41-47. DOI: 10.1016/j.bone.2013.11.022. 美國國立衛生研究院康復醫學部對 81 例多骨型患者(5–57 歲)的橫斷面研究:骨病變負荷與髖周肌力、關節活動度、下肢不等長和步行能力的關係,以及低衝擊訓練與墊高鞋的建議。引用於:McCune-Albright 綜合徵
  674. Bernier R, Golzio C, Xiong B, 等. Disruptive CHD8 mutations define a subtype of autism early in development[J]. Cell, 2014, 158(2): 263-276. DOI: 10.1016/j.cell.2014.06.017.引用於:CHD8 相關神經發育障礙
  675. van Gaalen J, Kerstens FG, Maas RP, 等. Drug-induced cerebellar ataxia: a systematic review[J]. CNS Drugs, 2014, 28(12): 1139–1153. DOI: 10.1007/s40263-014-0200-4.引用於:神經元蠟樣脂褐質沉積症
  676. Eliasson AC, Sjöstrand L, Ek L, 等. Efficacy of baby-CIMT: study protocol for a randomised controlled trial on infants below age 12 months, with clinical signs of unilateral CP[J]. BMC Pediatrics, 2014, 14: 141. DOI: 10.1186/1471-2431-14-141.
  677. Sakzewski L, Ziviani J, Boyd RN. Efficacy of upper limb therapies for unilateral cerebral palsy: a meta-analysis[J]. Pediatrics, 2014, 133(1): e175-204. DOI: 10.1542/peds.2013-0675.引用於:目標導向與任務導向訓練
  678. Arns M, Heinrich H, Strehl U. Evaluation of neurofeedback in ADHD: the long and winding road[J]. Biological Psychology, 2014, 95: 108-15. DOI: 10.1016/j.biopsycho.2013.11.013.引用於:神經反饋
  679. Morgan C, Novak I, Dale RC, 等. GAME (Goals - Activity - Motor Enrichment): protocol of a single blind randomised controlled trial of motor training, parent education and environmental enrichment for infants at high risk of cerebral palsy[J]. BMC Neurology, 2014, 14: 203. DOI: 10.1186/s12883-014-0203-2.引用於:目標導向與任務導向訓練、康復與干預方法
  680. Liao ST, Hwang YS, Chen YJ, 等. Home-based DIR/Floortime intervention program for preschool children with autism spectrum disorders: preliminary findings[J]. Physical & Occupational Therapy in Pediatrics, 2014, 34(4): 356-67. DOI: 10.3109/01942638.2014.918074.引用於:地板時光(DIR)
  681. Lameris AL, Geesing CL, Hoenderop JG, 等. Importance of dietary calcium and vitamin D in the treatment of hypercalcaemia in Williams-Beuren syndrome[J]. Journal of Pediatric Endocrinology and Metabolism, 2014, 27(7-8): 757–761. DOI: 10.1515/jpem-2013-0229.引用於:威廉姆斯綜合徵
  682. Posey JE, Burrage LC, Miller MJ, 等. Lysinuric Protein Intolerance Presenting with Multiple Fractures[J]. Molecular Genetics and Metabolism Reports, 2014, 1: 176-183. DOI: 10.1016/j.ymgmr.2014.03.004. 以反覆骨折、骨質疏鬆與矮小起病的 1 例報告,並回顧了本病骨折與骨質疏鬆的既往資料及其與成骨不全症的分辨。引用於:賴氨酸尿蛋白不耐受症
  683. Li H, Spencer L, Nahhas F, 等. Novel mutations causing biotinidase deficiency in individuals identified by newborn screening in Michigan including an unique intronic mutation that alters mRNA expression of the biotinidase gene[J]. Molecular Genetics and Metabolism, 2014, 112(3): 242–246. DOI: 10.1016/j.ymgme.2014.04.002.引用於:生物素酶缺乏症
  684. Solomon R, Van Egeren LA, Mahoney G, 等. PLAY Project Home Consultation intervention program for young children with autism spectrum disorders: a randomized controlled trial[J]. Journal of Developmental and Behavioral Pediatrics : JDBP, 2014, 35(8): 475-85. DOI: 10.1097/DBP.0000000000000096.引用於:地板時光(DIR)
  685. Deenen JC, Arnts H, van der Maarel SM, 等. Population-based incidence and prevalence of facioscapulohumeral dystrophy[J]. Neurology, 2014, 83(12): 1056–1059. DOI: 10.1212/WNL.0000000000000797.引用於:面肩肱型肌營養不良症
  686. Leach EL, Shevell M, Bowden K, 等. Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review[J]. Orphanet Journal of Rare Diseases, 2014, 9: 197. DOI: 10.1186/s13023-014-0197-2. 系統綜述:可以表現得像腦性癱瘓、又有治療辦法的遺傳代謝病,以及各自能由哪一項一線化驗查出。引用於:全羧化酶合成酶缺乏症、非酮性高甘氨酸血症
  687. 周晉波, 郭蘭婷, 陳穎. 中文版注意缺陷多動障礙 SNAP-Ⅳ 評定量表-父母版的信效度[J]. 中國心理衛生雜誌, 2013, 27(6): 424-428.引用於:感覺統合與感覺處理困難、兒童注意力不集中、注意缺陷多動障礙(多動症)、學習困難與學習障礙、評估量表一覽
  688. Hwang AW, Chao MY, Liu SW. A randomized controlled trial of routines-based early intervention for children with or at risk for developmental delay[J]. Research in Developmental Disabilities, 2013, 34(10): 3112-23. DOI: 10.1016/j.ridd.2013.06.037.引用於:高危兒早期干預、目標導向與任務導向訓練、發育遲緩的康復訓練方法、康復與干預方法
  689. Walker R, Belani KG, Braunlin EA, 等. Anaesthesia and airway management in mucopolysaccharidosis[J]. Journal of Inherited Metabolic Disease, 2013, 36(2): 211–219. DOI: 10.1007/s10545-012-9563-1.引用於:黏多糖貯積症
  690. Segura LG, Lorenz JD, Weingarten TN, 等. Anesthesia and Duchenne or Becker muscular dystrophy: review of 117 anesthetic exposures[J]. Paediatric Anaesthesia, 2013, 23(9): 855–864. DOI: 10.1111/pan.12248.引用於:杜氏肌營養不良
  691. Bhaskar P, John J, Sivamurthy SK, 等. Anesthetic management of an infant with Joubert syndrome for cardiac surgery[J]. Journal of Clinical Anesthesia, 2013, 25(6): 488–490. DOI: 10.1016/j.jclinane.2013.02.013.引用於:Joubert 綜合徵
  692. Ouyang Q, Lizarraga SB, Schmidt M, 等. Christianson syndrome protein NHE6 modulates TrkB endosomal signaling required for neuronal circuit development[J]. Neuron, 2013, 80(1): 97–112. DOI: 10.1016/j.neuron.2013.07.043.引用於:Christianson 綜合徵
  693. Ye J, Yang Y, Yu W, 等. Demographics, diagnosis and treatment of 256 patients with tetrahydrobiopterin deficiency in mainland China: results of a retrospective, multicentre study[J]. Journal of Inherited Metabolic Disease, 2013, 36(5): 893-901. DOI: 10.1007/s10545-012-9550-6. 上海交通大學醫學院附屬新華醫院等多中心:1985 至 2010 年出生的 256 例。引用於:四氫生物蝶呤缺乏症
  694. Yu T, Meiners LC, Danielsen K, 等. Deregulated FGF and homeotic gene expression underlies cerebellar vermis hypoplasia in CHARGE syndrome[J]. eLife, 2013, 2: e01305. DOI: 10.7554/eLife.01305.引用於:CHARGE 綜合徵
  695. Greaves S, Imms C, Dodd K, 等. Development of the Mini-Assisting Hand Assessment: evidence for content and internal scale validity[J]. Developmental Medicine and Child Neurology, 2013, 55(11): 1030-7. DOI: 10.1111/dmcn.12212.
  696. Cordelli DM, Garavelli L, Savasta S, 等. Epilepsy in Mowat-Wilson syndrome: delineation of the electroclinical phenotype[J]. American Journal of Medical Genetics Part A, 2013, 161A(2): 273–284. DOI: 10.1002/ajmg.a.35717.引用於:Mowat-Wilson 綜合徵
  697. Sharp WG, Berry RC, McCracken C, 等. Feeding problems and nutrient intake in children with autism spectrum disorders: a meta-analysis and comprehensive review of the literature[J]. Journal of Autism and Developmental Disorders, 2013, 43(9): 2159-73. DOI: 10.1007/s10803-013-1771-5.引用於:餵養與吞嚥治療
  698. Zhang P, Gao Z, Jiang Y, 等. Follow-up study of 25 Chinese children with PLA2G6-associated neurodegeneration[J]. European Journal of Neurology, 2013, 20(2): 322-330. DOI: 10.1111/j.1468-1331.2012.03856.x. 25 例經基因證實的中國兒童的隨訪研究,本頁引用其摘要中的癲癇比例、測序檢出率與單親二體病例。引用於:嬰兒神經軸索營養不良
  699. Sherafat-Kazemzadeh R, Ivey L, Kahn SR, 等. Hyperphagia among patients with Bardet-Biedl syndrome[J]. Pediatric Obesity, 2013, 8(5): e64–e67. DOI: 10.1111/j.2047-6310.2013.00182.x.引用於:Bardet-Biedl 綜合徵
  700. Silvera VM, Gordon LB, Orbach DB, 等. Imaging characteristics of cerebrovascular arteriopathy and stroke in Hutchinson-Gilford progeria syndrome[J]. AJNR. American Journal of Neuroradiology, 2013, 34(5): 1091–1097. DOI: 10.3174/ajnr.A3341.引用於:早老症
  701. Allen MM. Intervention efficacy and intensity for children with speech sound disorder[J]. Journal of Speech, Language, and Hearing Research : JSLHR, 2013, 56(3): 865-77. DOI: 10.1044/1092-4388(2012/11-0076).引用於:構音與語音訓練
  702. Giordano P, Franchini M, Lassandro G, 等. Issues in pediatric haemophilia care[J]. Italian Journal of Pediatrics, 2013, 39: 24. DOI: 10.1186/1824-7288-39-24. 兒童血友病照護的綜述:預防治療、抑制物、運動與生活參與的原則。引用於:血友病
  703. Yinon Y, Katorza E, Nassie DI, 等. Late diagnosis of fetal central nervous system anomalies following a normal second trimester anatomy scan[J]. Prenatal Diagnosis, 2013, 33(10): 929–934. DOI: 10.1002/pd.4163.引用於:無腦回畸形
  704. Casenhiser DM, Shanker SG, Stieben J. Learning through interaction in children with autism: preliminary data from asocial-communication-based intervention[J]. Autism : the International Journal of Research and Practice, 2013, 17(2): 220-41. DOI: 10.1177/1362361311422052.引用於:地板時光(DIR)
  705. Wijburg FA, Węgrzyn G, Burton BK, 等. Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder[J]. Acta Paediatrica, 2013, 102(5): 462–470. DOI: 10.1111/apa.12169.引用於:黏多糖貯積症
  706. Foley AR, Quijano-Roy S, Collins J, 等. Natural history of pulmonary function in collagen VI-related myopathies[J]. Brain, 2013, 136(Pt 12): 3625–3633. DOI: 10.1093/brain/awt284.引用於:先天性肌營養不良(膠原Ⅵ相關肌病)
  707. Adle-Biassette H, Saugier-Veber P, Fallet-Bianco C, 等. Neuropathological review of 138 cases genetically tested for X-linked hydrocephalus: evidence for closely related clinical entities of unknown molecular bases[J]. Acta Neuropathologica, 2013, 126(3): 427–442. DOI: 10.1007/s00401-013-1146-1.引用於:L1 綜合徵
  708. Ohlsson A, Jacobs SE. NIDCAP: a systematic review and meta-analyses of randomized controlled trials[J]. Pediatrics, 2013, 131(3): e881-93. DOI: 10.1542/peds.2012-2121.引用於:康復與干預方法
  709. Garcia-Filion P, Borchert M. Optic nerve hypoplasia syndrome: a review of the epidemiology and clinical associations[J]. Current Treatment Options in Neurology, 2013, 15(1): 78-89. DOI: 10.1007/s11940-012-0209-2. 洛杉磯兒童醫院的綜述:命名的來歷、視神經發育不良的眼科表現、下丘腦功能障礙與各項激素缺乏的比例、發育落後與孤獨症、眼科與內分泌的隨訪安排,以及物理、作業、言語治療與早期干預的要點。引用於:視隔發育不良
  710. Kaiser AP, Roberts MY. Parent-implemented enhanced milieu teaching with preschool children who have intellectual disabilities[J]. Journal of Speech, Language, and Hearing Research : JSLHR, 2013, 56(1): 295-309. DOI: 10.1044/1092-4388(2012/11-0231).引用於:自然發展行為干預(NDBI)、家長實施的語言干預
  711. Oono IP, Honey EJ, McConachie H. Parent-mediated early intervention for young children with autism spectrum disorders (ASD)[J]. Cochrane Database of Systematic Reviews, 2013, (4): CD009774.引用於:孤獨症譜系障礙(自閉症)、家庭育兒指導課程、行為矯正訓練、家長介導干預、家長行為管理培訓(PMT)、術語表
  712. Xia J, Wang L. Pelizaeus-Merzbacher disease: Molecular diagnosis and therapy[J]. Intractable & Rare Diseases Research, 2013, 2(3): 103–105. DOI: 10.5582/irdr.2013.v2.3.103.引用於:Pelizaeus-Merzbacher 病
  713. Sun Z, Zou L, Zhang J, 等. Prevalence and associated risk factors of dyslexic children in a middle-sized city of China: a cross-sectional study[J]. PLoS One, 2013, 8(2): e56688.引用於:學習困難與學習障礙、術語表
  714. Barger BD, Campbell JM, McDonough JD. Prevalence and onset of regression within autism spectrum disorders: a meta-analytic review[J]. Journal of Autism and Developmental Disorders, 2013, 43(4): 817–828. DOI: 10.1007/s10803-012-1621-x.引用於:Rett 綜合徵
  715. Rasmussen J, Nielsen OW, Lund AM, 等. Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events[J]. Journal of Inherited Metabolic Disease, 2013, 36(1): 35–41. DOI: 10.1007/s10545-012-9488-8.引用於:原發性肉鹼缺乏症
  716. Houghton K, Schuchard J, Lewis C, 等. Promoting child-initiated social-communication in children with autism: Son-Rise Program intervention effects[J]. Journal of Communication Disorders, 2013, 46(5-6): 495-506. DOI: 10.1016/j.jcomdis.2013.09.004.引用於:康復與干預方法
  717. Abikoff H, Gallagher R, Wells KC, 等. Remediating organizational functioning in children with ADHD: immediate and long-term effects from a randomized controlled trial[J]. Journal of Consulting and Clinical Psychology, 2013, 81(1): 113-28. DOI: 10.1037/a0029648.引用於:注意力與認知訓練、康復與干預方法
  718. Shirley MD, Tang H, Gallione CJ, 等. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ[J]. The New England Journal of Medicine, 2013, 368(21): 1971–1979. DOI: 10.1056/NEJMoa1213507.引用於:Sturge-Weber 綜合徵
  719. Virues-Ortega J, Julio FM, Pastor-Barriuso R. The TEACCH program for children and adults with autism: a meta-analysis of intervention studies[J]. Clinical Psychology Review, 2013, 33(8): 940-953.引用於:孤獨症譜系障礙(自閉症)、訓練器材與教具、術語表
  720. Titulaer MJ, McCracken L, Gabilondo I, 等. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study[J]. The Lancet Neurology, 2013, 12(2): 157–165. DOI: 10.1016/S1474-4422(12)70310-1.引用於:語言發育遲緩
  721. Sutton RA, Mumm S, Coburn SP, 等. "Atypical femoral fractures" during bisphosphonate exposure in adult hypophosphatasia[J]. Journal of Bone and Mineral Research, 2012, 27(5): 987–994. DOI: 10.1002/jbmr.1565.引用於:低鹼性磷酸酶血症
  722. Grünert SC, Stucki M, Morscher RJ, 等. 3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals[J]. Orphanet Journal of Rare Diseases, 2012, 7: 31. DOI: 10.1186/1750-1172-7-31. 88 例患者的臨床、生化、酶學與基因資料:無症狀者的比例、急性失代償的表現、繼發性肉鹼缺乏的比例,以及基因型與表型之間沒有對應關係。引用於:3-甲基巴豆酰輔酶 A 羧化酶缺乏症
  723. Kuroda S, Houkin K. Bypass surgery for moyamoya disease: concept and essence of sugical techniques[J]. Neurologia medico-chirurgica, 2012, 52(5): 287–294. DOI: 10.2176/nmc.52.287.引用於:煙霧病
  724. Petri H, Vissing J, Witting N, 等. Cardiac manifestations of myotonic dystrophy type 1[J]. International Journal of Cardiology, 2012, 160(2): 82–88. DOI: 10.1016/j.ijcard.2011.08.037.引用於:肌強直性營養不良
  725. Dijkstal JM, Cooley SS, Holleschau AM, 等. Change in visual acuity in albinism in the early school years[J]. Journal of Pediatric Ophthalmology and Strabismus, 2012, 49(2): 81–86. DOI: 10.3928/01913913-20110628-02.引用於:眼皮膚白化病
  726. Grünert SC, Wendel U, Lindner M, 等. Clinical and neurocognitive outcome in symptomatic isovaleric acidemia[J]. Orphanet Journal of Rare Diseases, 2012, 7: 9. DOI: 10.1186/1750-1172-7-9.引用於:異戊酸血症
  727. Jones WD, Dafou D, McEntagart M, 等. De novo mutations in MLL cause Wiedemann-Steiner syndrome[J]. American Journal of Human Genetics, 2012, 91(2): 358-364. DOI: 10.1016/j.ajhg.2012.06.008. 用外顯子組測序在 6 名患者中的 5 名找到 MLL(現稱 KMT2A)基因的新發截短變異,明確了本病的致病基因。引用於:Wiedemann-Steiner 綜合徵
  728. Puche JE, Castilla-Cortázar I. Human conditions of insulin-like growth factor-I (IGF-I) deficiency[J]. Journal of Translational Medicine, 2012, 10: 224. DOI: 10.1186/1479-5876-10-224. IGF-1 缺乏狀態的綜述,其中一節彙總萊倫氏綜合徵的生長速度、肌肉系統發育不足與走路偏晚的比例。引用於:萊倫氏綜合徵
  729. Wang KC, Phi JH, Lee JY, 等. Indirect revascularization surgery for moyamoya disease in children and its special considerations[J]. Korean journal of pediatrics, 2012, 55(11): 408-413. DOI: 10.3345/kjp.2012.55.11.408. 兒童間接血管重建手術與圍手術期照護的綜述:術後避免哭鬧與過度換氣、3 歲以下起病的特點,以及甲狀腺功能亢進的影響。引用於:煙霧病
  730. Morgan AT, Dodrill P, Ward EC. Interventions for oropharyngeal dysphagia in children with neurological impairment[J]. Cochrane Database of Systematic Reviews, 2012, 10(10): CD009456. DOI: 10.1002/14651858.CD009456.pub2.引用於:餵養與吞嚥治療、口部運動治療與口肌訓練
  731. Abe Y, Aoki Y, Kuriyama S, 等. Prevalence and clinical features of Costello syndrome and cardio-facio-cutaneous syndrome in Japan: findings from a nationwide epidemiological survey[J]. American Journal of Medical Genetics Part A, 2012, 158A(5): 1083–1094. DOI: 10.1002/ajmg.a.35292.引用於:Costello 綜合徵
  732. Rodda JM, Scheffer IE, McMahon JM, 等. Progressive gait deterioration in adolescents with Dravet syndrome[J]. Archives of Neurology, 2012, 69(7): 873–878. DOI: 10.1001/archneurol.2011.3275.引用於:嬰兒嚴重肌陣攣性癲癇
  733. Shipster C, Morgan A, Dunaway D. Psychosocial, feeding, and drooling outcomes in children with Beckwith Wiedemann syndrome following tongue reduction surgery[J]. The Cleft Palate-Craniofacial Journal, 2012, 49(4): e25-34. DOI: 10.1597/10-232. 10 例患兒舌減容手術前後的進食、流涎與心理社會情況:術前進食困難出在口腔準備期的唇閉合與食團控制。引用於:Beckwith-Wiedemann 綜合徵
  734. Borchert M. Reappraisal of the optic nerve hypoplasia syndrome[J]. Journal of Neuro-Ophthalmology, 2012, 32(1): 58–67. DOI: 10.1097/WNO.0b013e31824442b8.引用於:視隔發育不良
  735. American Academy of Pediatrics Section on Complementary and Integrative Medicine, Council on Children with Disabilities. Sensory integration therapies for children with developmental and behavioral disorders[J]. Pediatrics, 2012, 129(6): 1186-1189.引用於:感覺統合與感覺處理困難、兒童注意力不集中、注意缺陷多動障礙(多動症)、感覺統合訓練、作業訓練、感覺統合治療(ASI)、聽覺統合訓練(AIT)、感覺處理困難(感統失調)的干預方法、康復與干預方法、術語表
  736. Reichow B, Steiner AM, Volkmar F. Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD)[J]. Cochrane Database of Systematic Reviews, 2012, 2012(7): CD008511. DOI: 10.1002/14651858.CD008511.pub2.引用於:社交技能小組訓練
  737. Herbst J, Byard RW. Sudden death and Angelman syndrome[J]. Journal of Forensic Sciences, 2012, 57(1): 257–259. DOI: 10.1111/j.1556-4029.2011.01901.x.引用於:Angelman 綜合徵
  738. Magoulas PL, El-Hattab AW. Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management[J]. Orphanet Journal of Rare Diseases, 2012, 7: 68. DOI: 10.1186/1750-1172-7-68.引用於:原發性肉鹼缺乏症
  739. Engström P, Tedroff K. The prevalence and course of idiopathic toe-walking in 5-year-old children[J]. Pediatrics, 2012, 130(2): 279-284. DOI: 10.1542/peds.2012-0225.
  740. Stanton RP, Ippolito E, Springfield D, 等. The surgical management of fibrous dysplasia of bone[J]. Orphanet Journal of Rare Diseases, 2012, 7 Suppl 1: S1. DOI: 10.1186/1750-1172-7-S1-S1. 骨科專家在美國國立衛生研究院會議上形成的手術處理建議:兒童多骨型的隨訪、骨折與畸形的固定方式、脊柱側彎與下肢不等長。引用於:McCune-Albright 綜合徵
  741. Briskin S, LaBotz M; Council on Sports Medicine and Fitness. Trampoline safety in childhood and adolescence[J]. Pediatrics, 2012, 130(4): 774-779. DOI: 10.1542/peds.2012-2082. PMID 23008455。美國兒科學會政策聲明,不建議家庭娛樂性使用蹦床;多數損傷發生在同時多人使用時引用於:感覺統合與感覺處理困難
  742. Shah RP, Spruyt K, Kragie BC, 等. Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas[J]. Diabetes Care, 2012, 35(10): 2086-2088. DOI: 10.2337/dc11-2225. 19 例 KCNJ11 相關新生兒糖尿病兒童的視覺—運動整合測驗,按基因型分組比較手眼協調。引用於:新生兒糖尿病
  743. 徐姍姍, 等. 貝莉嬰幼兒發育量表-第三版評價上海市嬰幼兒發育水平的應用初探[J]. 中國兒童保健雜誌, 2011, 19(1): 30-32.引用於:全面發育遲緩、兒童發育與行為評估、評估量表一覽
  744. Pajareya K, Nopmaneejumruslers K. A pilot randomized controlled trial of DIR/Floortime™ parent training intervention for pre-school children with autistic spectrum disorders[J]. Autism : the International Journal of Research and Practice, 2011, 15(5): 563-77. DOI: 10.1177/1362361310386502.引用於:地板時光(DIR)
  745. Carter AS, Messinger DS, Stone WL, 等. A randomized controlled trial of Hanen's 'More Than Words' in toddlers with early autism symptoms[J]. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 2011, 52(7): 741-52. DOI: 10.1111/j.1469-7610.2011.02395.x.引用於:家長介導干預、家長實施的語言干預
  746. Hoy MM, Egan MY, Feder KP. A systematic review of interventions to improve handwriting[J]. Canadian Journal of Occupational Therapy. Revue Canadienne D'ergotherapie, 2011, 78(1): 13-25. DOI: 10.2182/cjot.2011.78.1.3.引用於:書寫與精細動作訓練
  747. Kaler SG. ATP7A-related copper transport diseases-emerging concepts and future trends[J]. Nature Reviews Neurology, 2011, 7(1): 15–29. DOI: 10.1038/nrneurol.2010.180.引用於:Menkes 病
  748. Sinha Y, Silove N, Hayen A, 等. Auditory integration training and other sound therapies for autism spectrum disorders (ASD)[J]. Cochrane Database of Systematic Reviews, 2011, 2011(12): CD003681. DOI: 10.1002/14651858.CD003681.pub3.引用於:感覺統合治療(ASI)、聽覺統合訓練(AIT)
  749. Manara R, Balao L, Baracchini C, 等. Brain magnetic resonance findings in symptomatic congenital cytomegalovirus infection[J]. Pediatric Radiology, 2011, 41(8): 962–970. DOI: 10.1007/s00247-011-2120-5.引用於:多小腦回
  750. Arnoux JB, Verkarre V, Saint-Martin C, 等. Congenital hyperinsulinism: current trends in diagnosis and therapy[J]. Orphanet Journal of Rare Diseases, 2011, 6: 63. DOI: 10.1186/1750-1172-6-63.引用於:中鏈酰基輔酶 A 脫氫酶缺乏症
  751. Parham LD, Roley SS, May-Benson TA, 等. Development of a fidelity measure for research on the effectiveness of the Ayres Sensory Integration intervention[J]. American Journal of Occupational Therapy, 2011, 65(2): 133-142.引用於:感覺統合與感覺處理困難、感覺統合訓練、懸吊訓練(SET)、感覺統合治療(ASI)、感覺處理困難(感統失調)的干預方法、訓練器材與教具、術語表
  752. Lessen BS. Effect of the premature infant oral motor intervention on feeding progression and length of stay in preterm infants[J]. Advances in Neonatal Care : Official Journal of the National Association of Neonatal Nurses, 2011, 11(2): 129-39. DOI: 10.1097/ANC.0b013e3182115a2a.引用於:康復與干預方法
  753. Baker E, McLeod S. Evidence-based practice for children with speech sound disorders: part 1 narrative review[J]. Language, Speech, and Hearing Services in Schools, 2011, 42(2): 102-39. DOI: 10.1044/0161-1461(2010/09-0075).引用於:構音與語音訓練
  754. Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva: clinical and genetic aspects[J]. Orphanet Journal of Rare Diseases, 2011, 6: 80. DOI: 10.1186/1750-1172-6-80.引用於:進行性骨化性纖維發育不良、粗大運動發育落後
  755. Ozelius LJ, Bressman SB. Genetic and clinical features of primary torsion dystonia[J]. Neurobiology of Disease, 2011, 42(2): 127-135. DOI: 10.1016/j.nbd.2010.12.012. 原發性扭轉性肌張力障礙的遺傳與臨床綜述,其中一節專寫早髮型 DYT1:受累部位的分佈、外顯率與攜帶者的發病年齡上限。引用於:DYT-TOR1A 肌張力障礙
  756. Prust M, Wang J, Morizono H, 等. GFAP mutations, age at onset, and clinical subtypes in Alexander disease[J]. Neurology, 2011, 77(13): 1287–1294. DOI: 10.1212/WNL.0b013e3182309f72.引用於:亞歷山大病
  757. Froissart R, Piraud M, Boudjemline AM, 等. Glucose-6-phosphatase deficiency[J]. Orphanet Journal of Rare Diseases, 2011, 6: 27. DOI: 10.1186/1750-1172-6-27. 葡萄糖-6-磷酸酶缺乏症的綜述:命名與分型的由來、代謝改變、鑑別診斷與飲食治療。引用於:糖原累積病Ⅰ型
  758. McCandless S E, Committee on Genetics, American Academy of Pediatrics. Health supervision for children with Prader-Willi syndrome[J]. Pediatrics, 2011, 127(1): 195-204. DOI: 10.1542/peds.2010-2820.引用於:Prader-Willi 綜合徵、染色體與基因組印記異常
  759. Liu W, Morito D, Takashima S, 等. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development[J]. PloS one, 2011, 6(7): e22542. DOI: 10.1371/journal.pone.0022542. 確認 RNF213 為易感基因的原始研究:p.R4810K 奠基者變異在日本、韓國與中國病例和對照中的攜帶情況,以及該蛋白的結構與功能線索。引用於:煙霧病
  760. Estrada-Cuzcano A, Koenekoop RK, Coppieters F, 等. IQCB1 mutations in patients with leber congenital amaurosis[J]. Investigative Ophthalmology & Visual Science, 2011, 52(2): 834–839. DOI: 10.1167/iovs.10-5221. 11 名攜帶 IQCB1 變異的 Leber 先天性黑矇患者中 7 人後來出現腎單位腎癆,作者建議密切隨訪腎臟。引用於:Leber 先天性黑矇
  761. Handler SM, Fierson WM, Section on Ophthalmology, 等. Learning disabilities, dyslexia, and vision[J]. Pediatrics, 2011, 127(3): e818-56. DOI: 10.1542/peds.2010-3670.引用於:書寫與精細動作訓練
  762. Groeschel S, Kehrer C, Engel C, 等. Metachromatic leukodystrophy: natural course of cerebral MRI changes in relation to clinical course[J]. Journal of Inherited Metabolic Disease, 2011, 34(5): 1095–1102. DOI: 10.1007/s10545-011-9361-1.引用於:異染性腦白質營養不良
  763. Kim YJ, Byun SY, Jo SA, 等. Miller-Dieker syndrome with der(17)t(12;17)(q24.33;p13.3)pat presenting with a potential risk of mis-identification as a de novo submicroscopic deletion of 17p13.3[J]. The Korean Journal of Laboratory Medicine, 2011, 31(1): 49–53. DOI: 10.3343/kjlm.2011.31.1.49.引用於:無腦回畸形
  764. Subcommittee on Febrile Seizures, American Academy of Pediatrics. Neurodiagnostic evaluation of the child with a simple febrile seizure[J]. Pediatrics, 2011, 127(2): 389–394. DOI: 10.1542/peds.2010-3318.引用於:亞歷山大病
  765. Miller J L, Lynn C H, Driscoll D C, 等. Nutritional phases in Prader-Willi syndrome[J]. American Journal of Medical Genetics Part A, 2011, 155A(5): 1040-1049. DOI: 10.1002/ajmg.a.33951. 把 Prader-Willi 綜合徵的進食變化分成 0 至 4 期七個階段。引用於:肌強直性營養不良、Prader-Willi 綜合徵、餵養困難
  766. White KK. Orthopaedic aspects of mucopolysaccharidoses[J]. Rheumatology, 2011, 50 Suppl 5: v26–v33. DOI: 10.1093/rheumatology/ker393.引用於:黏多糖貯積症
  767. Sahu S, Lata I, Singh S, 等. Revisiting hemophilia management in acute medicine[J]. Journal of Emergencies, Trauma, and Shock, 2011, 4(2): 292–298. DOI: 10.4103/0974-2700.82225.引用於:血友病
  768. D'Amico A, Mercuri E, Tiziano FD, 等. Spinal muscular atrophy[J]. Orphanet Journal of Rare Diseases, 2011, 6: 71. DOI: 10.1186/1750-1172-6-71.引用於:脊髓性肌萎縮症、先天性肌營養不良(膠原Ⅵ相關肌病)
  769. Bönnemann CG. The collagen VI-related myopathies: muscle meets its matrix[J]. Nature Reviews Neurology, 2011, 7(7): 379–390. DOI: 10.1038/nrneurol.2011.81.引用於:先天性肌營養不良(膠原Ⅵ相關肌病)
  770. Roberts MY, Kaiser AP. The effectiveness of parent-implemented language interventions: a meta-analysis[J]. American Journal of Speech-Language Pathology, 2011, 20(3): 180-199.引用於:語言發育遲緩與構音障礙、家庭育兒指導課程、言語認知訓練、家長介導干預、家長實施的語言干預、家長行為管理培訓(PMT)、語言發育遲緩與構音障礙的訓練方法
  771. Kehrer C, Blumenstock G, Gieselmann V, 等. The natural course of gross motor deterioration in metachromatic leukodystrophy[J]. Developmental Medicine and Child Neurology, 2011, 53(9): 850–855. DOI: 10.1111/j.1469-8749.2011.04028.x.引用於:異染性腦白質營養不良
  772. Morgan TM, Schlegel C, Edwards KM, 等. Vaccines are not associated with metabolic events in children with urea cycle disorders[J]. Pediatrics, 2011, 127(5): e1147–e1153. DOI: 10.1542/peds.2010-1628.引用於:鳥氨酸氨甲酰基轉移酶缺乏症
  773. 鮑秀蘭. 0~1 歲神經運動 20 項檢查(52 項簡化法)[J]. 中國兒童康復, 2010, 2(2): 9-10.引用於:高危兒與早產兒早期干預、兒童腦癱康復、兒童發育與行為評估、0~1 歲神經運動 20 項檢查、評估量表一覽、術語表
  774. 卞曉燕, 姚國英, Squires J, 等. 年齡與發育進程問卷上海市兒童常模及心理測量學特性研究[J]. 中華兒科雜誌, 2010, 48(7): 492-496.引用於:兒童發育與行為評估、家庭育兒指導課程、評估量表一覽、術語表
  775. Carr AS, Cardwell CR, McCarron PO, 等. A systematic review of population based epidemiological studies in Myasthenia Gravis[J]. BMC Neurology, 2010, 10: 46. DOI: 10.1186/1471-2377-10-46.引用於:全身型重症肌無力
  776. Lemmers RJ, van der Vliet PJ, Klooster R, 等. A unifying genetic model for facioscapulohumeral muscular dystrophy[J]. Science, 2010, 329(5999): 1650–1653. DOI: 10.1126/science.1189044.引用於:面肩肱型肌營養不良症
  777. Mervis CB, John AE. Cognitive and behavioral characteristics of children with Williams syndrome: implications for intervention approaches[J]. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2010, 154C(2): 229–248. DOI: 10.1002/ajmg.c.30263.引用於:威廉姆斯綜合徵
  778. Fukushima K, Yazaki M, Nakamura M, 等. Conventional diet therapy for hyperammonemia is risky in the treatment of hepatic encephalopathy associated with citrin deficiency[J]. Internal Medicine, 2010, 49(3): 243–247. DOI: 10.2169/internalmedicine.49.2712.引用於:瓜氨酸血症
  779. Bergman JE, Blake KD, Bakker MK, 等. Death in CHARGE syndrome after the neonatal period[J]. Clinical Genetics, 2010, 77(3): 232–240. DOI: 10.1111/j.1399-0004.2009.01334.x.引用於:CHARGE 綜合徵
  780. Widger J, O'Toole J, Geoghegan O, 等. Diet and visually significant cataracts in galactosaemia: is regular follow up necessary?[J]. Journal of Inherited Metabolic Disease, 2010, 33(2): 129–132. DOI: 10.1007/s10545-009-9042-5.引用於:半乳糖血症
  781. Mills PB, Footitt EJ, Mills KA, 等. Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency)[J]. Brain, 2010, 133(Pt 7): 2148-2159. DOI: 10.1093/brain/awq143. 30 個家系 37 名患者的臨床、生化、腦電圖與磁共振表現,是新生兒期多系統表現與運動、言語落後比例的來源。引用於:吡哆醇依賴性癲癇
  782. Raymond GV, Seidman R, Monteith TS, 等. Head trauma can initiate the onset of adreno-leukodystrophy[J]. Journal of the Neurological Sciences, 2010, 290(1–2): 70–74. DOI: 10.1016/j.jns.2009.11.005.引用於:X-連鎖腎上腺腦白質營養不良
  783. Gripp KW, Hopkins E, Doyle D, 等. High incidence of progressive postnatal cerebellar enlargement in Costello syndrome: brain overgrowth associated with HRAS mutations as the likely cause of structural brain and spinal cord abnormalities[J]. American Journal of Medical Genetics Part A, 2010, 152A(5): 1161–1168. DOI: 10.1002/ajmg.a.33391.引用於:Costello 綜合徵
  784. Berti A, Janes A, Furlan R, 等. High prevalence of minor neurologic deficits in a long-term neurodevelopmental follow-up of children with severe persistent pulmonary hypertension of the newborn: a cohort study[J]. Italian Journal of Pediatrics, 2010, 36: 45. DOI: 10.1186/1824-7288-36-45. 意大利單中心隊列,平均 41 月齡隨訪:語言與行為方面的輕度缺陷,以及隨訪要延續到學齡的理由。引用於:新生兒持續肺動脈高壓
  785. Trauner DA, Williams J, Ballantyne AO, 等. Neurological impairment in nephropathic cystinosis: motor coordination deficits[J]. Pediatric Nephrology, 2010, 25(10): 2061–2066. DOI: 10.1007/s00467-010-1589-8.引用於:胱氨酸貯積症
  786. Feldman DS, Jordan C, Fonseca L. Orthopaedic manifestations of neurofibromatosis type 1[J]. The Journal of the American Academy of Orthopaedic Surgeons, 2010, 18(6): 346–357. DOI: 10.5435/00124635-201006000-00007.引用於:神經纖維瘤病
  787. Green J, Charman T, McConachie H, 等. Parent-mediated communication-focused treatment in children with autism (PACT): a randomised controlled trial[J]. Lancet (London, England), 2010, 375(9732): 2152-60. DOI: 10.1016/S0140-6736(10)60587-9.引用於:家長介導干預、社交技能小組訓練
  788. Bales CB, Kamath BM, Munoz PS, 等. Pathologic lower extremity fractures in children with Alagille syndrome[J]. Journal of Pediatric Gastroenterology and Nutrition, 2010, 51(1): 66–70. DOI: 10.1097/MPG.0b013e3181cb9629.引用於:Alagille 綜合徵
  789. Sharp WG, Jaquess DL, Morton JF, 等. Pediatric feeding disorders: a quantitative synthesis of treatment outcomes[J]. Clinical Child and Family Psychology Review, 2010, 13(4): 348-65. DOI: 10.1007/s10567-010-0079-7.引用於:應用行為分析(ABA)、餵養與吞嚥治療
  790. Dawson G, Rogers S, Munson J, 等. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model[J]. Pediatrics, 2010, 125(1): e17-e23. DOI: 10.1542/peds.2009-0958.引用於:孤獨症譜系障礙(自閉症)、行為矯正訓練、早期介入丹佛模式(ESDM)、術語表
  791. Rosenberg AA, Lee NR, Vaver KN, 等. School-age outcomes of newborns treated for persistent pulmonary hypertension[J]. Journal of Perinatology, 2010, 30(2): 127-134. DOI: 10.1038/jp.2009.139. 109 名存活兒平均 7.1 歲時的隨訪:智力、適應行為與學業,感音神經性聽力損失與呼吸問題的比例。引用於:新生兒持續肺動脈高壓
  792. Webb EA, Dattani MT. Septo-optic dysplasia[J]. European Journal of Human Genetics, 2010, 18(4): 393-397. DOI: 10.1038/ejhg.2009.125. 倫敦大學學院兒童健康研究所的綜述:三聯徵的診斷標準、新生兒期的識別線索、垂體功能與磁共振的檢查要點、HESX1 與 SOX2、再發風險與多學科隨訪。引用於:視隔發育不良
  793. Parr JR, Dale NJ, Shaffer LM, 等. Social communication difficulties and autism spectrum disorder in young children with optic nerve hypoplasia and/or septo-optic dysplasia[J]. Developmental Medicine and Child Neurology, 2010, 52(10): 917-921. DOI: 10.1111/j.1469-8749.2010.03664.x. 一家發育性視覺專科門診 83 例重度或極重度視力損害患兒的病歷研究:社交溝通困難與孤獨症譜系障礙的比例、臨床診斷的年齡段。引用於:視隔發育不良
  794. Kokina A, Kern L. Social Story interventions for students with autism spectrum disorders: a meta-analysis[J]. Journal of Autism and Developmental Disorders, 2010, 40(7): 812-26. DOI: 10.1007/s10803-009-0931-0.引用於:社交故事
  795. Bahr D, Rosenfeld-Johnson S. Treatment of Children With Speech Oral Placement Disorders (OPDs): A Paradigm Emerges[J]. Communication Disorders Quarterly, 2010, 31(3): 131-138. DOI: 10.1177/1525740109350217.引用於:口部運動治療與口肌訓練
  796. 張厚粲. 韋氏兒童智力量表第四版(WISC-Ⅳ)中文版的修訂[J]. 心理科學, 2009, 32(5): 1177-1179.引用於:兒童注意力不集中、注意缺陷多動障礙(多動症)、學習困難與學習障礙、評估量表一覽
  797. 韓彤立, 鄒麗萍, 鄭華, 等. 粗大運動功能分類系統在痙攣型腦性癱瘓兒童中的信度和效度[J]. 臨床兒科雜誌, 2009, 27(3): 264-266.引用於:兒童腦癱康復、評估量表一覽、術語表
  798. Florance NR, Davis RL, Lam C, 等. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents[J]. Annals of Neurology, 2009, 66(1): 11–18. DOI: 10.1002/ana.21756.引用於:自身免疫性腦炎、語言發育遲緩
  799. Bamshad M, Van Heest AE, Pleasure D. Arthrogryposis: a review and update[J]. The Journal of Bone and Joint Surgery. American Volume, 2009, 91 Suppl 4: 40-46. DOI: 10.2106/JBJS.I.00281. 綜述:以神經系統查體是否正常為起點的分類思路、遠端關節攣縮的分型與基因、肌電圖與麻醉的注意事項。引用於:先天性多發性關節攣縮
  800. McCauley RJ, Strand E, Lof GL, 等. Evidence-based systematic review: effects of nonspeech oral motor exercises on speech[J]. American Journal of Speech-Language Pathology, 2009, 18(4): 343-360.引用於:語言發育遲緩與構音障礙、餵養困難與兒童營養諮詢、言語認知訓練、訓練器材與教具
  801. Arzimanoglou A, French J, Blume WT, 等. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology[J]. The Lancet Neurology, 2009, 8(1): 82–93. DOI: 10.1016/S1474-4422(08)70292-8.引用於:Lennox-Gastaut 綜合徵
  802. Hamdan F F, Gauthier J, Spiegelman D, 等. Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation[J]. New England Journal of Medicine, 2009, 360(6): 599-605. DOI: 10.1056/NEJMoa0805392. 首次報告 SYNGAP1 的新發截短變異。引用於:SYNGAP1 相關智力障礙
  803. Nadeau A, Kinali M, Main M, 等. Natural history of Ullrich congenital muscular dystrophy[J]. Neurology, 2009, 73(1): 25–31. DOI: 10.1212/WNL.0b013e3181aae851.引用於:先天性肌營養不良(膠原Ⅵ相關肌病)
  804. Novak I, Cusick A, Lannin N. Occupational therapy home programs for cerebral palsy: double-blind, randomized, controlled trial[J]. Pediatrics, 2009, 124(4): e606-14. DOI: 10.1542/peds.2009-0288.引用於:目標導向與任務導向訓練
  805. Laugeson EA, Frankel F, Mogil C, 等. Parent-assisted social skills training to improve friendships in teens with autism spectrum disorders[J]. Journal of Autism and Developmental Disorders, 2009, 39(4): 596-606. DOI: 10.1007/s10803-008-0664-5.引用於:社交技能小組訓練
  806. Dlamini N, Goyal S, Jarosz J, 等. Paroxysmal episodes, "re-build up" phenomenon and moyamoya disease[J]. Epileptic Disorders, 2009, 11(4): 324–328. DOI: 10.1684/epd.2009.0276.引用於:煙霧病
  807. Fintini D, Brufani C, Cappa M. Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency[J]. Therapeutics and Clinical Risk Management, 2009, 5(3): 553-559. DOI: 10.2147/tcrm.s6178. 重組人 IGF-1(美卡舍明)的綜述:美國與歐洲的獲批時間和適應證原文、低血糖出現的規律、長期治療中的不良事件。引用於:萊倫氏綜合徵
  808. Peredo DE, Hannibal MC. The floppy infant: evaluation of hypotonia[J]. Pediatrics in Review, 2009, 30(9): e66–e76. DOI: 10.1542/pir.30-9-e66.引用於:肌張力低下
  809. Lof GL, Watson MM. A nationwide survey of nonspeech oral motor exercise use: implications for evidence-based practice[J]. Language, Speech, and Hearing Services in Schools, 2008, 39(3): 392-407. DOI: 10.1044/0161-1461(2008/037).引用於:口部運動治療與口肌訓練
  810. Zaccara G, Gangemi PF, Cincotta M. Central nervous system adverse effects of new antiepileptic drugs. A meta-analysis of placebo-controlled studies[J]. Seizure, 2008, 17(5): 405–421. DOI: 10.1016/j.seizure.2007.12.003.引用於:神經元蠟樣脂褐質沉積症
  811. Young Infants Clinical Signs Study Group. Clinical signs that predict severe illness in children under age 2 months: a multicentre study[J]. The Lancet, 2008, 371(9607): 135–142. DOI: 10.1016/S0140-6736(08)60106-3.引用於:餵養困難
  812. Bell GS, Gaitatzis A, Bell CL, 等. Drowning in people with epilepsy: how great is the risk?[J]. Neurology, 2008, 71(8): 578–582. DOI: 10.1212/01.wnl.0000323813.36193.4d.引用於:戈謝病
  813. Schlosser RW, Wendt O. Effects of augmentative and alternative communication intervention on speech production in children with autism: a systematic review[J]. American Journal of Speech-Language Pathology, 2008, 17(3): 212-230. DOI: 10.1044/1058-0360(2008/021). 系統評價:替代溝通干預不妨礙口語產出,部分研究中口語有所增加引用於:訓練器材與教具
  814. Wakeman B, Babu D, Tarleton J, 等. Extraocular muscle hypertrophy in myotonia congenita[J]. Journal of AAPOS, 2008, 12(3): 294–296. DOI: 10.1016/j.jaapos.2007.12.002.引用於:先天性肌強直
  815. Dobbelsteyn C, Peacocke SD, Blake K, 等. Feeding difficulties in children with CHARGE syndrome: prevalence, risk factors, and prognosis[J]. Dysphagia, 2008, 23(2): 127–135. DOI: 10.1007/s00455-007-9111-6.引用於:CHARGE 綜合徵
  816. Tiger JH, Hanley GP, Bruzek J. Functional communication training: a review and practical guide[J]. Behavior Analysis in Practice, 2008, 1(1): 16-23. DOI: 10.1007/BF03391716.引用於:應用行為分析(ABA)、語言行為與 VB-MAPP、問題行為的功能評估與正向行為支持(PBS)、輔助與替代溝通(AAC)
  817. Kikuchi G, Motokawa Y, Yoshida T, 等. Glycine cleavage system: reaction mechanism, physiological significance, and hyperglycinemia[J]. Proceedings of the Japan Academy, Series B, Physical and Biological Sciences, 2008, 84(7): 246-263. DOI: 10.2183/pjab.84.246. 甘氨酸裂解酶系統的綜述:四個蛋白組分、反應產物、組織分佈,以及本病酶缺陷的發現經過。引用於:非酮性高甘氨酸血症
  818. Kaler SG, Holmes CS, Goldstein DS, 等. Neonatal diagnosis and treatment of Menkes disease[J]. The New England Journal of Medicine, 2008, 358(6): 605–614. DOI: 10.1056/NEJMoa070613.引用於:Menkes 病
  819. Kutzbach BR, Summers CG, Holleschau AM, 等. Neurodevelopment in children with albinism[J]. Ophthalmology, 2008, 115(10): 1805–1808. DOI: 10.1016/j.ophtha.2008.03.006.引用於:眼皮膚白化病
  820. Ruscello DM. Nonspeech oral motor treatment issues related to children with developmental speech sound disorders[J]. Language, Speech, and Hearing Services in Schools, 2008, 39(3): 380-91. DOI: 10.1044/0161-1461(2008/036).引用於:口部運動治療與口肌訓練
  821. Dunlap G, Carr EG, Horner RH, 等. Positive behavior support and applied behavior analysis: a familial alliance[J]. Behavior Modification, 2008, 32(5): 682-98. DOI: 10.1177/0145445508317132.引用於:應用行為分析(ABA)、問題行為的功能評估與正向行為支持(PBS)
  822. Wang LY, Ross AK, Li JS, 等. Cardiac arrhythmias following anesthesia induction in infantile-onset Pompe disease: a case series[J]. Paediatric Anaesthesia, 2007, 17(8): 738–748. DOI: 10.1111/j.1460-9592.2007.02215.x.引用於:糖原累積病Ⅱ型
  823. Lund AM, Joensen F, Hougaard DM, 等. Carnitine transporter and holocarboxylase synthetase deficiencies in The Faroe Islands[J]. Journal of Inherited Metabolic Disease, 2007, 30(3): 341–349. DOI: 10.1007/s10545-007-0527-9.引用於:全羧化酶合成酶缺乏症
  824. Hedequist D, Emans J. Congenital scoliosis: a review and update[J]. Journal of Pediatric Orthopedics, 2007, 27(1): 106–116. DOI: 10.1097/BPO.0b013e31802b4993.引用於:先天性脊柱側凸
  825. Leet AI, Collins MT. Current approach to fibrous dysplasia of bone and McCune-Albright syndrome[J]. Journal of Children’s Orthopaedics, 2007, 1(1): 3-17. DOI: 10.1007/s11832-007-0006-8. 小兒骨科視角的綜述:命名由來、變異如何造成骨與骨外表現、新患兒的評估方案與脊柱側彎的處理。引用於:McCune-Albright 綜合徵
  826. Konduri GG, Vohr B, Robertson C, 等. Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up[J]. The Journal of Pediatrics, 2007, 150(3): 235-240, 240.e1. DOI: 10.1016/j.jpeds.2006.11.065. 多中心隨機試驗的 18–24 月齡隨訪(234 名存活兒):神經發育損害、腦性癱瘓、聽力、生長、再住院與出院後用藥的比例。引用於:新生兒持續肺動脈高壓
  827. Gordon AM, Schneider JA, Chinnan A, 等. Efficacy of a hand-arm bimanual intensive therapy (HABIT) in children with hemiplegic cerebral palsy: a randomized control trial[J]. Developmental Medicine and Child Neurology, 2007, 49(11): 830-8. DOI: 10.1111/j.1469-8749.2007.00830.x.引用於:強制性誘導運動療法與雙手強化訓練(CIMT)
  828. Gutstein SE, Burgess AF, Montfort K. Evaluation of the relationship development intervention program[J]. Autism : the International Journal of Research and Practice, 2007, 11(5): 397-411. DOI: 10.1177/1362361307079603.引用於:家長介導干預、人際關係發展干預(RDI)
  829. Torres RJ, Puig JG. Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome[J]. Orphanet Journal of Rare Diseases, 2007, 2: 48. DOI: 10.1186/1750-1172-2-48. 綜述:命名由來、嘌呤代謝通路、生化與酶學診斷、降尿酸治療的原則,以及康復與防護性約束的建議。引用於:Lesch-Nyhan 綜合徵
  830. Amiel J, Rio M, de Pontual L, 等. Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction[J]. American Journal of Human Genetics, 2007, 80(5): 988-993. DOI: 10.1086/515582.引用於:Pitt-Hopkins 綜合徵
  831. Niemeijer AS, Smits-Engelsman BC, Schoemaker MM. Neuromotor task training for children with developmental coordination disorder: a controlled trial[J]. Developmental Medicine and Child Neurology, 2007, 49(6): 406-11. DOI: 10.1111/j.1469-8749.2007.00406.x.引用於:康復與干預方法
  832. van der Burgt I. Noonan syndrome[J]. Orphanet Journal of Rare Diseases, 2007, 2: 4. DOI: 10.1186/1750-1172-2-4.引用於:Noonan 綜合徵、Smith-Lemli-Opitz 綜合徵
  833. Green-Golan L, Yates C, Drinkard B, 等. Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glycemic control during prolonged moderate-intensity exercise[J]. The Journal of Clinical Endocrinology and Metabolism, 2007, 92(8): 3019–3024. DOI: 10.1210/jc.2007-0493.引用於:21-羥化酶缺乏症
  834. Wong V C N, Li S Y. Rett syndrome: prevalence among Chinese and a comparison of MECP2 mutations of classic and atypical forms[J]. Journal of Child Neurology, 2007, 22(12): 1397-1400. DOI: 10.1177/0883073807307091. 香港地區數據,是目前可查的中國人群患病率來源。引用於:Rett 綜合徵
  835. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection[J]. Reviews in Medical Virology, 2007, 17(4): 253–276. DOI: 10.1002/rmv.535.引用於:非綜合徵型耳聾
  836. Baujat G, Cormier-Daire V. Sotos syndrome[J]. Orphanet Journal of Rare Diseases, 2007, 2: 36. DOI: 10.1186/1750-1172-2-36.引用於:Sotos 綜合徵
  837. Krumlinde-Sundholm L, Holmefur M, Kottorp A, 等. The Assisting Hand Assessment: current evidence of validity, reliability, and responsiveness to change[J]. Developmental Medicine and Child Neurology, 2007, 49(4): 259-64. DOI: 10.1111/j.1469-8749.2007.00259.x.
  838. Stewart DR, Kleefstra T. The chromosome 9q subtelomere deletion syndrome[J]. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2007, 145C(4): 383–392. DOI: 10.1002/ajmg.c.30148.引用於:Kleefstra 綜合徵
  839. Howlin P, Gordon RK, Pasco G, 等. The effectiveness of Picture Exchange Communication System (PECS) training for teachers of children with autism: a pragmatic, group randomised controlled trial[J]. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 2007, 48(5): 473-81. DOI: 10.1111/j.1469-7610.2006.01707.x.引用於:圖片交換溝通系統(PECS)
  840. 吳漢榮, 宋然然, 姚彬. 兒童漢語閱讀障礙量表的初步編制[J]. 中國學校衛生, 2006, 27(3): 189-190.引用於:學習困難與學習障礙、評估量表一覽
  841. Koolen D A, Vissers L E, Pfundt R, 等. A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism[J]. Nature Genetics, 2006, 38(9): 999-1001. DOI: 10.1038/ng1853.引用於:Koolen-de Vries 綜合徵
  842. Williams C A, Beaudet A L, Clayton-Smith J, 等. Angelman syndrome 2005: updated consensus for diagnostic criteria[J]. American Journal of Medical Genetics Part A, 2006, 140(5): 413-418. DOI: 10.1002/ajmg.a.31074.引用於:Angelman 綜合徵、兒童罕見病、語言發育遲緩、癲癇發作、頭圍增長異常、共濟失調
  843. Cerruti Mainardi P. Cri du Chat syndrome[J]. Orphanet Journal of Rare Diseases, 2006, 1: 33. DOI: 10.1186/1750-1172-1-33.引用於:貓叫綜合徵
  844. Rainier S, Sher C, Reish O, 等. De novo occurrence of novel SPG3A/atlastin mutation presenting as cerebral palsy[J]. Archives of Neurology, 2006, 63(3): 445–447. DOI: 10.1001/archneur.63.3.445.引用於:遺傳性痙攣性截癱
  845. Jinnah HA, Visser JE, Harris JC, 等. Delineation of the motor disorder of Lesch-Nyhan disease[J]. Brain, 2006, 129(Pt 5): 1201-1217. DOI: 10.1093/brain/awl056. 44 例經典型患者的多中心前瞻性觀察,並彙總此前 122 篇報告的 254 例:首發表現、各運動體徵的比例、病程是否進展、影像與屍檢所見。引用於:Lesch-Nyhan 綜合徵
  846. Symington A, Pinelli J. Developmental care for promoting development and preventing morbidity in preterm infants[J]. Cochrane Database of Systematic Reviews, 2006, 2006(2): CD001814. DOI: 10.1002/14651858.CD001814.pub2.引用於:袋鼠式護理(KMC)、康復與干預方法
  847. Charles JR, Wolf SL, Schneider JA, 等. Efficacy of a child-friendly form of constraint-induced movement therapy in hemiplegic cerebral palsy: a randomized control trial[J]. Developmental Medicine and Child Neurology, 2006, 48(8): 635-42. DOI: 10.1017/S0012162206001356.引用於:強制性誘導運動療法與雙手強化訓練(CIMT)
  848. Byers PH, Krakow D, Nunes ME, 等. Genetic evaluation of suspected osteogenesis imperfecta (OI)[J]. Genetics in Medicine, 2006, 8(6): 383–388. DOI: 10.1097/01.gim.0000223557.54670.aa.引用於:成骨不全症
  849. 史惟, 等. GMFM 66 在 0-3 歲腦性癱瘓患兒粗大運動評估中的信度和效度研究[J]. 中華流行病學雜誌, 2006, 27(6).引用於:兒童腦癱康復、評估量表一覽
  850. del Gaudio D, Fang P, Scaglia F, 等. Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males[J]. Genetics in Medicine, 2006, 8(12): 784–792. DOI: 10.1097/01.gim.0000250502.28516.3c.引用於:MECP2 重複綜合徵
  851. Kasari C, Freeman S, Paparella T. Joint attention and symbolic play in young children with autism: a randomized controlled intervention study[J]. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 2006, 47(6): 611-20. DOI: 10.1111/j.1469-7610.2005.01567.x.引用於:自然發展行為干預(NDBI)、康復與干預方法
  852. Kleefstra T, Brunner H G, Amiel J, 等. Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome[J]. American Journal of Human Genetics, 2006, 79(2): 370-377. DOI: 10.1086/505693.引用於:Kleefstra 綜合徵
  853. Verheij JB, Sival DA, van der Hoeven JH, 等. Shah-Waardenburg syndrome and PCWH associated with SOX10 mutations: a case report and review of the literature[J]. European Journal of Paediatric Neurology, 2006, 10(1): 11–17. DOI: 10.1016/j.ejpn.2005.10.004.引用於:Waardenburg 綜合徵
  854. Reynhout G, Carter M. Social Stories for children with disabilities[J]. Journal of Autism and Developmental Disorders, 2006, 36(4): 445-69. DOI: 10.1007/s10803-006-0086-1.引用於:社交故事
  855. Haltia M. The neuronal ceroid-lipofuscinoses: from past to present[J]. Biochimica et Biophysica Acta, 2006, 1762(10): 850-856. DOI: 10.1016/j.bbadis.2006.06.010.引用於:神經元蠟樣脂褐質沉積症
  856. Williams KR. The Son-Rise Program intervention for autism: prerequisites for evaluation[J]. Autism : the International Journal of Research and Practice, 2006, 10(1): 86-102. DOI: 10.1177/1362361306062012.引用於:康復與干預方法
  857. Spire M, Tilikete C, Habault C, 等. Thomsen myotonia congenita and strabismus: recording saccades in myotonic diseases[J]. Journal Français d'Ophtalmologie, 2006, 29(3): 271–280. DOI: 10.1016/s0181-5512(06)73783-4. 原文為法文,題名用 PubMed 收錄的英文譯名。引用於:先天性肌強直
  858. WHO Multicentre Growth Reference Study Group. WHO Motor Development Study: windows of achievement for six gross motor development milestones[J]. Acta Paediatrica Supplement, 2006, 450: 86-95. DOI: 10.1111/j.1651-2227.2006.tb02379.x. PMID 16817682。五國 816 名兒童縱向隨訪,六項大運動里程碑的達成年齡百分位引用於:寶秀蘭兒童神經發育綜合評估系統、評估量表一覽
  859. 鮑秀蘭, 早期干預降低早產兒腦性癱瘓發生率研究協作組. 降低早產兒腦性癱瘓發生率的臨床研究[J]. 中華兒科雜誌, 2005, 43(4): 244-247. PMID 15924710引用於:高危兒與早產兒早期干預、兒童腦癱康復、早期綜合訓練、高危兒早期干預、嬰兒撫觸與被動操、機構沿革、鮑秀蘭教授
  860. 中華醫學會兒科學分會新生兒學組. 新生兒缺氧缺血性腦病診斷標準[J]. 中國當代兒科雜誌, 2005, 7(2): 97-98. 全文 PDF 字體未嵌入可讀編碼,診斷條件按期刊頁的中文摘要核對。
  861. Dubey P, Raymond GV, Moser AB, 等. Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening[J]. The Journal of Pediatrics, 2005, 146(4): 528–532. DOI: 10.1016/j.jpeds.2004.10.067.引用於:X-連鎖腎上腺腦白質營養不良
  862. Klingberg T, Fernell E, Olesen PJ, 等. Computerized training of working memory in children with ADHD--a randomized, controlled trial[J]. Journal of the American Academy of Child and Adolescent Psychiatry, 2005, 44(2): 177-86. DOI: 10.1097/00004583-200502000-00010.引用於:注意力與認知訓練
  863. 範娟, 杜亞松, 王立偉. Conners 父母症狀問卷的中國城市常模和信度研究[J]. 上海精神醫學, 2005, 17(6): 321-323.引用於:兒童注意力不集中、注意缺陷多動障礙(多動症)、學習困難與學習障礙、評估量表一覽、術語表
  864. Kleefstra T, Smidt M, Banning M J, 等. Disruption of the gene Euchromatin Histone Methyl Transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome[J]. Journal of Medical Genetics, 2005, 42(4): 299-306. DOI: 10.1136/jmg.2004.028464. 一例新發平衡易位打斷 EHMT1 的女孩,首次把這組表現與 EHMT1 聯繫起來。引用於:Kleefstra 綜合徵
  865. Van Esch H, Bauters M, Ignatius J, 等. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males[J]. American Journal of Human Genetics, 2005, 77(3): 442-453. DOI: 10.1086/444549.引用於:MECP2 重複綜合徵
  866. Fligor BJ, Neault MW, Mullen CH, 等. Factors associated with sensorineural hearing loss among survivors of extracorporeal membrane oxygenation therapy[J]. Pediatrics, 2005, 115(6): 1519-1528. DOI: 10.1542/peds.2004-0247. 新生兒期做過體外膜肺氧合的孩子:感音神經性聽力損失的比例、被發現的年齡範圍與相關因素。引用於:新生兒持續肺動脈高壓
  867. Roelfsema J H, White S J, Ariyürek Y, 等. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease[J]. American Journal of Human Genetics, 2005, 76(4): 572-580. DOI: 10.1086/429130.引用於:Rubinstein-Taybi 綜合徵
  868. Takken T, Custers J, Visser G, 等. Prolonged exercise testing in two children with a mild Multiple Acyl-CoA-Dehydrogenase deficiency[J]. Nutrition & Metabolism, 2005, 2(1): 12. DOI: 10.1186/1743-7075-2-12. 兩名輕型患兒的 90 分鐘低強度踏車試驗:運動中的脂肪酸氧化與運動後血尿代謝物的變化。引用於:多種酰基輔酶 A 脫氫酶缺乏症
  869. Hammarén E, Kjellby-Wendt G, Lindberg C. Quantification of mobility impairment and self-assessment of stiffness in patients with myotonia congenita by the physiotherapist[J]. Neuromuscular Disorders, 2005, 15(9-10): 610–617. DOI: 10.1016/j.nmd.2005.07.002.引用於:先天性肌強直
  870. Jones M, Onslow M, Packman A, 等. Randomised controlled trial of the Lidcombe programme of early stuttering intervention[J]. BMJ (Clinical Research Ed.), 2005, 331(7518): 659. DOI: 10.1136/bmj.38520.451840.E0.引用於:康復與干預方法
  871. Yazaki M, Takei Y, Kobayashi K, 等. Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adult-onset type II citrullinemia (CTLN2)[J]. Internal Medicine, 2005, 44(3): 188–195. DOI: 10.2169/internalmedicine.44.188.引用於:瓜氨酸血症
  872. Somerville M J, Mervis C B, Young E J, 等. Severe expressive-language delay related to duplication of the Williams-Beuren locus[J]. New England Journal of Medicine, 2005, 353(16): 1694-1701. DOI: 10.1056/NEJMoa051962. 首次報告威廉姆斯綜合徵缺失區的鏡像重複。引用於:7q11.23 重複綜合徵
  873. Butler M G, Dasouki M J, Zhou X P, 等. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations[J]. Journal of Medical Genetics, 2005, 42(4): 318-321. DOI: 10.1136/jmg.2004.024646.引用於:PTEN 錯構瘤腫瘤綜合徵
  874. Bratton SC, Ray D, Rhine T, 等. The Efficacy of Play Therapy With Children: A Meta-Analytic Review of Treatment Outcomes[J]. Professional Psychology: Research and Practice, 2005, 36(4): 376-390. DOI: 10.1037/0735-7028.36.4.376.引用於:地板時光(DIR)、遊戲治療與沙盤遊戲
  875. Hedequist D, Emans J. Congenital scoliosis[J]. The Journal of the American Academy of Orthopaedic Surgeons, 2004, 12(4): 266–275. DOI: 10.5435/00124635-200407000-00007.引用於:先天性脊柱側凸
  876. Leet AI, Chebli C, Kushner H, 等. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome[J]. Journal of Bone and Mineral Research, 2004, 19(4): 571-577. DOI: 10.1359/jbmr.0301262. 35 例多骨型患者平均隨訪 14.2 年的骨折記錄:四肢骨折的高峰年齡、部位分佈,以及腎性失磷與骨折的關係。引用於:McCune-Albright 綜合徵
  877. Ørngreen MC, Nørgaard MG, Sacchetti M, 等. Fuel utilization in patients with very long-chain acyl-CoA dehydrogenase deficiency[J]. Annals of Neurology, 2004, 56(2): 279–283. DOI: 10.1002/ana.20168.引用於:極長鏈酰基輔酶 A 脫氫酶缺乏症
  878. Vickers A, Ohlsson A, Lacy JB, 等. Massage for promoting growth and development of preterm and/or low birth-weight infants[J]. Cochrane Database of Systematic Reviews, 2004, 2004(2): CD000390. DOI: 10.1002/14651858.CD000390.pub2.引用於:袋鼠式護理(KMC)、嬰兒撫觸與被動操
  879. Inoue K, Khajavi M, Ohyama T, 等. Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations[J]. Nature Genetics, 2004, 36(4): 361–369. DOI: 10.1038/ng1322.引用於:Waardenburg 綜合徵
  880. Ricchetti ET, States L, Hosalkar HS, 等. Radiographic study of the upper cervical spine in the 22q11.2 deletion syndrome[J]. The Journal of Bone and Joint Surgery. American Volume, 2004, 86(8): 1751–1760. DOI: 10.2106/00004623-200408000-00020.引用於:22q11.2 缺失綜合徵
  881. Chinnery PF, DiMauro S, Shanske S, 等. Risk of developing a mitochondrial DNA deletion disorder[J]. The Lancet, 2004, 364(9434): 592–596. DOI: 10.1016/S0140-6736(04)16851-7.引用於:線粒體腦肌病
  882. Mei Z, Grummer-Strawn LM, Thompson D, 等. Shifts in percentiles of growth during early childhood: analysis of longitudinal data from the California Child Health and Development Study[J]. Pediatrics, 2004, 113(6): e617–e627. DOI: 10.1542/peds.113.6.e617.引用於:原發性生長激素缺乏症
  883. 鮑秀蘭. 新生兒行為能力和測查方法[J]. 實用診斷與治療雜誌, 2003, 17(6): 441-443. DOI: 10.3969/j.issn.1674-3474.2003.06.001.引用於:NBNA 方法頁
  884. Farbu E, Søfteland E, Bindoff LA. Anaesthetic complications associated with myotonia congenita: case study and comparison with other myotonic disorders[J]. Acta Anaesthesiologica Scandinavica, 2003, 47(5): 630–634. DOI: 10.1034/j.1399-6576.2003.00116.x.引用於:先天性肌強直
  885. Sanger TD, Delgado MR, Gaebler-Spira D, 等. Classification and definition of disorders causing hypertonia in childhood[J]. Pediatrics, 2003, 111(1): e89–e97. DOI: 10.1542/peds.111.1.e89.引用於:芳香族 L-氨基酸脫羧酶缺乏症
  886. Raqbi F, Le Bihan C, Morisseau-Durand MP, 等. Early prognostic factors for intellectual outcome in CHARGE syndrome[J]. Developmental Medicine and Child Neurology, 2003, 45(7): 483–488. DOI: 10.1017/s0012162203000896.引用於:CHARGE 綜合徵
  887. Hanley GP, Iwata BA, McCord BE. Functional analysis of problem behavior: a review[J]. Journal of Applied Behavior Analysis, 2003, 36(2): 147-85. DOI: 10.1901/jaba.2003.36-147.引用於:問題行為的功能評估與正向行為支持(PBS)
  888. Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial[J]. Archives of Ophthalmology, 2003, 121(12): 1684–1694. DOI: 10.1001/archopht.121.12.1684. 早期治療早產兒視網膜病變研究:需要治療的 1 型病變按分區、分期與有無附加病變定義。引用於:早產兒視網膜病變
  889. Law J, Garrett Z, Nye C. Speech and language therapy interventions for children with primary speech and language delay or disorder[J]. Cochrane Database of Systematic Reviews, 2003, (3): CD004110.引用於:語言發育遲緩與構音障礙、言語認知訓練
  890. Kiesler J, Ricer R. The abnormal fontanel[J]. American Family Physician, 2003, 67(12): 2547-2552. PMID 12825844。
  891. Basu PS, Elsebaie H, Noordeen MH. Congenital spinal deformity: a comprehensive assessment at presentation[J]. Spine, 2002, 27(20): 2255–2259. DOI: 10.1097/00007632-200210150-00014.引用於:先天性脊柱側凸
  892. Ishmael HA, Begleiter ML, Butler MG. Drowning as a cause of death in Angelman syndrome[J]. American Journal of Mental Retardation, 2002, 107(1): 69–70. DOI: 10.1352/0895-8017(2002)107<0069:DAACOD>2.0.CO;2.引用於:Angelman 綜合徵
  893. Kornreich L, Horev G, Schwarz M, 等. Laron syndrome abnormalities: spinal stenosis, os odontoideum, degenerative changes of the atlanto-odontoid joint, and small oropharynx[J]. American Journal of Neuroradiology, 2002, 23(4): 625–631.引用於:萊倫氏綜合徵
  894. Robertson CM, Tyebkhan JM, Hagler ME, 等. Late-onset, progressive sensorineural hearing loss after severe neonatal respiratory failure[J]. Otology & Neurotology, 2002, 23(3): 353-356. DOI: 10.1097/00129492-200205000-00022. 加拿大 9 家中心的前瞻性研究:重度新生兒呼吸衰竭存活兒隨訪到 4 歲,遲發與進行性感音神經性聽力損失的比例。引用於:新生兒持續肺動脈高壓
  895. Evans DG, Baser ME, McGaughran J, 等. Malignant peripheral nerve sheath tumours in neurofibromatosis 1[J]. Journal of Medical Genetics, 2002, 39(5): 311–314. DOI: 10.1136/jmg.39.5.311.引用於:神經纖維瘤病
  896. Kanumakala S, Boneh A, Zacharin M. Pamidronate treatment improves bone mineral density in children with Menkes disease[J]. Journal of Inherited Metabolic Disease, 2002, 25(5): 391–398. DOI: 10.1023/a:1020103901969.引用於:Menkes 病
  897. Rosenbaum PL, Walter SD, Hanna SE, 等. Prognosis for gross motor function in cerebral palsy: creation of motor development curves[J]. JAMA, 2002, 288(11): 1357-1363.引用於:兒童腦癱康復、腦癱(腦性癱瘓)的康復訓練方法、評估量表一覽、術語表
  898. Rovner AJ, Schall JI, Jawad AF, 等. Rethinking growth failure in Alagille syndrome: the role of dietary intake and steatorrhea[J]. Journal of Pediatric Gastroenterology and Nutrition, 2002, 35(4): 495–502. DOI: 10.1097/00005176-200210000-00007.引用於:Alagille 綜合徵
  899. Parazzini C, Baldoli C, Scotti G, 等. Terminal zones of myelination: MR evaluation of children aged 20-40 months[J]. AJNR. American Journal of Neuroradiology, 2002, 23(10): 1669-1673.
  900. 中文早期語言與溝通發展量表——普通話版的再標準化[J]. 中國兒童保健雜誌, 2001, 9(5).引用於:語言發育遲緩與構音障礙、兒童發育與行為評估、S-S 法、評估量表一覽
  901. Bezman L, Moser AB, Raymond GV, 等. Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening[J]. Annals of Neurology, 2001, 49(4): 512–517.引用於:X-連鎖腎上腺腦白質營養不良
  902. Item C B, Stöckler-Ipsiroglu S, Stromberger C, 等. Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans[J]. American Journal of Human Genetics, 2001, 69(5): 1127-1133. DOI: 10.1086/323765.引用於:腦肌酸缺乏綜合徵
  903. Polatajko HJ, Mandich AD, Missiuna C, 等. Cognitive orientation to daily occupational performance (CO-OP): part III--the protocol in brief[J]. Physical & Occupational Therapy in Pediatrics, 2001, 20(2-3): 107-23.引用於:康復與干預方法
  904. Delprato DJ. Comparisons of discrete-trial and normalized behavioral language intervention for young children with autism[J]. Journal of Autism and Developmental Disorders, 2001, 31(3): 315-25. DOI: 10.1023/a:1010747303957.引用於:應用行為分析(ABA)、自然發展行為干預(NDBI)、回合式教學(DTT)、關鍵反應訓練(PRT)
  905. Martorell L, Monckton DG, Sanchez A, 等. Frequency and stability of the myotonic dystrophy type 1 premutation[J]. Neurology, 2001, 56(3): 328–335. DOI: 10.1212/wnl.56.3.328.引用於:肌強直性營養不良
  906. American Academy of Pediatrics Committee on Injury and Poison Prevention. Injuries associated with infant walkers[J]. Pediatrics, 2001, 108(3): 790-792. DOI: 10.1542/peds.108.3.790.
  907. De Leersnyder H, De Blois MC, Claustrat B, 等. Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome[J]. The Journal of Pediatrics, 2001, 139(1): 111–116. DOI: 10.1067/mpd.2001.115018.引用於:日間嗜睡與睡眠節律紊亂
  908. Koegel RL, Koegel LK, McNerney EK. Pivotal areas in intervention for autism[J]. Journal of Clinical Child Psychology, 2001, 30(1): 19-32. DOI: 10.1207/S15374424JCCP3001_4.引用於:關鍵反應訓練(PRT)、早期介入丹佛模式(ESDM)
  909. Sundberg ML, Michael J. The benefits of Skinner's analysis of verbal behavior for children with autism[J]. Behavior Modification, 2001, 25(5): 698-724. DOI: 10.1177/0145445501255003.引用於:應用行為分析(ABA)、回合式教學(DTT)、語言行為與 VB-MAPP、圖片交換溝通系統(PECS)
  910. Gunay-Aygun M, Schwartz S, Heeger S, 等. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria[J]. Pediatrics, 2001, 108(5): E92. DOI: 10.1542/peds.108.5.e92.引用於:Prader-Willi 綜合徵
  911. Bondy A, Frost L. The Picture Exchange Communication System[J]. Behavior Modification, 2001, 25(5): 725-44. DOI: 10.1177/0145445501255004.引用於:語言行為與 VB-MAPP、輔助與替代溝通(AAC)、圖片交換溝通系統(PECS)
  912. Salomons G S, van Dooren S J, Verhoeven N M, 等. X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome[J]. American Journal of Human Genetics, 2001, 68(6): 1497-1500. DOI: 10.1086/320595.引用於:腦肌酸缺乏綜合徵
  913. Springer S, Erlewein R, Naegele T, 等. Alexander disease--classification revisited and isolation of a neonatal form[J]. Neuropediatrics, 2000, 31(2): 86–92. DOI: 10.1055/s-2000-7479.引用於:亞歷山大病
  914. Yu H, Tint G S, Salen G, Patel S B. Detection of a common mutation in the RSH or Smith-Lemli-Opitz syndrome by a PCR-RFLP assay: IVS8-G-->C is found in over sixty percent of US propositi[J]. American Journal of Medical Genetics, 2000, 90(4): 347-350. DOI: 10.1002/(sici)1096-8628(20000214)90:4<347::aid-ajmg16>3.0.co;2-7.引用於:Smith-Lemli-Opitz 綜合徵
  915. Jaffe M, Tal Y, Dabbah H, 等. Infants with a thumb-in-fist posture[J]. Pediatrics, 2000, 105(3): E41. DOI: 10.1542/peds.105.3.e41.引用於:L1 綜合徵
  916. Potocki L, Chen K S, Park S S, 等. Molecular mechanism for duplication 17p11.2 — the homologous recombination reciprocal of the Smith-Magenis microdeletion[J]. Nature Genetics, 2000, 24(1): 84-87. DOI: 10.1038/71743.引用於:Potocki-Lupski 綜合徵
  917. Hoffmann-Riem M, Diener W, Benninger C, 等. Nonconvulsive status epilepticus--a possible cause of mental retardation in patients with Lennox-Gastaut syndrome[J]. Neuropediatrics, 2000, 31(4): 169–174. DOI: 10.1055/s-2000-7456.引用於:Lennox-Gastaut 綜合徵
  918. Smith T, Groen AD, Wynn JW. Randomized trial of intensive early intervention for children with pervasive developmental disorder[J]. American Journal of Mental Retardation : AJMR, 2000, 105(4): 269-85. DOI: 10.1352/0895-8017(2000)105<0269:RTOIEI>2.0.CO;2.引用於:應用行為分析(ABA)
  919. Abadie V, Wiener-Vacher S, Morisseau-Durand MP, 等. Vestibular anomalies in CHARGE syndrome: investigations on and consequences for postural development[J]. European Journal of Pediatrics, 2000, 159(8): 569–574. DOI: 10.1007/s004319900409.引用於:CHARGE 綜合徵
  920. Bao X, Sun S, Wei S. Early intervention promotes intellectual development of premature infants: a preliminary report[J]. Chinese Medical Journal, 1999, 112(6): 520-523. PMID 11605609引用於:高危兒與早產兒早期干預、高危兒早期干預、鮑秀蘭教授
  921. Siegel AC, Burton RV. Effects of baby walkers on motor and mental development in human infants[J]. Journal of Developmental and Behavioral Pediatrics, 1999, 20(5): 355-360. DOI: 10.1097/00004703-199910000-00010.
  922. Emerick KM, Rand EB, Goldmuntz E, 等. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis[J]. Hepatology, 1999, 29(3): 822–829. DOI: 10.1002/hep.510290331.引用於:Alagille 綜合徵
  923. Beales PL, Elcioglu N, Woolf AS, 等. New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey[J]. Journal of Medical Genetics, 1999, 36(6): 437–446.引用於:Bardet-Biedl 綜合徵
  924. Ho TP, Chow V, Fung C, 等. Parent management training in a Chinese population: application and outcome[J]. Journal of the American Academy of Child and Adolescent Psychiatry, 1999, 38(9): 1165-72. DOI: 10.1097/00004583-199909000-00022.引用於:家長行為管理培訓(PMT)
  925. Hoogerwaard EM, Bakker E, Ippel PF, 等. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study[J]. The Lancet, 1999, 353(9170): 2116–2119. DOI: 10.1016/S0140-6736(98)10028-4.引用於:杜氏肌營養不良
  926. Furukawa Y, Nygaard TG, Gütlich M, 等. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia[J]. Neurology, 1999, 53(5): 1032–1041. DOI: 10.1212/wnl.53.5.1032.引用於:多巴反應性肌張力障礙
  927. Reddihough DS, King J, Coleman G, 等. Efficacy of programmes based on Conductive Education for young children with cerebral palsy[J]. Developmental Medicine and Child Neurology, 1998, 40(11): 763-70. DOI: 10.1111/j.1469-8749.1998.tb12345.x.引用於:引導式教育(CE)
  928. Seidner G, Alvarez M G, Yeh J I, 等. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier[J]. Nature Genetics, 1998, 18(2): 188-191. DOI: 10.1038/ng0298-188.引用於:GLUT1 缺乏綜合徵
  929. Mowat D R, Croaker G D, Cass D T, 等. Hirschsprung disease, microcephaly, mental retardation, and characteristic facial features: delineation of a new syndrome and identification of a locus at chromosome 2q22-q23[J]. Journal of Medical Genetics, 1998, 35(8): 617-623. DOI: 10.1136/jmg.35.8.617.引用於:Mowat-Wilson 綜合徵
  930. Fitzky B U, Witsch-Baumgartner M, Erdel M, 等. Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome[J]. Proceedings of the National Academy of Sciences of the United States of America, 1998, 95(14): 8181-8186. DOI: 10.1073/pnas.95.14.8181.引用於:Smith-Lemli-Opitz 綜合徵
  931. Wassif C A, Maslen C, Kachilele-Linjewile S, 等. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome[J]. American Journal of Human Genetics, 1998, 63(1): 55-62. DOI: 10.1086/301936.引用於:Smith-Lemli-Opitz 綜合徵
  932. Swango KL, Demirkol M, Hüner G, 等. Partial biotinidase deficiency is usually due to the D444H mutation in the biotinidase gene[J]. Human Genetics, 1998, 102(5): 571–575. DOI: 10.1007/s004390050742.引用於:生物素酶缺乏症
  933. Verkarre V, Fournet JC, de Lonlay P, 等. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia[J]. The Journal of Clinical Investigation, 1998, 102(7): 1286–1291. DOI: 10.1172/JCI4495.引用於:先天性高胰島素性低血糖血症
  934. Ryan AK, Bartlett K, Clayton P, 等. Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype[J]. Journal of Medical Genetics, 1998, 35(7): 558–565. DOI: 10.1136/jmg.35.7.558.引用於:Smith-Lemli-Opitz 綜合徵
  935. Sleat D E, Donnelly R J, Lackland H, 等. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis[J]. Science, 1997, 277(5333): 1802-1805. DOI: 10.1126/science.277.5333.1802.引用於:神經元蠟樣脂褐質沉積症
  936. Cameron RJ. Early intervention for young children with developmental delay: the Portage approach[J]. Child: Care, Health and Development, 1997, 23(1): 11-27. DOI: 10.1046/j.1365-2214.1997.838838.x.引用於:康復與干預方法
  937. Bao X, Sun S, Yu R, 等. Early intervention improves intellectual development in asphyxiated newborn infants[J]. Chinese Medical Journal, 1997, 110(11): 875-878. PMID 9772422引用於:高危兒早期干預、鮑秀蘭教授
  938. Brodsky MC, Conte FA, Taylor D, 等. Sudden death in septo-optic dysplasia. Report of 5 cases[J]. Archives of Ophthalmology, 1997, 115(1): 66-70. DOI: 10.1001/archopht.1997.01100150068011. 5 例猝死患兒的回顧:均有促腎上腺皮質激素缺乏與體溫調節障礙,多數在發熱、脫水時病情惡化。引用於:視隔發育不良
  939. Kuroda S, Houkin K, Hoshi Y, 等. Cerebral hypoxia after hyperventilation causes "re-build-up" phenomenon and TIA in childhood moyamoya disease. A near-infrared spectroscopy study[J]. Child's Nervous System, 1996, 12(8): 448–452. DOI: 10.1007/BF00261621.引用於:煙霧病
  940. Anderson PJ, Hall CM, Evans RD, 等. Cervical spine in Pfeiffer's syndrome[J]. The Journal of Craniofacial Surgery, 1996, 7(4): 275–279. DOI: 10.1097/00001665-199607000-00005.引用於:綜合徵性顱縫早閉
  941. de Vries BB, Wiegers AM, Smits AP, 等. Mental status of females with an FMR1 gene full mutation[J]. American Journal of Human Genetics, 1996, 58(5): 1025–1032.引用於:脆性 X 綜合徵
  942. Blair IP, Nash J, Gordon MJ, 等. Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: first report of a de novo duplication with a maternal origin[J]. American Journal of Human Genetics, 1996, 58(3): 472–476.引用於:腓骨肌萎縮症
  943. Petrij F, Giles R H, Dauwerse H G, 等. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP[J]. Nature, 1995, 376(6538): 348-351. DOI: 10.1038/376348a0.引用於:Rubinstein-Taybi 綜合徵
  944. 任桂英, 王玉鳳, 顧伯美, 等. 兒童感覺統合評定量表的測試報告[J]. 中國心理衛生雜誌, 1994, 8(4): 145-147.引用於:感覺統合與感覺處理困難、感覺統合訓練、感覺統合治療(ASI)、康復與干預方法、評估量表一覽
  945. Stöckler S, Holzbach U, Hanefeld F, 等. Creatine deficiency in the brain: a new, treatable inborn error of metabolism[J]. Pediatric Research, 1994, 36(3): 409-413. DOI: 10.1203/00006450-199409000-00023. 第一種肌酸代謝缺陷的報告,後來明確為 GAMT 缺乏症。引用於:腦肌酸缺乏綜合徵
  946. Tint G S, Irons M, Elias E R, 等. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome[J]. New England Journal of Medicine, 1994, 330(2): 107-113. DOI: 10.1056/NEJM199401133300205.引用於:Smith-Lemli-Opitz 綜合徵
  947. Marin G, Domené HM, Barnes KM, 等. The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys[J]. The Journal of Clinical Endocrinology and Metabolism, 1994, 79(2): 537–541. DOI: 10.1210/jcem.79.2.8045974.引用於:原發性生長激素缺乏症
  948. Iwata BA, Dorsey MF, Slifer KJ, 等. Toward a functional analysis of self-injury[J]. Journal of Applied Behavior Analysis, 1994, 27(2): 197-209. DOI: 10.1901/jaba.1994.27-197.引用於:應用行為分析(ABA)、問題行為的功能評估與正向行為支持(PBS)
  949. Bao XL, Yu RJ, Li ZS. 20-item neonatal behavioral neurological assessment used in predicting prognosis of asphyxiated newborn[J]. Chinese Medical Journal, 1993, 106(3): 211-215. PMID 8325146引用於:鮑秀蘭教授、NBNA 方法頁
  950. 楊曉玲, 黃悅勤, 賈美香, 等. 孤獨症行為量表試測報告[J]. 中國心理衛生雜誌, 1993, 7(6): 279-280.引用於:孤獨症譜系障礙(自閉症)、評估量表一覽
  951. Bourgeois M, Aicardi J, Goutières F. Alternating hemiplegia of childhood[J]. The Journal of Pediatrics, 1993, 122(5 Pt 1): 673–679. DOI: 10.1016/s0022-3476(06)80003-x.引用於:兒童交替性偏癱
  952. McEachin JJ, Smith T, Lovaas OI. Long-term outcome for children with autism who received early intensive behavioral treatment[J]. American Journal of Mental Retardation : AJMR, 1993, 97(4): 359-72; discussion 373-91.引用於:應用行為分析(ABA)
  953. Holm V A, Cassidy S B, Butler M G, 等. Prader-Willi syndrome: consensus diagnostic criteria[J]. Pediatrics, 1993, 91(2): 398-402. DOI: 10.1542/peds.91.2.398.引用於:Prader-Willi 綜合徵
  954. Mosser J, Douar A M, Sarde C O, 等. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters[J]. Nature, 1993, 361(6414): 726-730. DOI: 10.1038/361726a0. 用定位克隆找到致病基因,即今天的 ABCD1。引用於:X-連鎖腎上腺腦白質營養不良
  955. 新生兒行為神經研究協作組, 鮑秀蘭, 虞人傑, 等. 新生兒20項行為神經測定在窒息兒的臨床應用[J]. 中國生育健康雜誌, 1992, (3): 22-25.引用於:NBNA 方法頁
  956. Bao XL, Shi YF, Du YC, 等. Prevalence of growth hormone deficiency of children in Beijing[J]. Chinese Medical Journal, 1992, 105(5): 401-405. PMID 1499371引用於:鮑秀蘭教授
  957. Bao X L, Shi Y F, Du Y C, 等. Prevalence of growth hormone deficiency of children in Beijing[J]. Chinese Medical Journal, 1992, 105(5): 401-405. 北京 10 萬餘名 6 至 15 歲中小學生篩查,是目前可查的中國兒童生長激素缺乏症患病率數據。引用於:原發性生長激素缺乏症
  958. De Vivo D C, Trifiletti R R, Jacobson R I, 等. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay[J]. New England Journal of Medicine, 1991, 325(10): 703-709. DOI: 10.1056/NEJM199109053251006. 本病的首次報告。引用於:GLUT1 缺乏綜合徵
  959. Bao XL, Yu RJ, Li ZS, 等. Twenty-item behavioral neurological assessment for normal newborns in 12 cities of China[J]. Chinese Medical Journal, 1991, 104(9): 742-746. PMID 1935355引用於:高危兒與早產兒早期干預、兒童發育與行為評估、21 三體綜合徵、鮑秀蘭教授、NBNA 方法頁、0~1 歲神經運動 20 項檢查、評估量表一覽、術語表
  960. 全國新生兒行為神經科研協作組, 全國新生兒生長發育科研協作組. 中國12城市正常新生兒20項行為神經評價[J]. 中華兒科雜誌, 1990, 28(3): 160-162.引用於:鮑秀蘭教授、NBNA 方法頁
  961. Shi YF, Liu R, Bao XL, 等. Clinical trial with somatonorm in idiopathic growth hormone deficiency in children[J]. Chinese Medical Journal, 1990, 103(6): 470-477. PMID 2119959引用於:鮑秀蘭教授
  962. 中華預防醫學會婦女保健學會、兒童保健學會成立[J]. 中國婦幼保健, 1989, (6).引用於:鮑秀蘭教授
  963. Kaplan P, Kirschner M, Watters G, 等. Contractures in patients with Williams syndrome[J]. Pediatrics, 1989, 84(5): 895–899.引用於:威廉姆斯綜合徵
  964. Koegel RL, O'Dell MC, Koegel LK. A natural language teaching paradigm for nonverbal autistic children[J]. Journal of Autism and Developmental Disorders, 1987, 17(2): 187-200. DOI: 10.1007/BF01495055.引用於:回合式教學(DTT)、關鍵反應訓練(PRT)
  965. Hemmer KM, McAlister WH, Marsh JL. Cervical spine anomalies in the craniosynostosis syndromes[J]. The Cleft Palate Journal, 1987, 24(4): 328–333.引用於:綜合徵性顱縫早閉
  966. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity[J]. Physical Therapy, 1987, 67(2): 206–207. DOI: 10.1093/ptj/67.2.206.引用於:脊髓性肌萎縮症、杜氏肌營養不良、神經節苷脂貯積症、先天性肌營養不良(膠原Ⅵ相關肌病)、Canavan 病、芳香族 L-氨基酸脫羧酶缺乏症、先天性脊柱側凸
  967. Holland BA, Haas DK, Norman D, 等. MRI of normal brain maturation[J]. AJNR. American Journal of Neuroradiology, 1986, 7(2): 201-208.
  968. Field TM, Schanberg SM, Scafidi F, 等. Tactile/kinesthetic stimulation effects on preterm neonates[J]. Pediatrics, 1986, 77(5): 654-8.引用於:嬰兒撫觸與被動操
  969. Staheli L T, Corbett M, Wyss C, 等. Lower-extremity rotational problems in children: normal values to guide management[J]. The Journal of Bone and Joint Surgery (American Volume), 1985, 67(1): 39-47. DOI: 10.2106/00004623-198567010-00006.
  970. Carr EG, Durand VM. Reducing behavior problems through functional communication training[J]. Journal of Applied Behavior Analysis, 1985, 18(2): 111-26. DOI: 10.1901/jaba.1985.18-111.引用於:問題行為的功能評估與正向行為支持(PBS)
  971. Burri BJ, Sweetman L, Nyhan WL. Mutant holocarboxylase synthetase: evidence for the enzyme defect in early infantile biotin-responsive multiple carboxylase deficiency[J]. The Journal of Clinical Investigation, 1981, 68(6): 1491-1495. DOI: 10.1172/jci110402. 在早發嬰兒型患者的成纖維細胞裡證實酶缺陷出在全羧化酶合成酶。引用於:生物素酶缺乏症、全羧化酶合成酶缺乏症
  972. Krägeloh I, Aicardi J. Alternating hemiplegia in infants: report of five cases[J]. Developmental Medicine and Child Neurology, 1980, 22(6): 784–791. DOI: 10.1111/j.1469-8749.1980.tb03746.x.引用於:兒童交替性偏癱
  973. Pitt D, Hopkins I. A syndrome of mental retardation, wide mouth and intermittent overbreathing[J]. Australian Paediatric Journal, 1978, 14(3): 182-184. DOI: 10.1111/jpc.1978.14.3.182. 本病的首次報告,病名由此而來。引用於:Pitt-Hopkins 綜合徵
  974. Lubar JF, Shouse MN. EEG and behavioral changes in a hyperkinetic child concurrent with training of the sensorimotor rhythm (SMR): a preliminary report[J]. Biofeedback and Self-regulation, 1976, 1(3): 293-306. DOI: 10.1007/BF01001170.引用於:神經反饋
  975. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis[J]. Journal of Molecular Biology, 1975, 98(3): 503–517. DOI: 10.1016/s0022-2836(75)80083-0.引用於:脆性 X 綜合徵
  976. Hart B, Risley TR. Incidental teaching of language in the preschool[J]. Journal of Applied Behavior Analysis, 1975, 8(4): 411-20. DOI: 10.1901/jaba.1975.8-411.引用於:自然發展行為干預(NDBI)、回合式教學(DTT)
  977. Herrmann J, Pallister P D, Tiddy W, 等. The KBG syndrome — a syndrome of short stature, characteristic facies, mental retardation, macrodontia and skeletal anomalies[J]. Birth Defects Original Article Series, 1975, 11(5): 7-18. 本病的首次報告。引用於:KBG 綜合徵
  978. Coffin G S, Siris E. Mental retardation with absent fifth fingernail and terminal phalanx[J]. American Journal of Diseases of Children, 1970, 119(5): 433-439. DOI: 10.1001/archpedi.1970.02100050435009. 本病的首次報告,病名由此而來。引用於:Coffin-Siris 綜合徵
  979. Angelman H. 'Puppet' children: a report on three cases[J]. Developmental Medicine & Child Neurology, 1965, 7(6): 681-688. DOI: 10.1111/j.1469-8749.1965.tb07844.x. 首次報告三例,本病由此得名。引用於:Angelman 綜合徵
  980. Smith D W, Lemli L, Opitz J M. A newly recognized syndrome of multiple congenital anomalies[J]. Journal of Pediatrics, 1964, 64: 210-217. DOI: 10.1016/s0022-3476(64)80264-x. 本病的首次報告,病名由此而來。引用於:Smith-Lemli-Opitz 綜合徵
  981. Rubinstein J H, Taybi H. Broad thumbs and toes and facial abnormalities: a possible mental retardation syndrome[J]. American Journal of Diseases of Children, 1963, 105: 588-608. DOI: 10.1001/archpedi.1963.02080040590010. 本病的首次系統報告,病名由此而來。引用於:Rubinstein-Taybi 綜合徵
  982. Glaser R. Instructional technology and the measurement of learning outcomes: Some questions[J]. American Psychologist, 1963, 18(8): 519-521. DOI: 10.1037/h0049294. 校標參照(criterion-referenced)與常模參照(norm-referenced)之分的出處引用於:寶秀蘭兒童神經發育綜合評估系統、術語表

圖書15

  1. Betts JG, Young KA, Wise JA, 等. Anatomy and Physiology 2e: 14.3 Motor Responses[M]. Houston: OpenStax, 2022.
  2. World Health Organization. WHO recommendations for care of the preterm or low-birth-weight infant[M]. Geneva: World Health Organization, 2022. ISBN 978-92-4-005826-2.引用於:袋鼠式護理(KMC)
  3. 李曉捷 主編. 兒童康復[M]. 人民衛生出版社, 2020. ISBN 978-7-117-29514-7. 康復醫學系列叢書。引用於:物理因子治療、康復與干預方法
  4. World Health Organization. Improving early childhood development: WHO guideline[M]. World Health Organization, 2020.引用於:家庭育兒指導課程
  5. 鮑秀蘭. 0–3 歲兒童最佳的人生開端(正常兒卷、高危兒卷)[M]. 中國婦女出版社, 2019.引用於:家庭育兒指導課程、高危兒早期干預、0~1 歲神經運動 20 項檢查
  6. 鮑秀蘭 主編. 0~1 歲神經運動 20 項檢查(52 項簡化法)[M]. 寶秀蘭兒童早期發展優化中心, 2019. 機構內部印本引用於:高危兒與早產兒早期干預、0~1 歲神經運動 20 項檢查、評估量表一覽
  7. World Health Organization, UNICEF, World Bank Group. Nurturing care for early childhood development: a framework for helping children survive and thrive to transform health and human potential[M]. World Health Organization, 2018.引用於:家庭育兒指導課程、術語表
  8. 鄭毅, 劉靖. 中國注意缺陷多動障礙防治指南(第二版)[M]. 中華醫學電子音像出版社, 2015. ISBN 9787830050443.引用於:注意缺陷多動障礙(多動症)
  9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5)[M]. American Psychiatric Publishing, 2013.引用於:感覺統合與感覺處理困難、學習困難與學習障礙、學習困難與學習障礙的干預方法、術語表
  10. World Health Organization. International Classification of Functioning, Disability and Health: Children & Youth Version (ICF-CY)[M]. World Health Organization, 2007. ISBN 9789241547321.引用於:早期綜合訓練、作業訓練
  11. World Health Organization. Kangaroo mother care: a practical guide[M]. Geneva: World Health Organization, 2003.引用於:袋鼠式護理(KMC)
  12. Amiel-Tison C. Clinical assessment of the infant nervous system. In: Levene MI, Chervenak FA, Whittle M, eds. Fetal and neonatal neurology and neurosurgery. 3rd ed[M]. Churchill Livingstone, 2001. ISBN 9780443064395.引用於:0~1 歲神經運動 20 項檢查、評估量表一覽
  13. National Research Council. Educating Children with Autism[M]. National Academies Press, 2001.引用於:孤獨症譜系障礙(自閉症)、融合教育、行為矯正訓練
  14. Amiel-Tison C, Grenier A. Neurological assessment during the first year of life[M]. Oxford University Press, 1986. ISBN 9780195035070.引用於:0~1 歲神經運動 20 項檢查
  15. Brazelton TB. Neonatal Behavioral Assessment Scale[M]. Spastics International Medical Publications(Clinics in Developmental Medicine No. 50), 1973. ISBN 0-433-04030-0.引用於:鮑秀蘭教授

網頁與公開記錄601

  1. MedlinePlus Genetics. 15q11-q13 duplication syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:15q11.2-q13.1 重複綜合徵
  2. Orphanet. 15q11q13 微重複綜合徵(ORPHA:238446)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:15q11.2-q13.1 重複綜合徵
  3. Orphanet. 17p11.2 微重複綜合徵(ORPHA:1713)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:Potocki-Lupski 綜合徵
  4. Orphanet. 1p36 缺失綜合徵(ORPHA:1606)[EB/OL]. Orphanet, 2026. (訪問於 2026-10-07).引用於:1p36 缺失綜合徵
  5. 2026 年吉林省孤獨症兒童康復培訓班在長春圓滿舉辦[EB/OL]. 中國殘疾人聯合會, 2026. (訪問於 2026-09-30).引用於:自然發展行為干預(NDBI)
  6. Orphanet. 21 三體綜合徵(ORPHA:870)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:21 三體綜合徵
  7. Orphanet. 21-羥化酶缺乏症(ORPHA:90794)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:21-羥化酶缺乏症
  8. MedlinePlus Genetics. 21-hydroxylase deficiency[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:21-羥化酶缺乏症、內分泌與生長
  9. 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:21-羥化酶缺乏症
  10. Orphanet. 22q11.2 缺失綜合徵(ORPHA:567)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:22q11.2 缺失綜合徵
  11. MedlinePlus Genetics. 22q11.2 deletion syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:22q11.2 缺失綜合徵
  12. McDonald-McGinn D M, Hain H S, Emanuel B S, 等. 22q11.2 Deletion Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:22q11.2 缺失綜合徵、Pierre Robin 序列徵、假性甲狀旁腺功能減退症
  13. MedlinePlus Genetics. 22q13.3 deletion syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:Phelan-McDermid 綜合徵
  14. MedlinePlus Genetics. 3-M syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-10-07).引用於:Silver-Russell 綜合徵
  15. MedlinePlus Genetics. 3-methylcrotonyl-CoA carboxylase deficiency[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:3-甲基巴豆酰輔酶 A 羧化酶缺乏症
  16. Greeley SAW, Del Gaudio D. 6q24-Related Transient Neonatal Diabetes Mellitus[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2026. (訪問於 2026-09-30). 初版 2005 年,最近更新 2026 年 8 月 13 日。引用於:新生兒糖尿病
  17. Orphanet. 7q11.23 微重複綜合徵(ORPHA:96121)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:7q11.23 重複綜合徵
  18. MedlinePlus Genetics. 7q11.23 duplication syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:7q11.23 重複綜合徵
  19. 天使綜合徵之家. 天使綜合徵之家[EB/OL]. angelman-cn.com, 2026. (訪問於 2026-09-10). 中國的天使綜合徵患者與家屬組織,做疾病科普、患者登記與家庭互助。引用於:Angelman 綜合徵
  20. 北京大學醫學繼續教育學院獲批中國殘疾人康復協會“行為分析員技能培訓”授課資質[EB/OL]. 北京大學醫學部新聞網, 2026. (訪問於 2026-09-30).引用於:應用行為分析(ABA)、回合式教學(DTT)、語言行為與 VB-MAPP、問題行為的功能評估與正向行為支持(PBS)
  21. 首都之窗(北京市人民政府門戶網站). 北京市政務公開惠民便民地圖(類別:殘疾兒童康復服務定點機構)[EB/OL]. 北京市政務公開惠民便民地圖 map.beijing.gov.cn, 2026. (訪問於 2026-10-08).
  22. 北京至愛杜氏肌營養不良關愛中心. 北京至愛杜氏肌營養不良關愛中心[EB/OL]. china-dmd.org.cn, 2026. (訪問於 2026-09-10). 面向杜氏肌營養不良家庭的公益組織,做疾病科普、家長培訓與政策倡導。引用於:杜氏肌營養不良
  23. Orphanet. 四氫生物蝶呤缺乏所致高苯丙氨酸血症(ORPHA:238583)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:四氫生物蝶呤缺乏症
  24. Orphanet. 先天性肌無力綜合徵(ORPHA:590)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:先天性肌無力綜合徵
  25. Orphanet. 成骨不全症(ORPHA:666)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:成骨不全症
  26. Orphanet. 肌強直性營養不良(ORPHA:206647)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:肌強直性營養不良
  27. Orphanet. 肌酸缺乏綜合徵(ORPHA:79172)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:腦肌酸缺乏綜合徵
  28. Orphanet. 低磷性佝僂病(ORPHA:89936)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:低磷性佝僂病
  29. Orphanet. 近端 Xq28 重複綜合徵(ORPHA:1762)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:MECP2 重複綜合徵
  30. Orphanet. 威廉姆斯綜合徵(ORPHA:904)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:威廉姆斯綜合徵
  31. 美兒 SMA 關愛中心. 美兒 SMA 關愛中心[EB/OL]. meier.org.cn, 2026. (訪問於 2026-09-10). 面向脊髓性肌萎縮症家庭的公益組織,設疾病介紹、診斷檢測、治療管理、患者登記與關愛服務欄目。引用於:脊髓性肌萎縮症
  32. Orphanet. 苯丙酮尿症(ORPHA:716)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:苯丙酮尿症
  33. Orphanet. 神經元蠟樣脂褐質沉積症(ORPHA:216)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:神經元蠟樣脂褐質沉積症
  34. Orphanet. 神經纖維瘤病 1 型(ORPHA:636)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:神經纖維瘤病
  35. Orphanet. 脆性 X 綜合徵(ORPHA:908)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:脆性 X 綜合徵
  36. 健康中國微信公眾號. 蚊子藏隱患?乙腦怎麼防?這套“防護攻略”快收好丨科普時間[EB/OL]. 新華網, 2026. (訪問於 2026-10-07). 2026 年 5 月 15 日發佈。引用於:自身免疫性腦炎
  37. Orphanet. 異染性腦白質營養不良(ORPHA:512)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:異染性腦白質營養不良
  38. Orphanet. 軟骨發育不全(ORPHA:15)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:軟骨發育不全
  39. 北京市政務服務網. 殘疾兒童康復服務定點機構(常用查詢)[EB/OL]. 北京市政務服務網 常用查詢, 2026. (訪問於 2026-10-08).
  40. Orphanet. 結節性硬化症(ORPHA:805)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:結節性硬化症
  41. Orphanet. 腓骨肌萎縮症(ORPHA:166)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:腓骨肌萎縮症
  42. 彭韻佳. 新華鮮報丨用藥利好事關你我!國家醫保藥品“清單”一覽[EB/OL]. 新華網, 2026. (訪問於 2026-10-07). 2026 年 1 月 7 日發佈。新版醫保藥品目錄已於 2026 年 1 月 1 日實施,新增 114 種藥品,涵蓋腫瘤、罕見病、慢性病等。引用於:罕見病政策與保障
  43. Orphanet. 經典型 GLUT1 缺乏綜合徵(ORPHA:71277)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:GLUT1 缺乏綜合徵
  44. Orphanet. 糖原累積病 Ⅱ 型(ORPHA:365)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:糖原累積病Ⅱ型
  45. Orphanet. 貓叫綜合徵(ORPHA:281)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:貓叫綜合徵
  46. Orphanet. 遺傳性痙攣性截癱(ORPHA:685)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:遺傳性痙攣性截癱
  47. Orphanet. 黏多糖貯積症(ORPHA:79213)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:黏多糖貯積症
  48. 北京市衛生健康委員會. 醫療機構查詢[EB/OL]. 北京市衛生健康委員會網站 便民查詢, 2026. (訪問於 2026-10-08).
  49. Achondroplasia[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:軟骨發育不全、綜合徵性顱縫早閉、萊倫氏綜合徵
  50. MedlinePlus Genetics. Achondroplasia[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:軟骨發育不全
  51. MedlinePlus Genetics. ADNP syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:ADNP 綜合徵
  52. 美國國立醫學圖書館 DailyMed. AFINITOR/AFINITOR DISPERZ(everolimus)處方信息[EB/OL]. DailyMed, 2026. (訪問於 2026-10-07). 2026 年 6 月版說明書。引用於:結節性硬化症
  53. MedlinePlus Genetics. Alagille syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:Alagille 綜合徵
  54. MedlinePlus Genetics. Alternating hemiplegia of childhood[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:兒童交替性偏癱
  55. MedlinePlus Genetics. Angelman syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:Angelman 綜合徵
  56. Orphanet. Angelman syndrome(ORPHA:72)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:Angelman 綜合徵
  57. Morel Swols D, Tekin M. ANKRD11-Related KBG Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-11). 2018 年 3 月首發,2026 年 6 月更新;臨床描述依據 375 例以上已報道患者。引用於:KBG 綜合徵、Coffin-Siris 綜合徵
  58. McNutt M, Sun A, Crombez EA, 等. Arginase 1 Deficiency[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-10-07). 2004 年 10 月首發,2026 年 9 月 22 日更新。ARG1 基因定位 6q23.2。引用於:精氨酸酶缺乏症
  59. MedlinePlus Genetics. Aromatic l-amino acid decarboxylase deficiency[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:芳香族 L-氨基酸脫羧酶缺乏症、Lesch-Nyhan 綜合徵
  60. Arylsulfatase A Deficiency[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:異染性腦白質營養不良、嬰兒神經軸索營養不良
  61. McLeod S, Kawamura A, Orsino A. Assessing children and youth with global developmental delay and intellectual developmental disorder[EB/OL]. Canadian Paediatric Society, 2026-03-27. (訪問於 2026-09-23).
  62. McLeod S, Kawamura A, Orsino A. Assessing children and youth with global developmental delay and intellectual developmental disorder[EB/OL]. Canadian Paediatric Society, 2026. (訪問於 2026-09-25). 2026 年 3 月 27 日發佈,介紹全面發育遲緩與智力發育障礙的綜合評估、遺傳學檢查及有指徵的代謝檢查。引用於:全面發育遲緩、全面發育遲緩:病因評估與後續管理
  63. 美國食品藥品監督管理局(FDA). August 19, 2026 Approval Letter - GENGLYCOS(pariglasgene brecaparvovec-opnr,生物製品許可申請 BL 125858/0)[EB/OL]. 美國食品藥品監督管理局, 2026. (訪問於 2026-09-30). 2026 年 8 月 19 日加速批准,適用於 8 歲及以上的糖原累積病Ⅰa 型患者,作為營養管理的輔助。引用於:糖原累積病Ⅰ型
  64. MedlinePlus Genetics. Beckwith-Wiedemann syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:Beckwith-Wiedemann 綜合徵
  65. Eunice Kennedy Shriver National Institute of Child Health and Human Development. Benefits of Tummy Time[EB/OL]. Safe to Sleep®, 2026. (訪問於 2026-10-07).引用於:遺傳性大皰性表皮鬆解症
  66. Wolf B. Biotinidase Deficiency[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-12). 2000 年 3 月首發,2026 年 2 月修訂。引用於:生物素酶缺乏症、全羧化酶合成酶缺乏症
  67. Nagy A, Bley AE, 等. Canavan Disease[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-12). 1999 年 9 月首發,2026 年 6 月更新。引用於:亞歷山大病、Canavan 病
  68. MedlinePlus Genetics. Cardiofaciocutaneous syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:心-面-皮膚綜合徵
  69. Orphanet. CDKL5 缺乏症(ORPHA:505652)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:CDKL5 缺乏症
  70. MedlinePlus Genetics. CDKL5 deficiency disorder[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:CDKL5 缺乏症
  71. Benke T A, Demarest S, Angione K, 等. CDKL5 Deficiency Disorder[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:CDKL5 缺乏症、孤獨症譜系障礙的鑑別與病因評估
  72. MedlinePlus Genetics. Central core disease[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30). 中央軸空病的表現、RYR1 鈣通道的作用、遺傳方式與惡性高熱風險。引用於:先天性肌病
  73. MedlinePlus Genetics. Charcot-Marie-Tooth disease[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:腓骨肌萎縮症
  74. Charcot-Marie-Tooth Hereditary Neuropathy Overview[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:腓骨肌萎縮症、遺傳性痙攣性截癱
  75. Orphanet. CHARGE 綜合徵(ORPHA:138)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:CHARGE 綜合徵
  76. MedlinePlus Genetics. CHARGE syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:CHARGE 綜合徵
  77. van Ravenswaaij-Arts C, Martin D M, 等. CHD7 Disorder[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:CHARGE 綜合徵、Pierre Robin 序列徵
  78. Orphanet. CHD8 過度生長綜合徵(ORPHA:642675)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:CHD8 相關神經發育障礙
  79. MedlinePlus Genetics. CHD8 gene[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:CHD8 相關神經發育障礙
  80. MedlinePlus Genetics. Chediak-Higashi syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-10-07).引用於:眼皮膚白化病
  81. MedlinePlus Genetics. Christianson syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:Christianson 綜合徵
  82. Orphanet. Chronic inflammatory demyelinating polyneuropathy(ORPHA:2932)[EB/OL]. INSERM, 2026. (訪問於 2026-09-12).引用於:慢性炎性脫髓鞘性多發性神經根神經病
  83. Adam M P, Conta J, Bean L J H. Classic Mowat-Wilson Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-11). 2007 年 3 月首發,2026 年 6 月修訂。引用於:Mowat-Wilson 綜合徵
  84. MedlinePlus Genetics. CLN2 disease[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:神經元蠟樣脂褐質沉積症
  85. MedlinePlus Genetics. CLN3 disease[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:神經元蠟樣脂褐質沉積症
  86. Orphanet. Coffin-Siris 綜合徵(ORPHA:1465)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:Coffin-Siris 綜合徵
  87. MedlinePlus Genetics. Coffin-Siris syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:Coffin-Siris 綜合徵
  88. COL1A1- and COL1A2-Related Osteogenesis Imperfecta[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:成骨不全症、低磷性佝僂病、McCune-Albright 綜合徵、反覆骨折與骨脆性增高、骨骼與結締組織
  89. MedlinePlus Genetics. Collagen VI-related dystrophy[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-10-07).引用於:先天性肌營養不良(膠原Ⅵ相關肌病)
  90. MedlinePlus Genetics. Congenital hyperinsulinism[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:先天性高胰島素性低血糖血症、Beckwith-Wiedemann 綜合徵
  91. MedlinePlus Genetics. Congenital myasthenic syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:先天性肌無力綜合徵
  92. Congenital Myasthenic Syndromes Overview[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:先天性肌無力綜合徵
  93. Orphanet. Cornelia de Lange 綜合徵(ORPHA:199)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:Cornelia de Lange 綜合徵
  94. MedlinePlus Genetics. Cornelia de Lange syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:Cornelia de Lange 綜合徵
  95. Deardorff M A, Noon S E, Krantz I D. Cornelia de Lange Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:Cornelia de Lange 綜合徵、Rubinstein-Taybi 綜合徵、Lesch-Nyhan 綜合徵
  96. MedlinePlus Genetics. Costello syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:Costello 綜合徵
  97. MedlinePlus Genetics. Cowden syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:PTEN 錯構瘤腫瘤綜合徵
  98. MedlinePlus Genetics. Cri-du-chat syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:貓叫綜合徵
  99. MedlinePlus Genetics. Crouzon syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:綜合徵性顱縫早閉
  100. 美國食品藥品監督管理局(FDA). CRYSVITA(burosumab)處方信息,生物製品許可申請 761068[EB/OL]. DailyMed, 2026. (訪問於 2026-10-07). 現行標籤版本生效於 2026 年 4 月 22 日;適應證為成人與 6 月齡及以上兒童的 X 連鎖低磷血症。引用於:低磷性佝僂病
  101. MedlinePlus Genetics. Cystinosis[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:胱氨酸貯積症
  102. MedlinePlus Genetics. Dandy-Walker malformation[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-12).引用於:Dandy-Walker 畸形
  103. MedlinePlus Genetics. Dopa-responsive dystonia[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-10-07). 頁面最後更新於 2012 年 5 月。引用於:多巴反應性肌張力障礙
  104. MedlinePlus Genetics. Down syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:21 三體綜合徵、Beckwith-Wiedemann 綜合徵、染色體與基因組印記異常
  105. Pal A, Daley S F. Down Syndrome[EB/OL]. StatPearls,美國國家生物技術信息中心, 2026. (訪問於 2026-09-10).引用於:21 三體綜合徵
  106. Orphanet. Dravet 綜合徵(ORPHA:33069)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:嬰兒嚴重肌陣攣性癲癇
  107. MedlinePlus Genetics. Duchenne and Becker muscular dystrophy[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:杜氏肌營養不良
  108. Orphanet. Duchenne muscular dystrophy(ORPHA:98896)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:杜氏肌營養不良
  109. Orphanet. DYRK1A 綜合徵(ORPHA:464306)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:DYRK1A 綜合徵
  110. MedlinePlus Genetics. DYRK1A gene[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:DYRK1A 綜合徵
  111. Earl R K, Bernier R A, 等. DYRK1A Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:DYRK1A 綜合徵
  112. MedlinePlus Genetics. Dystrophic epidermolysis bullosa[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:遺傳性大皰性表皮鬆解症
  113. Lucky AW, Pope E, Crawford S. Dystrophic Epidermolysis Bullosa[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2026. (訪問於 2026-10-07).引用於:遺傳性大皰性表皮鬆解症
  114. MedlinePlus Genetics. Early-onset isolated dystonia[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:DYT-TOR1A 肌張力障礙
  115. MedlinePlus Genetics. Ehlers-Danlos syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30). 整組疾病的概述:分類沿革、各型的標誌性表現、患病率、相關基因與遺傳方式。引用於:Ehlers-Danlos 綜合徵
  116. MedlinePlus Genetics. Epidermolysis bullosa simplex[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:遺傳性大皰性表皮鬆解症
  117. MedlinePlus Genetics. Fabry disease[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:法佈雷病
  118. MedlinePlus Genetics. Facioscapulohumeral muscular dystrophy[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-10-07).引用於:面肩肱型肌營養不良症
  119. 美國食品藥品監督管理局(FDA). FDA Approves First Drug to Treat Alexander Disease[EB/OL]. 美國食品藥品監督管理局, 2026. (訪問於 2026-10-07). 2026 年 9 月 3 日新聞稿:批准 Zanvastro(zilganersen)注射液用於兒童與成人亞歷山大病。引用於:亞歷山大病、Canavan 病
  120. 美國食品藥品監督管理局(FDA). FDA Approves Therapy to Treat Ataxia in Patients with Ataxia-Telangiectasia, a Rare Genetic Disorder[EB/OL]. U.S. Food and Drug Administration, 2026. (訪問於 2026-10-07). 2026 年 9 月 18 日發佈。引用於:共濟失調毛細血管擴張症
  121. MedlinePlus Genetics. Fibrodysplasia ossificans progressiva[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-12).引用於:進行性骨化性纖維發育不良
  122. FMR1 Disorders[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:脆性 X 綜合徵、孤獨症譜系障礙的鑑別與病因評估
  123. MedlinePlus Genetics. Fragile X syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:脆性 X 綜合徵
  124. National Center for Biotechnology Information. Gene database[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-12). 基因的染色體定位以本庫的 maplocation 為準;《罕見病診療指南(2019 年版)》個別章節的定位有筆誤。引用於:尼曼匹克病、戊二酸血症Ⅰ型、同型半胱氨酸血症、Wolf-Hirschhorn 綜合徵、鳥氨酸氨甲酰基轉移酶缺乏症、瓜氨酸血症、精氨酸酶缺乏症、丙酸血症、異戊酸血症、半乳糖血症、原發性肉鹼缺乏症、戈謝病、全身型重症肌無力、低鹼性磷酸酶血症、馬凡綜合徵、面肩肱型肌營養不良症、先天性肌營養不良(膠原Ⅵ相關肌病)、Pelizaeus-Merzbacher 病、亞歷山大病、Canavan 病、Zellweger 譜系障礙、Menkes 病、L1 綜合徵、共濟失調毛細血管擴張症、KCNQ2 相關障礙、進行性骨化性纖維發育不良、Sturge-Weber 綜合徵、中鏈酰基輔酶 A 脫氫酶缺乏症、極長鏈酰基輔酶 A 脫氫酶缺乏症、HHH 綜合徵、原發性酪氨酸血症、芳香族 L-氨基酸脫羧酶缺乏症、法佈雷病、胱氨酸貯積症、眼皮膚白化病、視網膜色素變性、脊髓小腦性共濟失調、發作性睡病、Christianson 綜合徵、先天性高胰島素性低血糖血症、先天性肌強直、血友病、遺傳性大皰性表皮鬆解症、Alagille 綜合徵、早老症、糖原累積病Ⅰ型、遺傳性果糖不耐受症、全羧化酶合成酶缺乏症、多種酰基輔酶 A 脫氫酶缺乏症、長鏈 3-羥酰基輔酶 A 脫氫酶缺乏症、β-酮硫解酶缺乏症、賴氨酸尿蛋白不耐受症、Krabbe 病、PMM2-CDG、吡哆醇依賴性癲癇、Lesch-Nyhan 綜合徵、非酮性高甘氨酸血症、3-甲基巴豆酰輔酶 A 羧化酶缺乏症、肢帶型肌營養不良、先天性肌病、嬰兒神經軸索營養不良、泛酸激酶相關神經變性、DYT-TOR1A 肌張力障礙、兒童交替性偏癱、白質消融性白質腦病、SCN2A 相關疾病、Landau-Kleffner 綜合徵、Wiedemann-Steiner 綜合徵、Costello 綜合徵、心-面-皮膚綜合徵、煙霧病、Beckwith-Wiedemann 綜合徵、PIK3CA 相關過度生長綜合徵、綜合徵性顱縫早閉、Ehlers-Danlos 綜合徵、Pierre Robin 序列徵、McCune-Albright 綜合徵、萊倫氏綜合徵、假性甲狀旁腺功能減退症、新生兒糖尿病、視隔發育不良、Usher 綜合徵、Waardenburg 綜合徵
  125. Shearer A E, Hildebrand M S, Odell A M, 等. Genetic Hearing Loss Overview[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-12). 1999 年 2 月首發,2026 年 6 月修訂。引用於:非綜合徵型耳聾、Waardenburg 綜合徵
  126. MedlinePlus Genetics. GLUT1 deficiency syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:GLUT1 缺乏綜合徵
  127. Larson A, Coughlin C. Glutaric Acidemia Type 1[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-12). 2019 年 9 月首發,2026 年 6 月更新。引用於:戊二酸血症Ⅰ型、β-酮硫解酶缺乏症、Lesch-Nyhan 綜合徵
  128. MedlinePlus Genetics. Glutaric acidemia type II[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:多種酰基輔酶 A 脫氫酶缺乏症
  129. 美國國立醫學圖書館 DailyMed. GOMEKLI(mirdametinib)處方信息[EB/OL]. DailyMed, 2026. (訪問於 2026-10-07). 2026 年 7 月版說明書。引用於:神經纖維瘤病
  130. Orphanet. Helsmoortel-Van der Aa 綜合徵(ORPHA:404448)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:ADNP 綜合徵
  131. MedlinePlus Genetics. Hemophilia[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:血友病
  132. MedlinePlus Genetics. Hirschsprung disease[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:Waardenburg 綜合徵
  133. MedlinePlus Genetics. Holocarboxylase synthetase deficiency[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:全羧化酶合成酶缺乏症
  134. MedlinePlus Genetics. Homocystinuria[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-10-07).引用於:同型半胱氨酸血症
  135. MedlinePlus Genetics. Hutchinson-Gilford progeria syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:早老症
  136. MedlinePlus Genetics. Hypochondroplasia[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-10-07).引用於:軟骨發育不全
  137. Rhythm Pharmaceuticals, Inc. IMCIVREE (setmelanotide): prescribing information[EB/OL]. DailyMed, National Library of Medicine (US), 2026. (訪問於 2026-10-07). 美國食品藥品監督管理局批准的現行說明書(新藥申請 NDA 213793),生效日期 2026 年 4 月 1 日;適應證包括 2 歲及以上 Bardet-Biedl 綜合徵所致肥胖的減重與長期體重維持。引用於:Bardet-Biedl 綜合徵
  138. Orphanet. Infantile epileptic spasms syndrome(ORPHA:697160)[EB/OL]. Orphadata, 2026. (訪問於 2026-10-07).引用於:West 綜合徵
  139. MedlinePlus Genetics. Infantile neuroaxonal dystrophy[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:嬰兒神經軸索營養不良
  140. MedlinePlus Genetics. Isolated growth hormone deficiency[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:原發性生長激素缺乏症
  141. Isolated Methylmalonic Acidemia[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:甲基丙二酸血症、新生兒篩查結果異常
  142. MedlinePlus Genetics. Isolated Pierre Robin sequence[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:Pierre Robin 序列徵
  143. Glass I A, Dempsey J C, Parisi M, 等. Joubert Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-12). 2003 年 7 月首發,2026 年 2 月修訂。引用於:Joubert 綜合徵、視覺行為異常
  144. Orphanet. Kabuki 綜合徵(ORPHA:2322)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:Kabuki 綜合徵
  145. MedlinePlus Genetics. Kabuki syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:Kabuki 綜合徵
  146. Adam M P, Banka S, Bjornsson H T, 等. Kabuki Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:Kabuki 綜合徵
  147. Orphanet. KBG 綜合徵(ORPHA:2332)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:KBG 綜合徵
  148. MedlinePlus Genetics. KBG syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:KBG 綜合徵
  149. Orphanet. Kleefstra 綜合徵(ORPHA:261494)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:Kleefstra 綜合徵
  150. MedlinePlus Genetics. Kleefstra syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:Kleefstra 綜合徵
  151. MedlinePlus Genetics. Klippel-Trenaunay syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:PIK3CA 相關過度生長綜合徵
  152. Orphanet. Koolen-de Vries 綜合徵(ORPHA:96169)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:Koolen-de Vries 綜合徵
  153. MedlinePlus Genetics. Koolen-de Vries syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:Koolen-de Vries 綜合徵
  154. 美國國立醫學圖書館 DailyMed. KOSELUGO(selumetinib)處方信息[EB/OL]. DailyMed, 2026. (訪問於 2026-10-07). 2026 年 5 月版說明書。引用於:神經纖維瘤病
  155. MedlinePlus Genetics. Krabbe disease[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:Krabbe 病
  156. Orsini JJ, Escolar ML, Wasserstein MP, 等. Krabbe Disease[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2026. (訪問於 2026-09-30). 初版 2000 年,最近更新 2026 年 9 月 8 日。引用於:Krabbe 病
  157. MedlinePlus Genetics. Laron syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30). 美國國立醫學圖書館的病種條目:表現、患者人數、GHR 基因的作用與遺傳方式。引用於:萊倫氏綜合徵
  158. MedlinePlus Genetics. Leber congenital amaurosis[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-12).引用於:Leber 先天性黑矇、視隔發育不良
  159. MedlinePlus Genetics. Lesch-Nyhan syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:Lesch-Nyhan 綜合徵
  160. MedlinePlus Genetics. Leukoencephalopathy with vanishing white matter[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:白質消融性白質腦病
  161. MedlinePlus Genetics. Limb-girdle muscular dystrophy[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:肢帶型肌營養不良
  162. MedlinePlus Genetics. Loeys-Dietz syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-10-07).引用於:馬凡綜合徵
  163. MedlinePlus Genetics. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:長鏈 3-羥酰基輔酶 A 脫氫酶缺乏症
  164. MedlinePlus Genetics. Lysinuric protein intolerance[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:賴氨酸尿蛋白不耐受症
  165. MedlinePlus Genetics. Marfan syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-10-07).引用於:馬凡綜合徵
  166. MedlinePlus Genetics. McCune-Albright syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:McCune-Albright 綜合徵
  167. MedlinePlus Genetics. MECP2 duplication syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:MECP2 重複綜合徵
  168. MedlinePlus Genetics. Medium-chain acyl-CoA dehydrogenase deficiency[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:中鏈酰基輔酶 A 脫氫酶缺乏症、極長鏈酰基輔酶 A 脫氫酶缺乏症、遺傳代謝病
  169. MedlinePlus Genetics. Megalencephaly-capillary malformation syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:PIK3CA 相關過度生長綜合徵
  170. MedlinePlus Genetics. Menkes syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-10-07). 頁面最後更新於 2019 年 12 月。引用於:Menkes 病
  171. MedlinePlus Genetics. Metachromatic leukodystrophy[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:異染性腦白質營養不良、Canavan 病
  172. MedlinePlus Genetics. Methylmalonic acidemia[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:甲基丙二酸血症
  173. Orphanet. Mowat-Wilson 綜合徵(ORPHA:2152)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:Mowat-Wilson 綜合徵
  174. MedlinePlus Genetics. Mowat-Wilson syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:Mowat-Wilson 綜合徵
  175. MedlinePlus Genetics. Moyamoya disease[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30). 美國國立醫學圖書館的病種概述:病名由來、發生率、RNF213 基因與遺傳特點。引用於:煙霧病
  176. MedlinePlus Genetics. Mucopolysaccharidosis type I[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:黏多糖貯積症
  177. Mucopolysaccharidosis Type I[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:黏多糖貯積症、視覺行為異常
  178. Scarpa M, Lampe C. Mucopolysaccharidosis Type II[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:黏多糖貯積症
  179. MedlinePlus Genetics. Mucopolysaccharidosis type III[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:黏多糖貯積症
  180. MedlinePlus Genetics. Mucopolysaccharidosis type IV[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:黏多糖貯積症
  181. MedlinePlus Genetics. Myotonia congenita[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:先天性肌強直
  182. MedlinePlus Genetics. Myotonic dystrophy[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:肌強直性營養不良
  183. Myotonic Dystrophy Type 1[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:肌強直性營養不良
  184. MedlinePlus Genetics. Narcolepsy[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:發作性睡病
  185. MedlinePlus Genetics. Nemaline myopathy[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30). 桿狀體肌病的六個臨床類型、發生率、NEB 與 ACTA1 所佔比例及遺傳方式。引用於:先天性肌病
  186. Neurofibromatosis 1[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:神經纖維瘤病、Noonan 綜合徵、煙霧病、咖啡牛奶斑、色素脫失斑與鮮紅斑痣、孤獨症譜系障礙的鑑別與病因評估
  187. MedlinePlus Genetics. Neurofibromatosis type 1[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:神經纖維瘤病、咖啡牛奶斑、色素脫失斑與鮮紅斑痣
  188. MedlinePlus Genetics. Nonketotic hyperglycinemia[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:非酮性高甘氨酸血症
  189. Orphanet. Noonan 綜合徵(ORPHA:648)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:Noonan 綜合徵
  190. MedlinePlus Genetics. Noonan syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:Noonan 綜合徵、Smith-Lemli-Opitz 綜合徵、染色體與基因組印記異常
  191. Noonan Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:Noonan 綜合徵、原發性生長激素缺乏症、染色體與基因組印記異常
  192. MedlinePlus Genetics. Noonan syndrome with multiple lentigines[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-10-07).引用於:Noonan 綜合徵
  193. U.S. Food and Drug Administration. Novel Drug Approvals for 2026[EB/OL]. U.S. Food and Drug Administration, 2026. (訪問於 2026-10-07). Loargys(pegzilarginase-nbln)2026 年 2 月 23 日獲批。引用於:精氨酸酶缺乏症
  194. MedlinePlus Genetics. Ocular albinism[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-10-07).引用於:眼皮膚白化病
  195. MedlinePlus Genetics. Oculocutaneous albinism[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:眼皮膚白化病、Waardenburg 綜合徵
  196. MedlinePlus Genetics. Ornithine translocase deficiency[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:HHH 綜合徵
  197. MedlinePlus Genetics. Osteogenesis imperfecta[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:成骨不全症、反覆骨折與骨脆性增高
  198. Phelan-McDermid Syndrome Foundation. Our History[EB/OL]. Phelan-McDermid Syndrome Foundation, 2026. (訪問於 2026-09-10). 病名的由來出自這裡:2003 年由患者家長提議採用。引用於:Phelan-McDermid 綜合徵
  199. BioMarin Pharmaceutical Inc. Palynziq (pegvaliase-pqpz) injection: prescribing information[EB/OL]. DailyMed, National Library of Medicine (US), 2026. (訪問於 2026-10-07). 美國食品藥品監督管理局現行說明書,2026 年 3 月 2 日生效版。引用於:苯丙酮尿症
  200. MedlinePlus Genetics. Pantothenate kinase-associated neurodegeneration[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:泛酸激酶相關神經變性
  201. MedlinePlus Genetics. Permanent neonatal diabetes mellitus[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:新生兒糖尿病
  202. MedlinePlus Genetics. Pfeiffer syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:綜合徵性顱縫早閉
  203. Orphanet. Phelan-McDermid 綜合徵(ORPHA:48652)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:Phelan-McDermid 綜合徵
  204. Phelan K, Rogers R C, Boccuto L. Phelan-McDermid Syndrome-SHANK3 Related[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:Phelan-McDermid 綜合徵、腦性癱瘓的鑑別與病因評估:何時需要進一步檢查
  205. Phenylalanine Hydroxylase Deficiency[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:苯丙酮尿症、新生兒篩查結果異常
  206. MedlinePlus Genetics. Phenylketonuria[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:苯丙酮尿症
  207. Orphanet. Pitt-Hopkins 綜合徵(ORPHA:2896)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:Pitt-Hopkins 綜合徵
  208. MedlinePlus Genetics. Pitt-Hopkins syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:Pitt-Hopkins 綜合徵
  209. Gregory A, Kurian MA, Soo AKS, 等. PLA2G6-Associated Neurodegeneration[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2026. (訪問於 2026-09-30). 初版 2008 年,最近更新 2026 年 4 月 14 日。引用於:嬰兒神經軸索營養不良
  210. MedlinePlus Genetics. PMM2-congenital disorder of glycosylation[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:PMM2-CDG
  211. MedlinePlus Genetics. Polymicrogyria[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-12).引用於:多小腦回
  212. MedlinePlus Genetics. Pompe disease[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:糖原累積病Ⅱ型
  213. Pompe Disease[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:糖原累積病Ⅱ型
  214. MedlinePlus Genetics. Potocki-Lupski syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:Potocki-Lupski 綜合徵
  215. MedlinePlus Genetics. Prader-Willi syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:Prader-Willi 綜合徵
  216. Orphanet. Prader-Willi syndrome(ORPHA:739)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:Prader-Willi 綜合徵
  217. MedlinePlus Genetics. Primary carnitine deficiency[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-10-07).引用於:原發性肉鹼缺乏症
  218. Orphanet. Proximal spinal muscular atrophy(ORPHA:70)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:脊髓性肌萎縮症
  219. MedlinePlus Genetics. Pseudoachondroplasia[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-10-07).引用於:軟骨發育不全
  220. Orphanet. PTEN 錯構瘤腫瘤綜合徵(ORPHA:306498)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:PTEN 錯構瘤腫瘤綜合徵
  221. Tramontana T, Yehia L. PTEN Hamartoma Tumor Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-11). 2001 年 11 月首發,2026 年 7 月更新。引用於:PTEN 錯構瘤腫瘤綜合徵
  222. National Center for Biotechnology Information. PTS 6-pyruvoyl-tetrahydropterin synthase [Homo sapiens](Gene ID 5805)[EB/OL]. NCBI Gene, 2026. (訪問於 2026-09-11). QDPR、GCH1 的定位分別見 Gene ID 5860、2643。引用於:四氫生物蝶呤缺乏症
  223. Opladen T, Longo N, Blau N. PTS-Related Tetrahydrobiopterin Deficiency (PTPSD)[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-11). 2025 年 7 月首發,2026 年 3 月修訂。引用於:四氫生物蝶呤缺乏症
  224. MedlinePlus Genetics. Pyridoxine-dependent epilepsy[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:吡哆醇依賴性癲癇
  225. MedlinePlus Genetics. Retinitis pigmentosa[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:視網膜色素變性
  226. National Eye Institute. Retinopathy of Prematurity[EB/OL]. National Institutes of Health (US), 2026. (訪問於 2026-09-12).引用於:早產兒視網膜病變
  227. MedlinePlus Genetics. Rett syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:Rett 綜合徵
  228. Orphanet. Rubinstein-Taybi 綜合徵(ORPHA:783)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:Rubinstein-Taybi 綜合徵
  229. MedlinePlus Genetics. Rubinstein-Taybi syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:Rubinstein-Taybi 綜合徵
  230. MedlinePlus Genetics. Russell-Silver syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:Silver-Russell 綜合徵
  231. SCN1A Seizure Disorders[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:嬰兒嚴重肌陣攣性癲癇
  232. MedlinePlus Genetics. Septo-optic dysplasia[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:視隔發育不良
  233. Orphanet. Silver-Russell 綜合徵(ORPHA:813)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:Silver-Russell 綜合徵
  234. Silver-Russell Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:Silver-Russell 綜合徵、萊倫氏綜合徵
  235. 美國國立醫學圖書館 DailyMed. Sirolimus(西羅莫司)口服制劑處方信息[EB/OL]. DailyMed, 2026. (訪問於 2026-10-07). 2026 年 3 月版說明書(NDA021110),適應證含淋巴管肌瘤病。引用於:結節性硬化症
  236. Orphanet. Smith-Lemli-Opitz 綜合徵(ORPHA:818)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:Smith-Lemli-Opitz 綜合徵
  237. MedlinePlus Genetics. Smith-Lemli-Opitz syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:Smith-Lemli-Opitz 綜合徵
  238. Orphanet. Smith-Magenis 綜合徵(ORPHA:819)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:Smith-Magenis 綜合徵
  239. MedlinePlus Genetics. Smith-Magenis syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:Smith-Magenis 綜合徵
  240. Smith A C M, Boyd K E, Brennan C, 等. Smith-Magenis Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:Smith-Magenis 綜合徵、Potocki-Lupski 綜合徵、Lesch-Nyhan 綜合徵、日間嗜睡與睡眠節律紊亂
  241. Social and Emotional Development: 9 Months Old[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2026. (訪問於 2026-11-18).
  242. Orphanet. Sotos 綜合徵(ORPHA:821)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-10).引用於:Sotos 綜合徵
  243. MedlinePlus Genetics. Sotos syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:Sotos 綜合徵
  244. Tatton-Brown K, Cole T R P, Rahman N. Sotos Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:Sotos 綜合徵
  245. Parodi L, Rydning S L, Tallaksen C, 等. Spastic Paraplegia 4[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:遺傳性痙攣性截癱
  246. MedlinePlus Genetics. Spastic paraplegia type 4[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:遺傳性痙攣性截癱
  247. Speech Sound Disorders[EB/OL]. Communication Health Support Association(helpingyoucommunicate.org), 2026. (訪問於 2026-11-18).
  248. MedlinePlus Genetics. Spinal muscular atrophy[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:脊髓性肌萎縮症
  249. MedlinePlus Genetics. Spinocerebellar ataxia type 1[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:脊髓小腦性共濟失調
  250. MedlinePlus Genetics. Spinocerebellar ataxia type 3[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:脊髓小腦性共濟失調
  251. MedlinePlus Genetics. Sturge-Weber syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-12).引用於:Sturge-Weber 綜合徵、煙霧病、PIK3CA 相關過度生長綜合徵、咖啡牛奶斑、色素脫失斑與鮮紅斑痣
  252. Stuttering and Cluttering[EB/OL]. Communication Health Support Association(helpingyoucommunicate.org), 2026. (訪問於 2026-11-18).
  253. Orphanet. SYNGAP1 相關發育性癲癇性腦病(ORPHA:544254)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-11).引用於:SYNGAP1 相關智力障礙
  254. MedlinePlus Genetics. SYNGAP1-related intellectual disability[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:SYNGAP1 相關智力障礙
  255. MedlinePlus Genetics. Tetrahydrobiopterin deficiency[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-11).引用於:四氫生物蝶呤缺乏症
  256. MedlinePlus Genetics. Thanatophoric dysplasia[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-10-07).引用於:軟骨發育不全
  257. Tips for Your Child’s Speech and Language Development[EB/OL]. Communication Health Support Association(helpingyoucommunicate.org), 2026. (訪問於 2026-11-18).
  258. National Center for Biotechnology Information. TPP1 tripeptidyl peptidase 1 [Homo sapiens](Gene ID 1200)[EB/OL]. NCBI Gene, 2026. (訪問於 2026-09-11). PPT1、CLN3 的定位分別見 Gene ID 5538、1201。引用於:神經元蠟樣脂褐質沉積症
  259. MedlinePlus Genetics. Tuberous sclerosis complex[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:結節性硬化症、咖啡牛奶斑、色素脫失斑與鮮紅斑痣
  260. Tuberous Sclerosis Complex[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:結節性硬化症、West 綜合徵、咖啡牛奶斑、色素脫失斑與鮮紅斑痣、孤獨症譜系障礙的鑑別與病因評估
  261. MedlinePlus Genetics. Tyrosinemia[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:原發性酪氨酸血症
  262. Orphanet. Ullrich congenital muscular dystrophy(ORPHA:75840)[EB/OL]. Orphadata, 2026. (訪問於 2026-10-07). ORPHA:75840 對應 ICD-10 G71.2;Bethlem muscular dystrophy(ORPHA:610)對應 G71.0。引用於:先天性肌營養不良(膠原Ⅵ相關肌病)
  263. Uncomplicated (Pure) Hereditary Spastic Paraplegia Overview[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:腓骨肌萎縮症、遺傳性痙攣性截癱、腦性癱瘓的鑑別與病因評估:何時需要進一步檢查
  264. MedlinePlus Genetics. Usher syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30). 三個分型的概述、人群頻率與遺傳方式。引用於:視網膜色素變性、Usher 綜合徵
  265. Koenekoop RK, Arriaga MA, Gillies N, 等. Usher Syndrome Type I[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2026. (訪問於 2026-09-30). 初版 1999 年,最近更新 2026 年 6 月 9 日。Ⅰ型的臨床表現、診斷、管理、應避免的情形與遺傳諮詢。引用於:Usher 綜合徵
  266. Using sensory integration therapy, sensory-based interventions and sensory approaches with children and young people[EB/OL]. Royal College of Occupational Therapists, 2026. (訪問於 2026-09-25). 2026 年 3 月 Informed View。區分 ASI、感覺活動與參與支持;強調個體目標、證據侷限、限期複評及兒童可接受性,本文件不是系統評價。引用於:感覺統合治療(ASI)、感覺處理困難(感統失調)的干預方法、康復與干預方法、訓練器材與教具
  267. MedlinePlus Genetics. Very long-chain acyl-CoA dehydrogenase deficiency[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-23).引用於:中鏈酰基輔酶 A 脫氫酶缺乏症、極長鏈酰基輔酶 A 脫氫酶缺乏症
  268. MedlinePlus Genetics. Waardenburg syndrome[EB/OL]. National Library of Medicine (US), 2026. (訪問於 2026-09-30).引用於:Waardenburg 綜合徵
  269. Harmony Biosciences, LLC. WAKIX (pitolisant): prescribing information[EB/OL]. DailyMed, National Library of Medicine (US), 2026. (訪問於 2026-10-07). 美國食品藥品監督管理局核准的藥品說明書,現行版本 2026 年 2 月 26 日發佈。引用於:發作性睡病
  270. Orphanet. Wiedemann-Steiner 綜合徵(ORPHA:319182)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-30). 疾病定義、同義名與 OMIM、ICD-10 對照;名稱相近的 Beckwith-Wiedemann 綜合徵(ORPHA:116)與 Wiedemann-Rautenstrauch 綜合徵(ORPHA:3455)在該庫另有條目。引用於:Wiedemann-Steiner 綜合徵
  271. MedlinePlus Genetics. Williams syndrome[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:威廉姆斯綜合徵
  272. Williams Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:威廉姆斯綜合徵
  273. Orphanet. X-linked adrenoleukodystrophy(ORPHA:43)[EB/OL]. Orphanet, 2026. (訪問於 2026-09-12).引用於:X-連鎖腎上腺腦白質營養不良
  274. MedlinePlus Genetics. X-linked hypophosphatemia[EB/OL]. 美國國立醫學圖書館, 2026. (訪問於 2026-09-10).引用於:低磷性佝僂病
  275. X-Linked Hypophosphatemia[EB/OL]. GeneReviews®, University of Washington, Seattle, 2026. (訪問於 2026-09-10).引用於:低磷性佝僂病、反覆骨折與骨脆性增高
  276. Sentynl Therapeutics, Inc. ZOKINVY (lonafarnib): prescribing information[EB/OL]. DailyMed, National Library of Medicine (US), 2026. (訪問於 2026-10-07). 美國食品藥品監督管理局核准的藥品說明書,現行版本 2026 年 1 月 16 日發佈。引用於:早老症
  277. 北京市衛生健康委員會. 《學習困難門診的規範化建設專家共識》解讀[EB/OL]. 北京市衛生健康委員會, 2025. (訪問於 2026-09-07).引用於:學習困難與學習障礙、學習困難與學習障礙的干預方法
  278. 3 Early Signs of Autism in Children[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2025. (訪問於 2026-11-18).
  279. 傅蘇穎. 中國醫保商保“雙目錄”發佈 新藥可及性再提升[EB/OL]. 中證網, 2025. (訪問於 2026-10-07). 2025 年 12 月 8 日發佈。2025 年版國家醫保藥品目錄與首版《商業健康保險創新藥品目錄》於 2025 年 12 月 7 日印發,2026 年 1 月 1 日起實施;商保創新藥目錄納入 19 種藥品,其中有戈謝病、神經母細胞瘤等罕見病用藥。引用於:罕見病政策與保障
  280. 大江網. 家門口的“國家級”康復守護——劉維民博士定期在九江市婦幼保健院免費評估指導服務開啟[EB/OL]. 大江網 · 九江頻道, 2025. (訪問於 2026-09-22).引用於:媒體報道與公開發表
  281. 寶秀蘭醫療. 寶秀蘭南寧分中心「廣西特殊兒童保健康復中心」正式揭牌啟用(2025-08-07)[EB/OL]. 寶秀蘭醫療, 2025.引用於:機構沿革、合作機構
  282. World Federation of Occupational Therapists. About Occupational Therapy[EB/OL]. wfot.org, 2025. (訪問於 2026-09-30).引用於:書寫與精細動作訓練
  283. Harutyunyan L, Kooy R F, D’Incal C P, Van Dijck A. ADNP-Related Helsmoortel-Van der Aa Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-11). 2016 年 4 月首發,2025 年 8 月更新;臨床描述依據 78 例隊列。引用於:ADNP 綜合徵、Coffin-Siris 綜合徵
  284. Dagli A I, Mathews J, Williams C A. Angelman Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-10).引用於:Rett 綜合徵、Angelman 綜合徵、Prader-Willi 綜合徵、GLUT1 缺乏綜合徵、1p36 缺失綜合徵、FOXG1 綜合徵、Christianson 綜合徵、兒童罕見病、粗大運動發育落後、語言發育遲緩、餵養困難、癲癇發作、頭圍增長異常、共濟失調、日間嗜睡與睡眠節律紊亂、染色體與基因組印記異常、術語表
  285. Veenhuis S, van Os N, 等. Ataxia-Telangiectasia[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-12). 1999 年 3 月首發,2025 年 12 月更新。引用於:共濟失調毛細血管擴張症、脊髓小腦性共濟失調
  286. Ipsen Biopharmaceuticals, Inc. BYLVAY (odevixibat): prescribing information[EB/OL]. DailyMed, National Library of Medicine (US), 2025. (訪問於 2026-10-07). 美國食品藥品監督管理局核准的藥品說明書,現行版本 2025 年 12 月 31 日發佈。引用於:Alagille 綜合徵
  287. Angelini C. Calpainopathy[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2025. (訪問於 2026-09-30). 初版 2005 年,最近一次全面更新 2022 年 12 月 1 日,2025 年 5 月 1 日修訂。CAPN3 相關型(LGMD R1/D4)的表現、診斷、管理與應避免的情形。引用於:肢帶型肌營養不良
  288. Morrow EM, Pescosolido MF. Christianson Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-10-07). 2018 年 1 月首發,2025 年 9 月修訂。引用於:Christianson 綜合徵
  289. Song YZ, Oishi K, Saheki T, 等. Citrin Deficiency[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-12). 2005 年 9 月首發,2025 年 3 月更新。第一作者來自暨南大學附屬第一醫院。引用於:瓜氨酸血症
  290. Schrier Vergano S, Santen G, Wieczorek D, 等. Coffin-Siris Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-11). 2013 年 4 月首發,2025 年 5 月更新。引用於:Coffin-Siris 綜合徵
  291. Mercimek-Andrews S, Salomons G S. Creatine Deficiency Disorders[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-11). 2009 年 1 月首發,2022 年 2 月全面更新,2025 年 8 月修訂。引用於:腦肌酸缺乏綜合徵
  292. Edens Hurst A C. Cri du chat syndrome[EB/OL]. MedlinePlus 醫學百科(A.D.A.M.),美國國立醫學圖書館, 2025. (訪問於 2026-09-10). 末次審校 2025-07-28。引用於:貓叫綜合徵
  293. Geis T, Uyanik G, Aigner L, 等. DCX-Related Disorders[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-12). 2007 年 10 月首發,2025 年 6 月更新。引用於:無腦回畸形
  294. Aoki M, Takahashi T. Dysferlinopathy[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2025. (訪問於 2026-09-30). 初版 2004 年,最近一次全面更新 2021 年 5 月 27 日,2025 年 12 月 4 日修訂。DYSF 相關型(LGMD R2/Miyoshi 肌病)的表型、起病年齡、隨訪與應避免的情形。引用於:肢帶型肌營養不良
  295. Ozelius L, Lubarr N. DYT-TOR1A[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2025. (訪問於 2026-09-30). 初版 1999 年,最近更新 2025 年 11 月 20 日。引用於:DYT-TOR1A 肌張力障礙
  296. Preston MK, Wang LH, 等. Facioscapulohumeral Muscular Dystrophy[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-12). 1999 年 3 月首發,2025 年 7 月更新。引用於:面肩肱型肌營養不良症
  297. 美國食品藥品監督管理局(FDA). FDA Approves Required Labeling Changes for Increased Risk of Hematologic Malignancy Following Treatment with Skysona (elivaldogene autotemcel)[EB/OL]. Vaccines, Blood & Biologics, 2025. (訪問於 2026-10-07). 2025 年 8 月 7 日發佈。引用於:X-連鎖腎上腺腦白質營養不良
  298. Brockmann K, Staudt M. FOXG1 Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-12). 2024 年 6 月首發,2025 年 5 月修訂。引用於:FOXG1 綜合徵
  299. Wang D, Sands T, Tang M, 等. Glucose Transporter Type 1 Deficiency Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-11). 2002 年 7 月首發,2025 年 3 月更新。引用於:GLUT1 缺乏綜合徵、神經元蠟樣脂褐質沉積症、兒童交替性偏癱
  300. Sacharow S J, Levy H L. Homocystinuria due to Cystathionine Beta-Synthase Deficiency[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-12). 2004 年 1 月首發,2025 年 9 月更新。引用於:同型半胱氨酸血症
  301. Gordon LB, Brown WT, Collins FS. Hutchinson-Gilford Progeria Syndrome[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2025. (訪問於 2026-10-07).引用於:早老症
  302. MedlinePlus Medical Encyclopedia. Hydrocephalus[EB/OL]. National Library of Medicine (US), 2025. (訪問於 2026-10-07).引用於:Dandy-Walker 畸形
  303. Camacho J, Rioseco-Camacho N. Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-10-07). 2012 年 5 月 31 日首發;PubMed 題錄(PMID 22649802)標註的更新日期為 2025 年 4 月 10 日。引用於:HHH 綜合徵
  304. Eton Pharmaceuticals, Inc. INCRELEX (mecasermin) injection: prescribing information[EB/OL]. DailyMed, National Library of Medicine (US), 2025. (訪問於 2026-10-07). DailyMed 收錄的美卡舍明注射液說明書,第 4 版,2025 年 11 月 17 日發佈。引用於:萊倫氏綜合徵
  305. Mirum Pharmaceuticals, Inc. LIVMARLI (maralixibat): prescribing information[EB/OL]. DailyMed, National Library of Medicine (US), 2025. (訪問於 2026-10-07). 美國食品藥品監督管理局核准的藥品說明書,現行版本 2025 年 4 月 28 日發佈。引用於:Alagille 綜合徵
  306. CanChild Centre for Childhood Disability Research. Manual Ability Classification System (MACS)[EB/OL]. CanChild Centre for Childhood Disability Research(McMaster University), 2025. (訪問於 2026-10-08).引用於:術語表
  307. Kaur S, Christodoulou J. MECP2 Disorders[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-10).引用於:Rett 綜合徵、MECP2 重複綜合徵、GLUT1 缺乏綜合徵、神經發育障礙與癲癇性腦病
  308. Lohmann K, Lange L, Klein C, 等. Monogenic Isolated Dystonia Overview[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2025. (訪問於 2026-09-30). 初版 2003 年,最近更新 2025 年 12 月 11 日。單基因單純型肌張力障礙的分類、命名、鑑別與管理總覽。引用於:DYT-TOR1A 肌張力障礙
  309. Gregory A, Kurian MA, Wilson J, 等. Neurodegeneration with Brain Iron Accumulation Disorders Overview[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2025. (訪問於 2026-09-30). 初版 2013 年,最近更新 2025 年 3 月 6 日。腦組織鐵沉積神經變性病各型的臨床、影像、管理與隨訪總覽。引用於:泛酸激酶相關神經變性
  310. Malik K, Santucci K, Sremba L, 等. Neuronal Ceroid Lipofuscinoses Overview[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-11). 2001 年 10 月首發,2025 年 5 月全面更新。引用於:GLUT1 缺乏綜合徵、神經元蠟樣脂褐質沉積症、視覺行為異常
  311. Bremova-Ertl T, Patterson M. Niemann-Pick Disease Type C[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-12). 2000 年 1 月首發,2025 年 11 月更新。引用於:尼曼匹克病
  312. Riazi S, Biesecker LG, Rosenberg H, 等. Nonsyndromic Malignant Hyperthermia Susceptibility[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2025. (訪問於 2026-09-30). 初版 2003 年,最近更新 2025 年 8 月 7 日。惡性高熱易感性的誘發藥物、需要避免的情形、與 RYR1 相關肌病的關係及家系遺傳。引用於:先天性肌病
  313. Sweetser D A, Gipson K S, Zar-Kessler C. Pitt-Hopkins Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-11). 2012 年 8 月首發,2025 年 5 月更新。引用於:Pitt-Hopkins 綜合徵、Kleefstra 綜合徵
  314. Playground Safety: How to Ensure Injury-Free Fun[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2025. (訪問於 2026-09-25). 2025-03-31 更新。用於滑梯、鞦韆和攀爬設施的防墜落、纏掛及看護原則,不據此推斷感覺統合療效。引用於:訓練器材與教具
  315. MedlinePlus Genetics. PLP1 gene[EB/OL]. National Library of Medicine (US), 2025. (訪問於 2026-10-07). 2025 年 9 月更新。引用於:Pelizaeus-Merzbacher 病
  316. Wolf NI, van Spaendonk RML, 等. PLP1-Related Disorders[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-12). 1999 年 6 月首發,2025 年 6 月更新。涵蓋 Pelizaeus-Merzbacher 病與 PLP1 相關痙攣性截癱。引用於:Pelizaeus-Merzbacher 病
  317. Celiberti D, Nelson S, Larsson E. Relationship Development Intervention (RDI®)[EB/OL]. Association for Science in Autism Treatment, 2025. (訪問於 2026-09-30).引用於:人際關係發展干預(RDI)
  318. 美國食品藥品監督管理局(FDA). SKYSONA[EB/OL]. Vaccines, Blood & Biologics, 2025. (訪問於 2026-10-07). elivaldogene autotemcel 的產品頁,列有現行適應證;批准函日期為 2022 年 9 月 16 日、2024 年 4 月 5 日與 2025 年 8 月 7 日。引用於:X-連鎖腎上腺腦白質營養不良
  319. 美國食品藥品監督管理局(FDA). STRENSIQ(asfotase alfa)處方信息,生物製品許可申請 125513[EB/OL]. DailyMed, 2025. (訪問於 2026-10-07). 現行標籤版本生效於 2025 年 12 月 12 日;適應證為圍生期/嬰兒期起病與青少年期起病的低鹼性磷酸酶血症。引用於:低鹼性磷酸酶血症
  320. Holder J L Jr, Hamdan F F, Michaud J L. SYNGAP1-Related Intellectual Disability[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-09-11). 2019 年 2 月首發,2025 年 8 月修訂。引用於:SYNGAP1 相關智力障礙
  321. Thera-putty Activities Sheet[EB/OL]. Gateshead Health NHS Foundation Trust, 2025. (訪問於 2026-09-25). 2025-04-22 更新。用於訓練泥的阻力選擇、手部任務、清潔和防誤食;不將單純抓捏等同於書寫或自理能力改善。引用於:訓練器材與教具
  322. Baple E, Day J, Newman A, 等. Troyer Syndrome[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2025. (訪問於 2026-10-07). Troyer 綜合徵即 SPG20 型遺傳性痙攣性截癱。初次發佈 2004 年;PubMed 記錄(PMID 20301556)的最近修訂日期為 2025 年 8 月 14 日。引用於:遺傳性痙攣性截癱
  323. Byers PH. Vascular Ehlers-Danlos Syndrome[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2025. (訪問於 2026-09-30). 初版 1999 年,最近更新 2025 年 4 月 10 日。血管型在兒童期的表現、照護團隊與應急安排、應避免的活動與檢查。引用於:Ehlers-Danlos 綜合徵
  324. Leslie ND, Saenz-Ayala S. Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency[EB/OL]. GeneReviews®, University of Washington, Seattle, 2025. (訪問於 2026-10-07). 2009 年 5 月首發,2025 年 8 月修訂。引用於:極長鏈酰基輔酶 A 脫氫酶缺乏症
  325. MedlinePlus Genetics. 1p36 deletion syndrome[EB/OL]. 美國國家醫學圖書館, 2024. (訪問於 2026-09-12).引用於:1p36 缺失綜合徵
  326. 山東新時代藥業有限公司. 2024 年國家醫保藥品目錄調整申報材料(公示版):鹽酸沙丙蝶呤片[EB/OL]. 國家醫療保障局, 2024. (訪問於 2026-09-11). 含說明書適應證與批准文號;原研藥 2007 年在美國上市、2010 年在國內上市、2023 年在國內退市。引用於:苯丙酮尿症、四氫生物蝶呤缺乏症
  327. 大江網. 九江市婦幼保健院赴北京寶秀蘭醫療中心拜訪鮑秀蘭教授(組圖)[EB/OL]. 大江網九江頻道, 2024. (訪問於 2026-09-17).引用於:合作機構、媒體報道與公開發表、鮑秀蘭教授
  328. 中國優生優育協會. 中國優生優育協會關於舉辦第十四屆全國兒童腦健康及行為發育醫工交叉學術大會暨第三屆全國近紅外腦功能評估臨床應用論壇的通知(中優〔2024〕213號)[EB/OL]. 中國優生優育協會, 2024. (訪問於 2026-09-17).引用於:合作機構、第十四屆全國兒童腦健康及行為發育醫工交叉學術大會、鮑秀蘭教授
  329. 南寧日報. 以高質量黨建引領公立醫院高質量發展[EB/OL]. 新浪財經, 2024. (訪問於 2026-09-17).引用於:合作機構
  330. 北京協和醫院. 協和老專家口述歷史:鮑秀蘭[EB/OL]. 北京協和醫院官網, 2024. (訪問於 2026-09-07).引用於:鮑秀蘭教授
  331. 肖丁良. 孩子新生兒聽力篩查通過就安全了嗎?[EB/OL]. 中華醫學會科學普及部, 2024. (訪問於 2026-09-30). 中華醫學會官網的科普圖文,湖南省兒童醫院供稿並審核:遲發性聽力損失的圍產期因素、入住新生兒重症監護室嬰兒的出院前篩查,以及高危嬰幼兒的聽力隨訪間隔。引用於:新生兒持續肺動脈高壓
  332. 元羿生物. 首個用於 CDKL5缺乏症相關癲癇發作治療的新藥澤元安® (加那索龍口服混懸劑)在中國獲批[EB/OL]. 藥時代 DrugTimes, 2024. (訪問於 2026-10-07). 企業公告,2024 年 7 月 16 日發佈,由藥時代轉載。引用於:CDKL5 缺乏症
  333. 北京健康長城公益基金會. 探訪實錄|鮑秀蘭老師:拯救年幼天使們的天使[EB/OL]. 北京健康長城公益基金會 · 協和梧桐會, 2024. (訪問於 2026-09-22).引用於:媒體報道與公開發表、鮑秀蘭教授
  334. 中國優生優育協會. 第十四屆全國兒童腦健康及行為發育醫工交叉學術大會在京圓滿落幕[EB/OL]. 中國優生優育協會, 2024. (訪問於 2026-09-07).引用於:機構沿革、合作機構、第十四屆全國兒童腦健康及行為發育醫工交叉學術大會、鮑秀蘭教授
  335. 新華社. 診療水平再提升!全國罕見病診療協作網醫院達 419 家[EB/OL]. 中國政府網, 2024. (訪問於 2026-10-07). 2024 年 10 月 19 日報道:全國罕見病診療協作網醫院總數達到 419 家,涵蓋全國所有省份。引用於:脊髓性肌萎縮症、杜氏肌營養不良、腓骨肌萎縮症、肌強直性營養不良、先天性肌無力綜合徵、遺傳性痙攣性截癱、Rett 綜合徵、結節性硬化症、West 綜合徵、嬰兒嚴重肌陣攣性癲癇、脆性 X 綜合徵、神經纖維瘤病、CDKL5 缺乏症、Angelman 綜合徵、Prader-Willi 綜合徵、威廉姆斯綜合徵、Noonan 綜合徵、Silver-Russell 綜合徵、苯丙酮尿症、糖原累積病Ⅱ型、黏多糖貯積症、甲基丙二酸血症、異染性腦白質營養不良、成骨不全症、軟骨發育不全、低磷性佝僂病、21-羥化酶缺乏症、原發性生長激素缺乏症、DYRK1A 綜合徵、Kabuki 綜合徵、Cornelia de Lange 綜合徵、Sotos 綜合徵、21 三體綜合徵、22q11.2 缺失綜合徵、Phelan-McDermid 綜合徵、Smith-Magenis 綜合徵、貓叫綜合徵、CHARGE 綜合徵、SYNGAP1 相關智力障礙、ADNP 綜合徵、CHD8 相關神經發育障礙、PTEN 錯構瘤腫瘤綜合徵、MECP2 重複綜合徵、15q11.2-q13.1 重複綜合徵、Potocki-Lupski 綜合徵、Pitt-Hopkins 綜合徵、Mowat-Wilson 綜合徵、KBG 綜合徵、Coffin-Siris 綜合徵、Koolen-de Vries 綜合徵、7q11.23 重複綜合徵、Kleefstra 綜合徵、Rubinstein-Taybi 綜合徵、Smith-Lemli-Opitz 綜合徵、腦肌酸缺乏綜合徵、GLUT1 缺乏綜合徵、神經元蠟樣脂褐質沉積症、四氫生物蝶呤缺乏症、X-連鎖腎上腺腦白質營養不良、線粒體腦肌病、尼曼匹克病、神經節苷脂貯積症、戊二酸血症Ⅰ型、楓糖尿症、生物素酶缺乏症、同型半胱氨酸血症、肝豆狀核變性、多巴反應性肌張力障礙、Lennox-Gastaut 綜合徵、非綜合徵型耳聾、1p36 缺失綜合徵、Wolf-Hirschhorn 綜合徵、Joubert 綜合徵、無腦回畸形、FOXG1 綜合徵、STXBP1 相關發育性癲癇性腦病、CTNNB1 相關神經發育障礙、SATB2 相關障礙、鳥氨酸氨甲酰基轉移酶缺乏症、瓜氨酸血症、精氨酸酶缺乏症、丙酸血症、異戊酸血症、半乳糖血症、原發性肉鹼缺乏症、戈謝病、全身型重症肌無力、低鹼性磷酸酶血症、馬凡綜合徵、面肩肱型肌營養不良症、先天性肌營養不良(膠原Ⅵ相關肌病)、慢性炎性脫髓鞘性多發性神經根神經病、Pelizaeus-Merzbacher 病、亞歷山大病、Canavan 病、Zellweger 譜系障礙、Menkes 病、Aicardi-Goutières 綜合徵、L1 綜合徵、共濟失調毛細血管擴張症、KCNQ2 相關障礙、進行性骨化性纖維發育不良、Dandy-Walker 畸形、Sturge-Weber 綜合徵、多小腦回、Bardet-Biedl 綜合徵、Leber 先天性黑矇、早產兒視網膜病變、中鏈酰基輔酶 A 脫氫酶缺乏症、極長鏈酰基輔酶 A 脫氫酶缺乏症、HHH 綜合徵、原發性酪氨酸血症、芳香族 L-氨基酸脫羧酶缺乏症、法佈雷病、胱氨酸貯積症、眼皮膚白化病、視網膜色素變性、脊髓小腦性共濟失調、發作性睡病、Christianson 綜合徵、自身免疫性腦炎、先天性脊柱側凸、先天性高胰島素性低血糖血症、先天性肌強直、血友病、遺傳性大皰性表皮鬆解症、Alagille 綜合徵、早老症、糖原累積病Ⅰ型、遺傳性果糖不耐受症、全羧化酶合成酶缺乏症、多種酰基輔酶 A 脫氫酶缺乏症、長鏈 3-羥酰基輔酶 A 脫氫酶缺乏症、β-酮硫解酶缺乏症、賴氨酸尿蛋白不耐受症、Krabbe 病、PMM2-CDG、吡哆醇依賴性癲癇、Lesch-Nyhan 綜合徵、非酮性高甘氨酸血症、3-甲基巴豆酰輔酶 A 羧化酶缺乏症、肢帶型肌營養不良、先天性肌病、先天性多發性關節攣縮、嬰兒神經軸索營養不良、泛酸激酶相關神經變性、DYT-TOR1A 肌張力障礙、兒童交替性偏癱、白質消融性白質腦病、SCN2A 相關疾病、Landau-Kleffner 綜合徵、Wiedemann-Steiner 綜合徵、Costello 綜合徵、心-面-皮膚綜合徵、煙霧病、Beckwith-Wiedemann 綜合徵、PIK3CA 相關過度生長綜合徵、新生兒持續肺動脈高壓、綜合徵性顱縫早閉、Ehlers-Danlos 綜合徵、Pierre Robin 序列徵、McCune-Albright 綜合徵、萊倫氏綜合徵、假性甲狀旁腺功能減退症、新生兒糖尿病、視隔發育不良、Usher 綜合徵、Waardenburg 綜合徵、兒童罕見病、罕見病政策與保障
  336. 北京市廣播電視局. 廣播電視節目製作經營許可證行政許可公示(北京寶秀蘭愛兒門診部有限公司,2024-09-14)[EB/OL]. 北京市廣播電視局, 2024. (訪問於 2026-09-07).引用於:機構沿革、合作機構
  337. 北京協和醫院官網. 鮑秀蘭:做醫生一定要有同情心[EB/OL]. 北京協和醫院官網, 2024. (訪問於 2026-09-22).引用於:媒體報道與公開發表、鮑秀蘭教授
  338. 中國婦幼保健協會. 關於舉辦第89期《兒童早期發育評價、指導和干預技術》培訓班的通知[EB/OL]. 中國婦幼保健協會, 2024. (訪問於 2026-09-17).引用於:合作機構、NBNA 方法頁
  339. MedlinePlus Genetics. Aicardi-Goutières syndrome[EB/OL]. National Library of Medicine (US), 2024. (訪問於 2026-10-07). 2024 年 9 月更新。引用於:Aicardi-Goutières 綜合徵
  340. Are Trampolines Safe for Kids?[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2024. (訪問於 2026-09-25). 2024-09-03 更新。用於蹦床娛樂活動的傷害風險與安全限制,不作為康復療效或專業場景無風險的證明。引用於:訓練器材與教具
  341. Brashear A, Sweadner KJ, Haq I, 等. ATP1A3-Related Disorder[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2024. (訪問於 2026-09-30). 初版 2008 年,最近更新 2024 年 12 月 5 日。涵蓋兒童交替性偏癱在內的四種 ATP1A3 相關表型。引用於:兒童交替性偏癱
  342. 美國食品藥品監督管理局(FDA). BRINEURA(cerliponase alfa)生物製品許可申請 761052[EB/OL]. Drugs@FDA, 2024. (訪問於 2026-09-11). 2017 年 4 月 27 日首次批准;2024 年 7 月 24 日批准擴展適用人群的補充申請。引用於:神經元蠟樣脂褐質沉積症
  343. Malfait F, Symoens S, Syx D. Classic Ehlers-Danlos Syndrome[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2024. (訪問於 2026-09-30). 初版 2007 年,最近更新 2024 年 2 月 1 日。經典型的皮膚與關節表現、Beighton 評分、基因檢測、傷口處理、護具與應避免的運動。引用於:Ehlers-Danlos 綜合徵
  344. International League Against Epilepsy. Dravet syndrome (DS):Clinical Overview[EB/OL]. EpilepsyDiagnosis.org, 2024. (訪問於 2026-10-07). 國際抗癲癇聯盟的診斷手冊,網站文字最後更新於 2024 年 6 月 30 日。引用於:嬰兒嚴重肌陣攣性癲癇
  345. Szymczuk V, Florenzano P, de Castro LF, 等. Fibrous Dysplasia / McCune-Albright Syndrome[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2024. (訪問於 2026-09-30). 初版 2015 年,最近更新 2024 年 2 月 8 日。引用於:McCune-Albright 綜合徵
  346. Strehlow V, Myers KA, Morgan AT, 等. GRIN2A-Related Disorders[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2024. (訪問於 2026-09-30). 初版 2016 年,最近更新 2024 年 7 月 4 日。Landau-Kleffner 綜合徵是 GRIN2A 相關疾病譜中的一種表型。引用於:Landau-Kleffner 綜合徵
  347. Centers for Disease Control and Prevention. How Hemophilia Is Inherited[EB/OL]. Hemophilia, CDC, 2024. (訪問於 2026-10-07). 頁面更新於 2024 年 5 月 16 日。引用於:血友病
  348. Hakim A. Hypermobile Ehlers-Danlos Syndrome[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2024. (訪問於 2026-09-30). 初版 2004 年,最近更新 2024 年 2 月 22 日。過度活動型的 2017 年臨床標準、兒童期的分類辦法、鑑別診斷與各系統的處理。引用於:Ehlers-Danlos 綜合徵
  349. International League Against Epilepsy. Infantile epileptic spasms syndrome (IESS):Clinical Overview[EB/OL]. EpilepsyDiagnosis.org, 2024. (訪問於 2026-10-07). 國際抗癲癇聯盟的診斷手冊,網站文字最後更新於 2024 年 6 月 30 日。引用於:West 綜合徵
  350. International League Against Epilepsy. Infantile epileptic spasms syndrome (IESS):Diagnostic Criteria[EB/OL]. EpilepsyDiagnosis.org, 2024. (訪問於 2026-10-07). 國際抗癲癇聯盟的診斷手冊,網站文字最後更新於 2024 年 6 月 30 日。引用於:West 綜合徵
  351. MedlinePlus Genetics. Isolated lissencephaly sequence[EB/OL]. 美國國家醫學圖書館, 2024. (訪問於 2026-09-12).引用於:無腦回畸形
  352. MedlinePlus Genetics. Joubert syndrome[EB/OL]. 美國國家醫學圖書館, 2024. (訪問於 2026-09-12).引用於:Joubert 綜合徵
  353. Pandey N, Blair K, John S. Kayser-Fleischer Ring[EB/OL]. StatPearls,美國國家生物技術信息中心, 2024. (訪問於 2026-10-07).引用於:肝豆狀核變性
  354. International League Against Epilepsy. Lennox-Gastaut syndrome (LGS):Clinical Overview[EB/OL]. EpilepsyDiagnosis.org, 2024. (訪問於 2026-10-07). 國際抗癲癇聯盟的診斷手冊,網站文字最後更新於 2024 年 6 月 30 日。引用於:Lennox-Gastaut 綜合徵
  355. International League Against Epilepsy. Lennox-Gastaut syndrome (LGS):Diagnostic Criteria[EB/OL]. EpilepsyDiagnosis.org, 2024. (訪問於 2026-10-07). 國際抗癲癇聯盟的診斷手冊,網站文字最後更新於 2024 年 6 月 30 日。引用於:Lennox-Gastaut 綜合徵
  356. Chang IJ, Lam C, Vockley J. Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency[EB/OL]. GeneReviews®, University of Washington, Seattle, 2024. (訪問於 2026-10-07). 2000 年 4 月首發,2024 年 9 月修訂。引用於:中鏈酰基輔酶 A 脫氫酶缺乏症
  357. MedlinePlus Genetics. Miller-Dieker syndrome[EB/OL]. National Library of Medicine (US), 2024. (訪問於 2026-10-07).引用於:無腦回畸形
  358. Ball M, Thorburn D R, Rahman S. Mitochondrial DNA-Associated Leigh Syndrome Spectrum[EB/OL]. GeneReviews®, University of Washington, Seattle, 2024. (訪問於 2026-09-12). 2003 年 10 月首發,2024 年 5 月更新。引用於:線粒體腦肌病
  359. Texas Department of State Health Services. Newborn Screening ACT Sheet: Increased Citrulline (Amino Aciduria/Urea Cycle Disorder)[EB/OL]. Texas Department of State Health Services, 2024. (訪問於 2026-10-07). 2024 年 5 月 23 日修訂,據美國醫學遺傳學與基因組學學會的處置單改編。引用於:瓜氨酸血症
  360. Newborn Screening Results and Follow-Up[EB/OL]. Health Resources and Services Administration, 2024. (訪問於 2026-09-25). 說明新生兒篩查陽性、陰性及臨界結果的含義與隨訪原則;具體召回流程按當地篩查機構安排。引用於:新生兒篩查結果異常、內分泌與生長、其他系統與多系統受累
  361. De León DD, Pinney SE. Permanent Neonatal Diabetes Mellitus[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2024. (訪問於 2026-09-30). 初版 2008 年,最近一次全面更新 2024 年 11 月 14 日,2025 年 9 月 25 日修訂。引用於:新生兒糖尿病
  362. Rohrbach M, Giunta C. PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrome[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2024. (訪問於 2026-09-30). 初版 2000 年,最近更新 2024 年 6 月 13 日。脊柱後側凸型的肌張力低下與運動發育、與先天性肌病的區分、物理治療與隨訪安排。引用於:Ehlers-Danlos 綜合徵
  363. Zarate Y A, Bosanko K, Fish J. SATB2-Associated Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2024. (訪問於 2026-09-12). 2017 年 10 月首發,2024 年 6 月更新。引用於:SATB2 相關障礙
  364. Screening for Hearing Loss[EB/OL]. U.S. Centers for Disease Control and Prevention, 2024. (訪問於 2026-09-25). 2024-10-08 更新。用於兒童出現聽覺疑慮時及時接受聽力篩查或完整評估;對玩具聲音的反應不能替代檢查。引用於:訓練器材與教具
  365. Signs and Symptoms of Autism Spectrum Disorder[EB/OL]. U.S. Centers for Disease Control and Prevention, 2024. (訪問於 2026-11-18).
  366. Prior T W, Leach M E, Finanger E. Spinal Muscular Atrophy[EB/OL]. GeneReviews®, University of Washington, Seattle, 2024. (訪問於 2026-09-10).引用於:脊髓性肌萎縮症
  367. MedlinePlus Genetics. Wolf-Hirschhorn syndrome[EB/OL]. 美國國家醫學圖書館, 2024. (訪問於 2026-09-12).引用於:Wolf-Hirschhorn 綜合徵
  368. MedlinePlus Genetics. X-linked adrenoleukodystrophy[EB/OL]. 美國國家醫學圖書館, 2024. (訪問於 2026-09-12).引用於:X-連鎖腎上腺腦白質營養不良
  369. 國家醫療保障局. 《國家基本醫療保險、工傷保險和生育保險藥品目錄(2022 年)》解讀[EB/OL]. 國家醫療保障局, 2023. (訪問於 2026-09-10).引用於:脊髓性肌萎縮症、罕見病政策與保障
  370. 3 Tummy Time Activities to Try With Your Baby[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2023. (訪問於 2026-11-18).
  371. 中國優生優育協會. 小兒科的大醫世界——記中國優生優育協會嬰幼兒發育專委會榮譽主任、我國泰斗級兒科專家鮑秀蘭教授[EB/OL]. 中國優生優育協會, 2023. (訪問於 2026-09-07).引用於:機構沿革
  372. 中國優生優育協會. 全國第十三屆兒童發育與臨床多學科合作學術研討會暨兒童早期發展和早期干預多學科(MDT)論壇在京成功舉辦[EB/OL]. 中國優生優育協會, 2023. (訪問於 2026-09-24). 主辦、承辦、議程與講者名單以這一篇為準。引用於:機構沿革、合作機構
  373. 醫師報. 我國泰斗級兒科專家鮑秀蘭教授從醫 65 週年座談會在京成功舉辦[EB/OL]. 醫師報, 2023. (訪問於 2026-09-10).引用於:合作機構
  374. 中國優生優育協會. 我國泰斗級兒科專家鮑秀蘭教授從醫65週年座談會在京成功舉辦[EB/OL]. 中國優生優育協會, 2023. (訪問於 2026-09-07).引用於:媒體報道與公開發表、鮑秀蘭教授
  375. 中國優生優育協會. 我國泰斗級兒科專家鮑秀蘭教授從醫65週年座談會在京成功舉辦[EB/OL]. 中國優生優育協會, 2023. (訪問於 2026-09-07).引用於:機構沿革、合作機構
  376. 中國優生優育協會. 新生兒神經行為檢查技能培訓班通知[EB/OL]. 中國優生優育協會, 2023. (訪問於 2026-09-07).引用於:鮑秀蘭教授、NBNA 方法頁
  377. 中國優生優育協會. 新生兒神經行為檢查技能培訓班通知[EB/OL]. 中國優生優育協會, 2023. (訪問於 2026-09-07).引用於:機構沿革、合作機構
  378. 湖南省醫療保障局. 對省十四屆人大一次會議第 0186 號建議的答覆(湘醫保建函〔2023〕46 號)[EB/OL]. 湖南省醫療保障局, 2023. (訪問於 2026-10-02).引用於:認知能力訓練
  379. 寶秀蘭醫療. 鮑秀蘭教授從醫 65 週年座談會暨愛兒門診部剪綵紀要(2023-10-17)[EB/OL]. 寶秀蘭醫療, 2023.引用於:機構沿革、合作機構、NBNA 方法頁
  380. 北京市大興區衛生健康委員會. 關於北京寶秀蘭愛兒門診部擬執業登記註冊相關情況公示(2023 年第 8 號)[EB/OL]. 北京市大興區人民政府, 2023. (訪問於 2026-09-07).引用於:機構沿革、合作機構、術語表
  381. 鹽酸沙丙蝶呤首仿藥獲批上市[EB/OL]. 中國醫藥報, 2023. (訪問於 2026-09-11). 2023 年 6 月 29 日獲批,山東新時代藥業有限公司,國藥準字 H20233796。引用於:苯丙酮尿症、四氫生物蝶呤缺乏症
  382. Wasserstein M P, Schuchman E H. Acid Sphingomyelinase Deficiency[EB/OL]. GeneReviews®, University of Washington, Seattle, 2023. (訪問於 2026-09-12). 2006 年 12 月首發,2023 年 4 月更新;即尼曼匹克病 A/B 型。引用於:尼曼匹克病
  383. Forsyth R, Gunay-Aygun M. Bardet-Biedl Syndrome Overview[EB/OL]. GeneReviews®, University of Washington, Seattle, 2023. (訪問於 2026-09-12). 2003 年 7 月首發,2023 年 3 月更新。引用於:Bardet-Biedl 綜合徵
  384. Shuman C, Kalish JM, Weksberg R. Beckwith-Wiedemann Syndrome[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2023. (訪問於 2026-09-30). 初版 2000 年,最近一次全面更新 2023 年 6 月 8 日,2023 年 9 月 21 日修訂。引用於:Beckwith-Wiedemann 綜合徵
  385. Rauen KA. Cardiofaciocutaneous Syndrome[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2023. (訪問於 2026-09-30). 初版 2007 年,最近全面更新 2023 年 2 月 9 日,2026 年 5 月 21 日修訂。引用於:心-面-皮膚綜合徵
  386. 美國食品藥品監督管理局(FDA). DAYBUE(trofinetide)新藥申請 217026[EB/OL]. Drugs@FDA, 2023. (訪問於 2026-09-10).引用於:Rett 綜合徵
  387. Smith R J H, Azaiez H, Booth K. GJB2-Related Autosomal Recessive Nonsyndromic Hearing Loss[EB/OL]. GeneReviews®, University of Washington, Seattle, 2023. (訪問於 2026-09-12). 1998 年 9 月首發,2023 年 7 月更新。引用於:非綜合徵型耳聾
  388. MedlinePlus Genetics. GM1 gangliosidosis[EB/OL]. 美國國立醫學圖書館, 2023. (訪問於 2026-10-07). 2023 年 4 月更新。引用於:神經節苷脂貯積症
  389. Introne WJ, Huizing M, Malicdan MCV, 等. Hermansky-Pudlak Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2023. (訪問於 2026-10-07). 2000 年 7 月首發,2023 年 5 月更新(PMID 20301464)。引用於:眼皮膚白化病
  390. Gripp KW, Weaver KN. HRAS-Related Costello Syndrome[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2023. (訪問於 2026-09-30). 初版 2006 年,最近一次全面更新 2023 年 12 月 21 日,2026 年 5 月 21 日有修訂。引用於:Costello 綜合徵
  391. Kleefstra T, de Leeuw N. Kleefstra Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2023. (訪問於 2026-09-11). 2010 年 10 月首發,2023 年 1 月更新。引用於:Kleefstra 綜合徵
  392. Koolen D A, Morgan A, de Vries B B A. Koolen-de Vries Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2023. (訪問於 2026-09-11). 2010 年 1 月首發,2023 年 2 月更新。引用於:Koolen-de Vries 綜合徵
  393. European Medicines Agency. Loargys (pegzilarginase): European public assessment report[EB/OL]. European Medicines Agency, 2023. (訪問於 2026-10-07). 2023 年 12 月 15 日獲歐盟上市許可,用於 2 歲及以上的精氨酸酶 1 缺乏症患者。引用於:精氨酸酶缺乏症
  394. NHS. Low blood sugar (hypoglycaemia)[EB/OL]. 英國國家醫療服務體系(NHS), 2023. (訪問於 2026-10-07). 頁面最近一次審閱在 2023 年 8 月 3 日。引用於:糖原累積病Ⅰ型
  395. National Organization for Rare Disorders (NORD). Moyamoya Disease[EB/OL]. NORD Rare Disease Database, 2023. (訪問於 2026-09-30). 美國罕見病組織的病種報告,由波士頓兒童醫院神經外科醫生協助撰寫:RNF213 變異的外顯率、其他相關基因與頭痛用藥的注意事項。引用於:煙霧病
  396. Kruszka P, Rolle M, Kahle KT, 等. Muenke Syndrome[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2023. (訪問於 2026-09-30). 初版 2006 年,最近更新 2023 年 3 月 30 日。引用於:綜合徵性顱縫早閉
  397. Mirzaa G, Graham JM Jr, Keppler-Noreuil K. PIK3CA-Related Overgrowth Spectrum[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2023. (訪問於 2026-09-30). 初版 2013 年,最近全面更新 2021 年 12 月 23 日,2023 年 4 月 6 日修訂。引用於:PIK3CA 相關過度生長綜合徵
  398. Driscoll D J, Miller J L, Cassidy S B. Prader-Willi Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2023. (訪問於 2026-09-10).引用於:Prader-Willi 綜合徵、假性甲狀旁腺功能減退症、染色體與基因組印記異常、術語表
  399. National Organization for Rare Disorders (NORD). Pseudohypoparathyroidism[EB/OL]. NORD Rare Disease Database, 2023. (訪問於 2026-09-30). 面向患者與家庭的英文疾病報告,最近更新 2023 年 8 月 1 日,頁內列有相關患者組織與援助項目。引用於:假性甲狀旁腺功能減退症
  400. Stevens C A. Rubinstein-Taybi Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2023. (訪問於 2026-09-11). 2002 年 8 月首發,2023 年 11 月更新。引用於:Rubinstein-Taybi 綜合徵、綜合徵性顱縫早閉
  401. Goldstein A, Falk MJ. Single Large-Scale Mitochondrial DNA Deletion Syndromes[EB/OL]. GeneReviews®, University of Washington, Seattle, 2023. (訪問於 2026-10-07). 2003 年 12 月首發,2023 年 9 月修訂。引用於:線粒體腦肌病
  402. Stammering[EB/OL]. National Health Service (UK), 2023. (訪問於 2026-11-18).
  403. Mortier G. Stickler Syndrome[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2023. (訪問於 2026-09-30). 初版 2000 年,最近更新 2023 年 9 月 7 日。本病最常合併的綜合徵,支持眼、聽力隨訪與遺傳方式部分。引用於:Pierre Robin 序列徵
  404. Mercimek-Andrews S. STXBP1 Encephalopathy with Epilepsy[EB/OL]. GeneReviews®, University of Washington, Seattle, 2023. (訪問於 2026-09-12). 2016 年 12 月首發,2023 年 9 月更新。引用於:STXBP1 相關發育性癲癇性腦病、SCN2A 相關疾病
  405. NHS. What to do if someone has a seizure (fit)[EB/OL]. 英國國家醫療服務體系(NHS), 2023. (訪問於 2026-10-07). 頁面最近一次審閱在 2023 年 12 月 19 日。引用於:癲癇發作
  406. Wheelchair provision guidelines[EB/OL]. World Health Organization, 2023. (訪問於 2026-09-25). 用於輪椅及相關坐姿支持的個體評估、適配、使用培訓與隨訪原則;不是所有擺位用品的獨立療效證據。引用於:訓練器材與教具
  407. Weiss K H, Schilsky M. Wilson Disease[EB/OL]. GeneReviews®, University of Washington, Seattle, 2023. (訪問於 2026-09-12). 1999 年 10 月首發,2023 年 1 月更新。引用於:肝豆狀核變性、DYT-TOR1A 肌張力障礙
  408. Raymond G V, Moser A B, Fatemi A. X-Linked Adrenoleukodystrophy[EB/OL]. GeneReviews®, University of Washington, Seattle, 2023. (訪問於 2026-09-12). 1999 年 3 月首發,2023 年 4 月更新。引用於:X-連鎖腎上腺腦白質營養不良
  409. 寶秀蘭醫療. 兒童節,這份來自鮑奶奶的祝福請查收(2022-06-02)[EB/OL]. 寶秀蘭醫療, 2022.引用於:機構沿革
  410. 賈美香. 殘疾兒童康復專家諮詢常見問題:孤獨症·生活自理問題 1[EB/OL]. 中國殘疾人聯合會, 2022. (訪問於 2026-10-02).引用於:日常生活活動能力訓練
  411. 蘆燕雲. 殘疾兒童康復專家諮詢常見問題:智力殘疾·生活自理能力[EB/OL]. 中國殘疾人聯合會, 2022. (訪問於 2026-10-02).引用於:日常生活活動能力訓練
  412. Baby Walkers: A Dangerous Choice[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2022. (訪問於 2026-09-25). 2022-08-15 更新。針對帶座兜和輪子的嬰兒學步車風險;不能與經評估適配的康復助行器混同。引用於:訓練器材與教具
  413. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10). 2 月齡至 5 歲共 12 份清單、159 條里程碑引用於:寶秀蘭兒童神經發育綜合評估系統
  414. Mitchel M W, Myers S M, Heidlebaugh A R, 等. CHD8-Related Neurodevelopmental Disorder with Overgrowth[EB/OL]. GeneReviews®, University of Washington, Seattle, 2022. (訪問於 2026-09-11). 2022 年 10 月首發;臨床描述依據 115 例已報道患者。引用於:CHD8 相關神經發育障礙、PTEN 錯構瘤腫瘤綜合徵
  415. Quinonez SC, Lee KN. Citrullinemia Type I[EB/OL]. GeneReviews®, University of Washington, Seattle, 2022. (訪問於 2026-09-12). 2004 年 7 月首發,2022 年 8 月更新。引用於:瓜氨酸血症
  416. Ho S K L, Tsang M H Y, Lee M, 等. CTNNB1 Neurodevelopmental Disorder[EB/OL]. GeneReviews®, University of Washington, Seattle, 2022. (訪問於 2026-09-12). 2022 年 5 月發佈。引用於:CTNNB1 相關神經發育障礙
  417. Darras B T, Urion D K, Ghosh P S. Dystrophinopathies[EB/OL]. GeneReviews®, University of Washington, Seattle, 2022. (訪問於 2026-09-10).引用於:杜氏肌營養不良、兒童罕見病、血清肌酸激酶升高
  418. Dietz H. FBN1-Related Marfan Syndrome[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2022. (訪問於 2026-10-07). 2001 年 4 月首發,2022 年 2 月更新。引用於:馬凡綜合徵、骨骼與結締組織
  419. American Academy of Pediatrics. Health Care Information for Families of Children and Adolescents with Down Syndrome. Child’s Age: 1 Year to 5 Years[EB/OL]. 美國兒科學會, 2022. (訪問於 2026-10-07). 家庭版,第 2 版,2022 年 10 月。引用於:21 三體綜合徵
  420. American Academy of Pediatrics. Health Care Information for Families of Children and Adolescents with Down Syndrome. Child’s Age: 5 to 12 Years[EB/OL]. 美國兒科學會, 2022. (訪問於 2026-10-07). 家庭版,第 2 版,2022 年 10 月。引用於:21 三體綜合徵
  421. Miceli F, Soldovieri MV, 等. KCNQ2-Related Disorders[EB/OL]. GeneReviews®, University of Washington, Seattle, 2022. (訪問於 2026-09-12). 2010 年 4 月首發,2022 年 5 月更新。引用於:KCNQ2 相關障礙、SCN2A 相關疾病
  422. Prasun P, LoPiccolo MK, Ginevic I. Long-Chain Hydroxyacyl-CoA Dehydrogenase Deficiency / Trifunctional Protein Deficiency[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2022. (訪問於 2026-09-30). 初版 2022 年 9 月 1 日。引用於:長鏈 3-羥酰基輔酶 A 脫氫酶缺乏症
  423. Lichter-Konecki U, Caldovic L, Morizono H, 等. Ornithine Transcarbamylase Deficiency[EB/OL]. GeneReviews®, University of Washington, Seattle, 2022. (訪問於 2026-09-12). 2013 年 8 月首發,2022 年 5 月更新。OTC 基因定位 Xp11.4。引用於:鳥氨酸氨甲酰基轉移酶缺乏症、HHH 綜合徵
  424. Gospe SM Jr. Pyridoxine-Dependent Epilepsy – ALDH7A1[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2022. (訪問於 2026-09-30). 初版 2001 年,最近更新 2022 年 9 月 22 日。引用於:吡哆醇依賴性癲癇
  425. Milunsky JM. Waardenburg Syndrome Type I[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2022. (訪問於 2026-09-30). 初版 2001 年,最近更新 2022 年 10 月 20 日。論述的是 1 型,鑑別診斷一節比較了 2 型、4 型與斑駁病。引用於:Waardenburg 綜合徵
  426. Sheppard SE, Quintero-Rivera F. Wiedemann-Steiner Syndrome[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2022. (訪問於 2026-09-30). 2022 年 5 月 26 日首發。診斷、各系統表現的比例、確診後的評估與隨訪、遺傳諮詢均以本章為主。引用於:Wiedemann-Steiner 綜合徵
  427. 中華醫學會醫學遺傳學分會, 中國醫師協會醫學遺傳醫師分會, 中國罕見病聯盟, 北京協和醫院. 《中國罕見病定義研究報告 2021》發佈[EB/OL]. 新華網, 2021. (訪問於 2026-09-10). 中國罕見病定義:新生兒發病率小於萬分之一、患病率小於萬分之一、患病人數少於 14 萬,三者符合其一即為罕見病。引用於:21 三體綜合徵、7q11.23 重複綜合徵、先天性多發性關節攣縮、SCN2A 相關疾病、Beckwith-Wiedemann 綜合徵、新生兒持續肺動脈高壓、Ehlers-Danlos 綜合徵、視隔發育不良、兒童罕見病、罕見病政策與保障、術語表
  428. Mervis C B, Morris C A, Klein-Tasman B P, 等. 7q11.23 Duplication Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2021. (訪問於 2026-09-11). 2015 年 11 月首發,2021 年 3 月更新。引用於:7q11.23 重複綜合徵
  429. 人力資源社會保障部公佈 2021 年版《國家職業資格目錄》[EB/OL]. 北京市人力資源和社會保障局, 2021. (訪問於 2026-09-30).引用於:早期介入丹佛模式(ESDM)、語言行為與 VB-MAPP、問題行為的功能評估與正向行為支持(PBS)
  430. 鮑秀蘭診室(機構賬號). 北京寶秀蘭兒科診所開業[EB/OL]. 新浪看點, 2021. (訪問於 2026-09-07).引用於:機構沿革
  431. 中國優生優育協會. 記中國優生優育協會嬰幼兒發育專委會榮譽主任、我國泰斗級兒科專家鮑秀蘭教授[EB/OL]. 中國優生優育協會, 2021. (訪問於 2026-09-22).引用於:媒體報道與公開發表、鮑秀蘭教授
  432. 中國優生優育協會. 第十二屆全國兒童發育與臨床學術研討會在京成功舉辦[EB/OL]. 中國優生優育協會, 2021. (訪問於 2026-09-07).引用於:機構沿革、合作機構
  433. 生命時報. 鮑秀蘭專家團入駐醫聯,四方共建嬰幼兒行為神經發育專業[EB/OL]. 生命時報, 2021. (訪問於 2026-09-22).引用於:媒體報道與公開發表、鮑秀蘭教授
  434. 中國優生優育協會嬰幼兒發育專業委員會. 關於舉辦《兒童早期發展指導師》培訓班通知[EB/OL]. 中國優生優育協會, 2021. (訪問於 2026-09-07).引用於:機構沿革、合作機構、NBNA 方法頁
  435. Kaler SG. ATP7A-Related Copper Transport Disorders[EB/OL]. GeneReviews®, University of Washington, Seattle, 2021. (訪問於 2026-09-12). 2003 年 5 月首發,2021 年 4 月更新。涵蓋 Menkes 病、枕角綜合徵與 ATP7A 相關遠端運動神經病。引用於:Menkes 病
  436. Childproofing Tips for Home Exercise Equipment[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2021. (訪問於 2026-09-25). 用於家用跑步機等設備的移動帶傷害、看護、斷電及安全鑰匙管理;不是兒童跑臺訓練療效證據。引用於:訓練器材與教具
  437. Berry GT. Classic Galactosemia and Clinical Variant Galactosemia[EB/OL]. GeneReviews®, University of Washington, Seattle, 2021. (訪問於 2026-09-12). 2000 年 2 月首發,2021 年 3 月更新。記載即使早期規範治療,患兒仍有發育落後、言語失用與構音障礙及運動功能異常的風險。引用於:半乳糖血症
  438. Foley AR, Bönnemann CG, 等. Collagen VI-Related Dystrophies[EB/OL]. GeneReviews®, University of Washington, Seattle, 2021. (訪問於 2026-09-12). 2004 年 6 月首發,2021 年 3 月更新。涵蓋 Bethlem 肌病、中間型與 Ullrich 先天性肌營養不良。引用於:先天性肌營養不良(膠原Ⅵ相關肌病)
  439. Sloan J L, Carrillo N, Adams D, 等. Disorders of Intracellular Cobalamin Metabolism[EB/OL]. GeneReviews®, University of Washington, Seattle, 2021. (訪問於 2026-09-12). 2008 年 2 月首發,2021 年 12 月修訂;cblC 等類型同時有甲基丙二酸血症與同型半胱氨酸血症。引用於:同型半胱氨酸血症
  440. Regier D S, Tifft C J, Rothermel C E. GLB1-Related Disorders[EB/OL]. GeneReviews®, University of Washington, Seattle, 2021. (訪問於 2026-09-12). 2013 年 10 月首發,2021 年 4 月更新;涵蓋 GM1 神經節苷脂貯積症與黏多糖貯積症ⅣB 型。引用於:神經節苷脂貯積症
  441. Bali DS, El-Gharbawy A, Austin S, 等. Glycogen Storage Disease Type I[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2021. (訪問於 2026-09-30). 初版 2006 年,最近更新 2021 年 10 月 14 日。引用於:糖原累積病Ⅰ型
  442. Gaughan S, Ayres L, Baker PR. Hereditary Fructose Intolerance[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2021. (訪問於 2026-09-30). 初版 2015 年,最近更新 2021 年 2 月 18 日。引用於:遺傳性果糖不耐受症
  443. European Medicines Agency. Imcivree (setmelanotide): European public assessment report[EB/OL]. European Medicines Agency, 2021. (訪問於 2026-10-07). 2021 年 7 月 16 日獲歐盟上市許可;適應證包括經基因確診的 Bardet-Biedl 綜合徵成人與 2 歲及以上兒童的肥胖治療與飢餓感控制。引用於:Bardet-Biedl 綜合徵
  444. Stumpel C, Vos YJ. L1 Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2021. (訪問於 2026-09-12). 2004 年 4 月首發,2021 年 1 月更新。涵蓋 X 連鎖腦積水、MASA 綜合徵與 L1CAM 相關痙攣性截癱。引用於:L1 綜合徵
  445. Lusk L, Vogel-Farley V, DiStefano C, 等. Maternal 15q Duplication Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2021. (訪問於 2026-09-11). 2016 年 6 月首發,2021 年 7 月更新。引用於:15q11.2-q13.1 重複綜合徵
  446. Movement Milestones: Babies 4 to 7 Months[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2021. (訪問於 2026-11-13).
  447. Dunø M, Vissing J. Myotonia Congenita[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2021. (訪問於 2026-10-07). 初次發佈 2005 年;PubMed 記錄(PMID 20301529)的最近修訂日期為 2021 年 2 月 25 日。引用於:先天性肌強直
  448. Brock S, Dobyns W B, Jansen A. PAFAH1B1-Related Lissencephaly / Subcortical Band Heterotopia[EB/OL]. GeneReviews®, University of Washington, Seattle, 2021. (訪問於 2026-09-12). 2009 年 3 月首發,2021 年 3 月更新。引用於:無腦回畸形
  449. Lam C, Krasnewich DM. PMM2-CDG[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2021. (訪問於 2026-09-30). 初版 2005 年,最近更新 2021 年 5 月 20 日。引用於:PMM2-CDG
  450. Chinnery P F. Primary Mitochondrial Disorders Overview[EB/OL]. GeneReviews®, University of Washington, Seattle, 2021. (訪問於 2026-09-12).引用於:線粒體腦肌病
  451. MedlinePlus Genetics. Sandhoff disease[EB/OL]. 美國國立醫學圖書館, 2021. (訪問於 2026-10-07). 2021 年 12 月更新。引用於:神經節苷脂貯積症
  452. MedlinePlus Genetics. Tay-Sachs disease[EB/OL]. 美國國立醫學圖書館, 2021. (訪問於 2026-10-07). 2021 年 9 月更新。引用於:神經節苷脂貯積症
  453. 北京陽光知識產權與法律發展基金會. 「鮑秀蘭陽光優智」兒童早期干預和早期發展公益基金(三方發起公告)[EB/OL]. 北京陽光知識產權與法律發展基金會, 2020. (訪問於 2026-09-07).引用於:機構沿革、合作機構
  454. 夏瑾. 兒童感覺統合治療師需求大,行業亂象亟須解決[EB/OL]. 中國青年報(人民網轉載), 2020. (訪問於 2026-09-30).引用於:感覺統合治療(ASI)
  455. 北京市殘疾人康復服務指導中心. 腦癱患兒康復[EB/OL]. 北京市殘疾人聯合會, 2020. (訪問於 2026-10-02).引用於:日常生活活動能力訓練
  456. Srivastava S, Waldman A, 等. Alexander Disease[EB/OL]. GeneReviews®, University of Washington, Seattle, 2020. (訪問於 2026-09-12). 2002 年 11 月首發,2020 年 11 月更新。引用於:亞歷山大病、Canavan 病
  457. Steinbrenner JR, Hume K, Odom SL, 等. Evidence-Based Practices for Children, Youth, and Young Adults with Autism[EB/OL]. National Clearinghouse on Autism Evidence and Practice, FPG Child Development Institute, The University of North Carolina at Chapel Hill, 2020. (訪問於 2026-09-30).引用於:問題行為的功能評估與正向行為支持(PBS)、家長介導干預、結構化教學(TEACCH)、社交技能小組訓練、社交故事、遊戲治療與沙盤遊戲、輔助與替代溝通(AAC)、圖片交換溝通系統(PECS)、感覺統合治療(ASI)、康復與干預方法
  458. Wenger T, Miller D, Evans K. FGFR Craniosynostosis Syndromes Overview[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2020. (訪問於 2026-09-30). 初版 1998 年,最近更新 2020 年 4 月 16 日(4 月 30 日修訂)。引用於:綜合徵性顱縫早閉
  459. Akesson LS, Savarirayan R. Fibrodysplasia Ossificans Progressiva[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2020. (訪問於 2026-10-07). 2020 年 6 月首發;PubMed 題錄(PMID 32525643)2024 年 5 月修訂。引用於:骨骼與結締組織
  460. Toro C, Shirvan L, Tifft C. HEXA Disorders[EB/OL]. GeneReviews®, University of Washington, Seattle, 2020. (訪問於 2026-09-12). 1999 年 3 月首發,2020 年 10 月更新;即 Tay-Sachs 病所屬的 GM2 神經節苷脂貯積症。引用於:神經節苷脂貯積症
  461. Jinnah HA. HPRT1 Disorders[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2020. (訪問於 2026-09-30). 初版 2000 年,最近更新 2020 年 8 月 6 日。引用於:Lesch-Nyhan 綜合徵
  462. Strauss K A, Puffenberger E G, Carson V J. Maple Syrup Urine Disease[EB/OL]. GeneReviews®, University of Washington, Seattle, 2020. (訪問於 2026-09-12). 2006 年 1 月首發,2020 年 4 月更新。引用於:楓糖尿症
  463. Van Esch H. MECP2 Duplication Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2020. (訪問於 2026-09-11). 2008 年 1 月首發,2020 年 5 月更新。引用於:MECP2 重複綜合徵
  464. Prasun P. Multiple Acyl-CoA Dehydrogenase Deficiency[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2020. (訪問於 2026-09-30). 2020 年 6 月 18 日發佈。分型、診斷依據、日常與急症管理、應避免的情形和遺傳諮詢。引用於:多種酰基輔酶 A 脫氫酶缺乏症
  465. Short Stature: A Guide for Families[EB/OL]. Pediatric Endocrine Society, 2020. (訪問於 2026-09-25). 身高、生長速度及家族遺傳背景在矮小評估中的意義。引用於:身材矮小、骨骼與結締組織、內分泌與生長
  466. Nowaczyk M J M, Wassif C A. Smith-Lemli-Opitz Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2020. (訪問於 2026-09-11). 1998 年 11 月首發,2020 年 1 月更新。引用於:Smith-Lemli-Opitz 綜合徵
  467. Hedera P. Spastic Paraplegia 3A[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2020. (訪問於 2026-10-07). 初次發佈 2010 年;PubMed 記錄(PMID 20862796)的最近修訂日期為 2020 年 6 月 18 日。引用於:遺傳性痙攣性截癱
  468. International Dyslexia Association. Structured Literacy: Effective Instruction for Students with Dyslexia and Related Reading Difficulties[EB/OL]. dyslexiaida.org, 2020. (訪問於 2026-09-30).引用於:康復與干預方法
  469. Koenekoop R, Arriaga M, Trzupek KM, 等. Usher Syndrome Type II[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2020. (訪問於 2026-09-30). 初版 1999 年,最近一次全面更新 2020 年 10 月 22 日,2023 年 3 月 23 日修訂。Ⅱ型的聽力、視力與前庭表現,診斷與管理。引用於:Usher 綜合徵
  470. Steinberg SJ, Raymond GV, Braverman NE, 等. Zellweger Spectrum Disorder[EB/OL]. GeneReviews®, University of Washington, Seattle, 2020. (訪問於 2026-09-12). 2003 年 12 月首發,2020 年 10 月更新。引用於:Zellweger 譜系障礙
  471. 新浪育兒. 鮑秀蘭教授專訪:嬰幼兒照護,這些關鍵點家長要知道[EB/OL]. 新浪育兒, 2019. (訪問於 2026-09-22).引用於:媒體報道與公開發表、鮑秀蘭教授
  472. Wenger TL, Hing AV, Evans KN. Apert Syndrome[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2019. (訪問於 2026-09-30). 2019 年 5 月 30 日發佈。引用於:綜合徵性顱縫早閉
  473. van der Knaap MS, Fogli A, Boespflug-Tanguy O, 等. Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2019. (訪問於 2026-09-30). 初版 2003 年,最近更新 2019 年 4 月 4 日。引用於:白質消融性白質腦病
  474. Furukawa Y. GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia[EB/OL]. GeneReviews®, University of Washington, Seattle, 2019. (訪問於 2026-09-12). 2002 年 2 月首發,2019 年 1 月更新。引用於:多巴反應性肌張力障礙、Lesch-Nyhan 綜合徵
  475. World Health Organization. ICD-10 Version:2019(G71.2 Congenital myopathies)[EB/OL]. International Statistical Classification of Diseases and Related Health Problems 10th Revision, 2019. (訪問於 2026-10-07). G71.2 的包含項列有 Congenital muscular dystrophy。引用於:先天性肌營養不良(膠原Ⅵ相關肌病)
  476. Van Hove JLK, Coughlin C II, Swanson M, 等. Nonketotic Hyperglycinemia[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2019. (訪問於 2026-09-30). 初版 2002 年,最近更新 2019 年 5 月 23 日。引用於:非酮性高甘氨酸血症
  477. Behavior Analyst Certification Board. Recent Changes to the BACB’s International Focus[EB/OL]. bacb.com, 2019. (訪問於 2026-09-30).引用於:應用行為分析(ABA)、回合式教學(DTT)、語言行為與 VB-MAPP、問題行為的功能評估與正向行為支持(PBS)、康復與干預方法
  478. MedlinePlus Genetics. Subcortical band heterotopia[EB/OL]. National Library of Medicine (US), 2019. (訪問於 2026-10-07).引用於:無腦回畸形
  479. Suspected neurological conditions: recognition and referral (NG127): recommendations for children aged under 16[EB/OL]. National Institute for Health and Care Excellence, 2019. (訪問於 2026-09-25). 兒童運動發育遲緩、肌無力、發育倒退及頭圍異常等神經系統表現的評估與轉診建議。引用於:肌張力低下、發育倒退、粗大運動發育落後、癲癇發作、頭圍增長異常、腦性癱瘓的鑑別與病因評估:何時需要進一步檢查
  480. World Health Organization. To grow up healthy, children need to sit less and play more[EB/OL]. World Health Organization, 2019. (訪問於 2026-09-30). 新聞稿,載有《5 歲以下兒童身體活動、久坐行為和睡眠指南》的推薦原文引用於:康復與干預方法
  481. 中國罕見病聯盟. 聯盟簡介[EB/OL]. 中國罕見病聯盟, 2018. (訪問於 2026-09-10). 2018 年 10 月成立,北京協和醫院等發起。引用於:脊髓性肌萎縮症、杜氏肌營養不良、腓骨肌萎縮症、肌強直性營養不良、先天性肌無力綜合徵、遺傳性痙攣性截癱、Rett 綜合徵、結節性硬化症、West 綜合徵、嬰兒嚴重肌陣攣性癲癇、脆性 X 綜合徵、神經纖維瘤病、CDKL5 缺乏症、Angelman 綜合徵、Prader-Willi 綜合徵、威廉姆斯綜合徵、Noonan 綜合徵、Silver-Russell 綜合徵、苯丙酮尿症、糖原累積病Ⅱ型、黏多糖貯積症、甲基丙二酸血症、異染性腦白質營養不良、成骨不全症、軟骨發育不全、低磷性佝僂病、21-羥化酶缺乏症、原發性生長激素缺乏症、DYRK1A 綜合徵、Kabuki 綜合徵、Cornelia de Lange 綜合徵、Sotos 綜合徵、21 三體綜合徵、22q11.2 缺失綜合徵、Phelan-McDermid 綜合徵、Smith-Magenis 綜合徵、貓叫綜合徵、CHARGE 綜合徵、SYNGAP1 相關智力障礙、ADNP 綜合徵、CHD8 相關神經發育障礙、PTEN 錯構瘤腫瘤綜合徵、MECP2 重複綜合徵、15q11.2-q13.1 重複綜合徵、Potocki-Lupski 綜合徵、Pitt-Hopkins 綜合徵、Mowat-Wilson 綜合徵、KBG 綜合徵、Coffin-Siris 綜合徵、Koolen-de Vries 綜合徵、7q11.23 重複綜合徵、Kleefstra 綜合徵、Rubinstein-Taybi 綜合徵、Smith-Lemli-Opitz 綜合徵、腦肌酸缺乏綜合徵、GLUT1 缺乏綜合徵、神經元蠟樣脂褐質沉積症、四氫生物蝶呤缺乏症、X-連鎖腎上腺腦白質營養不良、線粒體腦肌病、尼曼匹克病、神經節苷脂貯積症、戊二酸血症Ⅰ型、楓糖尿症、生物素酶缺乏症、同型半胱氨酸血症、肝豆狀核變性、多巴反應性肌張力障礙、Lennox-Gastaut 綜合徵、非綜合徵型耳聾、1p36 缺失綜合徵、Wolf-Hirschhorn 綜合徵、Joubert 綜合徵、無腦回畸形、FOXG1 綜合徵、STXBP1 相關發育性癲癇性腦病、CTNNB1 相關神經發育障礙、SATB2 相關障礙、鳥氨酸氨甲酰基轉移酶缺乏症、瓜氨酸血症、精氨酸酶缺乏症、丙酸血症、異戊酸血症、半乳糖血症、原發性肉鹼缺乏症、戈謝病、全身型重症肌無力、低鹼性磷酸酶血症、馬凡綜合徵、面肩肱型肌營養不良症、先天性肌營養不良(膠原Ⅵ相關肌病)、慢性炎性脫髓鞘性多發性神經根神經病、Pelizaeus-Merzbacher 病、亞歷山大病、Canavan 病、Zellweger 譜系障礙、Menkes 病、Aicardi-Goutières 綜合徵、L1 綜合徵、共濟失調毛細血管擴張症、KCNQ2 相關障礙、進行性骨化性纖維發育不良、Dandy-Walker 畸形、Sturge-Weber 綜合徵、多小腦回、Bardet-Biedl 綜合徵、Leber 先天性黑矇、早產兒視網膜病變、中鏈酰基輔酶 A 脫氫酶缺乏症、極長鏈酰基輔酶 A 脫氫酶缺乏症、HHH 綜合徵、原發性酪氨酸血症、芳香族 L-氨基酸脫羧酶缺乏症、法佈雷病、胱氨酸貯積症、眼皮膚白化病、視網膜色素變性、脊髓小腦性共濟失調、發作性睡病、Christianson 綜合徵、自身免疫性腦炎、先天性脊柱側凸、先天性高胰島素性低血糖血症、先天性肌強直、血友病、遺傳性大皰性表皮鬆解症、Alagille 綜合徵、早老症、糖原累積病Ⅰ型、遺傳性果糖不耐受症、全羧化酶合成酶缺乏症、多種酰基輔酶 A 脫氫酶缺乏症、長鏈 3-羥酰基輔酶 A 脫氫酶缺乏症、β-酮硫解酶缺乏症、賴氨酸尿蛋白不耐受症、Krabbe 病、PMM2-CDG、吡哆醇依賴性癲癇、Lesch-Nyhan 綜合徵、非酮性高甘氨酸血症、3-甲基巴豆酰輔酶 A 羧化酶缺乏症、肢帶型肌營養不良、先天性肌病、先天性多發性關節攣縮、嬰兒神經軸索營養不良、泛酸激酶相關神經變性、DYT-TOR1A 肌張力障礙、兒童交替性偏癱、白質消融性白質腦病、SCN2A 相關疾病、Landau-Kleffner 綜合徵、Wiedemann-Steiner 綜合徵、Costello 綜合徵、心-面-皮膚綜合徵、煙霧病、Beckwith-Wiedemann 綜合徵、PIK3CA 相關過度生長綜合徵、新生兒持續肺動脈高壓、綜合徵性顱縫早閉、Ehlers-Danlos 綜合徵、Pierre Robin 序列徵、McCune-Albright 綜合徵、萊倫氏綜合徵、假性甲狀旁腺功能減退症、新生兒糖尿病、視隔發育不良、Usher 綜合徵、Waardenburg 綜合徵、兒童罕見病
  482. National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management (NICE guideline NG87)[EB/OL]. NICE, 2018. (訪問於 2026-09-30). 2018 年 3 月發佈,所引條文據 2019 年 9 月更新版引用於:家長行為管理培訓(PMT)、康復與干預方法
  483. ClinGen Hearing Loss Gene Curation Expert Panel. GJB3 curation results[EB/OL]. Clinical Genome Resource (ClinGen), 2018. (訪問於 2026-10-07). GJB3 與常染色體顯性非綜合徵型遺傳性聽力損失的關係評為「有爭議」(Disputed),評定日期 2018 年 2 月 27 日。引用於:非綜合徵型耳聾
  484. Nunes V, Niinikoski H. Lysinuric Protein Intolerance[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2018. (訪問於 2026-09-30). 初版 2006 年,最近更新 2018 年 4 月 12 日。引用於:賴氨酸尿蛋白不耐受症
  485. El-Hattab A W, Almannai M, Scaglia F. MELAS[EB/OL]. GeneReviews®, University of Washington, Seattle, 2018. (訪問於 2026-09-12). 2001 年 2 月首發,2018 年 11 月更新。引用於:線粒體腦肌病、煙霧病
  486. MedlinePlus Genetics. Pelizaeus-Merzbacher disease[EB/OL]. National Library of Medicine (US), 2018. (訪問於 2026-10-07). 2018 年 2 月更新。引用於:Pelizaeus-Merzbacher 病
  487. Cooney E. Pioneering Pediatrician Passes[EB/OL]. Harvard Medical School News, 2018. (訪問於 2026-09-20).引用於:鮑秀蘭教授
  488. Stutterd CA, Dobyns WB, 等. Polymicrogyria Overview[EB/OL]. GeneReviews®, University of Washington, Seattle, 2018. (訪問於 2026-09-12). 2005 年 4 月首發,2018 年 8 月最後更新;該章節已歸檔,僅作歷史參考。引用於:多小腦回
  489. National Institute of Diabetes and Digestive and Kidney Diseases. Treatment for Adrenal Insufficiency & Addison's Disease[EB/OL]. 美國國立衛生研究院, 2018. (訪問於 2026-10-07). 2018 年 9 月審定。引用於:X-連鎖腎上腺腦白質營養不良
  490. Dowling JJ, Lawlor MW, Das S. X-Linked Myotubular Myopathy[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2018. (訪問於 2026-09-30). 初版 2002 年,最近更新 2018 年 8 月 23 日。X 連鎖肌管肌病的分型、病程、遺傳諮詢與管理。引用於:先天性肌病
  491. 中國殘疾人聯合會. 全國殘疾人康復工作簡報(2017 年第四期)[EB/OL]. 中國殘疾人聯合會, 2017. (訪問於 2026-09-07).引用於:鮑秀蘭教授
  492. 國家級繼續醫學教育認可項目《BOBATH 治療技術在小兒腦癱中的臨床應用》培訓班招生通知[EB/OL]. 中國康復研究中心, 2017. (訪問於 2026-09-30).引用於:Bobath 療法(NDT)
  493. 歐洲藥品管理局(EMA). Brineura(cerliponase alfa)歐洲公開評估報告[EB/OL]. European Medicines Agency, 2017. (訪問於 2026-09-11). 2017 年 5 月 30 日獲歐盟上市許可,適應證為 CLN2 病(三肽基肽酶 1 缺乏症)。引用於:神經元蠟樣脂褐質沉積症
  494. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25). 涵蓋腦癱診斷、需重新評估的神經系統表現、功能參與與移動支持;1.12.9 明確不應僅為預防低骨密度提供站立架。引用於:發育倒退、共濟失調、腦性癱瘓的鑑別與病因評估:何時需要進一步檢查、訓練器材與教具
  495. Developmental follow-up of children and young people born preterm (NG72)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-11-02). 早產兒發育問題的風險與獨立危險因素、2 歲(矯正)前的強化隨訪與 4 歲評估、矯正年齡的使用。
  496. Haldeman-Englert CR, Hurst ACE, Levine MA. Disorders of GNAS Inactivation[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2017. (訪問於 2026-09-30). 2017 年 10 月 26 日發佈。涵蓋假性甲狀旁腺功能減退症Ⅰa、Ⅰb、Ⅰc 型,假假性甲狀旁腺功能減退症與進行性骨發育異常。引用於:假性甲狀旁腺功能減退症
  497. Gregory A, Hayflick SJ. Pantothenate Kinase-Associated Neurodegeneration[EB/OL]. GeneReviews® [Internet]. Seattle (WA): University of Washington, 2017. (訪問於 2026-09-30). 初版 2002 年,最近更新 2017 年 8 月 3 日。引用於:泛酸激酶相關神經變性、DYT-TOR1A 肌張力障礙
  498. Potocki L, Neira-Fresneda J, Yuan B. Potocki-Lupski Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2017. (訪問於 2026-09-11). 2017 年 8 月首發。引用於:Potocki-Lupski 綜合徵
  499. National Institute on Deafness and Other Communication Disorders. Stuttering[EB/OL]. National Institutes of Health, 2017. (訪問於 2026-11-18).
  500. Crow YJ. Aicardi-Goutières Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2016. (訪問於 2026-09-12). 2005 年 6 月首發,2016 年 11 月更新。引用於:Aicardi-Goutières 綜合徵
  501. Great Ormond Street Hospital for Children NHS Foundation Trust. Landau Kleffner syndrome[EB/OL]. Great Ormond Street Hospital: Conditions we treat, 2016. (訪問於 2026-09-30). 英國大奧蒙德街兒童醫院發育性癲癇門診編寫的家長資料,頁面標註的最近一次審閱為 2016 年 10 月。引用於:Landau-Kleffner 綜合徵
  502. Auditory Sensory Strategies[EB/OL]. Oxford Health NHS Foundation Trust, Children’s Community Occupational Therapy, 2015. (訪問於 2026-09-25). 僅用於聲音環境調整、按需要提供耳罩及避免全天持續佩戴的使用原則;不將耳罩視為治療或聽力檢查工具。引用於:訓練器材與教具
  503. Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges (NG11)[EB/OL]. National Institute for Health and Care Excellence, 2015. (訪問於 2026-09-25). 用於智力障礙人群行為支持的功能評估、環境調整、個體化強化與最少限制原則,不支持以獎勵替代基本需要或溝通支持。引用於:訓練器材與教具
  504. 歐洲藥品管理局(EMA). Strensiq(asfotase alfa)歐洲公開評估報告[EB/OL]. European Medicines Agency, 2015. (訪問於 2026-10-07). 2015 年 8 月 28 日獲歐盟上市許可;適應證為兒童期起病的低鹼性磷酸酶血症患者的長期酶替代治療,用於治療骨骼表現。引用於:低鹼性磷酸酶血症
  505. Battaglia A, Carey J C, South S T. Wolf-Hirschhorn Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2015. (訪問於 2026-09-12). 2002 年 4 月首發,2015 年 8 月更新;該章節已歸檔。引用於:Wolf-Hirschhorn 綜合徵
  506. 北京市殘疾人聯合會(部分與北京市衛生計生委/衛生健康委、北京市中醫管理局、北京市民政局聯合). 政策法規 > 康復(欄目列表內的定點機構名單與新增通知,共 10 份)[EB/OL]. 北京市殘疾人聯合會網站, 2014—2024. (訪問於 2026-10-08).
  507. Looking after your child's splint[EB/OL]. Great Ormond Street Hospital for Children NHS Foundation Trust, 2014. (訪問於 2026-09-25). 頁面標註 2014 年複核。用於支具的清潔、熱變形、皮膚受壓及疼痛腫脹時聯繫專業人員等護理原則,不確定具體型號或穿戴時長。引用於:訓練器材與教具
  508. Battaglia A. 1p36 Deletion Syndrome[EB/OL]. GeneReviews®, University of Washington, Seattle, 2013. (訪問於 2026-09-12). 2008 年 2 月首發,2013 年 6 月更新;該章節已歸檔。引用於:1p36 缺失綜合徵
  509. 智障兒童系統康復訓練內容[EB/OL]. 北京市殘疾人聯合會, 2013. (訪問於 2026-10-02).引用於:認知能力訓練、日常生活活動能力訓練
  510. 蔻德罕見病中心. 關於我們[EB/OL]. 蔻德罕見病中心(CORD), 2013. (訪問於 2026-09-10). 2013 年成立的罕見病領域公益組織,原名罕見病發展中心。引用於:脊髓性肌萎縮症、腓骨肌萎縮症、肌強直性營養不良、先天性肌無力綜合徵、遺傳性痙攣性截癱、Rett 綜合徵、結節性硬化症、West 綜合徵、嬰兒嚴重肌陣攣性癲癇、脆性 X 綜合徵、神經纖維瘤病、CDKL5 缺乏症、Prader-Willi 綜合徵、威廉姆斯綜合徵、Noonan 綜合徵、Silver-Russell 綜合徵、苯丙酮尿症、糖原累積病Ⅱ型、黏多糖貯積症、甲基丙二酸血症、異染性腦白質營養不良、成骨不全症、軟骨發育不全、低磷性佝僂病、21-羥化酶缺乏症、原發性生長激素缺乏症、DYRK1A 綜合徵、Kabuki 綜合徵、Cornelia de Lange 綜合徵、Sotos 綜合徵、21 三體綜合徵、22q11.2 缺失綜合徵、Phelan-McDermid 綜合徵、Smith-Magenis 綜合徵、貓叫綜合徵、CHARGE 綜合徵、SYNGAP1 相關智力障礙、ADNP 綜合徵、CHD8 相關神經發育障礙、PTEN 錯構瘤腫瘤綜合徵、MECP2 重複綜合徵、15q11.2-q13.1 重複綜合徵、Potocki-Lupski 綜合徵、Pitt-Hopkins 綜合徵、Mowat-Wilson 綜合徵、KBG 綜合徵、Coffin-Siris 綜合徵、Koolen-de Vries 綜合徵、7q11.23 重複綜合徵、Kleefstra 綜合徵、Rubinstein-Taybi 綜合徵、Smith-Lemli-Opitz 綜合徵、腦肌酸缺乏綜合徵、GLUT1 缺乏綜合徵、神經元蠟樣脂褐質沉積症、四氫生物蝶呤缺乏症、X-連鎖腎上腺腦白質營養不良、線粒體腦肌病、尼曼匹克病、神經節苷脂貯積症、戊二酸血症Ⅰ型、楓糖尿症、生物素酶缺乏症、同型半胱氨酸血症、肝豆狀核變性、多巴反應性肌張力障礙、Lennox-Gastaut 綜合徵、非綜合徵型耳聾、1p36 缺失綜合徵、Wolf-Hirschhorn 綜合徵、Joubert 綜合徵、無腦回畸形、FOXG1 綜合徵、STXBP1 相關發育性癲癇性腦病、CTNNB1 相關神經發育障礙、SATB2 相關障礙、鳥氨酸氨甲酰基轉移酶缺乏症、瓜氨酸血症、精氨酸酶缺乏症、丙酸血症、異戊酸血症、原發性肉鹼缺乏症、戈謝病、全身型重症肌無力、低鹼性磷酸酶血症、馬凡綜合徵、面肩肱型肌營養不良症、先天性肌營養不良(膠原Ⅵ相關肌病)、慢性炎性脫髓鞘性多發性神經根神經病、亞歷山大病、Zellweger 譜系障礙、Menkes 病、Aicardi-Goutières 綜合徵、L1 綜合徵、共濟失調毛細血管擴張症、KCNQ2 相關障礙、進行性骨化性纖維發育不良、Dandy-Walker 畸形、Sturge-Weber 綜合徵、多小腦回、Bardet-Biedl 綜合徵、Leber 先天性黑矇、早產兒視網膜病變、中鏈酰基輔酶 A 脫氫酶缺乏症、極長鏈酰基輔酶 A 脫氫酶缺乏症、HHH 綜合徵、原發性酪氨酸血症、芳香族 L-氨基酸脫羧酶缺乏症、法佈雷病、胱氨酸貯積症、眼皮膚白化病、視網膜色素變性、脊髓小腦性共濟失調、發作性睡病、Christianson 綜合徵、自身免疫性腦炎、先天性脊柱側凸、先天性高胰島素性低血糖血症、先天性肌強直、血友病、遺傳性大皰性表皮鬆解症、Alagille 綜合徵、早老症、糖原累積病Ⅰ型、遺傳性果糖不耐受症、全羧化酶合成酶缺乏症、多種酰基輔酶 A 脫氫酶缺乏症、長鏈 3-羥酰基輔酶 A 脫氫酶缺乏症、β-酮硫解酶缺乏症、賴氨酸尿蛋白不耐受症、Krabbe 病、PMM2-CDG、吡哆醇依賴性癲癇、Lesch-Nyhan 綜合徵、非酮性高甘氨酸血症、3-甲基巴豆酰輔酶 A 羧化酶缺乏症、肢帶型肌營養不良、先天性肌病、先天性多發性關節攣縮、嬰兒神經軸索營養不良、泛酸激酶相關神經變性、DYT-TOR1A 肌張力障礙、兒童交替性偏癱、白質消融性白質腦病、SCN2A 相關疾病、Landau-Kleffner 綜合徵、Wiedemann-Steiner 綜合徵、Costello 綜合徵、心-面-皮膚綜合徵、煙霧病、Beckwith-Wiedemann 綜合徵、PIK3CA 相關過度生長綜合徵、新生兒持續肺動脈高壓、綜合徵性顱縫早閉、Ehlers-Danlos 綜合徵、Pierre Robin 序列徵、McCune-Albright 綜合徵、萊倫氏綜合徵、假性甲狀旁腺功能減退症、新生兒糖尿病、視隔發育不良、Usher 綜合徵、Waardenburg 綜合徵、兒童罕見病
  511. Autism spectrum disorder in under 19s: support and management (CG170)[EB/OL]. National Institute for Health and Care Excellence, 2013. (訪問於 2026-09-25). 2021 年更新。用於有意義的視覺提示、感覺環境調整與遊戲互動支持原則;不代表圖卡、計時器或玩具具有獨立療效。引用於:訓練器材與教具
  512. Weleber RG, 等. Leber Congenital Amaurosis[EB/OL]. GeneReviews®, University of Washington, Seattle, 2013. (訪問於 2026-09-12). 2004 年 7 月首發,2013 年 5 月最後更新;該章節已歸檔,僅作歷史參考。引用於:Leber 先天性黑矇
  513. Sparks SE, Quijano-Roy S, 等. Congenital Muscular Dystrophy Overview[EB/OL]. GeneReviews®, University of Washington, Seattle, 2012. (訪問於 2026-09-12). 2001 年 1 月首發,2012 年 8 月最後更新;該章節已歸檔,僅作歷史參考。引用於:先天性肌營養不良(膠原Ⅵ相關肌病)
  514. Spasticity in under 19s: management (CG145)[EB/OL]. National Institute for Health and Care Excellence, 2012. (訪問於 2026-09-25). 2016 年更新。用於痙攣兒童物理治療的個體目標、器材安全、照護培訓、體位支持及矯形器評估原則,不證明某一器材的療效。引用於:姿勢管理與體位擺放、訓練器材與教具
  515. Autism spectrum disorder in under 19s: recognition, referral and diagnosis (CG128)[EB/OL]. National Institute for Health and Care Excellence, 2011. (訪問於 2026-09-25). 孤獨症的識別、臨床診斷、伴隨疾病與有指徵的病因檢查;語言或社交能力倒退也可見於孤獨症。引用於:發育倒退、語言發育遲緩、孤獨症譜系障礙的鑑別與病因評估、神經發育障礙與癲癇性腦病
  516. Jaundice in newborn babies under 28 days (CG98)[EB/OL]. National Institute for Health and Care Excellence, 2010. (訪問於 2026-11-13).
  517. MedlinePlus Genetics. Rhizomelic chondrodysplasia punctata[EB/OL]. 美國國立醫學圖書館, 2010. (訪問於 2026-10-07). 2010 年 7 月更新。引用於:Zellweger 譜系障礙
  518. 李忠良. 新生兒行為神經測定[EB/OL]. 好大夫在線(濰坊市婦幼保健院), 2009. (訪問於 2026-09-07).引用於:NBNA 方法頁
  519. Palisano R, Rosenbaum P, Bartlett D, Livingston M. GMFCS – E & R: Gross Motor Function Classification System, Expanded and Revised[EB/OL]. CanChild Centre for Childhood Disability Research(McMaster University), 2007. (訪問於 2026-10-17). CanChild 的使用許可不允許公開轉載分級描述全文,頁面上只寫各級標題的大意與使用說明。
  520. U.S. Food and Drug Administration. Class 1 Device Recall Vail 500 Enclosed Bed System[EB/OL]. 美國食品藥品監督管理局醫療器械召回數據庫, 2005. (訪問於 2026-10-07).引用於:Smith-Magenis 綜合徵
  521. M. Rhonda Folio, Rebecca R. Fewell. Peabody Developmental Motor Scales, Second Edition (PDMS-2)[EB/OL]. Pearson Assessments, 2000. (訪問於 2026-09-25). 用於核對第二版量表的運動評估範圍及出生至未滿 6 歲的適用年齡;選擇工具時仍需考慮版本、常模與兒童情況。引用於:高危兒與早產兒早期干預、兒童腦癱康復
  522. U.S. Food and Drug Administration. Drugs@FDA: INOMAX (nitric oxide), NDA 020845[EB/OL]. Drugs@FDA, 1999. (訪問於 2026-10-07). 原始新藥申請的批准日期為 1999 年 12 月 23 日。引用於:新生兒持續肺動脈高壓
  523. 寶秀蘭醫療. "醫"路有愛,守護花開——寶秀蘭醫療攜手漯河市第二人民醫院、漯河市兒童醫院開展大型兒童健康義診活動(2024-11-15)[EB/OL]. 寶秀蘭醫療.引用於:合作機構
  524. WPS. (PEP-3) Psychoeducational Profile, Third Edition[EB/OL]. wpspublish.com. (訪問於 2026-09-30).引用於:語言行為與 VB-MAPP、結構化教學(TEACCH)
  525. 《孤獨症嬰幼兒早期介入丹佛模式》圖書頁[EB/OL]. 上海科學技術出版社. (訪問於 2026-09-30).引用於:早期介入丹佛模式(ESDM)
  526. 中國康復研究中心成功舉辦第二屆腦癱兒童神經發育療法(BOBATH)培訓班[EB/OL]. 首都醫科大學新聞網. (訪問於 2026-09-30).引用於:Bobath 療法(NDT)
  527. 香港耀能協會. 引導式教育[EB/OL]. sahk1963.org.hk. (訪問於 2026-09-30).引用於:引導式教育(CE)
  528. 劉維民. 肌張力高是腦癱?低是唐氏?關於肌張力家長最關心的 10 個問題[EB/OL]. 丁香醫生. (訪問於 2026-09-22).引用於:媒體報道與公開發表
  529. 寶秀蘭醫療. 門診部門口銅牌(實地照片)[EB/OL]. 寶秀蘭醫療.引用於:機構沿革
  530. 康復治療(兒童康復科)[EB/OL]. 中國康復研究中心. (訪問於 2026-10-02).引用於:日常生活活動能力訓練、物理因子治療、康復與干預方法
  531. 第十一屆應用行為分析教師(CNABA 丙級)培訓班招生簡章[EB/OL]. 中國精協孤獨症工作委員會主辦,承辦方網站 ccaba.com.cn. (訪問於 2026-09-30).引用於:應用行為分析(ABA)、回合式教學(DTT)、康復與干預方法
  532. 運動療法[EB/OL]. 中國康復研究中心. (訪問於 2026-10-02). 健康科普欄目,按體位介紹腦癱兒童的家庭訓練。引用於:姿勢管理與體位擺放
  533. 寶秀蘭醫療. 團隊榮譽[EB/OL]. 寶秀蘭醫療.引用於:鮑秀蘭教授
  534. 衛生專業技術資格考試專業目錄[EB/OL]. 衛生專業技術資格考試通知附件. (訪問於 2026-09-30).引用於:目標導向與任務導向訓練、強制性誘導運動療法與雙手強化訓練(CIMT)、減重步行與跑臺訓練、懸吊訓練(SET)、Vojta 療法、引導式教育(CE)、S-S 法、家長實施的語言干預、構音與語音訓練、輔助與替代溝通(AAC)、餵養與吞嚥治療、口部運動治療與口肌訓練、感覺統合治療(ASI)、書寫與精細動作訓練、康復與干預方法
  535. 百度百科. 鮑秀蘭(中國協和醫科大學兒科教授)[EB/OL]. 百度百科. (訪問於 2026-09-07). 三級來源,與同名詞條區分引用於:鮑秀蘭教授
  536. 北京協和醫院. 鮑秀蘭(專家介紹)[EB/OL]. 北京協和醫院官網. (訪問於 2026-09-07).引用於:機構沿革、鮑秀蘭教授、NBNA 方法頁
  537. 好大夫在線. 鮑秀蘭醫生簡介[EB/OL]. 好大夫在線. (訪問於 2026-09-07).引用於:鮑秀蘭教授
  538. 中國優生優育協會. 嬰幼兒發育專業委員會(委員名單)[EB/OL]. 中國優生優育協會. (訪問於 2026-09-07).引用於:機構沿革、合作機構、鮑秀蘭教授
  539. Semmelweis University András Pető Faculty. About Conductive Education[EB/OL]. semmelweis.hu. (訪問於 2026-09-30).引用於:引導式教育(CE)
  540. TEACCH Autism Program. About Us[EB/OL]. UNC School of Medicine, The University of North Carolina at Chapel Hill. (訪問於 2026-09-30).引用於:結構化教學(TEACCH)
  541. ESDM Training Program, UC Davis MIND Institute. Apprentice Trainer Certification[EB/OL]. esdm.co. (訪問於 2026-09-30).引用於:早期介入丹佛模式(ESDM)
  542. Augmentative and Alternative Communication (AAC)[EB/OL]. American Speech-Language-Hearing Association, Practice Portal. (訪問於 2026-09-25). 用於 AAC 的多種形式、功能性溝通、個體適配及無需先備能力的原則;溝通板不等於特定圖片交換教學程序。引用於:輔助與替代溝通(AAC)、圖片交換溝通系統(PECS)、訓練器材與教具
  543. Behavioral Intervention Plans (Elementary): Page 7 — Reinforcement-Based Interventions[EB/OL]. The IRIS Center, Vanderbilt University. (訪問於 2026-09-25). 用於學校行為支持中代幣記錄、個體化獎勵、替代技能與進展監測的實施原則,不把代幣板本身當作治療。引用於:訓練器材與教具
  544. Collaborative for Leadership in Ayres Sensory Integration. Certificate in Ayres Sensory Integration (CASI)[EB/OL]. cl-asi.org. (訪問於 2026-09-30).引用於:感覺統合治療(ASI)
  545. Pyramid Educational Consultants. Certified PECS Implementers, Managers, and Supervisors[EB/OL]. pecsusa.com. (訪問於 2026-09-30).引用於:圖片交換溝通系統(PECS)
  546. American Speech-Language-Hearing Association. Childhood Apraxia of Speech[EB/OL]. ASHA Practice Portal. (訪問於 2026-09-30).引用於:構音與語音訓練、輔助與替代溝通(AAC)、口部運動治療與口肌訓練、康復與干預方法
  547. Clinical Practice Guidelines: Ataxia[EB/OL]. The Royal Children’s Hospital Melbourne. (訪問於 2026-09-25). 兒童急性共濟失調的常見病因、危險徵象與評估原則。引用於:共濟失調
  548. Clinical Practice Guidelines: Metabolic disorders[EB/OL]. The Royal Children’s Hospital Melbourne. (訪問於 2026-09-25). 疑似代謝性急症的識別、緊急評估與專科協作原則;不用於家庭自行制定飲食或治療方案。引用於:急性代謝危象、遺傳代謝病
  549. Developmental co-ordination disorder (dyspraxia) in children — Treatment[EB/OL]. NHS. (訪問於 2026-09-25). 用於發育性協調障礙支持中的具體任務分析、活動分解與工具調整原則;不據教具表現診斷,也不將建議視為所有人群的器材療效證明。引用於:訓練器材與教具
  550. International Council on Development and Learning. DIRFloortime® Training Program Overview[EB/OL]. icdl.com. (訪問於 2026-09-30).引用於:地板時光(DIR)
  551. Pyramid Educational Consultants. Get PECS® Certified[EB/OL]. pecsusa.com. (訪問於 2026-09-30).引用於:輔助與替代溝通(AAC)、圖片交換溝通系統(PECS)
  552. Help Your Child’s Speech Sounds Develop – Pre-School (PIAG 0092)[EB/OL]. Alder Hey Children’s NHS Foundation Trust, Children’s Speech & Language Therapy Service. (訪問於 2026-11-18).
  553. Helpful activities for balance, coordination and stability[EB/OL]. Bedfordshire and Luton Children’s Health, NHS. (訪問於 2026-09-25). 用於治療球及平衡活動中的體位、足部接觸與任務示例;頁面面向協調困難兒童,不能照搬為嬰兒或所有殘障兒童的統一處方。引用於:訓練器材與教具
  554. MedlinePlus Genetics. Hereditary fructose intolerance[EB/OL]. National Library of Medicine (US). (訪問於 2026-09-30). 面向公眾的病種說明:表現、病因、遺傳方式,以及與果糖吸收不良的區別。引用於:遺傳性果糖不耐受症
  555. How to Keep Your Sleeping Baby Safe: AAP Policy Explained[EB/OL]. American Academy of Pediatrics — HealthyChildren.org. (訪問於 2026-09-25). 用於區分清醒且受看護的俯臥活動與嬰兒睡眠;睡眠應仰臥、使用堅實平坦表面,不用楔形墊或鬆軟定位用品代替。引用於:姿勢管理與體位擺放、康復與干預方法、訓練器材與教具
  556. International Bobath Instructors Training Association. IBITA[EB/OL]. ibita.org. (訪問於 2026-09-30).引用於:Bobath 療法(NDT)
  557. If your child is stammering (stuttering)[EB/OL]. STAMMA (British Stammering Association). (訪問於 2026-11-18).
  558. International Behavior Analysis Organization. International Behavior Analysis Organization[EB/OL]. theibao.com. (訪問於 2026-09-30).引用於:應用行為分析(ABA)
  559. Behavior Analyst Certification Board. International Development & Support[EB/OL]. bacb.com. (訪問於 2026-09-30).引用於:應用行為分析(ABA)、康復與干預方法
  560. Internationale Vojta Gesellschaft. International Vojta Society[EB/OL]. vojta.com. (訪問於 2026-09-30).引用於:Vojta 療法
  561. The Hanen Centre. It Takes Two to Talk® Program for Parents of Children with Language Delays[EB/OL]. hanen.org. (訪問於 2026-09-30). 課程版權方官網引用於:家長實施的語言干預
  562. The Hanen Centre. It Takes Two to Talk® workshop[EB/OL]. hanen.org. (訪問於 2026-09-30).引用於:家長介導干預、家長實施的語言干預
  563. Kasari Lab, UCLA. JASPER[EB/OL]. jaspertraining.org. (訪問於 2026-09-30).引用於:自然發展行為干預(NDBI)、遊戲治療與沙盤遊戲、康復與干預方法
  564. American Speech-Language-Hearing Association. Late Language Emergence[EB/OL]. ASHA Practice Portal. (訪問於 2026-09-30).引用於:家長實施的語言干預、輔助與替代溝通(AAC)、語言發育遲緩與構音障礙的訓練方法
  565. The Hanen Centre. More Than Words® workshop[EB/OL]. hanen.org. (訪問於 2026-09-30).引用於:家長介導干預
  566. Neuro-Developmental Treatment Association. NDT Certification[EB/OL]. ndta.org. (訪問於 2026-09-30).引用於:Bobath 療法(NDT)
  567. Brazelton Institute, Boston Children’s Hospital. Neonatal Behavioral Assessment Scale (NBAS)[EB/OL]. Boston Children’s Hospital. (訪問於 2026-09-20). 量表條目數各版本與各頁口徑不一,本站不寫條目數引用於:鮑秀蘭教授
  568. Redcord AS. NEURAC[EB/OL]. redcord.com. (訪問於 2026-09-30).引用於:懸吊訓練(SET)
  569. Pyramid Educational Consultants. Office Locations[EB/OL]. pecs.com. (訪問於 2026-09-30).引用於:輔助與替代溝通(AAC)、圖片交換溝通系統(PECS)
  570. Koegel Autism Consultants. Online PRT Certification[EB/OL]. autismprthelp.com. (訪問於 2026-09-30).引用於:自然發展行為干預(NDBI)、關鍵反應訓練(PRT)
  571. Brazelton Touchpoints Center. Our Founder: T. Berry Brazelton (1918–2018)[EB/OL]. Brazelton Touchpoints Center. (訪問於 2026-09-20).引用於:鮑秀蘭教授
  572. The Incredible Years. Parent Programs[EB/OL]. incredibleyears.com. (訪問於 2026-09-30).引用於:家長行為管理培訓(PMT)
  573. Pyramid Educational Consultants. PECS®: An Evidence-Based Practice[EB/OL]. pecsusa.com. (訪問於 2026-09-30). PECS 版權方官網引用於:語言行為與 VB-MAPP、結構化教學(TEACCH)、圖片交換溝通系統(PECS)
  574. Pediatric Feeding and Swallowing[EB/OL]. American Speech-Language-Hearing Association, Practice Portal. (訪問於 2026-09-25). 用於餵養吞嚥評估、適配餐具與體位、異常表現及單獨口部運動或感覺練習的證據侷限。引用於:餵養困難與兒童營養諮詢、餵養與吞嚥治療、口部運動治療與口肌訓練、餵養困難與吞嚥問題的干預方法、訓練器材與教具
  575. Pencil grips - tips and advice[EB/OL]. Children and Family Health Devon, NHS. (訪問於 2026-09-25). 用於圍繞書寫清晰度、速度、疼痛和疲勞評估握筆方式,並試用合適輔助工具;不要求所有兒童使用同一種握姿。引用於:訓練器材與教具
  576. 協康會. PEP-3 自閉症兒童心理教育評核工具及材料套(第三版—修訂)[EB/OL]. heephong.org. (訪問於 2026-09-30).引用於:結構化教學(TEACCH)
  577. Internationale Vojta Gesellschaft. Prof Václav Vojta[EB/OL]. vojta.com. (訪問於 2026-09-30).引用於:Vojta 療法
  578. Qualified Applied Behavior Analysis Credentialing Board. QABA Credentialing Board[EB/OL]. qababoard.com. (訪問於 2026-09-30).引用於:應用行為分析(ABA)
  579. RDIconnect. RDI Professional Autism Certification Program[EB/OL]. rdiconnect.com. (訪問於 2026-09-30).引用於:人際關係發展干預(RDI)
  580. Internationale Vojta Gesellschaft. Reflex Locomotion – The Fundamentals of Vojta Therapy[EB/OL]. vojta.com. (訪問於 2026-09-30).引用於:Bobath 療法(NDT)、Vojta 療法、引導式教育(CE)
  581. USC Chan Division of Occupational Science and Occupational Therapy. Sensory Integration[EB/OL]. chan.usc.edu. (訪問於 2026-09-30).引用於:嬰兒撫觸與被動操、感覺統合治療(ASI)
  582. Gray C. Social Stories™[EB/OL]. carolgraysocialstories.com. (訪問於 2026-09-30).引用於:社交故事
  583. Speech Sound Disorders: Articulation and Phonology[EB/OL]. American Speech-Language-Hearing Association, Practice Portal. (訪問於 2026-09-25). 用於兒童語音評估、鏡面視覺提示與聲學反饋的特定用途,不把可見口形或屏幕表現當作診斷。引用於:S-S 法、構音與語音訓練、口部運動治療與口肌訓練、訓練器材與教具
  584. Spoken Language Disorders[EB/OL]. American Speech-Language-Hearing Association, Practice Portal. (訪問於 2026-09-25). 用於語言目標、圖片情景、互動共讀與自然情境中的練習原則;不證明某套卡片、書或手偶具有獨立療效。引用於:訓練器材與教具
  585. American Speech-Language-Hearing Association. Stuttering, Cluttering, and Fluency[EB/OL]. ASHA Practice Portal. (訪問於 2026-11-18).
  586. Talking with a child who stammers[EB/OL]. STAMMA (British Stammering Association). (訪問於 2026-11-18).
  587. TEACCH Autism Program. TEACCH® Certification Program[EB/OL]. teacch.com. (訪問於 2026-09-30).引用於:結構化教學(TEACCH)
  588. International Council on Development and Learning. The Functional Emotional Developmental Capacities (FEDCs)[EB/OL]. icdl.com. (訪問於 2026-10-01).引用於:地板時光(DIR)
  589. The PROMPT Institute. The PROMPT Training Process[EB/OL]. prompt.org. (訪問於 2026-09-30).引用於:構音與語音訓練
  590. ESDM Training Program, UC Davis MIND Institute. Therapist Certification[EB/OL]. esdm.co. (訪問於 2026-09-30).引用於:自然發展行為干預(NDBI)、早期介入丹佛模式(ESDM)
  591. Toys — Safety Education[EB/OL]. U.S. Consumer Product Safety Commission. (訪問於 2026-09-25). 僅用於玩具能力匹配、小件誤吞、包裝及產品安全信息;普通玩具與教具的安全資料不是醫療療效試驗。引用於:訓練器材與教具
  592. World Health Organization. Training for caregivers of children with developmental disabilities, including autism[EB/OL]. World Health Organization. (訪問於 2026-09-30).引用於:家長介導干預
  593. Triple P International. Triple P in a nutshell[EB/OL]. triplep.net. (訪問於 2026-09-30).引用於:家長行為管理培訓(PMT)
  594. UCLA Semel Institute for Neuroscience and Human Behavior. UCLA PEERS® Clinic[EB/OL]. semel.ucla.edu. (訪問於 2026-09-30).引用於:社交技能小組訓練
  595. Sundberg ML. VB-MAPP[EB/OL]. marksundberg.com. (訪問於 2026-09-30).引用於:語言行為與 VB-MAPP
  596. Voice Disorders[EB/OL]. American Speech-Language-Hearing Association, Practice Portal. (訪問於 2026-09-25). 用於嗓音的醫學與專業評估、聲學測量及反饋;持續嘶啞或發聲不適不應僅靠增加訓練強度處理。引用於:訓練器材與教具
  597. International Council on Development and Learning. What is DIR®?[EB/OL]. icdl.com. (訪問於 2026-09-30).引用於:地板時光(DIR)
  598. International Council on Development and Learning. What is Floortime?[EB/OL]. icdl.com. (訪問於 2026-09-30).引用於:早期介入丹佛模式(ESDM)、家長介導干預、地板時光(DIR)、遊戲治療與沙盤遊戲
  599. PCIT International. What is PCIT?[EB/OL]. pcit.org. (訪問於 2026-09-30).引用於:遊戲治療與沙盤遊戲、家長行為管理培訓(PMT)
  600. RDIconnect. What is RDI® for Autism?[EB/OL]. rdiconnect.com. (訪問於 2026-09-30).引用於:人際關係發展干預(RDI)
  601. Work System[EB/OL]. Nebraska Autism Spectrum Disorders Network, University of Nebraska–Lincoln. (訪問於 2026-09-25). 用於工作系統對任務、數量、完成與後續活動的提示,以及個體化佈局和跨情境應用;盒子只是組織形式。引用於:結構化教學(TEACCH)、訓練器材與教具

文章參考文獻534

育兒課堂各篇文章末尾列出的參考文獻,按文章歸組。

自閉症最早幾個月能看出來:1–2 歲要留意哪些表現

  1. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  2. 中華醫學會兒科學分會發育行為學組, 中國醫師協會兒科分會兒童保健專業委員會, 兒童孤獨症診斷與防治技術和標準研究項目專家組. 孤獨症譜系障礙兒童早期識別篩查和早期干預專家共識[J]. 中華兒科雜誌, 2017, 55(12): 890-897. DOI: 10.3760/cma.j.issn.0578-1310.2017.12.004.
  3. 衛生部辦公廳. 兒童孤獨症診療康復指南(衛辦醫政發〔2010〕123 號)[S]. 衛生部, 2010. (訪問於 2026-09-07).
  4. 3 Early Signs of Autism in Children[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2025. (訪問於 2026-11-18).
  5. Signs and Symptoms of Autism Spectrum Disorder[EB/OL]. U.S. Centers for Disease Control and Prevention, 2024. (訪問於 2026-11-18).
  6. 國家衛生計生委. 國家基本公共衛生服務規範(第三版):0~6 歲兒童健康管理服務規範(國衛基層發〔2017〕13 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-07).
  7. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).

寶寶幾個月會抬頭:抬頭不穩、總歪向一邊怎麼辦

  1. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  2. 潘虹地, 張悅, 李一辰, 等. 2020年中國15省嬰幼兒大運動發育進程研究[J]. 中國兒童保健雜誌, 2022, 30(10): 1053-1057. DOI: 10.11852/zgetbjzz2022-0342.
  3. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  4. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10).
  5. Zubler JM, Wiggins LD, Macias MM, 等. Evidence-Informed Milestones for Developmental Surveillance Tools[J]. Pediatrics, 2022, 149(3): e2021052138. DOI: 10.1542/peds.2021-052138.
  6. Movement Milestones: Babies 4 to 7 Months[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2021. (訪問於 2026-11-13).
  7. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25).
  8. Suspected neurological conditions: recognition and referral (NG127): recommendations for children aged under 16[EB/OL]. National Institute for Health and Care Excellence, 2019. (訪問於 2026-09-25).
  9. 唐婉秋, 羅小鴻, 張雨平. 《先天性肌性斜頸的物理治療管理:美國物理治療協會兒科物理治療學會2024年循證臨床實踐指南》解讀[J]. 中國當代兒科雜誌, 2025, 27(9): 1045-1049. DOI: 10.7499/j.issn.1008-8830.2502066.
  10. Kaplan SL, Coulter C, Sargent B. Physical therapy management of congenital muscular torticollis: a 2018 evidence-based clinical practice guideline from the APTA Academy of Pediatric Physical Therapy[J]. Pediatric Physical Therapy, 2018, 30(4): 240-290. DOI: 10.1097/PEP.0000000000000544.
  11. 北京市衛生和計劃生育委員會. 北京市衛生和計劃生育委員會關於落實《早產兒保健工作規範》的通知[S]. 北京市衛生健康委員會網站, 2018. (訪問於 2026-10-08).
  12. 3 Tummy Time Activities to Try With Your Baby[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2023. (訪問於 2026-11-18).
  13. How to Keep Your Sleeping Baby Safe: AAP Policy Explained[EB/OL]. American Academy of Pediatrics — HealthyChildren.org. (訪問於 2026-09-25).
  14. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).

孩子說話不清楚:幾歲該吐字清楚,要不要剪舌繫帶

  1. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  2. Speech Sound Disorders[EB/OL]. Communication Health Support Association(helpingyoucommunicate.org), 2026. (訪問於 2026-11-18).
  3. Messner AH, Walsh J, Rosenfeld RM, 等. Clinical consensus statement: ankyloglossia in children[J]. Otolaryngology–Head and Neck Surgery, 2020, 162(5): 597-611. DOI: 10.1177/0194599820915457.
  4. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10).
  5. Speech Sound Disorders: Articulation and Phonology[EB/OL]. American Speech-Language-Hearing Association, Practice Portal. (訪問於 2026-09-25).
  6. 中華人民共和國教育部. 3-6 歲兒童學習與發展指南(教基二〔2012〕4 號)[S]. 中華人民共和國教育部, 2012. (訪問於 2026-09-10).
  7. 黃麗萍, 曾佩佩, 陳玲, 等. 不同年齡段兒童功能性構音障礙臨床特徵分析[J]. 中國兒童保健雜誌, 2020, 28(9): 1024-1027. DOI: 10.11852/zgetbjzz2020-0596.
  8. 中華醫學會兒科學分會神經學組, 中國醫師協會神經內科分會兒童神經疾病專業委員會. 兒童智力障礙或全面發育遲緩病因診斷策略專家共識[J]. 中華兒科雜誌, 2018, 56(11): 806-810. DOI: 10.3760/cma.j.issn.0578-1310.2018.11.003.
  9. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  10. 汲嶽芝, 阮文華. 嬰幼兒舌繫帶過短的診斷及治療[J]. 華西口腔醫學雜誌, 2020, 38(4).
  11. 黃椿棚, 劉顯, 包崇雲. 嬰幼兒舌繫帶過短的臨床診療新進展[J]. 國際口腔醫學雜誌, 2018, 45(4).
  12. 國家衛生計生委. 國家基本公共衛生服務規範(第三版):0~6 歲兒童健康管理服務規範(國衛基層發〔2017〕13 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-07).
  13. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  14. Help Your Child’s Speech Sounds Develop – Pre-School (PIAG 0092)[EB/OL]. Alder Hey Children’s NHS Foundation Trust, Children’s Speech & Language Therapy Service. (訪問於 2026-11-18).
  15. Tips for Your Child’s Speech and Language Development[EB/OL]. Communication Health Support Association(helpingyoucommunicate.org), 2026. (訪問於 2026-11-18).

寶寶認人幾個月開始:認生怎麼回事,不認生要緊嗎

  1. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  2. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  3. Social and Emotional Development: 9 Months Old[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2026. (訪問於 2026-11-18).
  4. 國家衛生計生委辦公廳. 兒童心理保健技術規範(含兒童心理行為發育問題預警徵象篩查表)[S]. 國家衛生計生委, 2013. (訪問於 2026-09-07).
  5. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  6. 衛生部辦公廳. 兒童孤獨症診療康復指南(衛辦醫政發〔2010〕123 號)[S]. 衛生部, 2010. (訪問於 2026-09-07).
  7. 中華醫學會兒科學分會發育行為學組, 中國醫師協會兒科分會兒童保健專業委員會, 兒童孤獨症診斷與防治技術和標準研究項目專家組. 孤獨症譜系障礙兒童早期識別篩查和早期干預專家共識[J]. 中華兒科雜誌, 2017, 55(12): 890-897. DOI: 10.3760/cma.j.issn.0578-1310.2017.12.004.

孩子說話結巴怎麼辦:是口吃嗎,什麼時候評估

  1. Stuttering and Cluttering[EB/OL]. Communication Health Support Association(helpingyoucommunicate.org), 2026. (訪問於 2026-11-18).
  2. American Speech-Language-Hearing Association. Stuttering, Cluttering, and Fluency[EB/OL]. ASHA Practice Portal. (訪問於 2026-11-18).
  3. 馬丹, 張文麗, 曹玲, 等. 發育性口吃的機制、評估和干預進展[J]. 中國兒童保健雜誌, 2022, 30(7): 750-754. DOI: 10.11852/zgetbjzz2021-0665.
  4. National Institute on Deafness and Other Communication Disorders. Stuttering[EB/OL]. National Institutes of Health, 2017. (訪問於 2026-11-18).
  5. If your child is stammering (stuttering)[EB/OL]. STAMMA (British Stammering Association). (訪問於 2026-11-18).
  6. Stammering[EB/OL]. National Health Service (UK), 2023. (訪問於 2026-11-18).
  7. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  8. Talking with a child who stammers[EB/OL]. STAMMA (British Stammering Association). (訪問於 2026-11-18).
  9. 中華人民共和國教育部. 3-6 歲兒童學習與發展指南(教基二〔2012〕4 號)[S]. 中華人民共和國教育部, 2012. (訪問於 2026-09-10).

寶寶歪頭是斜頸嗎:怎麼區分,幾個月要看

  1. Kaplan SL, Coulter C, Sargent B. Physical therapy management of congenital muscular torticollis: a 2018 evidence-based clinical practice guideline from the APTA Academy of Pediatric Physical Therapy[J]. Pediatric Physical Therapy, 2018, 30(4): 240-290. DOI: 10.1097/PEP.0000000000000544.
  2. 唐婉秋, 羅小鴻, 張雨平. 《先天性肌性斜頸的物理治療管理:美國物理治療協會兒科物理治療學會2024年循證臨床實踐指南》解讀[J]. 中國當代兒科雜誌, 2025, 27(9): 1045-1049. DOI: 10.7499/j.issn.1008-8830.2502066.
  3. Suspected neurological conditions: recognition and referral (NG127): recommendations for children aged under 16[EB/OL]. National Institute for Health and Care Excellence, 2019. (訪問於 2026-09-25).
  4. Laughlin J, Luerssen TG, Dias MS, 等. Prevention and management of positional skull deformities in infants[J]. Pediatrics, 2011, 128(6): 1236-1241. DOI: 10.1542/peds.2011-2220.
  5. Sargent B, Coulter C, Cannoy J, 等. Physical therapy management of congenital muscular torticollis: a 2024 evidence-based clinical practice guideline from the American Physical Therapy Association Academy of Pediatric Physical Therapy[J]. Pediatric Physical Therapy, 2024, 36(4): 370-421. DOI: 10.1097/PEP.0000000000001114.
  6. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  7. 3 Tummy Time Activities to Try With Your Baby[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2023. (訪問於 2026-11-18).
  8. How to Keep Your Sleeping Baby Safe: AAP Policy Explained[EB/OL]. American Academy of Pediatrics — HealthyChildren.org. (訪問於 2026-09-25).

學步車能用嗎:幾個月能坐,對學走路有沒有幫助

  1. Baby Walkers: A Dangerous Choice[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2022. (訪問於 2026-09-25).
  2. American Academy of Pediatrics Committee on Injury and Poison Prevention. Injuries associated with infant walkers[J]. Pediatrics, 2001, 108(3): 790-792. DOI: 10.1542/peds.108.3.790.
  3. Sims A, Chounthirath T, Yang J, 等. Infant walker-related injuries in the United States[J]. Pediatrics, 2018, 142(4): e20174332. DOI: 10.1542/peds.2017-4332.
  4. Badihian S, Adihian N, Yaghini O. The effect of baby walker on child development: a systematic review[J]. Iranian Journal of Child Neurology, 2017, 11(4): 1-6.
  5. Siegel AC, Burton RV. Effects of baby walkers on motor and mental development in human infants[J]. Journal of Developmental and Behavioral Pediatrics, 1999, 20(5): 355-360. DOI: 10.1097/00004703-199910000-00010.
  6. WHO Multicentre Growth Reference Study Group. WHO Motor Development Study: windows of achievement for six gross motor development milestones[J]. Acta Paediatrica Supplement, 2006, 450: 86-95. DOI: 10.1111/j.1651-2227.2006.tb02379.x.
  7. 潘虹地, 張悅, 李一辰, 等. 2020年中國15省嬰幼兒大運動發育進程研究[J]. 中國兒童保健雜誌, 2022, 30(10): 1053-1057. DOI: 10.11852/zgetbjzz2022-0342.
  8. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  9. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  10. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10).
  11. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  12. Suspected neurological conditions: recognition and referral (NG127): recommendations for children aged under 16[EB/OL]. National Institute for Health and Care Excellence, 2019. (訪問於 2026-09-25).
  13. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25).

寶寶幾個月會翻身:不會翻身、只往一邊翻要緊嗎

  1. Movement Milestones: Babies 4 to 7 Months[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2021. (訪問於 2026-11-13).
  2. 潘虹地, 張悅, 李一辰, 等. 2020年中國15省嬰幼兒大運動發育進程研究[J]. 中國兒童保健雜誌, 2022, 30(10): 1053-1057. DOI: 10.11852/zgetbjzz2022-0342.
  3. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  4. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10).
  5. Zubler JM, Wiggins LD, Macias MM, 等. Evidence-Informed Milestones for Developmental Surveillance Tools[J]. Pediatrics, 2022, 149(3): e2021052138. DOI: 10.1542/peds.2021-052138.
  6. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  7. 國家衛生計生委辦公廳. 兒童心理保健技術規範(含兒童心理行為發育問題預警徵象篩查表)[S]. 國家衛生計生委, 2013. (訪問於 2026-09-07).
  8. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25).
  9. Suspected neurological conditions: recognition and referral (NG127): recommendations for children aged under 16[EB/OL]. National Institute for Health and Care Excellence, 2019. (訪問於 2026-09-25).
  10. How to Keep Your Sleeping Baby Safe: AAP Policy Explained[EB/OL]. American Academy of Pediatrics — HealthyChildren.org. (訪問於 2026-09-25).
  11. 國家衛生計生委. 0 歲~5 歲兒童睡眠衛生指南 WS/T 579—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  12. 北京市衛生和計劃生育委員會. 北京市衛生和計劃生育委員會關於落實《早產兒保健工作規範》的通知[S]. 北京市衛生健康委員會網站, 2018. (訪問於 2026-10-08).
  13. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).

寶寶幾個月會坐:坐不穩、往後倒,什麼時候要評估

  1. 潘虹地, 張悅, 李一辰, 等. 2020年中國15省嬰幼兒大運動發育進程研究[J]. 中國兒童保健雜誌, 2022, 30(10): 1053-1057. DOI: 10.11852/zgetbjzz2022-0342.
  2. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  3. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  4. WHO Multicentre Growth Reference Study Group. WHO Motor Development Study: windows of achievement for six gross motor development milestones[J]. Acta Paediatrica Supplement, 2006, 450: 86-95. DOI: 10.1111/j.1651-2227.2006.tb02379.x.
  5. Movement Milestones: Babies 4 to 7 Months[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2021. (訪問於 2026-11-13).
  6. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10).
  7. Zubler JM, Wiggins LD, Macias MM, 等. Evidence-Informed Milestones for Developmental Surveillance Tools[J]. Pediatrics, 2022, 149(3): e2021052138. DOI: 10.1542/peds.2021-052138.
  8. Suspected neurological conditions: recognition and referral (NG127): recommendations for children aged under 16[EB/OL]. National Institute for Health and Care Excellence, 2019. (訪問於 2026-09-25).
  9. 北京市衛生和計劃生育委員會. 北京市衛生和計劃生育委員會關於落實《早產兒保健工作規範》的通知[S]. 北京市衛生健康委員會網站, 2018. (訪問於 2026-10-08).
  10. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  11. Nordon DG, Passone CGB, da Silva CAA, 等. W-Sitting In Childhood: A Systematic Review[J]. Acta Ortopedica Brasileira, 2024, 32(6): e279277. DOI: 10.1590/1413-785220243206e279277.

發育遲緩是智力障礙嗎:全面發育遲緩與智力障礙怎麼區分

  1. 中華醫學會兒科學分會神經學組, 中國醫師協會神經內科分會兒童神經疾病專業委員會. 兒童智力障礙或全面發育遲緩病因診斷策略專家共識[J]. 中華兒科雜誌, 2018, 56(11): 806-810. DOI: 10.3760/cma.j.issn.0578-1310.2018.11.003.
  2. McLeod S, Kawamura A, Orsino A. Assessing children and youth with global developmental delay and intellectual developmental disorder[EB/OL]. Canadian Paediatric Society, 2026-03-27. (訪問於 2026-09-23).
  3. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  4. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-25).
  5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5)[M]. American Psychiatric Publishing, 2013.
  6. 李曉捷, 唐久來, 馬丙祥, 等. 腦性癱瘓的定義、診斷標準及臨床分型[J]. 中華實用兒科臨床雜誌, 2014, 29(19): 1520. DOI: 10.3760/cma.j.issn.2095-428X.2014.19.024.
  7. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).

囟門幾個月閉合:囟門大小和智力有關嗎,是缺鈣嗎

  1. Kiesler J, Ricer R. The abnormal fontanel[J]. American Family Physician, 2003, 67(12): 2547-2552.
  2. Liu Y, Li H, Zhang YQ, 等. Development of anterior fontanelle in Chinese children in 2015[J]. Zhonghua Er Ke Za Zhi, 2017, 55(8): 602-607. DOI: 10.3760/cma.j.issn.0578-1310.2017.08.011.
  3. 國家衛生健康委. 7 歲以下兒童生長標準 WS/T 423—2022[S]. 中華人民共和國衛生行業標準, 2022. (訪問於 2026-09-07).
  4. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  5. Munns CF, Shaw N, Kiely M, 等. Global consensus recommendations on prevention and management of nutritional rickets[J]. The Journal of Clinical Endocrinology & Metabolism, 2016, 101(2): 394-415. DOI: 10.1210/jc.2015-2175.
  6. 陳蝶, 李軒, 唐孟言, 等. 0~3歲嬰幼兒前囟遲閉的影響因素研究[J]. 中國兒童保健雜誌, 2021, 29(2): 226-229. DOI: 10.11852/zgetbjzz2020-0043.
  7. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  8. 國家衛生計生委. 國家基本公共衛生服務規範(第三版):0~6 歲兒童健康管理服務規範(國衛基層發〔2017〕13 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-07).

新生兒黃疸高會影響智力嗎:膽紅素腦病與出院後的隨訪

  1. 中華醫學會兒科學分會新生兒學組, 《中國當代兒科雜誌》編輯委員會. 基層醫療衛生機構常見新生兒疾病診療指南:新生兒黃疸(2025年)[J]. 中國當代兒科雜誌, 2025, 27(12): 1433-1443. DOI: 10.7499/j.issn.1008-8830.2505012.
  2. Jaundice in newborn babies under 28 days (CG98)[EB/OL]. National Institute for Health and Care Excellence, 2010. (訪問於 2026-11-13).
  3. Kemper AR, Newman TB, Slaughter JL, 等. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation[J]. Pediatrics, 2022, 150(3): e2022058859. DOI: 10.1542/peds.2022-058859.
  4. Itoh S, Okada H, Koyano K, 等. Fetal and neonatal bilirubin metabolism[J]. Frontiers in Pediatrics, 2022, 10: 1002408. DOI: 10.3389/fped.2022.1002408.
  5. 衛生部辦公廳. 新生兒訪視技術規範(《新生兒訪視等兒童保健技術規範》附件 1,衛辦婦社發〔2012〕49 號)[S]. 衛生部, 2012. (訪問於 2026-10-08).

早產兒智力會受影響嗎:長大後能和足月兒一樣嗎

  1. 北京市衛生和計劃生育委員會. 北京市衛生和計劃生育委員會關於落實《早產兒保健工作規範》的通知[S]. 北京市衛生健康委員會網站, 2018. (訪問於 2026-10-08).
  2. Developmental follow-up of children and young people born preterm (NG72)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-11-02).
  3. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-25).
  4. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  5. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  6. 中國醫師協會新生兒科醫師分會早產兒專業委員會, 中華兒科雜誌編輯委員會. 早產兒出院後隨訪與健康管理專家共識(2025)[J]. 中華兒科雜誌, 2025, 63(7): 721-736. DOI: 10.3760/cma.j.cn112140-20250117-00050.

一歲不會說話正常嗎:1 歲該會什麼,什麼時候要評估

  1. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  2. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10).
  3. American Speech-Language-Hearing Association. Late Language Emergence[EB/OL]. ASHA Practice Portal. (訪問於 2026-09-30).
  4. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  5. 衛生部辦公廳. 兒童孤獨症診療康復指南(衛辦醫政發〔2010〕123 號)[S]. 衛生部, 2010. (訪問於 2026-09-07).
  6. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  7. 北京市衛生和計劃生育委員會. 北京市衛生和計劃生育委員會關於落實《早產兒保健工作規範》的通知[S]. 北京市衛生健康委員會網站, 2018. (訪問於 2026-10-08).
  8. 北京市衛生和計劃生育委員會, 北京市殘疾人聯合會, 北京市財政局. 北京市衛生和計劃生育委員會 北京市殘疾人聯合會 北京市財政局關於開展 0-6歲兒童殘疾篩查工作的通知[S]. 北京市衛生健康委員會網站 政策文件, 2018. (訪問於 2026-10-08).

寶寶幾個月會說話:0–2 歲語言發育時間表

  1. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10).
  2. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  3. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  4. American Speech-Language-Hearing Association. Late Language Emergence[EB/OL]. ASHA Practice Portal. (訪問於 2026-09-30).
  5. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  6. 北京市衛生和計劃生育委員會. 北京市衛生和計劃生育委員會關於落實《早產兒保健工作規範》的通知[S]. 北京市衛生健康委員會網站, 2018. (訪問於 2026-10-08).

寶寶語言啟蒙怎麼做:0–3 歲在家怎樣和寶寶說話

  1. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  2. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10).
  3. American Speech-Language-Hearing Association. Late Language Emergence[EB/OL]. ASHA Practice Portal. (訪問於 2026-09-30).
  4. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).

寶寶肌張力高怎麼辦:是不是腦癱,要不要康復訓練

  1. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25).
  2. 李曉捷, 唐久來, 馬丙祥, 等. 腦性癱瘓的定義、診斷標準及臨床分型[J]. 中華實用兒科臨床雜誌, 2014, 29(19): 1520. DOI: 10.3760/cma.j.issn.2095-428X.2014.19.024.
  3. Suspected neurological conditions: recognition and referral (NG127): recommendations for children aged under 16[EB/OL]. National Institute for Health and Care Excellence, 2019. (訪問於 2026-09-25).
  4. Novak I, Morgan C, Adde L, 等. Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment[J]. JAMA Pediatrics, 2017, 171(9): 897-907. DOI: 10.1001/jamapediatrics.2017.1689.
  5. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第二章:腦性癱瘓高危兒的評定與干預[J]. 中華實用兒科臨床雜誌, 2022, 37(13): 974-982. DOI: 10.3760/cma.j.cn101070-20220519-00574.
  6. 中國醫師協會兒科醫師分會兒童保健學組. NICU出院高危兒0~3歲生長發育隨訪管理技術的專家共識[J]. 中國兒童保健雜誌, 2021, 29(8): 809-814. DOI: 10.11852/zgetbjzz2020-2035.
  7. Amiel-Tison C, Grenier A. Neurological assessment during the first year of life[M]. Oxford University Press, 1986. ISBN 9780195035070.
  8. 吳衛紅, 鮑秀蘭, 席冰玉, 等. 0~1 歲 52 項神經運動檢查和簡化 20 項相關性研究[J]. 中國兒童保健雜誌, 2014, 22(3): 310-311.
  9. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-25).
  10. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).

腦白質發育落後是什麼:核磁報告寫髓鞘化延遲要緊嗎

  1. Holland BA, Haas DK, Norman D, 等. MRI of normal brain maturation[J]. AJNR. American Journal of Neuroradiology, 1986, 7(2): 201-208.
  2. Parazzini C, Baldoli C, Scotti G, 等. Terminal zones of myelination: MR evaluation of children aged 20-40 months[J]. AJNR. American Journal of Neuroradiology, 2002, 23(10): 1669-1673.
  3. 中華醫學會兒科學分會神經學組, 中國醫師協會神經內科分會兒童神經疾病專業委員會. 兒童智力障礙或全面發育遲緩病因診斷策略專家共識[J]. 中華兒科雜誌, 2018, 56(11): 806-810. DOI: 10.3760/cma.j.issn.0578-1310.2018.11.003.
  4. Murias K, Moir A, Myers KA, et al. Systematic review of MRI findings in children with developmental delay or cognitive impairment[J]. Brain and Development, 2017, 39(8): 644-655. DOI: 10.1016/j.braindev.2017.04.006.
  5. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25).
  6. 李曉捷, 唐久來, 馬丙祥, 等. 腦性癱瘓的定義、診斷標準及臨床分型[J]. 中華實用兒科臨床雜誌, 2014, 29(19): 1520. DOI: 10.3760/cma.j.issn.2095-428X.2014.19.024.

新生兒腦損傷會腦癱嗎:腦白質軟化、缺氧缺血性腦病怎麼隨訪

  1. 中國醫師協會新生兒專業委員會. 早產兒腦損傷診斷與防治專家共識[J]. 中國當代兒科雜誌, 2012, 14(12): 883-884.
  2. 中華醫學會兒科學分會新生兒學組. 新生兒缺氧缺血性腦病診斷標準[J]. 中國當代兒科雜誌, 2005, 7(2): 97-98.
  3. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25).
  4. Chakkarapani E, de Vries LS, Ferriero DM, 等. Neonatal encephalopathy and hypoxic-ischemic encephalopathy: the state of the art[J]. Pediatric Research, 2025, 98(7): 2444-2458. DOI: 10.1038/s41390-025-03986-2.
  5. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-25).
  6. Novak I, Morgan C, Adde L, 等. Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment[J]. JAMA Pediatrics, 2017, 171(9): 897-907. DOI: 10.1001/jamapediatrics.2017.1689.
  7. 李曉捷, 唐久來, 馬丙祥, 等. 腦性癱瘓的定義、診斷標準及臨床分型[J]. 中華實用兒科臨床雜誌, 2014, 29(19): 1520. DOI: 10.3760/cma.j.issn.2095-428X.2014.19.024.
  8. 中國醫師協會兒科醫師分會兒童保健學組. NICU出院高危兒0~3歲生長發育隨訪管理技術的專家共識[J]. 中國兒童保健雜誌, 2021, 29(8): 809-814. DOI: 10.11852/zgetbjzz2020-2035.
  9. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第二章:腦性癱瘓高危兒的評定與干預[J]. 中華實用兒科臨床雜誌, 2022, 37(13): 974-982. DOI: 10.3760/cma.j.cn101070-20220519-00574.

大運動落後要康復嗎:運動發育遲緩能追上嗎

  1. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  2. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  3. 中華醫學會兒科學分會神經學組, 中國醫師協會神經內科分會兒童神經疾病專業委員會. 兒童智力障礙或全面發育遲緩病因診斷策略專家共識[J]. 中華兒科雜誌, 2018, 56(11): 806-810. DOI: 10.3760/cma.j.issn.0578-1310.2018.11.003.
  4. 李曉捷, 唐久來, 馬丙祥, 等. 腦性癱瘓的定義、診斷標準及臨床分型[J]. 中華實用兒科臨床雜誌, 2014, 29(19): 1520. DOI: 10.3760/cma.j.issn.2095-428X.2014.19.024.
  5. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25).
  6. Suspected neurological conditions: recognition and referral (NG127): recommendations for children aged under 16[EB/OL]. National Institute for Health and Care Excellence, 2019. (訪問於 2026-09-25).
  7. 北京市衛生和計劃生育委員會, 北京市殘疾人聯合會, 北京市財政局. 北京市衛生和計劃生育委員會 北京市殘疾人聯合會 北京市財政局關於開展 0-6歲兒童殘疾篩查工作的通知[S]. 北京市衛生健康委員會網站 政策文件, 2018. (訪問於 2026-10-08).
  8. WHO Multicentre Growth Reference Study Group. WHO Motor Development Study: windows of achievement for six gross motor development milestones[J]. Acta Paediatrica Supplement, 2006, 450: 86-95. DOI: 10.1111/j.1651-2227.2006.tb02379.x.
  9. 北京市衛生和計劃生育委員會. 北京市衛生和計劃生育委員會關於落實《早產兒保健工作規範》的通知[S]. 北京市衛生健康委員會網站, 2018. (訪問於 2026-10-08).

一歲不會扶站正常嗎:扶站、獨站與腿軟站不住

  1. WHO Multicentre Growth Reference Study Group. WHO Motor Development Study: windows of achievement for six gross motor development milestones[J]. Acta Paediatrica Supplement, 2006, 450: 86-95. DOI: 10.1111/j.1651-2227.2006.tb02379.x.
  2. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  3. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  4. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10).
  5. Suspected neurological conditions: recognition and referral (NG127): recommendations for children aged under 16[EB/OL]. National Institute for Health and Care Excellence, 2019. (訪問於 2026-09-25).
  6. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25).
  7. 北京市衛生和計劃生育委員會. 北京市衛生和計劃生育委員會關於落實《早產兒保健工作規範》的通知[S]. 北京市衛生健康委員會網站, 2018. (訪問於 2026-10-08).

腦癱分型有哪些:痙攣型、不隨意運動型怎麼分,GMFCS 幾級能走

  1. 李曉捷, 唐久來, 馬丙祥, 等. 腦性癱瘓的定義、診斷標準及臨床分型[J]. 中華實用兒科臨床雜誌, 2014, 29(19): 1520. DOI: 10.3760/cma.j.issn.2095-428X.2014.19.024.
  2. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第一章:概論[J]. 中華實用兒科臨床雜誌, 2022, 37(12): 887-892.
  3. Novak I, Morgan C, Adde L, 等. Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment[J]. JAMA Pediatrics, 2017, 171(9): 897-907. DOI: 10.1001/jamapediatrics.2017.1689.
  4. Palisano R, Rosenbaum P, Bartlett D, Livingston M. GMFCS – E & R: Gross Motor Function Classification System, Expanded and Revised[EB/OL]. CanChild Centre for Childhood Disability Research(McMaster University), 2007. (訪問於 2026-10-17).
  5. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25).
  6. CanChild Centre for Childhood Disability Research. Manual Ability Classification System (MACS)[EB/OL]. CanChild Centre for Childhood Disability Research(McMaster University), 2025. (訪問於 2026-10-08).
  7. 中國殘疾人聯合會, 國家衛生和計劃生育委員會. 中華人民共和國殘疾人證管理辦法[S]. 岳陽市君山區人民政府網站(地方政府轉發文件附件 1), 2017. (訪問於 2026-10-17).

腦癱孩子智力正常嗎:語言、吞嚥、癲癇等伴隨問題怎麼查

  1. 李曉捷, 唐久來, 馬丙祥, 等. 腦性癱瘓的定義、診斷標準及臨床分型[J]. 中華實用兒科臨床雜誌, 2014, 29(19): 1520. DOI: 10.3760/cma.j.issn.2095-428X.2014.19.024.
  2. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25).
  3. Spasticity in under 19s: management (CG145)[EB/OL]. National Institute for Health and Care Excellence, 2012. (訪問於 2026-09-25).
  4. 國務院. 殘疾人教育條例(國務院令第 674 號)[S]. 中國政府網, 2017. (訪問於 2026-10-17).

腦癱兒童康復救助和殘疾證:能申請哪些補助,腦癱是幾級殘疾

  1. 國務院. 國務院關於建立殘疾兒童康復救助制度的意見(國發〔2018〕20 號)[S]. 中國政府網, 2018. (訪問於 2026-09-30).
  2. 北京市殘疾人聯合會, 北京市教育委員會, 北京市財政局, 北京市民政局, 北京市衛生健康委員會. 關於印發《北京市殘疾兒童康復服務辦法》的通知[S]. 首都之窗(北京市人民政府門戶網站)政策文件, 2019. (訪問於 2026-10-08).
  3. 北京市殘疾人聯合會. 關於印發《北京市殘疾兒童康復服務辦法實施細則》的通知[S]. 北京市殘疾人聯合會網站 政策法規—康復, 2020. (訪問於 2026-10-08).
  4. 中國殘疾人聯合會, 國家衛生和計劃生育委員會. 中華人民共和國殘疾人證管理辦法[S]. 岳陽市君山區人民政府網站(地方政府轉發文件附件 1), 2017. (訪問於 2026-10-17).
  5. 湖南省殘疾人聯合會, 湖南省衛生和計劃生育委員會. 湖南省殘疾人證管理辦法實施細則[S]. 岳陽市君山區人民政府網站(地方政府轉發文件附件 2), 2018. (訪問於 2026-10-17).
  6. Palisano R, Rosenbaum P, Bartlett D, Livingston M. GMFCS – E & R: Gross Motor Function Classification System, Expanded and Revised[EB/OL]. CanChild Centre for Childhood Disability Research(McMaster University), 2007. (訪問於 2026-10-17).

一歲不會走路正常嗎:到幾個月還不會走需要評估

  1. WHO Multicentre Growth Reference Study Group. WHO Motor Development Study: windows of achievement for six gross motor development milestones[J]. Acta Paediatrica Supplement, 2006, 450: 86-95. DOI: 10.1111/j.1651-2227.2006.tb02379.x.
  2. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  3. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10).
  4. Suspected neurological conditions: recognition and referral (NG127): recommendations for children aged under 16[EB/OL]. National Institute for Health and Care Excellence, 2019. (訪問於 2026-09-25).
  5. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  6. 中華醫學會兒科學分會神經學組, 中國醫師協會神經內科分會兒童神經疾病專業委員會. 兒童智力障礙或全面發育遲緩病因診斷策略專家共識[J]. 中華兒科雜誌, 2018, 56(11): 806-810. DOI: 10.3760/cma.j.issn.0578-1310.2018.11.003.
  7. 北京市衛生和計劃生育委員會, 北京市殘疾人聯合會, 北京市財政局. 北京市衛生和計劃生育委員會 北京市殘疾人聯合會 北京市財政局關於開展 0-6歲兒童殘疾篩查工作的通知[S]. 北京市衛生健康委員會網站 政策文件, 2018. (訪問於 2026-10-08).
  8. 北京市衛生和計劃生育委員會. 北京市衛生和計劃生育委員會關於落實《早產兒保健工作規範》的通知[S]. 北京市衛生健康委員會網站, 2018. (訪問於 2026-10-08).
  9. Baby Walkers: A Dangerous Choice[EB/OL]. American Academy of Pediatrics — HealthyChildren.org, 2022. (訪問於 2026-09-25).

腦癱兒早期干預方法:什麼時候開始,0–2 歲做什麼

  1. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第一章:概論[J]. 中華實用兒科臨床雜誌, 2022, 37(12): 887-892.
  2. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第二章:腦性癱瘓高危兒的評定與干預[J]. 中華實用兒科臨床雜誌, 2022, 37(13): 974-982. DOI: 10.3760/cma.j.cn101070-20220519-00574.
  3. 中國康復醫學會兒童康復專業委員會, 中國殘疾人康復協會小兒腦性癱瘓康復專業委員會, 中國醫師協會康復醫師分會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第四章:康復治療(上)[J]. 中華實用兒科臨床雜誌, 2022, 37(16): 1201-1229. DOI: 10.3760/cma.j.cn101070-20220711-00850.
  4. 中國康復醫學會兒童康復專業委員會, 中國殘疾人康復協會小兒腦性癱瘓康復專業委員會, 中國醫師協會康復醫師分會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第四章:康復治療(下)[J]. 中華實用兒科臨床雜誌, 2022, 37(17): 1281-1309. DOI: 10.3760/cma.j.cn101070-20220718-00875.
  5. 張建奎, 李曉捷, 唐久來, 等. 中國腦性癱瘓康復指南(2022)核心內容解讀[J]. 中華實用兒科臨床雜誌, 2022, 37(24): 1841-1853. DOI: 10.3760/cma.j.cn101070-20221118-01309.
  6. 中華醫學會兒科學分會康復學組. 2021年JAMA Pediatrics《0~2歲腦性癱瘓及其高危兒的早期干預:基於系統評價的國際臨床實踐指南》中國專家解讀[J]. 中華實用兒科臨床雜誌, 2021, 36(19): 1446-1451. DOI: 10.3760/cma.j.cn101070-20210729-00904.
  7. 唐久來, 王寶田, 李曉捷. 腦性癱瘓早期診斷和腦性癱瘓高風險兒診斷及早期干預進展[J]. 中華實用兒科臨床雜誌, 2018, 33(15): 1121-1125. DOI: 10.3760/cma.j.issn.2095-428X.2018.15.001.
  8. 國家衛生健康委辦公廳. 嬰幼兒早期發展服務指南(試行)(國衛辦婦幼函〔2024〕467 號)[S]. 中國政府網, 2024. (訪問於 2026-10-02).
  9. Morgan C, Fetters L, Adde L, 等. Early intervention for children aged 0 to 2 years with or at high risk of cerebral palsy: international clinical practice guideline based on systematic reviews[J]. JAMA Pediatrics, 2021, 175(8): 846-858. DOI: 10.1001/jamapediatrics.2021.0878.
  10. Novak I, Morgan C, Adde L, 等. Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment[J]. JAMA Pediatrics, 2017, 171(9): 897-907. DOI: 10.1001/jamapediatrics.2017.1689.

腦癱高危兒是什麼意思:屬於腦癱嗎,診斷標準與評估

  1. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第一章:概論[J]. 中華實用兒科臨床雜誌, 2022, 37(12): 887-892.
  2. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第二章:腦性癱瘓高危兒的評定與干預[J]. 中華實用兒科臨床雜誌, 2022, 37(13): 974-982. DOI: 10.3760/cma.j.cn101070-20220519-00574.
  3. 張建奎, 李曉捷, 唐久來, 等. 中國腦性癱瘓康復指南(2022)核心內容解讀[J]. 中華實用兒科臨床雜誌, 2022, 37(24): 1841-1853. DOI: 10.3760/cma.j.cn101070-20221118-01309.
  4. 唐久來, 王寶田, 李曉捷. 腦性癱瘓早期診斷和腦性癱瘓高風險兒診斷及早期干預進展[J]. 中華實用兒科臨床雜誌, 2018, 33(15): 1121-1125. DOI: 10.3760/cma.j.issn.2095-428X.2018.15.001.
  5. Novak I, Morgan C, Adde L, 等. Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment[J]. JAMA Pediatrics, 2017, 171(9): 897-907. DOI: 10.1001/jamapediatrics.2017.1689.
  6. 中華預防醫學會兒童保健分會, 中國疾病預防控制中心婦幼保健中心, 中國婦幼保健協會高危兒童健康管理專委會. 高危兒規範化健康管理專家共識[J]. 中國兒童保健雜誌, 2023, 31(6): 581-585. DOI: 10.11852/zgetbjzz2023-0347.
  7. 中華醫學會兒科學分會新生兒學組, 中華兒科雜誌編輯委員會. 高危新生兒分類分級管理專家共識(2023)[J]. 中華兒科雜誌, 2023, 61(10): 869-873. DOI: 10.3760/cma.j.cn112140-20230630-00434.
  8. 衛生部. 全國兒童保健工作規範(試行)[S]. 衛生部, 2009. (訪問於 2026-10-08).
  9. 衛生部辦公廳. 新生兒訪視技術規範(《新生兒訪視等兒童保健技術規範》附件 1,衛辦婦社發〔2012〕49 號)[S]. 衛生部, 2012. (訪問於 2026-10-08).
  10. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25).
  11. 中國康復醫學會兒童康復專業委員會, 中國殘疾人康復協會小兒腦性癱瘓康復專業委員會, 中國醫師協會康復醫師分會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第四章:康復治療(上)[J]. 中華實用兒科臨床雜誌, 2022, 37(16): 1201-1229. DOI: 10.3760/cma.j.cn101070-20220711-00850.
  12. 中國醫師協會兒科醫師分會兒童保健學組. NICU出院高危兒0~3歲生長發育隨訪管理技術的專家共識[J]. 中國兒童保健雜誌, 2021, 29(8): 809-814. DOI: 10.11852/zgetbjzz2020-2035.

兒童偏癱康復治療:小兒偏癱怎麼訓練,要康復到幾歲

  1. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第一章:概論[J]. 中華實用兒科臨床雜誌, 2022, 37(12): 887-892.
  2. 中華醫學會兒科學分會康復學組. 兒童腦性癱瘓運動障礙的康復建議[J]. 中華兒科雜誌, 2020, 58(2): 91-95. DOI: 10.3760/cma.j.issn.0578-1310.2020.02.005.
  3. 中國康復醫學會兒童康復專業委員會, 中國殘疾人康復協會小兒腦性癱瘓康復專業委員會, 中國醫師協會康復醫師分會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第三章:ICF-CY框架下的兒童腦癱評定[J]. 中華實用兒科臨床雜誌, 2022, 37(15): 1121-1141. DOI: 10.3760/cma.j.cn101070-20220621-00746.
  4. 中國康復醫學會兒童康復專業委員會, 中國殘疾人康復協會小兒腦性癱瘓康復專業委員會, 中國醫師協會康復醫師分會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第四章:康復治療(上)[J]. 中華實用兒科臨床雜誌, 2022, 37(16): 1201-1229. DOI: 10.3760/cma.j.cn101070-20220711-00850.
  5. 中國康復醫學會兒童康復專業委員會, 中國殘疾人康復協會小兒腦性癱瘓康復專業委員會, 中國醫師協會康復醫師分會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第四章:康復治療(下)[J]. 中華實用兒科臨床雜誌, 2022, 37(17): 1281-1309. DOI: 10.3760/cma.j.cn101070-20220718-00875.
  6. 中國康復醫學會兒童康復專業委員會, 中國殘疾人康復協會小兒腦性癱瘓康復專業委員會, 中國醫師協會康復醫師分會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第七章:康復途徑及管理[J]. 中華實用兒科臨床雜誌, 2022, 37(20): 1521-1526. DOI: 10.3760/cma.j.cn101070-20220919-01094.
  7. 中國醫師協會新生兒科醫師分會神經專業委員會. 新生兒動脈缺血性腦卒中臨床診治專家共識[J]. 中國當代兒科雜誌, 2017, 19(6): 611-613. DOI: 10.7499/j.issn.1008-8830.2017.06.001.
  8. He Y, Tang J, Zhang M, 等. Clinical practice guideline for the diagnosis and treatment of neonatal arterial ischemic stroke (2026)[J]. Chinese Medical Journal, 2026, 139(18): 2687-2689. DOI: 10.1097/CM9.0000000000004227.
  9. 夏倩倩, 侯新琳. 圍產期腦卒中的臨床表現、治療與結局[J]. 中華新生兒科雜誌, 2019, 34(2): 159-160. DOI: 10.3760/cma.j.issn.2096-2932.2019.02.019.
  10. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25).
  11. Hoare BJ, Wallen MA, Thorley MN, 等. Constraint-induced movement therapy in children with unilateral cerebral palsy[J]. Cochrane Database of Systematic Reviews, 2019, (4): CD004149. DOI: 10.1002/14651858.CD004149.pub3.
  12. Eliasson AC, Sjöstrand L, Ek L, 等. Efficacy of baby-CIMT: study protocol for a randomised controlled trial on infants below age 12 months, with clinical signs of unilateral CP[J]. BMC Pediatrics, 2014, 14: 141. DOI: 10.1186/1471-2431-14-141.
  13. Greaves S, Imms C, Dodd K, 等. Development of the Mini-Assisting Hand Assessment: evidence for content and internal scale validity[J]. Developmental Medicine and Child Neurology, 2013, 55(11): 1030-7. DOI: 10.1111/dmcn.12212.
  14. Krumlinde-Sundholm L, Holmefur M, Kottorp A, 等. The Assisting Hand Assessment: current evidence of validity, reliability, and responsiveness to change[J]. Developmental Medicine and Child Neurology, 2007, 49(4): 259-64. DOI: 10.1111/j.1469-8749.2007.00259.x.
  15. CanChild Centre for Childhood Disability Research. Manual Ability Classification System (MACS)[EB/OL]. CanChild Centre for Childhood Disability Research(McMaster University), 2025. (訪問於 2026-10-08).
  16. Betts JG, Young KA, Wise JA, 等. Anatomy and Physiology 2e: 14.3 Motor Responses[M]. Houston: OpenStax, 2022.

寶寶只用一隻手抓東西正常嗎:和偏癱有關嗎,幾個月要評估

  1. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25).
  2. Novak I, Morgan C, Adde L, 等. Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment[J]. JAMA Pediatrics, 2017, 171(9): 897-907. DOI: 10.1001/jamapediatrics.2017.1689.
  3. 唐久來, 王寶田, 李曉捷. 腦性癱瘓早期診斷和腦性癱瘓高風險兒診斷及早期干預進展[J]. 中華實用兒科臨床雜誌, 2018, 33(15): 1121-1125. DOI: 10.3760/cma.j.issn.2095-428X.2018.15.001.
  4. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-25).
  5. Eliasson AC, Sjöstrand L, Ek L, 等. Efficacy of baby-CIMT: study protocol for a randomised controlled trial on infants below age 12 months, with clinical signs of unilateral CP[J]. BMC Pediatrics, 2014, 14: 141. DOI: 10.1186/1471-2431-14-141.
  6. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第一章:概論[J]. 中華實用兒科臨床雜誌, 2022, 37(12): 887-892.
  7. Betts JG, Young KA, Wise JA, 等. Anatomy and Physiology 2e: 14.3 Motor Responses[M]. Houston: OpenStax, 2022.
  8. 夏倩倩, 侯新琳. 圍產期腦卒中的臨床表現、治療與結局[J]. 中華新生兒科雜誌, 2019, 34(2): 159-160. DOI: 10.3760/cma.j.issn.2096-2932.2019.02.019.
  9. 中國醫師協會新生兒科醫師分會神經專業委員會. 新生兒動脈缺血性腦卒中臨床診治專家共識[J]. 中國當代兒科雜誌, 2017, 19(6): 611-613. DOI: 10.7499/j.issn.1008-8830.2017.06.001.
  10. 國家衛生計生委. 國家基本公共衛生服務規範(第三版):0~6 歲兒童健康管理服務規範(國衛基層發〔2017〕13 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-07).
  11. Hay K, Nelin M, Carey H, 等. Hammersmith Infant Neurological Examination Asymmetry Score Distinguishes Hemiplegic Cerebral Palsy From Typical Development[J]. Pediatric Neurology, 2018, 87: 70-74. DOI: 10.1016/j.pediatrneurol.2018.07.002.
  12. Ryll UC, Krumlinde-Sundholm L, Verhage CH, 等. Predictive validity of the Hand Assessment for Infants in infants at risk of unilateral cerebral palsy[J]. Developmental Medicine and Child Neurology, 2021, 63(4): 436-443. DOI: 10.1111/dmcn.14739.

偏癱型腦癱是什麼:小兒偏癱屬於腦癱嗎

  1. 李曉捷, 唐久來, 馬丙祥, 等. 腦性癱瘓的定義、診斷標準及臨床分型[J]. 中華實用兒科臨床雜誌, 2014, 29(19): 1520. DOI: 10.3760/cma.j.issn.2095-428X.2014.19.024.
  2. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第一章:概論[J]. 中華實用兒科臨床雜誌, 2022, 37(12): 887-892.
  3. 中國醫師協會新生兒科醫師分會神經專業委員會. 新生兒動脈缺血性腦卒中臨床診治專家共識[J]. 中國當代兒科雜誌, 2017, 19(6): 611-613. DOI: 10.7499/j.issn.1008-8830.2017.06.001.
  4. He Y, Tang J, Zhang M, 等. Clinical practice guideline for the diagnosis and treatment of neonatal arterial ischemic stroke (2026)[J]. Chinese Medical Journal, 2026, 139(18): 2687-2689. DOI: 10.1097/CM9.0000000000004227.
  5. 夏倩倩, 侯新琳. 圍產期腦卒中的臨床表現、治療與結局[J]. 中華新生兒科雜誌, 2019, 34(2): 159-160. DOI: 10.3760/cma.j.issn.2096-2932.2019.02.019.
  6. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25).
  7. Novak I, Morgan C, Adde L, 等. Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment[J]. JAMA Pediatrics, 2017, 171(9): 897-907. DOI: 10.1001/jamapediatrics.2017.1689.
  8. Betts JG, Young KA, Wise JA, 等. Anatomy and Physiology 2e: 14.3 Motor Responses[M]. Houston: OpenStax, 2022.

早產兒康復訓練:都要做嗎、有哪些項目、做到幾歲

  1. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-25).
  2. 中國醫師協會新生兒科醫師分會早產兒專業委員會, 中華兒科雜誌編輯委員會. 早產兒出院後隨訪與健康管理專家共識(2025)[J]. 中華兒科雜誌, 2025, 63(7): 721-736. DOI: 10.3760/cma.j.cn112140-20250117-00050.
  3. 中國醫師協會兒科醫師分會兒童保健學組. NICU出院高危兒0~3歲生長發育隨訪管理技術的專家共識[J]. 中國兒童保健雜誌, 2021, 29(8): 809-814. DOI: 10.11852/zgetbjzz2020-2035.
  4. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第二章:腦性癱瘓高危兒的評定與干預[J]. 中華實用兒科臨床雜誌, 2022, 37(13): 974-982. DOI: 10.3760/cma.j.cn101070-20220519-00574.
  5. 中國優生優育協會嬰幼兒發育專業委員會. 高危新生兒行為神經發育早期干預專家共識[J]. 中國兒童保健雜誌, 2022, 30(3): 233-236. DOI: 10.11852/zgetbjzz2021-0625.
  6. Bao X, Sun S, Wei S. Early intervention promotes intellectual development of premature infants: a preliminary report[J]. Chinese Medical Journal, 1999, 112(6): 520-523.
  7. 國務院. 國務院關於建立殘疾兒童康復救助制度的意見(國發〔2018〕20 號)[S]. 中國政府網, 2018. (訪問於 2026-09-30).

早產兒隨訪到幾歲:隨訪時間和頻次,結案指什麼

  1. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-25).
  2. 中國醫師協會新生兒科醫師分會早產兒專業委員會, 中華兒科雜誌編輯委員會. 早產兒出院後隨訪與健康管理專家共識(2025)[J]. 中華兒科雜誌, 2025, 63(7): 721-736. DOI: 10.3760/cma.j.cn112140-20250117-00050.
  3. 北京市衛生和計劃生育委員會. 北京市衛生和計劃生育委員會關於落實《早產兒保健工作規範》的通知[S]. 北京市衛生健康委員會網站, 2018. (訪問於 2026-10-08).
  4. 中國醫師協會兒科醫師分會兒童保健學組. NICU出院高危兒0~3歲生長發育隨訪管理技術的專家共識[J]. 中國兒童保健雜誌, 2021, 29(8): 809-814. DOI: 10.11852/zgetbjzz2020-2035.
  5. 中華預防醫學會兒童保健分會, 中國疾病預防控制中心婦幼保健中心, 中國婦幼保健協會高危兒童健康管理專委會. 高危兒規範化健康管理專家共識[J]. 中國兒童保健雜誌, 2023, 31(6): 581-585. DOI: 10.11852/zgetbjzz2023-0347.
  6. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第二章:腦性癱瘓高危兒的評定與干預[J]. 中華實用兒科臨床雜誌, 2022, 37(13): 974-982. DOI: 10.3760/cma.j.cn101070-20220519-00574.

高危兒診斷標準:高危兒是診斷嗎,由誰制定、怎麼分類

  1. 衛生部辦公廳. 新生兒訪視技術規範(《新生兒訪視等兒童保健技術規範》附件 1,衛辦婦社發〔2012〕49 號)[S]. 衛生部, 2012. (訪問於 2026-10-08).
  2. 衛生部. 全國兒童保健工作規範(試行)[S]. 衛生部, 2009. (訪問於 2026-10-08).
  3. 中華醫學會兒科學分會新生兒學組, 中華兒科雜誌編輯委員會. 高危新生兒分類分級管理專家共識(2023)[J]. 中華兒科雜誌, 2023, 61(10): 869-873. DOI: 10.3760/cma.j.cn112140-20230630-00434.
  4. 中華預防醫學會兒童保健分會, 中國疾病預防控制中心婦幼保健中心, 中國婦幼保健協會高危兒童健康管理專委會. 高危兒規範化健康管理專家共識[J]. 中國兒童保健雜誌, 2023, 31(6): 581-585. DOI: 10.11852/zgetbjzz2023-0347.
  5. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-25).
  6. 中國優生優育協會嬰幼兒發育專業委員會. 高危新生兒行為神經發育早期干預專家共識[J]. 中國兒童保健雜誌, 2022, 30(3): 233-236. DOI: 10.11852/zgetbjzz2021-0625.
  7. 中國醫師協會兒科醫師分會兒童保健學組. NICU出院高危兒0~3歲生長發育隨訪管理技術的專家共識[J]. 中國兒童保健雜誌, 2021, 29(8): 809-814. DOI: 10.11852/zgetbjzz2020-2035.
  8. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第二章:腦性癱瘓高危兒的評定與干預[J]. 中華實用兒科臨床雜誌, 2022, 37(13): 974-982. DOI: 10.3760/cma.j.cn101070-20220519-00574.
  9. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第一章:概論[J]. 中華實用兒科臨床雜誌, 2022, 37(12): 887-892.
  10. 張建奎, 李曉捷, 唐久來, 等. 中國腦性癱瘓康復指南(2022)核心內容解讀[J]. 中華實用兒科臨床雜誌, 2022, 37(24): 1841-1853. DOI: 10.3760/cma.j.cn101070-20221118-01309.
  11. 張悅. 我國兒童保健工作中高危兒管理內涵和外延的探析[J]. 中國兒童保健雜誌, 2019, 27(2): 123-125. DOI: 10.11852/zgetbjzz2018-1853.
  12. 中華醫學會兒科學分會康復學組. 新生兒重症監護病房神經行為發育評估方法專家指導意見[J]. 中國實用兒科雜誌, 2017, 32(11): 801-806. DOI: 10.19538/j.ek2017110601.
  13. 北京市衛生和計劃生育委員會. 北京市衛生和計劃生育委員會關於落實《早產兒保健工作規範》的通知[S]. 北京市衛生健康委員會網站, 2018. (訪問於 2026-10-08).
  14. 中國醫師協會新生兒科醫師分會早產兒專業委員會, 中華兒科雜誌編輯委員會. 早產兒出院後隨訪與健康管理專家共識(2025)[J]. 中華兒科雜誌, 2025, 63(7): 721-736. DOI: 10.3760/cma.j.cn112140-20250117-00050.

北京兒童康復治療:康復機構有哪些類型、資質怎麼查

  1. 北京市殘疾人聯合會. 關於印發《北京市殘疾兒童康復服務辦法實施細則》的通知[S]. 北京市殘疾人聯合會網站 政策法規—康復, 2020. (訪問於 2026-10-08).
  2. 北京市殘疾人聯合會, 北京市民政局, 北京市市場監督管理局. 北京市殘疾兒童康復服務定點機構協議管理辦法(試行)[S]. 首都之窗 政策文件, 2024. (訪問於 2026-10-08).
  3. 中國康復醫學會兒童康復專業委員會, 中國殘疾人康復協會小兒腦性癱瘓康復專業委員會, 中國醫師協會康復醫師分會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第七章:康復途徑及管理[J]. 中華實用兒科臨床雜誌, 2022, 37(20): 1521-1526. DOI: 10.3760/cma.j.cn101070-20220919-01094.
  4. 北京市殘疾人聯合會, 北京市教育委員會, 北京市財政局, 北京市民政局, 北京市衛生健康委員會. 關於印發《北京市殘疾兒童康復服務辦法》的通知[S]. 首都之窗(北京市人民政府門戶網站)政策文件, 2019. (訪問於 2026-10-08).
  5. 北京市衛生健康委員會. 醫療機構查詢[EB/OL]. 北京市衛生健康委員會網站 便民查詢, 2026. (訪問於 2026-10-08).
  6. 國務院. 國務院關於建立殘疾兒童康復救助制度的意見(國發〔2018〕20 號)[S]. 中國政府網, 2018. (訪問於 2026-09-30).
  7. 北京市殘疾人聯合會(部分與北京市衛生計生委/衛生健康委、北京市中醫管理局、北京市民政局聯合). 政策法規 > 康復(欄目列表內的定點機構名單與新增通知,共 10 份)[EB/OL]. 北京市殘疾人聯合會網站, 2014—2024. (訪問於 2026-10-08).
  8. 北京市衛生和計劃生育委員會, 北京市殘疾人聯合會, 北京市財政局. 北京市衛生和計劃生育委員會 北京市殘疾人聯合會 北京市財政局關於開展 0-6歲兒童殘疾篩查工作的通知[S]. 北京市衛生健康委員會網站 政策文件, 2018. (訪問於 2026-10-08).
  9. 北京市殘疾人聯合會. 北京市殘疾兒童康復服務定點機構准入標準[S]. 北京市殘疾人聯合會網站 政策法規—康復, 2024. (訪問於 2026-10-08).
  10. 北京市政務服務網. 殘疾兒童康復服務定點機構(常用查詢)[EB/OL]. 北京市政務服務網 常用查詢, 2026. (訪問於 2026-10-08).
  11. 首都之窗(北京市人民政府門戶網站). 北京市政務公開惠民便民地圖(類別:殘疾兒童康復服務定點機構)[EB/OL]. 北京市政務公開惠民便民地圖 map.beijing.gov.cn, 2026. (訪問於 2026-10-08).
  12. 人力資源社會保障部, 國家衛生計生委, 民政部, 等. 關於新增部分醫療康復項目納入基本醫療保障支付範圍的通知(人社部發〔2016〕23 號)[S]. 中國政府網, 2016. (訪問於 2026-10-02).
  13. 北京市醫療保障局. 北京市醫療保障局關於調整物理、康復治療醫保報銷政策的通知[S]. 北京市醫療保障局網站 政策文件, 2024. (訪問於 2026-10-08).

兒童全面發育遲緩需要做哪些檢查?病因評估與就醫指南

  1. 國家兒童醫學中心, 首都醫科大學附屬北京兒童醫院保健中心, 等. 中國全面發育遲緩診斷指南(2024)[J]. 中華實用兒科臨床雜誌, 2024, 39(7): 481-489. DOI: 10.3760/cma.j.cn101070-20240426-00262.
  2. 中華醫學會兒科學分會神經學組, 中國醫師協會神經內科分會兒童神經疾病專業委員會. 兒童智力障礙或全面發育遲緩病因診斷策略專家共識[J]. 中華兒科雜誌, 2018, 56(11): 806-810. DOI: 10.3760/cma.j.issn.0578-1310.2018.11.003.
  3. Rodan LH, Stoler J, Chen E, et al. Genetic evaluation of the child with intellectual disability or global developmental delay: clinical report[J]. Pediatrics, 2025, 156(1): e2025072219. DOI: 10.1542/peds.2025-072219.
  4. Manickam K, McClain MR, Demmer LA, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)[J]. Genetics in Medicine, 2021, 23(11): 2029-2037. DOI: 10.1038/s41436-021-01242-6.
  5. Carter MT, Srour M, Au PYB, et al. Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists (CCMG)[J]. Journal of Medical Genetics, 2023, 60(6): 523-532. DOI: 10.1136/jmg-2022-108962.
  6. Bélanger SA, Caron J. Evaluation of the child with global developmental delay and intellectual disability[J]. Paediatrics & Child Health, 2018, 23(6): 403-410. DOI: 10.1093/pch/pxy093.
  7. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. American Journal of Human Genetics, 2010, 86(5): 749-764. DOI: 10.1016/j.ajhg.2010.04.006.
  8. Srivastava S, Love-Nichols JA, Dies KA, et al. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders[J]. Genetics in Medicine, 2019, 21(11): 2413-2421. DOI: 10.1038/s41436-019-0554-6.
  9. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genetics in Medicine, 2015, 17(5): 405-424. DOI: 10.1038/gim.2015.30.
  10. Deignan JL, Chung WK, Kearney HM, et al. Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG)[J]. Genetics in Medicine, 2019, 21(6): 1267-1270. DOI: 10.1038/s41436-019-0478-1.
  11. Hoytema van Konijnenburg EMM, Wortmann SB, Koelewijn MJ, et al. Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app[J]. Orphanet Journal of Rare Diseases, 2021, 16(1): 170. DOI: 10.1186/s13023-021-01727-2.
  12. Murias K, Moir A, Myers KA, et al. Systematic review of MRI findings in children with developmental delay or cognitive impairment[J]. Brain and Development, 2017, 39(8): 644-655. DOI: 10.1016/j.braindev.2017.04.006.
  13. Enokizono M, Aida N, Yagishita A, et al. Neuroimaging findings of inborn errors of metabolism: urea cycle disorders, aminoacidopathies, and organic acidopathies[J]. Japanese Journal of Radiology, 2023, 41: 683-702. DOI: 10.1007/s11604-023-01396-0.
  14. McLeod S, Kawamura A, Orsino A. Assessing children and youth with global developmental delay and intellectual developmental disorder[EB/OL]. Canadian Paediatric Society, 2026-03-27. (訪問於 2026-09-23).

發育遲緩和自閉症(孤獨症)有什麼區別

  1. 國家兒童醫學中心, 首都醫科大學附屬北京兒童醫院保健中心, 等. 中國全面發育遲緩診斷指南(2024)[J]. 中華實用兒科臨床雜誌, 2024, 39(7): 481-489. DOI: 10.3760/cma.j.cn101070-20240426-00262.
  2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5)[M]. American Psychiatric Publishing, 2013.
  3. 衛生部辦公廳. 兒童孤獨症診療康復指南(衛辦醫政發〔2010〕123 號)[S]. 衛生部, 2010. (訪問於 2026-09-07).
  4. 中華醫學會兒科學分會發育行為學組, 中國醫師協會兒科分會兒童保健專業委員會, 兒童孤獨症診斷與防治技術和標準研究項目專家組. 孤獨症譜系障礙兒童早期識別篩查和早期干預專家共識[J]. 中華兒科雜誌, 2017, 55(12): 890-897. DOI: 10.3760/cma.j.issn.0578-1310.2017.12.004.
  5. 中華醫學會兒科學分會神經學組, 中國醫師協會神經內科分會兒童神經疾病專業委員會. 兒童智力障礙或全面發育遲緩病因診斷策略專家共識[J]. 中華兒科雜誌, 2018, 56(11): 806-810. DOI: 10.3760/cma.j.issn.0578-1310.2018.11.003.
  6. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  7. 國家衛生計生委辦公廳. 兒童心理保健技術規範(含兒童心理行為發育問題預警徵象篩查表)[S]. 國家衛生計生委, 2013. (訪問於 2026-09-07).

寶寶不看人、眼神交流少,是孤獨症嗎?

  1. 中華醫學會兒科學分會發育行為學組, 中國醫師協會兒科分會兒童保健專業委員會, 兒童孤獨症診斷與防治技術和標準研究項目專家組. 孤獨症譜系障礙兒童早期識別篩查和早期干預專家共識[J]. 中華兒科雜誌, 2017, 55(12): 890-897. DOI: 10.3760/cma.j.issn.0578-1310.2017.12.004.
  2. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  3. 國家衛生計生委辦公廳. 兒童心理保健技術規範(含兒童心理行為發育問題預警徵象篩查表)[S]. 國家衛生計生委, 2013. (訪問於 2026-09-07).
  4. 國家衛生計生委. 國家基本公共衛生服務規範(第三版):0~6 歲兒童健康管理服務規範(國衛基層發〔2017〕13 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-07).
  5. Guo C, Luo M, Wang X, 等. Reliability and validity of the Chinese version of Modified Checklist for Autism in Toddlers, Revised, with Follow-Up (M-CHAT-R/F)[J]. Journal of Autism and Developmental Disorders, 2019, 49(1). DOI: 10.1007/s10803-018-3682-y.
  6. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10).
  7. Bao XL, Yu RJ, Li ZS, 等. Twenty-item behavioral neurological assessment for normal newborns in 12 cities of China[J]. Chinese Medical Journal, 1991, 104(9): 742-746.

寶寶入睡困難、夜醒頻繁,可以先調整什麼?

  1. 國家衛生計生委. 0 歲~5 歲兒童睡眠衛生指南 WS/T 579—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  2. Paruthi S, Brooks L J, D’Ambrosio C, 等. Recommended amount of sleep for pediatric populations: a consensus statement of the American Academy of Sleep Medicine[J]. Journal of Clinical Sleep Medicine, 2016, 12(6): 785-786. DOI: 10.5664/jcsm.5866.
  3. 中華人民共和國教育部. 3-6 歲兒童學習與發展指南(教基二〔2012〕4 號)[S]. 中華人民共和國教育部, 2012. (訪問於 2026-09-10).
  4. 中國兒童 OSA 診斷與治療指南制訂工作組, 中華醫學會耳鼻咽喉頭頸外科學分會小兒學組, 中華醫學會兒科學分會呼吸學組, 等. 中國兒童阻塞性睡眠呼吸暫停診斷與治療指南(2020)[J]. 中華耳鼻咽喉頭頸外科雜誌, 2020, 55(8): 729-747. DOI: 10.3760/cma.j.cn115330-20200521-00431.

精細動作發育:幾歲該會什麼,日常裡怎麼練

  1. 國家衛生計生委辦公廳. 兒童心理保健技術規範(含兒童心理行為發育問題預警徵象篩查表)[S]. 國家衛生計生委, 2013. (訪問於 2026-09-07).
  2. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10).
  3. Zubler JM, Wiggins LD, Macias MM, 等. Evidence-Informed Milestones for Developmental Surveillance Tools[J]. Pediatrics, 2022, 149(3): e2021052138. DOI: 10.1542/peds.2021-052138.
  4. 中華人民共和國教育部. 3-6 歲兒童學習與發展指南(教基二〔2012〕4 號)[S]. 中華人民共和國教育部, 2012. (訪問於 2026-09-10).
  5. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  6. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).

第一次去兒童發育門診,要準備什麼

  1. 國家衛生計生委辦公廳. 兒童心理保健技術規範(含兒童心理行為發育問題預警徵象篩查表)[S]. 國家衛生計生委, 2013. (訪問於 2026-09-07).
  2. 國家衛生計生委. 國家基本公共衛生服務規範(第三版):0~6 歲兒童健康管理服務規範(國衛基層發〔2017〕13 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-07).
  3. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-25).
  4. 中華醫學會兒科學分會新生兒學組, 中華兒科雜誌編輯委員會. 高危新生兒分類分級管理專家共識(2023)[J]. 中華兒科雜誌, 2023, 61(10): 869-873. DOI: 10.3760/cma.j.cn112140-20230630-00434.
  5. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  6. Lipkin PH, Macias MM. Promoting optimal development: identifying infants and young children with developmental disorders through developmental surveillance and screening[J]. Pediatrics, 2020, 145(1): e20193449.
  7. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).

大運動發育順序:各月齡該會什麼,範圍有多寬

  1. WHO Multicentre Growth Reference Study Group. WHO Motor Development Study: windows of achievement for six gross motor development milestones[J]. Acta Paediatrica Supplement, 2006, 450: 86-95. DOI: 10.1111/j.1651-2227.2006.tb02379.x.
  2. Zubler JM, Wiggins LD, Macias MM, 等. Evidence-Informed Milestones for Developmental Surveillance Tools[J]. Pediatrics, 2022, 149(3): e2021052138. DOI: 10.1542/peds.2021-052138.
  3. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10).
  4. 國家衛生計生委辦公廳. 兒童心理保健技術規範(含兒童心理行為發育問題預警徵象篩查表)[S]. 國家衛生計生委, 2013. (訪問於 2026-09-07).
  5. 國家兒童醫學中心, 首都醫科大學附屬北京兒童醫院保健中心, 等. 中國全面發育遲緩診斷指南(2024)[J]. 中華實用兒科臨床雜誌, 2024, 39(7): 481-489. DOI: 10.3760/cma.j.cn101070-20240426-00262.
  6. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-25).
  7. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).

居家康復訓練能代替到院康復嗎?家長在家配合什麼

  1. Roberts MY, Curtis PR, Sone BJ, 等. Association of parent training with child language development: a systematic review and meta-analysis[J]. JAMA Pediatrics, 2019, 173(7): 671-680. DOI: 10.1001/jamapediatrics.2019.1197.
  2. Oono IP, Honey EJ, McConachie H. Parent-mediated early intervention for young children with autism spectrum disorders (ASD)[J]. Cochrane Database of Systematic Reviews, 2013, (4): CD009774.
  3. Morgan C, Fetters L, Adde L, 等. Early intervention for children aged 0 to 2 years with or at high risk of cerebral palsy: international clinical practice guideline based on systematic reviews[J]. JAMA Pediatrics, 2021, 175(8): 846-858. DOI: 10.1001/jamapediatrics.2021.0878.
  4. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-25).
  5. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  6. World Health Organization, UNICEF, World Bank Group. Nurturing care for early childhood development: a framework for helping children survive and thrive to transform health and human potential[M]. World Health Organization, 2018.
  7. McCauley RJ, Strand E, Lof GL, 等. Evidence-based systematic review: effects of nonspeech oral motor exercises on speech[J]. American Journal of Speech-Language Pathology, 2009, 18(4): 343-360.
  8. Briskin S, LaBotz M; Council on Sports Medicine and Fitness. Trampoline safety in childhood and adolescence[J]. Pediatrics, 2012, 130(4): 774-779. DOI: 10.1542/peds.2012-2082.

入園能力評估:上幼兒園前要先看哪幾樣

  1. 中華人民共和國教育部. 3-6 歲兒童學習與發展指南(教基二〔2012〕4 號)[S]. 中華人民共和國教育部, 2012. (訪問於 2026-09-10).
  2. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  3. 國家衛生計生委辦公廳. 兒童心理保健技術規範(含兒童心理行為發育問題預警徵象篩查表)[S]. 國家衛生計生委, 2013. (訪問於 2026-09-07).
  4. 國家衛生計生委. 國家基本公共衛生服務規範(第三版):0~6 歲兒童健康管理服務規範(國衛基層發〔2017〕13 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-07).
  5. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  6. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  7. World Health Organization. International Classification of Functioning, Disability and Health: Children & Youth Version (ICF-CY)[M]. World Health Organization, 2007. ISBN 9789241547321.

孩子不合群、不跟小朋友玩,是發育問題嗎

  1. Zubler JM, Wiggins LD, Macias MM, 等. Evidence-Informed Milestones for Developmental Surveillance Tools[J]. Pediatrics, 2022, 149(3): e2021052138. DOI: 10.1542/peds.2021-052138.
  2. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10).
  3. 中華人民共和國教育部. 3-6 歲兒童學習與發展指南(教基二〔2012〕4 號)[S]. 中華人民共和國教育部, 2012. (訪問於 2026-09-10).
  4. 國家衛生計生委辦公廳. 兒童心理保健技術規範(含兒童心理行為發育問題預警徵象篩查表)[S]. 國家衛生計生委, 2013. (訪問於 2026-09-07).
  5. 中華醫學會兒科學分會發育行為學組, 中國醫師協會兒科分會兒童保健專業委員會, 兒童孤獨症診斷與防治技術和標準研究項目專家組. 孤獨症譜系障礙兒童早期識別篩查和早期干預專家共識[J]. 中華兒科雜誌, 2017, 55(12): 890-897. DOI: 10.3760/cma.j.issn.0578-1310.2017.12.004.
  6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5)[M]. American Psychiatric Publishing, 2013.
  7. Zhou H, Xu X, Yan W, 等. Prevalence of autism spectrum disorder in China: a nationwide multi-center population-based study among children aged 6 to 12 years[J]. Neuroscience Bulletin, 2020, 36(9): 961-971.

發育評估報告怎麼看:發育商、月齡當量是什麼

  1. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  2. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-25).
  3. 徐姍姍, 等. 貝莉嬰幼兒發育量表-第三版評價上海市嬰幼兒發育水平的應用初探[J]. 中國兒童保健雜誌, 2011, 19(1): 30-32.
  4. 卞曉燕, 姚國英, Squires J, 等. 年齡與發育進程問卷上海市兒童常模及心理測量學特性研究[J]. 中華兒科雜誌, 2010, 48(7): 492-496.
  5. Lipkin PH, Macias MM. Promoting optimal development: identifying infants and young children with developmental disorders through developmental surveillance and screening[J]. Pediatrics, 2020, 145(1): e20193449.
  6. 國家兒童醫學中心, 首都醫科大學附屬北京兒童醫院保健中心, 等. 中國全面發育遲緩診斷指南(2024)[J]. 中華實用兒科臨床雜誌, 2024, 39(7): 481-489. DOI: 10.3760/cma.j.cn101070-20240426-00262.
  7. 張厚粲. 韋氏兒童智力量表第四版(WISC-Ⅳ)中文版的修訂[J]. 心理科學, 2009, 32(5): 1177-1179.
  8. Glaser R. Instructional technology and the measurement of learning outcomes: Some questions[J]. American Psychologist, 1963, 18(8): 519-521. DOI: 10.1037/h0049294.
  9. 鮑秀蘭 主編. 0~1 歲神經運動 20 項檢查(52 項簡化法)[M]. 寶秀蘭兒童早期發展優化中心, 2019.

兒童康復訓練一週做幾次?頻次是怎麼定的

  1. Hoare BJ, Wallen MA, Thorley MN, 等. Constraint-induced movement therapy in children with unilateral cerebral palsy[J]. Cochrane Database of Systematic Reviews, 2019, (4): CD004149. DOI: 10.1002/14651858.CD004149.pub3.
  2. Spittle A, Orton J, Anderson PJ, 等. Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants[J]. Cochrane Database of Systematic Reviews, 2015, (11): CD005495. DOI: 10.1002/14651858.CD005495.pub4.
  3. Morgan C, Fetters L, Adde L, 等. Early intervention for children aged 0 to 2 years with or at high risk of cerebral palsy: international clinical practice guideline based on systematic reviews[J]. JAMA Pediatrics, 2021, 175(8): 846-858. DOI: 10.1001/jamapediatrics.2021.0878.
  4. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-25).
  5. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2022)第二章:腦性癱瘓高危兒的評定與干預[J]. 中華實用兒科臨床雜誌, 2022, 37(13): 974-982. DOI: 10.3760/cma.j.cn101070-20220519-00574.
  6. 史惟, 等. GMFM 66 在 0-3 歲腦性癱瘓患兒粗大運動評估中的信度和效度研究[J]. 中華流行病學雜誌, 2006, 27(6).
  7. World Health Organization. International Classification of Functioning, Disability and Health: Children & Youth Version (ICF-CY)[M]. World Health Organization, 2007. ISBN 9789241547321.
  8. 國家衛生計生委辦公廳. 兒童心理保健技術規範(含兒童心理行為發育問題預警徵象篩查表)[S]. 國家衛生計生委, 2013. (訪問於 2026-09-07).

感統訓練什麼情況下需要做,什麼情況下不需要

  1. American Academy of Pediatrics Section on Complementary and Integrative Medicine, Council on Children with Disabilities. Sensory integration therapies for children with developmental and behavioral disorders[J]. Pediatrics, 2012, 129(6): 1186-1189.
  2. Schaaf RC, Benevides T, Mailloux Z, 等. An intervention for sensory difficulties in children with autism: a randomized trial[J]. Journal of Autism and Developmental Disorders, 2014, 44(7): 1493-1506.
  3. Schoen SA, Lane SJ, Mailloux Z, 等. A systematic review of Ayres Sensory Integration intervention for children with autism[J]. Autism Research, 2019, 12(1): 6-19.
  4. Parham LD, Roley SS, May-Benson TA, 等. Development of a fidelity measure for research on the effectiveness of the Ayres Sensory Integration intervention[J]. American Journal of Occupational Therapy, 2011, 65(2): 133-142.
  5. 任桂英, 王玉鳳, 顧伯美, 等. 兒童感覺統合評定量表的測試報告[J]. 中國心理衛生雜誌, 1994, 8(4): 145-147.
  6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5)[M]. American Psychiatric Publishing, 2013.
  7. 中華醫學會兒科學分會康復學組. 兒童康復相關發育性疾病的命名現狀與建議[J]. 中國全科醫學, 2022, 25(8): 899-904. DOI: 10.12114/j.issn.1007-9572.2022.01.301.
  8. 中華醫學會兒科學分會發育行為學組. 注意缺陷多動障礙早期識別、規範診斷和治療的兒科專家共識[J]. 中華兒科雜誌, 2020, 58(3): 188-193. DOI: 10.3760/cma.j.issn.0578-1310.2020.03.006.
  9. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).

嬰兒睡眠時間該有多長?0~6 歲各年齡的範圍

  1. 國家衛生計生委. 0 歲~5 歲兒童睡眠衛生指南 WS/T 579—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  2. Paruthi S, Brooks L J, D’Ambrosio C, 等. Recommended amount of sleep for pediatric populations: a consensus statement of the American Academy of Sleep Medicine[J]. Journal of Clinical Sleep Medicine, 2016, 12(6): 785-786. DOI: 10.5664/jcsm.5866.
  3. 中華人民共和國教育部. 3-6 歲兒童學習與發展指南(教基二〔2012〕4 號)[S]. 中華人民共和國教育部, 2012. (訪問於 2026-09-10).
  4. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9 號)[S]. 國家衛生計生委, 2017. (訪問於 2026-09-25).
  5. 中國兒童 OSA 診斷與治療指南制訂工作組, 中華醫學會耳鼻咽喉頭頸外科學分會小兒學組, 中華醫學會兒科學分會呼吸學組, 等. 中國兒童阻塞性睡眠呼吸暫停診斷與治療指南(2020)[J]. 中華耳鼻咽喉頭頸外科雜誌, 2020, 55(8): 729-747. DOI: 10.3760/cma.j.cn115330-20200521-00431.

兒童打鼾、張口呼吸,要不要去就診?

  1. 中國兒童 OSA 診斷與治療指南制訂工作組, 中華醫學會耳鼻咽喉頭頸外科學分會小兒學組, 中華醫學會兒科學分會呼吸學組, 等. 中國兒童阻塞性睡眠呼吸暫停診斷與治療指南(2020)[J]. 中華耳鼻咽喉頭頸外科雜誌, 2020, 55(8): 729-747. DOI: 10.3760/cma.j.cn115330-20200521-00431.
  2. 國家衛生計生委. 0 歲~5 歲兒童睡眠衛生指南 WS/T 579—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  3. Paruthi S, Brooks L J, D’Ambrosio C, 等. Recommended amount of sleep for pediatric populations: a consensus statement of the American Academy of Sleep Medicine[J]. Journal of Clinical Sleep Medicine, 2016, 12(6): 785-786. DOI: 10.5664/jcsm.5866.

寶寶走路踮腳、內八字、扁平足要緊嗎:什麼情況要看醫生

  1. WHO Multicentre Growth Reference Study Group. WHO Motor Development Study: windows of achievement for six gross motor development milestones[J]. Acta Paediatrica Supplement, 2006, 450: 86-95. DOI: 10.1111/j.1651-2227.2006.tb02379.x.
  2. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  3. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  4. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25).
  5. Engström P, Tedroff K. The prevalence and course of idiopathic toe-walking in 5-year-old children[J]. Pediatrics, 2012, 130(2): 279-284. DOI: 10.1542/peds.2012-0225.
  6. Staheli L T, Corbett M, Wyss C, 等. Lower-extremity rotational problems in children: normal values to guide management[J]. The Journal of Bone and Joint Surgery (American Volume), 1985, 67(1): 39-47. DOI: 10.2106/00004623-198567010-00006.
  7. Carr J B, Yang S, Lather L A. Pediatric pes planus: a state-of-the-art review[J]. Pediatrics, 2016, 137(3): e20151230. DOI: 10.1542/peds.2015-1230.
  8. Suspected neurological conditions: recognition and referral (NG127): recommendations for children aged under 16[EB/OL]. National Institute for Health and Care Excellence, 2019. (訪問於 2026-09-25).
  9. 北京市衛生和計劃生育委員會. 北京市衛生和計劃生育委員會關於落實《早產兒保健工作規範》的通知[S]. 北京市衛生健康委員會網站, 2018. (訪問於 2026-10-08).

會回答問題,為什麼不主動聊天

  1. 中華醫學會兒科學分會發育行為學組, 中國醫師協會兒科分會兒童保健專業委員會, 等. 孤獨症譜系障礙兒童早期識別篩查和早期干預專家共識[J]. 中華兒科雜誌, 2017, 55(12): 890-897.
  2. 國家衛生和計劃生育委員會辦公廳. 兒童心理保健技術規範(衛辦婦社發〔2013〕26號附件)[EB/OL]. 2013-04-15.
  3. 國家衛生健康委辦公廳. 0~6歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12號)[EB/OL]. 2022-08-23.
  4. 中華醫學會物理醫學與康復學分會言語語言康復學組, 中國康復醫學會言語康復專業委員會, 中華醫學會兒科學分會康復學組. 發展性語言障礙早期識別專家建議(2025)[J]. 中華兒科雜誌, 2025, 63(6): 600-605.

吃糖會影響孩子的大腦發育嗎?

  1. World Health Organization. Guideline: sugars intake for adults and children[EB/OL]. Geneva: WHO, 2015.
  2. 中國營養學會. 中國居民膳食指南(2022)[M]. 北京: 人民衛生出版社, 2022.
  3. Vos M B, et al. Added sugars and cardiovascular disease risk in children: a scientific statement from the American Heart Association[J]. Circulation, 2017, 135(19): e1017-e1034.
  4. Wolraich M L, Wilson D B, White J W. The effect of sugar on behavior or cognition in children: a meta-analysis[J]. JAMA, 1995, 274(20): 1617-1621.
  5. Hsu T M, et al. Effects of sucrose and high fructose corn syrup consumption on spatial memory function and hippocampal neuroinflammation in adolescent rats[J]. Hippocampus, 2015, 25(2): 227-239.

黃疸能靠曬太陽退嗎?

  1. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation[J]. Pediatrics, 2004, 114(1): 297-316.
  2. Kemper A R, et al. Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation[J]. Pediatrics, 2022, 150(3): e2022058859.
  3. 中華醫學會兒科學分會新生兒學組, 《中華兒科雜誌》編輯委員會. 新生兒高膽紅素血症診斷和治療專家共識[J]. 中華兒科雜誌, 2014, 52(10): 745-748.
  4. 中華醫學會兒科學分會新生兒學組, 中華兒科雜誌編輯委員會. 新生兒高膽紅素血症診治指南(2025)[EB/OL]. 2025.

叫名字不理人,要緊嗎?

  1. 國家衛生和計劃生育委員會辦公廳. 兒童心理保健技術規範(衛辦婦社發〔2013〕26號附件)[EB/OL]. 2013-04-15.
  2. 中華醫學會兒科學分會發育行為學組, 等. 孤獨症譜系障礙兒童早期識別篩查和早期干預專家共識[J]. 中華兒科雜誌, 2017, 55(12): 890-897.
  3. Zubler J M, et al. Evidence-informed milestones for developmental surveillance tools[J]. Pediatrics, 2022, 149(3): e2021052138.
  4. 國家衛生和計劃生育委員會辦公廳. 兒童耳及聽力保健技術規範(衛辦婦社發〔2013〕26號附件)[EB/OL]. 2013-04-15.
  5. Nadig A S, et al. A prospective study of response to name in infants at risk for autism[J]. Arch Pediatr Adolesc Med, 2007, 161(4): 378-383.

NICU 出院後:早產兒家庭觀察與隨訪

  1. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9號)[EB/OL]. 2017-02-22.
  2. National Institute for Health and Care Excellence. Developmental follow-up of children and young people born preterm: NG72[EB/OL]. 2017. (訪問於 2026-09-25).
  3. Anderson N, Narvey M; Canadian Paediatric Society, Fetus and Newborn Committee. Discharge planning of the preterm infant[EB/OL]. 2022-03-04. (訪問於 2026-09-25).
  4. American Academy of Pediatrics. How Should I Feed My Premature Baby?[EB/OL]. 2023-01-25. (訪問於 2026-09-25).
  5. Eunice Kennedy Shriver National Institute of Child Health and Human Development. Ways to Reduce Baby's Risk[EB/OL]. Safe to Sleep. (訪問於 2026-09-25).
  6. National Institute for Health and Care Excellence. Postnatal care: NG194, recommendations 1.4.7–1.4.10[EB/OL]. 2021. (訪問於 2026-09-25).
  7. American Academy of Pediatrics. What Kinds of Follow-Up Care Will My Baby Need After NICU Discharge?[EB/OL]. 2023-01-26. (訪問於 2026-09-25).

學得慢,是認知還是注意力?

  1. 中華醫學會兒科學分會康復學組. 兒童康復相關發育性疾病的命名現狀與建議[J]. 中國全科醫學, 2022, 25(8): 899-904.
  2. 國家衛生和計劃生育委員會. 0歲~6歲兒童發育行為評估量表: WS/T 580—2017[S]. 2017.
  3. 中華醫學會兒科學分會發育行為學組. 注意缺陷多動障礙早期識別、規範診斷和治療的兒科專家共識[J]. 中華兒科雜誌, 2020, 58(3): 188-193.
  4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5[M]. 5th ed. Arlington, VA: American Psychiatric Publishing, 2013.

後腦勺睡平了,會影響智力嗎?

  1. Laughlin J, Luerssen T G, Dias M S, et al. Prevention and management of positional skull deformities in infants[J]. Pediatrics, 2011, 128(6): 1236-1241.
  2. Flannery A M, et al. Congress of Neurological Surgeons systematic review and evidence-based guidelines for the management of patients with positional plagiocephaly: executive summary[J]. Neurosurgery, 2016, 79(5): 623-624.
  3. Moon R Y, et al. Sleep-related infant deaths: updated 2022 recommendations for reducing infant deaths in the sleep environment[J]. Pediatrics, 2022, 150(1): e2022057990.

孩子發育遲緩有哪些表現?里程碑觀察與就醫評估

  1. Zubler JM, Wiggins LD, Macias MM, et al. Evidence-Informed Milestones for Developmental Surveillance Tools[J]. Pediatrics, 2022, 149(3): e2021052138. DOI: 10.1542/peds.2021-052138.
  2. Centers for Disease Control and Prevention. Milestones by 6 Months[EB/OL]. 2026. (訪問於 2026-09-25).
  3. Centers for Disease Control and Prevention. Milestones by 9 Months[EB/OL]. 2026. (訪問於 2026-09-25).
  4. Centers for Disease Control and Prevention. Milestones by 1 Year[EB/OL]. 2026. (訪問於 2026-09-25).
  5. Centers for Disease Control and Prevention. Milestones by 18 Months[EB/OL]. 2026. (訪問於 2026-09-25).
  6. Centers for Disease Control and Prevention. Milestones by 2 Years[EB/OL]. 2026. (訪問於 2026-09-25).
  7. National Institute for Health and Care Excellence. Suspected neurological conditions: recognition and referral (NG127): Recommendations for children aged under 16[EB/OL]. (訪問於 2026-09-25).
  8. McLeod S, Kawamura A, Orsino A, Canadian Paediatric Society. Assessing children and youth with global developmental delay and intellectual developmental disorder[EB/OL]. 2026. (訪問於 2026-09-25).
  9. American Academy of Pediatrics. Corrected Age For Preemies[EB/OL]. 2018. (訪問於 2026-09-25).
  10. Lipkin PH, Macias MM. Promoting optimal development: identifying infants and young children with developmental disorders through developmental surveillance and screening[J]. Pediatrics, 2020, 145(1): e20193449.
  11. 國家衛生健康委辦公廳. 嬰幼兒早期發展服務指南(試行)(國衛辦婦幼函〔2024〕467號)[EB/OL]. 2024. (訪問於 2026-09-25).

飛機手、打挺、頭後仰、握拳、踮腳:寶寶這些姿勢是肌張力高嗎

  1. 李曉捷, 唐久來, 馬丙祥, 等. 腦性癱瘓的定義、診斷標準及臨床分型[J]. 中華實用兒科臨床雜誌, 2014, 29(19): 1520. DOI: 10.3760/cma.j.issn.2095-428X.2014.19.024.
  2. Cerebral palsy in under 25s: assessment and management (NG62)[EB/OL]. National Institute for Health and Care Excellence, 2017. (訪問於 2026-09-25).
  3. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  4. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  5. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10).
  6. American Academy of Pediatrics Committee on Fetus and Newborn, American College of Obstetricians and Gynecologists Committee on Obstetric Practice. The Apgar score[J]. Pediatrics, 2015, 136(4): 819-822. DOI: 10.1542/peds.2015-2651.
  7. 北京市衛生和計劃生育委員會. 北京市衛生和計劃生育委員會關於落實《早產兒保健工作規範》的通知[S]. 北京市衛生健康委員會網站, 2018. (訪問於 2026-10-08).

孩子坐不住,是多動症(ADHD)嗎?

  1. Centers for Disease Control and Prevention. Clinical Care of ADHD in Children[EB/OL]. 2026-07-30. (訪問於 2026-09-25).
  2. Wolraich ML, Hagan JF, Allan C, 等. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents[J]. Pediatrics, 2019, 144(4): e20192528.
  3. National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management, NG87[EB/OL]. 2018. (訪問於 2026-09-25).
  4. Centers for Disease Control and Prevention. Diagnosing ADHD[EB/OL]. (訪問於 2026-09-25).
  5. National Institute of Mental Health. Attention-Deficit/Hyperactivity Disorder: What You Need to Know[EB/OL]. (訪問於 2026-09-25).

氨基酸奶粉,能一直喝嗎?

  1. Vandenplas Y, et al. An ESPGHAN Position Paper on the Diagnosis, Management, and Prevention of Cow's Milk Allergy[J]. J Pediatr Gastroenterol Nutr, 2024, 78(2): 386-413. DOI: 10.1097/MPG.0000000000003897.
  2. Meyer R, et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update – VII – Milk elimination and reintroduction in the diagnostic process of cow's milk allergy[J]. World Allergy Organ J, 2023, 16(7): 100785. DOI: 10.1016/j.waojou.2023.100785.
  3. Venter C, et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guidelines update – XVI – Nutritional management of cow's milk allergy[J]. World Allergy Organ J, 2024, 17(8): 100931. DOI: 10.1016/j.waojou.2024.100931.
  4. Canadian Paediatric Society. Cow's milk protein allergy in infants and children[EB/OL]. Canadian Paediatric Society, 2024. (訪問於 2026-09-25).
  5. National Institute for Health and Care Excellence. Food allergy in under 19s: assessment and diagnosis (CG116), recommendations[EB/OL]. NICE. (訪問於 2026-09-25).
  6. Australasian Society of Clinical Immunology and Allergy. Cow's Milk (Dairy) Allergy[EB/OL]. ASCIA, 2024. (訪問於 2026-09-25).

架著腋下練走路,對孩子有幫助嗎?

  1. WHO Multicentre Growth Reference Study Group. WHO Motor Development Study: windows of achievement for six gross motor development milestones[J]. Acta Paediatr Suppl, 2006, 450: 86-95.
  2. 國家衛生和計劃生育委員會辦公廳. 兒童心理保健技術規範(衛辦婦社發〔2013〕26號附件)[EB/OL]. 2013-04-15.
  3. American Academy of Pediatrics Committee on Injury and Poison Prevention. Injuries associated with infant walkers[J]. Pediatrics, 2001, 108(3): 790-792.
  4. Engström P, Tedroff K. The prevalence and course of idiopathic toe-walking in 5-year-old children[J]. Pediatrics, 2012, 130(2): 279-284.
  5. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2015):第一部分[J]. 中國康復醫學雜誌, 2015, 30(7): 747-754.

不會爬卻想站,能跳過爬行嗎?

  1. WHO Multicentre Growth Reference Study Group. WHO Motor Development Study: windows of achievement for six gross motor development milestones[J]. Acta Paediatr Suppl, 2006, 450: 86-95.
  2. 國家衛生和計劃生育委員會辦公廳. 兒童心理保健技術規範(衛辦婦社發〔2013〕26號附件)[EB/OL]. 2013-04-15.
  3. 中國康復醫學會兒童康復專業委員會, 等. 中國腦性癱瘓康復指南(2015):第一部分[J]. 中國康復醫學雜誌, 2015, 30(7): 747-754.
  4. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9號)[EB/OL]. 2017-02-22.

早產兒出院後,為什麼還要查眼底

  1. 中華醫學會眼科學分會眼底病學組. 中國早產兒視網膜病變篩查指南(2014年)[J]. 中華眼科雜誌, 2014, 50(12): 933-935.
  2. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9號)[EB/OL]. 2017-02-22.
  3. Fierson W M, et al. Screening examination of premature infants for retinopathy of prematurity[J]. Pediatrics, 2018, 142(6): e20183061.
  4. American Association for Pediatric Ophthalmology and Strabismus. Retinopathy of prematurity[EB/OL]. 2023.

黃鼻涕不等於細菌感染

  1. Wald E R, et al. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years[J]. Pediatrics, 2013, 132(1): e262-e280.
  2. Chow A W, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults[J]. Clin Infect Dis, 2012, 54(8): e72-e112.
  3. 中國兒童普通感冒規範診治專家共識(2013年)[J]. 中國實用兒科雜誌, 2013, 28(9): 680-686.
  4. Pantell R H, et al. Evaluation and management of well-appearing febrile infants 8 to 60 days old[J]. Pediatrics, 2021, 148(2): e2021052228.
  5. 中國0至5歲兒童病因不明急性發熱診斷和處理若干問題循證指南(標準版)[J]. 中國循證兒科雜誌, 2016, 11(2): 81-96.

走路姿勢不好看,就是肌張力問題嗎?

  1. 李曉捷, 唐久來, 馬丙祥, 等. 腦性癱瘓的定義、診斷標準及臨床分型[J]. 中華實用兒科臨床雜誌, 2014, 29(19): 1520. DOI: 10.3760/cma.j.issn.2095-428X.2014.19.024.
  2. 中國康復醫學會兒童康復專業委員會, 中國殘疾人康復協會小兒腦性癱瘓康復專業委員會, 《中國腦性癱瘓康復指南》編委會. 中國腦性癱瘓康復指南(2015):第一部分[J]. 中國康復醫學雜誌, 2015, 30(7): 747-754. DOI: 10.3969/j.issn.1001-1242.2015.07.028.
  3. 吳衛紅, 鮑秀蘭, 席冰玉, 等. 0~1 歲 52 項神經運動檢查和簡化 20 項相關性研究[J]. 中國兒童保健雜誌, 2014, 22(3): 310-311.
  4. 鮑秀蘭 主編. 0~1 歲神經運動 20 項檢查(52 項簡化法)[M]. 寶秀蘭兒童早期發展優化中心, 2019.
  5. Amiel-Tison C. Clinical assessment of the infant nervous system. In: Levene MI, Chervenak FA, Whittle M, eds. Fetal and neonatal neurology and neurosurgery. 3rd ed[M]. Churchill Livingstone, 2001. ISBN 9780443064395.
  6. 國家衛生計生委辦公廳. 兒童心理保健技術規範(含兒童心理行為發育問題預警徵象篩查表)[S]. 國家衛生計生委, 2013. (訪問於 2026-09-07).
  7. WHO Multicentre Growth Reference Study Group. WHO Motor Development Study: windows of achievement for six gross motor development milestones[J]. Acta Paediatrica Supplement, 2006, 450: 86-95. DOI: 10.1111/j.1651-2227.2006.tb02379.x.
  8. Novak I, Morgan C, Adde L, 等. Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment[J]. JAMA Pediatrics, 2017, 171(9): 897-907. DOI: 10.1001/jamapediatrics.2017.1689.
  9. Engström P, Tedroff K. The prevalence and course of idiopathic toe-walking in 5-year-old children[J]. Pediatrics, 2012, 130(2): 279-284. DOI: 10.1542/peds.2012-0225.

孤獨症孩子為什麼容易挑食

  1. Sharp W G, et al. Feeding problems and nutrient intake in children with autism spectrum disorders: a meta-analysis and comprehensive review of the literature[J]. J Autism Dev Disord, 2013, 43(9): 2159-2173. DOI: 10.1007/s10803-013-1771-5.
  2. Buie T, et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report[J]. Pediatrics, 2010, 125(Suppl 1): S1-S18. DOI: 10.1542/peds.2009-1878C.
  3. Goday P S, et al. Pediatric Feeding Disorder: Consensus Definition and Conceptual Framework[J]. J Pediatr Gastroenterol Nutr, 2019, 68(1): 124-129. DOI: 10.1097/MPG.0000000000002188.
  4. American Speech-Language-Hearing Association. Pediatric feeding and swallowing[EB/OL]. ASHA Practice Portal. (訪問於 2026-09-25).
  5. National Institute for Health and Care Excellence. Autism spectrum disorder in under 19s: support and management (CG170), recommendations[EB/OL]. NICE. (訪問於 2026-09-25).
  6. American Speech-Language-Hearing Association. Feeding and Swallowing Milestones: Age Ranges[EB/OL]. ASHA. (訪問於 2026-09-25).
  7. Hyman S L, et al. Identification, Evaluation, and Management of Children With Autism Spectrum Disorder[J]. Pediatrics, 2020, 145(1): e20193447. DOI: 10.1542/peds.2019-3447.

孤獨症女孩為什麼容易被漏診

  1. Loomes R, Hull L, Mandy W P L. What is the male-to-female ratio in autism spectrum disorder? A systematic review and meta-analysis[J]. J Am Acad Child Adolesc Psychiatry, 2017, 56(6): 466-474.
  2. Hull L, Petrides K V, Mandy W. The female autism phenotype and camouflaging: a narrative review[J]. Review Journal of Autism and Developmental Disorders, 2020, 7(4): 306-317.
  3. Zhou H, et al. Prevalence of autism spectrum disorder in China: a nationwide multi-center population-based study among children aged 6 to 12 years[J]. Neurosci Bull, 2020, 36(9): 961-971.
  4. 中華醫學會兒科學分會發育行為學組, 中國醫師協會兒科分會兒童保健專業委員會, 等. 孤獨症譜系障礙兒童早期識別篩查和早期干預專家共識[J]. 中華兒科雜誌, 2017, 55(12): 890-897.

一歲半、兩歲不會說話正常嗎:語言發育遲緩的表現與評估

  1. 國家衛生健康委辦公廳. 0~6 歲兒童孤獨症篩查干預服務規範(試行)(國衛辦婦幼發〔2022〕12 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  2. 國家衛生計生委. 0 歲~6 歲兒童發育行為評估量表 WS/T 580—2017[S]. 中華人民共和國衛生行業標準, 2017. (訪問於 2026-09-07).
  3. Centers for Disease Control and Prevention. CDC’s Developmental Milestones(Learn the Signs. Act Early.)[EB/OL]. U.S. Centers for Disease Control and Prevention, 2022. (訪問於 2026-09-10).
  4. American Speech-Language-Hearing Association. Late Language Emergence[EB/OL]. ASHA Practice Portal. (訪問於 2026-09-30).
  5. 國家衛生健康委辦公廳. 3 歲以下嬰幼兒健康養育照護指南(試行)(國衛辦婦幼函〔2022〕409 號)[S]. 中國政府網, 2022. (訪問於 2026-09-07).
  6. 中華醫學會物理醫學與康復學分會言語語言康復學組, 中國康復醫學會言語康復專業委員會, 中華醫學會兒科學分會康復學組. 發展性語言障礙早期識別專家建議(2025)[J]. 中華兒科雜誌, 2025, 63(6): 600-605. DOI: 10.3760/cma.j.cn112140-20250115-00038.
  7. 中華醫學會兒科學分會神經學組, 中國醫師協會神經內科分會兒童神經疾病專業委員會. 兒童智力障礙或全面發育遲緩病因診斷策略專家共識[J]. 中華兒科雜誌, 2018, 56(11): 806-810. DOI: 10.3760/cma.j.issn.0578-1310.2018.11.003.
  8. Suspected neurological conditions: recognition and referral (NG127): recommendations for children aged under 16[EB/OL]. National Institute for Health and Care Excellence, 2019. (訪問於 2026-09-25).

早產兒轉奶怎麼轉?什麼時候換普通配方

  1. 《中華兒科雜誌》編輯委員會, 中華醫學會兒科學分會兒童保健學組, 中華醫學會兒科學分會新生兒學組. 早產、低出生體重兒出院後餵養建議[J]. 中華兒科雜誌, 2016, 54(1): 6-12.
  2. 中華人民共和國衛生部. 食品安全國家標準 特殊醫學用途嬰兒配方食品通則: GB 25596—2010[S]. 2010.
  3. 國家衛生計生委辦公廳. 早產兒保健工作規範(國衛辦婦幼發〔2017〕9號)[EB/OL]. 2017-02-22.
  4. Embleton N D, et al. Enteral nutrition in preterm infants (2022): a position paper from the ESPGHAN Committee on Nutrition and invited experts[J]. J Pediatr Gastroenterol Nutr, 2023, 76(2): 248-268.
常見問題

關於出處與文獻

這些出處是怎麼選的?

優先國家衛生行業標準與國家衛生健康委的規範文件,其次中華醫學會、中華預防醫學會等學會的指南與專家共識,再次世界衛生組織、美國兒科學會的文件與同行評議期刊的系統評價和隨機對照試驗。每條都在引用它的頁面上有腳註編號。

怎麼核對一條出處?

點條目的鏈接可到期刊、標準或政府網站的原文;期刊文章給出 DOI 或 PubMed 編號,標準給出發佈機構的 PDF。

發現引用有誤怎麼反饋?

發郵件到 marketing@baoxiulan.com,寫明頁面地址與條目編號。核實後會更正頁面並更新日期。

瞭解詳情